Date post: | 29-Apr-2023 |
Category: |
Documents |
Upload: | khangminh22 |
View: | 0 times |
Download: | 0 times |
Selective Transformations of Sulfondiimines
Von der Fakultät für Mathematik, Informatik und Naturwissenschaften der
RWTH Aachen University zur Erlangung des akademischen Grades einer Doktorin
der Naturwissenschaften genehmigte Dissertation
vorgelegt von
Master of Science
Rebekka Anna Bohmann
aus Düsseldorf, Deutschland
Berichter:
Univ.-Prof. Dr. rer. nat. Carsten Bolm
Univ.-Prof. Dr. rer. nat. Dieter Enders
Tag der mündlichen Prüfung: 01.03.2017
Diese Dissertation ist auf den Internetseiten der Universitätsbibliothek online verfügbar.
The work presented in this thesis was carried out from October 2012 to December 2016 at the
Institute of Organic Chemistry of RWTH Aachen University under the supervision of Professor
Dr. Carsten Bolm. Part of the work presented in chapter 4.2 and 7 was conducted from March
to May 2015 at the Department of Applied Chemistry of the Graduate School of Engineering of
Osaka University under the supervision of Professor Dr. Masahiro Miura.
I would like to express my deepest gratitude to Prof. Dr. Carsten Bolm for the opportunity to
choose and work on challenging and exciting projects under excellent working conditions, and
for his continuous support during my doctoral studies in Aachen. In addition, I thank Prof. Dr.
Masahiro Miura for giving me the opportunity to work in his group on highly interesting topics.
Furthermore, I would like to thank Prof. Dr. Dieter Enders for delivering a second expert opin-
ion. I am grateful to the Deuts he Fors hu gsge ei s haft (international research training
group 1628: Selectivity in Chemo- and Biocatalysis ) for financial support during this doctoral
thesis.
Parts of this work have already been published:
R. A. Bohmann, C. Bolm, Org. Lett. 2013, 15, 4277–4279.
C. M. M. Hendriks, R. A. Bohmann, M. Bohlem, C. Bolm, Adv. Synth. Catal. 2014, 356, 1847–1852.
R. A. Bohmann, Y. Unoh, M. Miura, C. Bolm, Chem. Eur. J. 2016, 22, 6783–6786.
R. A. Bohmann, J.-H. Schöbel, C. Bolm, Synlett 2016, 27, 2201–2204.
T a b l e o f C o n t e n t s | I
Table of Contents
I. INTRODUCTION .......................................................................................................... 1
1 Sulfur (VI) Derivatives ..................................................................................................... 1
1.1 Sulfondiimine derivatives ............................................................................................................ 2
1.1.1 Syntheses ................................................................................................................................ 5
1.1.2 N-Functionalization reactions ............................................................................................... 10
1.1.3 Applications ........................................................................................................................... 16
1.1.3.1 Biologically active derivatives .................................................................................................... 16
1.1.3.2 In synthetic organic chemistry................................................................................................... 19
1.1.3.3 In heterocyclic chemistry ........................................................................................................... 20
II. PROBLEM DEFINITION AND OBJECTIVES ..................................................... 27
III. RESULTS AND DISCUSSION ............................................................................... 29
2 N-Functionalizations ..................................................................................................... 29
2.1 N-Arylations and N-alkenylation of N-monosubstituted sulfondiimines (Project P1) .............. 29
2.1.1 Background and aim of the project ....................................................................................... 29
2.1.2 Optimization .......................................................................................................................... 29
2.1.3 Substrate scope ..................................................................................................................... 31
2.1.4 Upscaling attempts ............................................................................................................... 34
2.1.5 Summary and outlook ........................................................................................................... 35
2.2 N-Alkylations of N-monosubstituted sulfondiimines (Project P2) ............................................ 35
2.2.1 Background and aim of the project ....................................................................................... 35
2.2.2 Optimization .......................................................................................................................... 36
2.2.3 Substrate scope ..................................................................................................................... 37
2.2.4 Application ............................................................................................................................ 40
2.2.5 Summary and outlook ........................................................................................................... 40
3 -Functionalizations ..................................................................................................... 41
3.1 -Functionalizations of N-mono- and N,N'-disubstituted sulfondiimines (Project P3) ............ 41
3.1.1 Background and aim of the project ....................................................................................... 41
3.1.2 Optimization .......................................................................................................................... 42
3.1.3 Substrate scope ..................................................................................................................... 42
3.1.3.1 N,N'-Disubstituted examples ..................................................................................................... 42
3.1.3.2 N-Monosubstituted examples ................................................................................................... 44
II | T a b l e o f C o n t e n t s
3.1.4 Summary and outlook ........................................................................................................... 45
4 Cyclizations towards 1,2-(Benzo)thiazines ..................................................................... 47
4.1 Syntheses of 1,2-thiazine oxides and imines (Project P4) ......................................................... 48
4.1.1 Background and aim of the project ....................................................................................... 48
4.1.2 Optimization .......................................................................................................................... 49
4.1.3 Selectivity .............................................................................................................................. 50
4.1.4 Substrate scope ..................................................................................................................... 50
4.1.4.1 Reactions of sulfoximines .......................................................................................................... 51
4.1.4.2 Reactions of sulfondiimines....................................................................................................... 52
4.1.5 Applications ........................................................................................................................... 53
4.1.5.1 Deprotection ............................................................................................................................. 53
4.1.5.2 Palladium–catalyzed amination and arylation .......................................................................... 54
4.1.5.3 Regiosele ti e dire t C‒H o d fu tio alizatio s ................................................................... 54
4.1.6 Summary and outlook ........................................................................................................... 56
4.2 Syntheses of 1,2-benzothiazine 1-imines (Project P5) .............................................................. 56
4.2.1 Background and aim of the project ....................................................................................... 56
4.2.2 Results and discussion.. ......................................................................................................... 58
4.2.2.1 Alkynes ...................................................................................................................................... 58
4.2.2.2 Diazo compounds ...................................................................................................................... 59
4.2.2.3 ɑ-Substituted ketones ............................................................................................................... 61
4.2.3 Summary and outlook ........................................................................................................... 63
IV. CONCLUSIONS AND OUTLOOK ......................................................................... 65
V. EXPERIMENTAL SECTION ................................................................................... 67
5 General Information ..................................................................................................... 67
5.1 Air-sensitive techniques ............................................................................................................ 67
5.2 Solvents ..................................................................................................................................... 67
5.3 Chemicals and reagents ............................................................................................................. 67
5.4 Instrumentation ......................................................................................................................... 68
5.5 Chromatography ........................................................................................................................ 69
5.6 General Procedures ................................................................................................................... 69
5.6.1 Copper–catalyzed N-arylations/N-alkenylation of NH-sulfondiimines (GP1) ....................... 69
5.6.2 N-Alkylations of NH-sulfondiimines with KOH in DMSO (GP2) ............................................. 69
5.6.3 Reactions of lithium sulfondiimidoyl carbanions (GP3) ........................................................ 70
5.6.4 Syntheses of 1,2-thiazines from NH-sulfoximines/NH-sulfondiimines (GP4) ....................... 70
5.6.5 Syntheses of 1,2-benzothiazines from NH-sulfondiimines (GP5 and GP6) ........................... 70
T a b l e o f C o n t e n t s | III
6 Synthetic Procedures and Analytical Data ..................................................................... 73
6.1 Syntheses of N-arylated sulfondiimines .................................................................................... 73
6.2 Synthesis of an N-alkenylated sulfondiimine ............................................................................ 80
6.3 Syntheses of N-alkylated sulfondiimines ................................................................................... 80
6.4 “ theses of β-hydroxy sulfondiimines ..................................................................................... 91
6.5 Alkylation of a lithium sulfondiimidoyl carbanion ..................................................................... 98
6.6 Syntheses of 1,2-thiazine 1-oxides ............................................................................................ 98
6.7 Syntheses of 1,2-thiazine 1-imines .......................................................................................... 105
6.8 Synthesis of an N-unsubstituted 1,2-thiazine 1-imine ............................................................ 112
6.9 Derivatizations of 1,2-thiazine 1-oxides .................................................................................. 113
6.10 Synthesis of a 2,1-benzothiazine ............................................................................................. 116
6.11 Syntheses of 1,2-benzothiazines ............................................................................................. 117
VI. APPENDIX ............................................................................................................. 121
7 Crystal Structural Data ................................................................................................ 121
7.1 N-H-N',S-diphenyl-S-methyl sulfondiimine (17) ...................................................................... 121
7.2 1-Methyl-3-phenylbenzo[e][1,2]thiazine 1-(N-phenylimine) (133g) ....................................... 131
8 Abbreviation List ........................................................................................................ 143
9 Acknowledgement...................................................................................................... 147
10 References ................................................................................................................. 149
I n t r o d u c t i o n | 1
I. INTRODUCTION
Sulfur (also spelled as sulphur) represents one of the few solid elements existing in nature in its
elemental state, and it is the 16th most abundant element in the earth crust. Often occurring as
brilliant yellow powder, it can be found in pure form in regions with high volcanic activity (Fig-
ure I). From ancient times, sulfur was well-known; medieval alchemists referred to sulfur as any
flammable substance. Already the Roman historian Pliny described the mining of sulfur in Italy
and Sicily, regions with high volcanic activity and its applications in medicine, bleach, matches,
and lamp wicks.[1]
Figure I: Sulfur deposits around steaming sulfur dome on volcanic solfatara vent. Mount Io (Io-zan, 硫黄
山, lit. "Sulfur Mountain"), Kussharo caldera, Akan National Park, Hokkaido, Japan. Copyright 2015,
Rebekka Anna Bohmann.
Sulfur has a highly variable, diverse chemistry of high importa e i toda ’s world. Sulfur com-
pounds are utilized in numerous chemical manufacturing processes, such as the production of
agricultural fertilizers, iron, steel, and paint pigments. Approximately 90% of all sulfur is applied
to the manufacture of sulfuric acid (H2SO4), which is the most abundant industrial chemical in
the world.[2] Various sulfur derivatives exist differing in the oxidation state at the sulfur atom (II,
IV, or VI). Among them are the tetracoordinated sulfur(VI) derivatives.
1 Sulfur (VI) Derivatives
From formal exchanges of the oxygen atoms of sulfones by nitrogens result the aza-analogous
sulfoximines and sulfondiimines, wherein the hexavalent sulfur atom forms two formal double
bonds with oxygen or nitrogen atoms and a single bond to each of the two carbon atoms (Fig-
ure 1-1).[3]
2 | I n t r o d u c t i o n
Figure 1-1: The diaza analogs of sulfones are the objectives of this thesis.
The sulfones represent an intensively investigated compound class (3124370 substance entries
in Scifinder®),[4] well-known for their applications in organic chemistry[3, 5] or as biologically ac-
tive compounds incorporated in drugs and agrochemicals.[6] Despite the potential stereogenic
center and increased structural variability of sulfoximines and sulfondiimines (Figure 1-1), to
date, both compound classes have been less frequently explored compared to sulfones. In di-
rect comparison, sulfoximines are more established than sulfondiimines (substance entries in
Scifinder®: 68069 versus 1343);[4] they have been applied in synthetic organic chemistry as chi-
ral auxiliaries and ligands,[7] in medicine, and in crop protection.[8] Exchanging the oxygen atom
of sulfoximines with a nitrogen atom leads to the structurally related sulfondiimines.[9]
1.1 Sulfondiimine derivatives
Despite the numerous valuable properties sulfondiimines exhibit, they have received only mar-
ginal interest from the scientific community to date, and their syntheses and applications ap-
pear significantly restricted. This chapter represents an introduction into sulfondiimine deriva-
tives with reviews about their syntheses, N-functionalization reactions, and applications.
Classification and nomenclature
In this thesis, several sulfondiimine subclasses will be differentiated, which vary in the substitu-
tion of the nitrogen atoms—N-unsubstituted (NH,N'H-), N-monosubstituted (NH-), and N,N'-
disubstituted sulfondiimines—or the sulfur—S,S-dialkyl, S-alkyl-S-aryl, and S,S-diaryl sul-
fondiimines (Figure 1-2).
Figure 1-2: Nomenclature of sulfondiimine subclasses.
I n t r o d u c t i o n | 3
Properties and reactivity
Sulfondiimines show versatile reactivities comparable to that of sulfoximines, including nucleo-
philic and basic nitrogen atoms and acidic hydrogen atoms at the nitrogen and in -position to
the sulfur atom. In contrast to the well-known structurally related sulfones, sulfoximines and
sulfondiimines possess a potentially stereogenic center at the sulfur atom (Figure 1-3).
Figure 1-3: Properties and reactivity of the sulfondiimine functional group.
Protonations of S,S-dialkyl NH,N'H-sulfondiimines 1 result in the formation of sulfonium salts 2
and their subsequent decompositions by C‒“ o d lea age in highly acidic and polar media
(Scheme 1-1). The pKa values of sulfonium salts 2 have been calculated from potentiometric
titrations and range from 5.26 to 5.93, indicating the weak basicity of the nitrogen atoms of
sulfondiimines 1.[10]
Scheme 1-1: Decomposition of S,S-dialkyl sulfondiimines 1 in acidic and polar media.[10]
Under certain conditions, sulfondiimines readily undergo deiminations (Scheme 1-2). For ex-
ample with elemental sulfur in liquid ammonia, N-unsubstituted and NH-N'-tosylated sul-
fondiimines 8 and 9 were reduced to the corresponding sulfides 10 and the N-tosylated sul-
filimines 11, respectively, at 100 °C after 2 h (path a).[11] Interestingly, different aromatic disul-
fides 12 were obtained by the degradation of S-(4-nitrophenyl) sulfondiimines 8 and 9 at 60 °C
after two to three hours (path b).[12]
4 | I n t r o d u c t i o n
Scheme 1-2: Deiminations of sulfondiimines occurred with elemental sulfur in liquid ammonia.[11-12]
The reduction of different S,S-diaryl or S-aryl-S-alkyl sulfondiimines 13 with tert-butyl nitrite in
chloroform or dichloromethane afforded N-tosylated sulfilimines 14 in almost quantitative
yields (Scheme 1-3).[13]
Scheme 1-3: Reduction of sulfondiimines 13 with tert-butyl nitrite in chloroform.[13]
Structure
The sulfone-analogous structure of sulfondiimines has firstly been proved for N-unsubstituted
S,S-dimethyl sulfondiimine 15 by X-ray crystallography (Figure 1-4)[14] and electron diffraction in
the gas phase.[10, 15]
Figure 1-4: Crystal structure of NH,N'H-S,S-dimethyl sulfondiimine (15).[14]
Both studies revealed a tetrahedral configuration around the sulfur atom (C2v, local symmetry),
hereas a ide ed N‒“‒N o d a gle r stal: ± °; gas: . ± . ° i di ates i tera tio of the nitrogen lone electron pairs. The “‒N dista es represent typical values for double bonds
(crystal: 1.53 ± 0.04 Å, gas: 1.533 ± 0.002 Å).[10, 15] In addition, NH,N'H-sulfondiimine 1 as a polar
functional group has been reported to undergo intermolecular hydrogen bonding in the crystal-
line state and in solution.[10]
I n t r o d u c t i o n | 5
The “‒N o d le gths o ser ed for N-H-N',S,S-triphenyl sulfondiimine [16; S‒N (N-Ph): 1.546 ±
0.001 Å, S‒N (N-H): 1.526 ± 0.002 Å] by YOSHIMURA and coworkers[16] and N-H-N',S-diphenyl-S-
methyl sulfondiimine (17; “‒N : . 88 ± 0.0017 Å, Figure 1-5), subjected to X-ray analysis as
the standard substrate of this thesis (chapter 7.1), are comparable to those observed for 15
(Figure 1-4).[16] In both cases, the “‒N dista e to the phenyl-substituted nitrogen appears
longer than that to the unsubstituted nitrogen, indicating lo er “‒N o d stre gth.
Figure 1-5: The molecular structure of N-H-N',S-diphenyl-S-methyl sulfondiimine (17).
Although the ature of the “‒N bonds in these structures is still under discussion, ranging from
semipolar single bonds to essentially covalent double bonds,[3] the doubly bonded description
will be used in this thesis.
1.1.1 Syntheses
This chapter will summarize the synthetic access to NH,N'H-sulfondiimines 18 and
N-monosubstituted sulfondiimines 19. The success of the particular imination methods strongly
depends on the substitution patterns at the sulfur atoms of the resulting S,S-dialkyl, S-alkyl-S-
aryl, and S,S-diaryl sulfondiimines (Scheme 1-4).
Scheme 1-4: Overview on the synthesis of sulfondiimine derivatives.
Sulfondiimines can be synthesized from different starting materials: sulfides 20, sulfilimines 21
and their derivatives 22|23, and S-fluorothiazynes 24. The particular imination strategies in-
volve different iminating agents.
6 | I n t r o d u c t i o n
Bisimination of sulfides
The first synthetic approach towards sulfondiimines was reported by COGLIANO and BRAUDE in
1964. Accidentally, they obtained S,S-dialkyl sulfondiimines 1 by the chloroamination of com-
mercially available dialkyl sulfides 25 (Scheme 1-5) in 2-propanol, and reported sulfiliminium
salts as the key intermediates of this transformation.[17] Subsequently, the selectivity of the
oxidative bisimination towards sulfondiimines 1 was enhanced by APPEL and coworkers in
1966[18] and LAUGHLIN and YELLIN in 1967.[19] Both groups succeeded in precluding the for-
mation of sulfones and sulfoximines as the major byproducts from moisture and hydroxylic sol-
vents by performing the reactions in dry acetonitrile. From some synthetic procedures, the hy-
drochlorides of the desired sulfondiimines resulted as well. The treatment with aqueous sodi-
um carbonate solutions for deprotonation and extraction with DCM delivered the desired sul-
fondiimines.
Scheme 1-5: Synthesis of NH,N'H-S,S-dialkyl sulfondiimines 1 by the chloroamination of sulfides 25.[17-19]
Disadvantageously, these protocols involved the generation of chloramine from gaseous chlo-
rine and ammonia, whereas the sulfondiimines were usually obtained in unpredictable and low
yields. As improvement, HAAKE and coworkers in 1970 reported the in situ generation of chlo-
ramine (NH2Cl) in dry acetonitrile from tert-butyl hypochlorite and liquid ammonia (Scheme
1-6). While this procedure proved readily applicable to the synthesis of several S,S-dialkyl sul-
fondiimines (12–85% yield),[20] the yields of S-alkyl-S-aryl sulfondiimines were low (14–26%),
and S,S-diaryl derivatives remained inaccessible.[10]
Scheme 1-6: The in situ generation of chloramine for the synthesis of sulfondiimines 18 was developed
by HAAKE and coworkers. [10, 20]
This result coincides with the work of FURUKAWA, OAE and coworkers, who failed to synthesize
S,S-diphenyl sulfondiimine from diphenyl sulfide and a combination of tert-butyl hypochlorite
and ammonia in dichloromethane. In lieu thereof they could identify S,S-diphenylsulfilimino-
S,S-diphenylsulfonium chloride (26) as the unexpected product (Scheme 1-7).[21]
Scheme 1-7: Attempted synthesis of S,S-diphenyl sulfondiimine by FURUKAWA and coworkers.[21]
I n t r o d u c t i o n | 7
Imination of S-fluorothiazynes
As an alternative to the sulfides as substrates, YOSHIMURA and coworkers in 1992 firstly re-
ported the preparation of S,S-diarylated S-fluorothiazynes such as 27 (Scheme 1-8) by the reac-
tion of N-bromo-S,S-diphenylsulfilimines with tetrabutylammonium fluoride (TBAF) at 0 °C in
dry tetrahydrofurane. From reactions of S,S-diphenylated S-fluorothiazyne 27 with excess
amounts of primary aryl- and alkylamines 28 (Scheme 1-8) the corresponding S,S-diaryl NH-
sulfondiimines 29 were accessed in mainly good yields (37–79%). With ammonia as the reagent,
the structurally related sulfoximine represented the major product (66% yield), whereas the
desired N-unsubstituted sulfondiimine 29a was obtained only in a low yield (23%).[22]
Scheme 1-8: S-Fluorothiazyne 27 served as alternative substrate for the synthesis of S,S-diphenyl sul-
fondiimines 29.[16, 22]
As advancement, in 2008 the same group further improved the structural variety and yields of
the products 29 (74–98%) by the use of acid catalysts or base under solvent-free conditions.
Nevertheless, the scope of sulfondiimines obtained from YOSHIMURA’s method remained re-
stricted to S,S-diphenylated products 29 (Scheme 1-8).[16]
Imination of sulfilimines
Sulfilimines and their derivatives, which are accessible from the imination of sulfides with a
range of iminating agents,[23] have been employed as alternative starting materials in the syn-
thesis of sulfondiimines.
In 1971, APPEL and KOHNKE employed S,S-dimethylsulfilimine 30 in a transformation with in
situ generated N-bromo alkylamines (Scheme 1-9) affording hygroscopic N-methyl (55%) and N-
ethyl sulfondiimines (45%) as hydrates in moderate yields.[24]
Scheme 1-9: Syntheses of N-alkylated S,S-dimethyl sulfondiimines 31 from sulfilimine 30.[24]
In addition, OAE and coworkers intensively investigated the oxidative imination of diaryl-
sulfilimines. Inspired by the chemistry of sulfoximines, initial attempts included electrophilic
oxidative iminations of S,S-diphenyl sulfilimine 32 (Scheme 1-10) with hydrazoic acid (path a) or
O-mesitylenesulfonylhydroxylamine (MSH; path b) and nucleophilic oxidative imination with a
combination of MSH and sodium carbonate (path c). However, at no time the desired sul-
fondiimine 29a was observed.[21]
8 | I n t r o d u c t i o n
Scheme 1-10: Initial attempts of OAE and coworkers for the synthesis of S,S-diphenyl sulfondiimine 29a
failed.[21]
In contrast, with sodium N-chloro 4-methylbenzenesulfonamide (chloramine-T) and excess so-
dium tosylamide the oxidative imination of sulfilimines 21 towards N-tosyl-protected sul-
fondiimines 33 proved successful (Scheme 1-11). As initial attempts were performed in metha-
nol, an S,S-diphenyl (54%) and an S,S-cyclohexyl sulfondiimine (33%) were obtained in nonsatis-
fying yields due to the formation of nonseparable sulfoximines byproducts.[25] Similar to the
chloroaminations of sulfides (Scheme 1-5),[18-19] the byproduct formation in the oxidative imina-
tion of sulfilimines was anticipated under strictly anhydrous reaction conditions in
acetonitrile.[26]
Scheme 1-11: Synthesis and deprotection of N-tosyl sulfondiimines 33.[25-26]
While this protocol proved readily applicable to the preparation of S,S-diarylated products in
good yields (31–90% yield), the yields of two S-aryl-S-alkyl sulfondiimines were lower (44–45%),
and no S,S-dialkyl sulfondiimine was reported. Advantageously, cleavage of the tosyl group
readily proceeded under acidic conditions, giving NH,N'H-sulfondiimines 8 in almost quantita-
tive yields (Scheme 1-11).[26]
During these studies, S,S-diphenyl-N-chlorosulfilimine (34) was detected by HPLC, and isolated.
As it readily reacted with nitrogen nucleophiles in dry acetonitrile, affording N-tosyl as well as
NH,N'H- and N-alkyl sulfondiimines 29 (Scheme 1-12), it was suggested as key intermediate of
the oxidative imination process.[21]
Scheme 1-12: Reactivity of N-chlorosulfilimine (34) with different nitrogen nucleophiles towards sul-
fondiimine derivatives 29.[21]
I n t r o d u c t i o n | 9
Under related conditions (Scheme 1-11; R1 = Me, R2 = para-tolyl), CHRISTENSEN and KJÆR re-
ported about the treatment of (R)-S-methyl-S-(para-tolyl)-sulfilimine [(R)-35] with chloramine-T
in liquid ammonia, affording the laevorotatory enantiomer of optically active N-tosyl-S-methyl-
S-(para-tolyl)-sulfondiimine [ ‒ -36]. As the resolution of racemic 36 failed, ‒ -36 was convert-
ed with nitrous acid (HNO2), a process known to proceed with retention of the configuration for
structurally related sulfoximines. As the reaction afforded sulfilimine (S)-35, (S)-configuration of
‒ -36 was proposed.[27] Comparable to OAE and coworkers,[26] YAGUPOL'SKII and coworkers
performed the oxidative imination of S,S-diphenylsulfilimine (32) in dry acetonitrile with sodium
N-chlorotriflamide as the iminating agent, affording sulfondiimine 37 in 85% yield (Scheme
1-13).[28]
Scheme 1-13: Synthesis of N-triflyl-protected sulfondiimine 37 by YAGUPOL'SKII and coworkers.[28]
Imination of sulfiliminium salts
A limiting factor for the scope of sulfondiimines accessible from free sulfilimines 21 and particu-
larly from their N-halo derivatives 22 (Scheme 1-4) is the lability of these substrates; notably,
violent decompositions of both have been reported in the literature.[17-18, 21]
As advancement, HAAKE and GEORG in 1983 reported the possibility of replacing free sul-
filimines 21 by their readily accessible and more stable salts 23 (Scheme 1-14). In the one-step
synthesis of NH,N'H-sulfondiimines with tert-butyl hypochlorite and liquid ammonia in acetoni-
trile, these salts gave comparable yields to the free sulfilimines as substrates. This protocol
proved suitable for the synthesis of S,S-diaryl sulfondiimines (36–57% yield) and two S-aryl-S-
alkyl sulfondiimines (21–60% yield). Noteworthy, the synthesis of S-methyl-S-(para-nitrophenyl)
sulfondiimine and of S,S-diaryl derivatives with electron-withdrawing substituents failed for this
procedure, and no S,S-dialkyl derivative was reported.[29]
Scheme 1-14: One-step synthesis of NH,N'H-sulfondiimines 18 from sulfiliminium salts 23.[29]
In summary, the most efficient synthetic approaches to sulfondiimines existed for
S,S-dialkylated and S,S-diarylated derivatives, whereas the access to S-aryl-S-alkyl sul-
fondiimines remained most challenging. To overcome this limitation, in 2012 BOLM and
coworkers developed a general one-pot oxidative imination protocol for sulfiliminium salts 23
(Scheme 1-15).[30]
10 | I n t r o d u c t i o n
In this process, in situ generated free sulfilimines underwent chlorination–imination sequences
facilitated by N-chlorosuccinimide (NCS) and primary amines. In related computational studies,
an S-chloro-S,S-dialkylnitridosulfane was proposed as the reactive intermediate of this reaction
process.[31] As the method proved generally applicable to different amines 28 and sulfiliminium
salts 23, it provided access to various N-monosubstituted sulfondiimines 19 in moderate to
good yields (27–80%).
Scheme 1-15: A general protocol for the synthesis of NH-sulfondiimines 19 from sulfiliminium salts 23
was developed by BOLM and coworkers.[30]
The significant functional–group tolerance included electron–donating as well as electron–withdrawing substituents. For instance, amines 28 with free hydroxyl or alkynyl moieties could
be applied. While various substituents on the aryl group of a range of synthetically challenging
S-alkyl-S-aryl derivatives were well-tolerated, electron-rich substrates gave the best results. It is
noteworthy that also representative NH,N'H-, S,S-dialkyl, and S,S-diaryl sulfondiimines 19 have
been prepared. In contrast to previous work,[27] a resolution of (rac)-N-phenyl-S-methyl-S-
phenyl sulfondiimine 17 by chiral supercritical-fluid chromatography (SFC) readily afforded
enantiomerically pure sulfondiimines (S)-17 and (R)-17, whose absolute configurations were
determined by the comparison of calculated and measured ECD spectra (Scheme 1-16).[30]
Scheme 1-16: Enantiomerically pure sulfondiimines with the stereogenic center at the sulfur atom.[30]
The N-unsubstituted and N-monosubstituted sulfondiimine derivatives accessible from differ-
ent precursors as illustrated in this chapter represent polyfunctional groups allowing a variety
of transformations. To date, mainly N-functionalization reactions have been investigated.
1.1.2 N-Functionalization reactions
Due to their weakly basic and nucleophilic functionalities, N-unsubstituted and
N-monosubstituted sulfondiimines undergo substitution reactions on the nitrogen atoms with
various electrophiles. Strongly depending on the particular conditions, N-functionalizations to-
wards N-monosubstituted (19) or N,N'-disubstituted (38) sulfondiimines as discussed in this
chapter (Scheme 1-17)[32] or cyclizations (chapter 1.1.3.3) can occur. In particular, NH,N'H-S,S-
dialkyl sulfondiimines 1 were employed as a model substrate for N-functionalization
reactions.[10]
I n t r o d u c t i o n | 11
Scheme 1-17: Overview on the N-functionalization reactions of sulfondiimines.
N-Halogenations
In the context of N-halogenation reactions (Scheme 1-18), the treatment of S,S-dimethyl sub-
strate 15 with halogens X2 afforded N-mono- (39, X = Br)[18] and N,N'-dihalogenated derivatives
40 (X = Cl, Br, I).[33] As they readily exchange halogen atoms with nucleophilic compounds of
various elements E (E = P, As, S, Se, Te), N-halogen sulfondiimines 39 and 40 appear as interest-
ing substrates for the synthesis of different N-substituted sulfondiimines; however, the serious
explosion hazard involved dramatically reduces their applicability.[34]
Scheme 1-18: N-Halogenations of NH,N'H-S,S-dimethyl sulfondiimine (15).[10, 18, 33-34]
N-Metalations
In particular, NH,N'H- and N-silylated sulfondiimines have been N-metallated with different
organometallic reagents (M = Al, Ge, Sn). Generally, the metal-complexing abilities of NH,N'H-
sulfondiimines 1 were reported to parallel those of aliphatic amine oxides for various metals M
(M = V, Cr, Fe, Cu)[19] except for silver and mercury; with both, they form insoluble
precipitates.[10] Of interest for subsequent N-alkylations (Scheme 1-25), with use of strong ba-
ses such as potassium amide in liquid ammonia[35] or sodium hydride in toluene,[10] monoalkali
salts 41 of S,S-dialkyl sulfondiimines 1 have been isolated (Scheme 1-19).
Scheme 1-19: N-Metalations of S,S-dialkyl sulfondiimines 1 afforded monoalkali metal salts 41.[10, 35]
12 | I n t r o d u c t i o n
Formation of N‒E bonds (E = Si, P, B, As, N, S)
Furthermore, especially NH,N'H- (1) and N-halogenated sulfondiimines 39 or 40 have been
combined with different organoelementary (E = Si, P, B, As) reagents, and various applications
of the N-functionalized products in the synthesis of variable sulfur-nitrogen-E-containing het-
erocycles have been reported.[10] In addition, nitrations of N-unsubstituted or N,N'-disilylated
sulfondiimines were reported to proceed with nitronium tetrafluoroborate or dinitrogen pent-
oxide in acetonitrile and to afford N,N'-dinitrated sulfondiimines (E = N).[36]
Of special interest as precursors of N-sulfenylaziridines (Scheme 1-33), N-sulfenyl sul-
fondiimines 42 proved accessible from S,S-diphenyl-N-tosyl sulfondiimine (29b) with arenesul-
fenyl chlorides 43 under basic conditions (Scheme 1-20).[37]
Scheme 1-20: N-Sulfenylations of sulfondiimines 29b by YOSHIMURA and coworkers.[37]
C‒N Bond formations
In close relation to S,S-dialkyl NH,N'H-sulfondiimines 1 applied in heterocyclic chemistry (chap-
ter 1.1.3.3), of special interest for this thesis, sulfondiimines can undergo C‒N bond-forming
reactions with a variety of electrophilic carbon sources.
As such, condensations of substrates 1 with cyanogen chloride[34] (N-cyanations), amino
acids[38] (Scheme 1-34), and acyl anhydrides or halides[39] (N-acylations) have been investigated.
Contextually, N-mono- (44) and N,N'-disubstituted sulfondiimines 45 were obtained in 80 to
100% yield from additions to heterocumulenes 46, whereas synthetic access to asymmetric bis-
adducts 45 was facilitated by the addition of a different isocyanate 47 to NH-sulfondiimine 44
(R3 ≠ R4, N-carbamoylations; Scheme 1-21).[10]
Scheme 1-21: N-Carbamoylations of sulfondiimines with isocyanates.[10]
More recently, an organocatalytic kinetic resolution of NH-sulfondiimine 17 with enal 72 was
reported by BOLM and coworkers. Depending on the catalyst, N-substituted product 38 was
obtained with –75% ee (with catalyst I) or 58% ee (with catalyst II). Disadvantageously, with
both catalysts unreacted substrate 17 was recovered with low ee values (Scheme 1-22).[40]
I n t r o d u c t i o n | 13
Scheme 1-22: Kinetic resolution of a sulfondiimine by BOLM and coworkers.[40]
Furthermore, reactions of sulfondiimines 1 with differently substituted cyanoimidates 48
(Scheme 1-23) have been reported by RIED and JACOBI,[41] and HAAKE and coworkers.[42]
Scheme 1-23: Overview on the N-functionalizations of sulfondiimines 1 with cyanoimidates 48.[41-42]
In the same context, some N-alkenylations of sulfondiimines 1 were reported. As such, N-alk-1-
enyliminosulfur compounds 50-52 were obtained from reactions with dimethyl acetylenedicar-
boxylate (53) in THF[10], ,β-unsaturated ketones 54[43], and nitriles 55
[44] (Scheme 1-24).
Scheme 1-24: N-Alkenylations of sulfondiimines 1 with activated alkyne 53 or alkenes 54|55.[10, 43-44]
14 | I n t r o d u c t i o n
N-Alkylations
Of special interest regarding the biological activity of the products (chapter 1.1.3.1) is the sur-
prisingly unexplored synthetic access towards N-(amino)alkylated sulfondiimines. To improve
the low basicity and nucleophilicity of the sulfondiimine nitrogens, N-alkylations of sul-
fondiimines predominantly started from the corresponding monoalkali metal salts 41 (Scheme
1-19).[10]
One of the scarce N-alkylations of sulfondiimines was reported by APPEL and ROSS in 1969.
While the use of ethyl iodide resulted in low product yields, by employing ethyl bromide for the
alkylation of NH,N'H-S,S-dimethyl-sulfondiimine potassium salt 41, the corresponding alkylated
product 56 was obtained in a high yield (path a, Scheme 1-25).[35a]
Scheme 1-25: N-Alkylations of sulfondiimines metal salts 41 with alkyl halides 57.[35a, 45]
In addition, HAAKE reported the synthesis of N-methyl-N'-H-S-benzyl-S-methyl sul-
fondiimine (58, 82% yield) by methylation of the corresponding N-free sulfondiimine 59 with
trimethyloxonium tetrafluoroborate (Me3O+BF4–) as a strong alkylating agent and subsequent
deprotonation of the resulting tetrafluoroborate salt (58–H+BF4–) in liquid ammonia.[10] As an
advancement, in a more general protocol HAAKE and coworkers presented the N-alkylation of
sulfondiimine sodium salts 41 with aminoalkyl chlorides, affording a range of N-aminoalkylated
S,S-diarylated sulfondiimines 56 in very good yields (path b, Scheme 1-25).[45-46] Disadvanta-
geously, due to the low nucleophilicity of the nitrogens in the substrates, both the metalation
and the N-alkylation step required long reaction times (two to seven days each). Interestingly,
when N-tosyl-activated sulfondiimine 29b was employed in MANNICH-type three-component
reactions with formaldehyde and secondary amines 60, N-aminomethyl-N'-tosyl sulfondiimines
56 could be isolated in good yields (Scheme 1-26).[45]
Scheme 1-26: MANNICH-type N-aminoalkylations of sulfondiimine 29b.[45]
Restricted to a single example, in 2012 BOLM and coworkers reported the one-pot N-alkylation
of NH-sulfondiimine 17 with 3-bromo-prop-1-yne (57n) in THF (Scheme 1-27).[30]
Scheme 1-27: Alkylation of NH-sulfondiimine 17 by BOLM and coworkers.[30]
I n t r o d u c t i o n | 15
N-Arylations
Firstly in 1986, RIED and PAULI reported about different N-(hetero)aromatic sulfondiimine de-
rivatives 61 of improved stability compared to NH,N'H- or N-methyl-N'H-sulfondiimines, acces-
sible through N-arylations of S,S-dialkyl sulfondiimines 1 with nitro-substituted (hetero)aryl
chlorides 62 under different basic conditions (Scheme 1-28).[39]
Scheme 1-28: N-Arylations of N-unsubstituted sulfondiimines 1 by RIED and PAULI.[39]
More recently, C‒N ross–coupling strategies well-established for NH-sulfoximines have been
investigated in connection with the N-arylation of NH-sulfondiimines by BOLM and
coworkers.[30, 47] From an ULLMANN-type cross-coupling of NH-sulfondiimine 17, N-(2-
nitrophenyl)-substituted product 61f was isolated in 50% yield (Scheme 1-29).[30]
Scheme 1-29: First ULLMANN-type cross–coupling of sulfondiimine 17 with an aryl iodide.[30]
As an improvement, a general and effective BUCHWALD–HARTWIG-type procedure for the
N-arylation of N'-monosubstituted sulfondiimines 19 with aryl bromides 64 was developed.
With a combination of tris(dibenzylideneacetone)dipalladium(0) [Pd2(dba)3] and 2-dicyclohexyl-
phosphino-2',6'-diisopropoxybiphenyl (RuPhos) as the catalyst system, access to functionalized
N,N'-disubstituted products 61 was provided in good to high yields (Scheme 1-30), including the
first sulfondiimine-based 2,1-benzothiazine (Scheme 1-45).[47]
Scheme 1-30: BUCHWALD–HARTWIG-type N-arylations of N'H-sulfondiimines 19.[47]
In the context of this work, a protocol for the cleavage of para-methoxyphenyl (PMP) groups in
N-PMP-protected sulfondiimines 61 has been discovered. With excess cerium ammonium ni-
trate (CAN) as the oxidant under basic conditions synthetically useful NH-derivatives 19, diffi-
cult to prepare by other means, have been accessed (Scheme 1-31).[47]
16 | I n t r o d u c t i o n
Scheme 1-31: Oxidative deprotection of N-PMP sulfondiimines 61.[47]
1.1.3 Applications
Presumably due to the limitations in the synthesis of sulfondiimines (chapter 1.1.1), to date, the
applications of this highly underestimated class of compounds appear restricted as well. This
chapter will give an introduction into the reports on biological activities of sulfondiimines and
into their applications in synthetic organic—particularly heterocyclic—chemistry.
1.1.3.1 Biologically active derivatives
This chapter will give an overview on the biological activities reported for sulfondiimine deriva-
tives. Notably, although a number of sulfondiimine derivatives with interesting biological activi-
ties have been patented as pharmaceutical or agricultural agents, no marketed compounds
have appeared to date.
Pharmacologically active sulfondiimines
In the context of pharmacologically active sulfondiimine derivatives, in 1976[46] and 1983,[45]
HAAKE and others reported on the synthesis of N-aminoalkylated examples 56 (Figure 1-6) with
neurotropic and musculotropic spasmolytic activity and on their use as spasmolytic agents. The
best results were obtained with an NH-S,S-diphenyl derivative, whose activity proved compara-
ble to some commercially available antihistamines and anticholinergic agents.
During the investigation of structure-activity relationships a special importance of the R-group
(O >> NH) on the effectivity of the spasmolytic agents was observed, whereas changes in the
S,S-diaryl group or the N'-side chain did not have a significant effect.[45]
Figure 1-6: N-Aminoalkylated aza-sulfone analogs 56 as spasmolytic agents.[45-46]
Furthermore, SCHWARTZ and WART in 1995 claimed the activity of NH,N'H-sulfondiimines 65
(Figure 1-7) as matrix metalloproteinase (MMP) inhibitors and their utility in the modulation of
physiological functions or the treatment of diseases associated with MMP modulation. Contex-
tually, MMPs represented proteinases believed to be responsible for the metabolic turnover of
protein components of the extracellular matrix of humans.[48]
I n t r o d u c t i o n | 17
Figure 1-7: NH,N'H-Sulfondiimines 65 are matrix metalloproteinase (MMP) inhibitors.[48]
More specifically, SCHWARTZ and others focused on sulfondiimine 66 as potent matrixins
(MMPs) inhibitor in 2000.[49] The compound proved potent against MMP-1 (IC50, 180 nM),
MMP-2 (IC50, 63 nM), and MMP-9 (IC50, 44 nM). Upon investigations of its role in human micro-
vascular endothelial cell proliferation, a correlation between the anti-metalloenzyme activity
and the effects of the inhibitor on the growth and invasion of endothelial cells was
suggested.[49a]
Figure 1-8: Sulfondiimine 66 represents a potent MMP inhibitor.[49]
As a recent example, in 2015 LÜCKING and others at Bayer Pharma claimed the utility of sul-
fondiimine-based disubstituted 5-fluoro pyrimidines 67 (Figure 1-9) for the treatment and
prophylaxis particularly of hyper-proliferative disorders and virally induced infectious diseases,
or cardiovascular diseases.[50]
Figure 1-9: Pharmacologically active sulfondiimine-based 5-fluoropyrimidines 67.[50]
The mitogen-activated protein kinase (MAPK) interacting protein kinases 1 and 2 (MNK1 and
MNK2) are of high importance in the control of signals involved in mRNA translation. Hence,
the represe t ke ediators of o ogenic progression, drug resistance, production of proin-
flammatory cytokines, and cytokine signaling .[51]
18 | I n t r o d u c t i o n
Contextually, WIEDENMAYER and others at Boehringer-Ingelheim recently reported on the syn-
thesis of sulfondiimine-containing substituted pyrrolotriazines 68, their inhibitory activity
against MNK1 and MNK2 kinases, and their use as agents for the treatment or amelioration of
MNK1- and MNK2-mediated disorders.[52]
Figure 1-10: Sulfondiimine-containing pyrrolotriazines 68 as MNK1 and MNK2 kinase inhibitors.[52]
In addition, TAMURA and others (Shionogi) very recently discovered the activating effects of
sulfondiimine-incorporating azaindole 69 (Figure 1-11) on the adenosine monophosphate-
activated protein kinase (AMPK), and claimed the use of 69 as antidiabetic agent.[53] In close
connection, the same effects of related sulfondiimine-based molecules have been claimed by
GOTTSCHLING and others (Boehringer Ingelheim) to be particularly useful against type 2 diabe-
tes.[54]
Figure 1-11: Sulfondiimine 69 with AMPK-activating effect.[53]
Sulfondiimines in pesticides
In terms of sulfondiimines incorporated in pesticides, in 1996[55] and 2000,[56] LOWDER and
others at Rhone-Poulenc Agrochimie investigated S-pyrazole, S-pyrrole, and S-imidazole sul-
fondiimines useful for controlling arthropod, nematodes, helminth, or protozoan pests, and
their applications as pesticides. More specifically describing the structure of the relevant
acrylamide-based sulfondiimine derivatives 70 (Figure 1-12), BINDSCHÄDLER and others (BASF)
more recently claimed the utility of these compounds for the control of invertebrate pests, in
particular of arthropod pests and nematodes, and their use as pesticides.[57]
Figure 1-12: Acrylamide-based sulfondiimine derivatives 70 useful as pesticides.[57]
I n t r o d u c t i o n | 19
Subsequently, PITTERNA and others (Syngenta) investigated an N-cyanated sulfondiimine 71
(Figure 1-13) in the context of bis-amide derivatives with insecticidal, acaricidal, nematicidal,
and molluscicidal activities, and their use as insecticides.[58]
Figure 1-13: Bis-amide-substituted sulfondiimine 71 was investigated as insecticide.[58]
1.1.3.2 In synthetic organic chemistry
In general, the applications of sulfondiimines most frequently focus on synthetic organic chem-
istry. As an example discovered by HAAKE and coworkers, NH,N'H-S,S-dimethyl sulfondiimine
(15) proved as a valuable reagent for the one-step transformation of aromatic aldehydes 72
into nitriles 73 via an eight-membered ring B isolated as the intermediate, leading to aryl-
substituted products 73 in excellent yields (95–100%; Scheme 1-32).[59]
Scheme 1-32: Thermal conversion of aromatic aldehydes 72 into nitriles 73 with sulfondiimine 15.[59]
More recently, an application of N-tosyl-N'-sulfenyl sulfondiimine 42 (Scheme 1-20) was re-
ported by YOSHIMURA and coworkers. They succeeded in the stereospecific synthesis of
N-sulfenylaziridines 74 in excellent yields by the thermolysis of reagent 42 and subsequent re-
actions with excess amounts of olefins 75 (Scheme 1-33).[37]
Scheme 1-33: Synthesis of N-sulfenylaziridines 74 from N-tosylated sulfondiimines 42.[37]
20 | I n t r o d u c t i o n
Moreover, S,S-dialkyl sulfondiimines 1 have found application in the synthesis of pseudopep-
tides. In 2005, BOLM and coworkers reported the transformation of N-protected amino acid 76
with different sulfondiimines 1 towards C2- or pseudo-C2-symmetric pseudopeptides 77 in good
yields (39–94%; Scheme 1-34).[38]
Scheme 1-34: Incorporation of S,S-dialkyl sulfondiimines 1 in pseudopeptides 77.[38]
Of special interest for this thesis is the most frequently investigated field of applications of sul-
fondiimines in synthetic organic chemistry: the heterocyclic chemistry.
1.1.3.3 In heterocyclic chemistry
Presumably due to the fact that synthetic access to NH,NH-S,S-dialkyl sulfondiimines 1 was in-
vestigated most frequently (chapter 1.1.1), these bifunctional molecules were incorporated in
most sulfondiimine building blocks applied in heterocyclic chemistry. In this chapter, the syn-
thesis and applications of heterocycles 78–80 involving C‒N o d for i g rea tio s of interest
for this thesis will be described more in detail (strategies a–c, Scheme 1-35).
Scheme 1-35: Cyclization strategies a–c apply sulfondiimines 18|19|38 as the precursors.
Contextually, by one-pot reactions of NH,NH-S,S-dialkyl sulfondiimines 1 with biselectrophiles a
variety of five- or six-membered heterocyclic products 78 can be accessed (strategy a, Scheme
1-35). As such, condensation reactions of sulfondiimines 1 with bifunctional dichlorides
81|82b|83|84[60] or malonic esters 82a
[61] have been extensively investigated by HAAKE and
coworkers.
I n t r o d u c t i o n | 21
Scheme 1-36: Heterocycles 78a–d prepared from building blocks 1 by HAAKE and coworkers.[10, 60-61]
With this synthetic strategy, differently substituted five- or six-membered heterocycles 78a–d
were accessed, including spirocyclic examples (Scheme 1-36). Typically, the reactions were car-
ried out in DCM with triethylamine.[10]
In addition, condensations of sulfondiimines 1 with diketene 85 (path a) or ethyl acetoacetates
86 (path b) were reported by RIED and PAULI to exclusively afford a range of 1λ6,2,6-
thiadiazines 78e (Scheme 1-37) in lieu of N-acetoacetylated products.[62]
Scheme 1-37: 1λ6,2,6-Thiadiazines 78e resulted from condensations of sulfondiimines 1.[62]
Interestingly, under certain conditions S-alkylated sulfondiimines are known to undergo C‒S
bond cleavage. Particularly in case of a positive charge on sulfur built up by protonation
(Scheme 1-1) or introduction of electron–withdrawing groups on one or both nitrogen atoms,
S-dealkylations (tert-alk l > e z l sec-alkyl > prim-alkyl) occur with nucleophiles.[63] This ob-
servation has been utilized in the synthesis of numerous heterocycles, including some 1,3,4-
oxathiazoles 87[64] and a variety of 1λ4,2,4,6-thiatriazines 79.[41b, 42, 65]
22 | I n t r o d u c t i o n
Of interest regarding the herbicidal activity of the products,[63a] HAAKE and coworkers recently
reported a protocol for the preparation of 1λ4,2,6-thiadiazine-3-ones 79a. The synthetic strate-
gy included addition–condensation reactions (acr) of S-alkyl-S-benzyl precursors 88 with acti-
vated carbonyl substrates (a: acetoacetates 89, b: Meldrum’s acid derivatives 90) and subse-
quent S-debenzylations of the resulting λ6,2,6-thiadiazine-3-ones 78f (Scheme 1-38). Different
S-alkyl-substituents R1 were well-tolerated, and the products could be accessed under mild re-
action conditions in good to high yields.[63b] A related strategy was utilized for the preparation
of 3-amino-1,2,4,6-thiatriazines 79b, claimed as suitable herbicides showing preemergence
herbicidal activity against avena, sinapsis, and stellaria at 2 kg/ha by HAAKE and others in
1996.[66]
Scheme 1-38: Synthesis of sulfur herbicides from sulfondiimine precursors 88.[63b]
In addition, NH,NH-S,S-dialkyl sulfondiimines 1 undergo cyclizations with activated multiple-
bond systems. In case of S,S-dimethyl sulfondiimine 15 subjected to dimethyl acetylenedicar-
boxylate (53) by HAAKE and coworkers, the solvent represented the critical point for the out-
come of the transformation. While an N-alkenylated product 51 was observed in THF (Scheme
1-24), in glacial acetic acid and ethanol thermally induced addition–condensation reactions to-
wards more stable 1λ6,2,6-thiadiazine 78g and an 1λ6,2,5-thiadiazole 78h, respectively, pro-
ceeded (Scheme 1-39).[10]
Scheme 1-39: Cyclizations towards 1,2,6-thiadiazine 78g or 1,2,5-thiadiazole 78h.[10]
Most frequently investigated by RIED and JACOBI[44, 67] is the synthesis of heterocycles by addi-
tion–condensation reactions of S,S-dialkyl sulfondiimines 1 with activated C=C double bond
systems. As an example, with ketene dithioacetals 91 heterocyclic products 78i were obtained
(right, Scheme 1-40).[44, 67] Closely related, HAAKE and coworkers reported the use of tetracy-
anoethylene (92) for the synthesis of heterocycle 78j (left, Scheme 1-40).[10]
I n t r o d u c t i o n | 23
Scheme 1-40: λ6,2,6-Thiadiazines 78i–j proved accessible from sulfondiimine precursor 1.[10, 44, 67]
In contrast to these one-pot protocols with biselectrophiles, multi-step cyclization strategies of
NH,N'H-sulfondiimines 1 towards heterocycles 78 and 79 have been developed as well (1. N-
functionalizations, 2. cyclization b in Scheme 1-35). Necessarily involving the isolation of
N-mono- (19) and N,N'-disubstituted (38) intermediates as additional steps, the yields achieved
with this strategy were generally lower. As such, N-vinylated sulfondiimines 52a and 52b were
prepared from NH,N'H-sulfondiimines 1 (Scheme 1-24), and converted into heterocycles
79c|78k, respectively, in dissatisfying yields. As illustrated in Scheme 1-41, upon thermal induc-
tion, intramolecular cyclization and S-debenzylation of 52a afforded heterocycles 79c in very
low yields,[43] and base-mediated cyclization of sulfondiimine 52b gave spirocyclic product 78k
(41%).[44]
Scheme 1-41: Cyclizations of N-vinylated sulfondiimines 52.[43-44]
As another example, N-carbamoylated sulfondiimines 44 prepared from NH,N'H-sulfondiimines
1 (Scheme 1-21) undergo cyclizations with phosgene 93 towards partially spirocyclic N-4-
substituted 1λ6,2,4,6-thiatriazines 78l in up to moderate yields (Scheme 1-42).[10]
24 | I n t r o d u c t i o n
Scheme 1-42: Preparatio of λ6,2,4,6-thiatriazines 78l from N-monosubstituted sulfondiimines 44.[10]
By utilizi g the possi ilit of “‒dealkylations described previously (Scheme 1-35), induced by
the addition of para-toluenesulfonic acid (PTSA; path a)[41b] or primary and secondary amines
94 (path b),[42] NH-sulfondiimines 49 generated from NH,N'H-sulfondiimines 1 and cyanoimi-
dates (Scheme 1-23) were cyclized to λ4,2,4,6-thiatriazines 79d in one step and good yields
(Scheme 1-43).
Scheme 1-43: Application of sulfondiimines 49 in the synthesis of thiatriazines 79d.[41b, 42]
In addition, N,N'-disubstituted sulfondiimines 95 have been prepared from the corresponding
NH-sulfondiimines under conditions described previously (Scheme 1-23), and employed as pre-
cursors for heterocycles 96a (strategy c in Scheme 1-35) and annulated derivatives 96b–c in
dissatisfying yields (Scheme 1-44).[41a]
Scheme 1-44: Applications of sulfondiimines 95 in the syntheses of 1,2,4-thiadiazine 1-imines 96.[41a]
I n t r o d u c t i o n | 25
More recently, in the context of palladium–catalyzed C‒N cross–couplings (Scheme 1-30)[47] of
NH-sulfondiimines 19 prepared from sulfiliminium salts 23 (Scheme 1-15),[30] BOLM and
coworkers could access the first sulfondiimine-based 2,1-benzothiazine 97. By combining NH-
sulfondiimine 17 with 2-bromobenzaldehyde as the coupling partner (Scheme 1-45) upon dif-
ferent reaction temperatures and times, either an N,N'-difunctionalized product (61, Scheme
1-30) or 2,1-benzothiazine 97 (strategy c in Scheme 1-35) was obtained with remarkably high
selectivity.[47]
Scheme 1-45: Sulfondiimine-based 2,1-benzothiazine 97 was reported by BOLM and coworkers.[47]
P r o b l e m D e f i n i t i o n a n d O b j e c t i v e s |27
II. PROBLEM DEFINITION AND OBJECTIVES
Despite the intriguing properties sulfondiimines exhibit, since their discovery in 1964 these
high-valent sulfur derivatives have received only marginal interest from the scientific communi-
ty, and syntheses and applications remained significantly restricted as reviewed in the previous
chapter. As contribution to overcome the existing limitations, the aim of this thesis included the
development of methods for the variable and selective modifications of sulfondiimine deriva-
tives. By involving one or both of the unsubstituted nitrogen atoms and the carbon substituent
of sulfur as key anchors of the sulfondiimine functional group, N- and -functionalization and
scarcely investigated cyclization strategies were the objectives of the planned investigations.
Thereby, a library of structurally diverse sulfondiimine-based products 38|98|99 of special in-
terest for possible applications, particularly as pharmacological agents, should be accessed
(Scheme II). In particular, the relatively unexplored class of NH-sulfondiimines 19 represented
the substrates of choice, readily available since the development of a synthetic approach by
BOLM and coworkers in 2012 (Scheme 1-15).[30] As such, NH-N-phenyl-S-phenyl-S-methyl sul-
fondiimine (17 ill e referred to a d utilized as the sta dard su strate for the opti izatio of the reaction conditions of the particular methods. The results of the corresponding projects
will be discussed in the following (chapters 2–4).
Scheme II: Overview on the modifications of NH-sulfondiimines 19 performed in this thesis.
R e s u l t s a n d D i s c u s s i o n | 29
III. RESULTS AND DISCUSSION
2 N-Functionalizations
2.1 N-Arylations and N-alkenylation of N-monosubstituted sul-fondiimines (Project P1)
2.1.1 Background and aim of the project
In previous work, a protocol for BUCHWALD–HARTWIG-type cross–couplings of
NH-sulfondiimines with aryl bromides has been developed, leading to a series of
N,N'-disubstituted sulfondiimines (Scheme 1-30).[47] However, this method is restricted by the
necessity for harsh reaction conditions such as high reaction temperatures and the use of ex-
pensive palladium catalysts and a glovebox. In consequence, the scope appeared limited, for
instance excluding the application of thermally labile sulfondiimines. In particular,
N-(hetero)aryl-substituted products, which appear of interest in the light of structurally related
sulfoximine analogs applied as anticancer agents[68] and agrochemicals[69] could not be ac-
cessed.
Hence, the aim of this project was to overcome the limitations of this method, and explore a
more mild, experimentally simple, and cost-efficient version. In this manner, the synthesis of a
more diverse library of N,N'-disubstituted sulfondiimines, including N-(hetero)aryl sul-
fondiimines, was envisioned.
Inspired by an N-arylation protocol previously reported for NH-sulfoximines by our group
(Scheme 2-1),[70] CHAN–LAM-type cross-couplings of NH-sulfondiimines with boronic acids 101
were attempted.[71] These reactions would have the advantage of mild and cost-effective reac-
tion conditions, as they proceed with copper catalysts at ambient temperature and without the
necessity for an external base.
Scheme 2-1: Copper– atal zed C‒N ross–couplings of sulfoximines 100 with boronic acids 101.[70]
2.1.2 Optimization
To explore the optimal reaction conditions, the cross–coupling of S-methyl-S-phenyl-N-phenyl-
N-H-sulfondiimine (17) and phenyl boronic acid (101a) was chosen as the representative test
reaction. According to the previously reported CHAN–LAM-type protocol (Scheme 2-1),[70] cop-
per acetate (0.1 equiv) was employed as the catalyst without any external base in dry methanol
while atmospheric moisture was excluded by a CaCl2-drying tube.
30 | R e s u l t s a n d D i s c u s s i o n
Favorably, this initial attempt gave the N,N'-disubstituted product in a high yield of 85%
(Scheme 2-2).
Scheme 2-2: First test reaction.
To further investigate this reaction process, the effects of all reaction parameters have been
evaluated in combination with different reaction temperatures and times. Alternative Cu(I)
[CuCN, CuI, Cu2O, CuBr, CuCl] or Cu(II) [Cu(acac)2, CuCl2, CuSO4, Cu(OTf)2, Cu(TFA)2·H2O,
Cu(OAc)2·H2O, Cu(PF6)2, Cu(SbF6)2] catalysts, as well as different anhydrous solvents (isopropa-
nol, ethanol, THF, DMF, DMSO, DCM) led to the decrease of yields and reactivity. The use of
potassium phenyl trifluoroborate (103a) as the coupling partner led to a maximum yield of 37%
of product 61a, when combined with Cu(OAc)2 (0.1 equiv) in anhydrous MeOH after 40 h at
40 °C. In this case, changing the anhydrous solvent to MeCN or DCM and using Cu(OAc)2*H2O in
the presence of molecular sieves in an oxygen atmosphere according to BATEY and coworkers
(Scheme 2-3)[72] led to lower yields and incomplete conversions.
Scheme 2-3: Arylation of amines 104 with aryl trifluoroborate salts 103 by BATEY and coworkers.[72]
As reported for other CHAN–LAM reactions,[73] the amount of oxygen and water present in the
reaction tube was critical for the outcome of the reaction. Compared to the reaction under the
exclusion of atmospheric moisture (Table 2-1, entry 1), performing the reaction in an oxygen
atmosphere and with molecular sieves slightly reduced the yield of N-phenylated product 61a
(both 82%; entries 2–3). Under an argon atmosphere, the coupling product was only obtained
in 64% yield (entry 4). Finally, reducing the amount of catalyst and boronic acid led to lower
yields of the product (entries 5–7).
During these investigations, it was noted that the yields depended on the reaction tempera-
ture. As such, in the case of incomplete conversions the elevation of reaction temperatures to
60 or 110 °C led to no improvement, but to the decrease of yields. Furthermore, reactions ini-
tially performed at ambient temperatures of 25 °C (Table 2-1) led to higher yields compared to
reactions at reduced temperatures. Consequently, when exploring the scope of this reaction
process, the reaction mixture was continuously heated to 25 °C.
R e s u l t s a n d D i s c u s s i o n | 31
Table 2-1: Screening of the reaction conditions.
Entry Cu(OAc)2 [equiv] PhB(OH)2 [equiv] Yield [%][a]
1 0.1 2.3 85 2 0.1 2.3 82[b]
3 0.1 2.3 82[c]
4 0.1 2.3 64[d]
5 0.05 2.3 79 6 0.1 1.0 50 7 0.1 2.0 79
[a] After column chromatography, atmospheric moisture excluded by CaCl2-drying tube. [b] Under an oxygen atmosphere. [c] Upon addition of MS 3 Å. [d] Under an argon atmosphere.
2.1.3 Substrate scope
With the optimal reaction conditions in hands (Table 2-1, entry 1), the scope of this reaction
process has been investigated with respect to the boronic acid 101 (Table 2-2) as well as the
NH-sulfondiimine 106 employed in the reaction (Scheme 2-4).
Initially, the cross–coupling of NH-sulfondiimine 17 as the representative substrate was con-
ducted with differently substituted commercially available boronic acids 101 as the coupling
partners, leading to a variety of N,N'-disubstituted sulfondiimines 61 (Table 2-2). In general, the
products were obtained in good yields and high functional–group diversity. Different electron–withdrawing as well as electron–donating substituents were tolerated on the phenylboronic
acid, affording methoxy- and thiomethyl-, as well as acetyl-, trifluoromethyl-, and nitro-
substituted products in good yields up to 90% (products 61b–f; entries 1–6). However, attempts
employing hydroxy- (entry 7) or cyanophenylboronic acid (entry 8) proved unsuccessful. It is of
note that in contrast to previous work[47] this protocol enables the preparation of halogen-
substituted products such as the N-ortho-bromo- and -chlorophenyl derivatives 61g and 61h in
very good yields up to 94% (entries 9–10). Favorably, the ar o ‒bromine bond remained ac-
cessible in the product for subsequent classical cross–coupling reactions.
Furthermore, steric factors remarkably influenced the reactivity of the substituted phenyl-
boronic acid. While para- or meta-methyl-substituted acids (101k–l) reacted smoothly, an or-
tho-methyl substituent in 101m caused a significantly lower product yield (products 61k–m,
87–85% versus 51%; entries 13–15). In accordance, attempts of applying a sterically demanding
mesitylboronic acid failed (entry 16). When butylboronic acid was tested as the coupling part-
ner, the desired product was not detected and sulfondiimine 17 partially decomposed (en-
try 17).
32 | R e s u l t s a n d D i s c u s s i o n
Table 2-2: Substrate scope with respect to the boronic acid 101.
Entry R1-, Boronic acid 101 Yield of 61[a]
[%]
1 C6H5-, a a, 85 2 4-MeO-C6H4-, b b, 72 3 4-MeS-C6H4-, c c, 67 4 4-Ac-C6H4-, d d, 90 5 3-F3C-C6H4-, e e, 89 6 2-O2N-C6H4-, f f, 56[b]
7 4-HO-C6H4- - 8 2-NC-C6H4- - 9 2-Br-C6H4-, g g, 94
10 2-Cl-C6H4-, h h, 85 11 4-biphenyl-, i i, 84 12 2-naphthyl-, j j, 94 13 4-Me-C6H4-, k k, 87 14 3-Me-C6H4-, l l, 85 15 2-Me-C6H4-, m m, 51 16 2,4,6-Me3-C6H4- - 17 C4H9- - 18 6-Cl-pyridin-3-yl-, n n, 84 19 thiophen-3-yl-, o o, 82 20 pyridine-3-yl- - 21 furan-3-yl- - 22 benzo[b]thien-3-yl-, p p, 41[c]
23 5-indolyl-, q q, 61[c]
[a] After column chromatography, atmospheric mois-ture excluded by CaCl2-drying tube. [b] Yield deter-mined by NMR. [c] Reaction performed for 40 h.
Of special interest, the protocol opens up access towards the previously unprecedented, highly
interesting class of N-(hetero)aryl sulfondiimines. For instance, the representative chloro-
pyridinyl (61n) and thiophenyl (61o) derivatives have been formed in good yields (entries 18–19). Whereas pyridyl- and furanylboronic acid did not afford the desired products (entries 20–21), benzo[b]thienyl (61p) and indolyl derivatives (61q) proved readily accessible after elonga-
tion of the reaction time (entries 22– . Fa ora l , the N‒H oiet of the i dole su stitue t in
61q remains amenable for subsequent chemical modifications.
R e s u l t s a n d D i s c u s s i o n | 33
Furthermore, reactions of different NH-sulfondiimines 106a–h have been performed with phe-
nylboronic acid (101a) as the representative coupling partner (Scheme 2-4). In general, S-aryl-S-
alkyl-NH-sulfondiimines reacted smoothly. As reported previously for CHAN-LAM-type aryla-
tions of other nitrogen nucleophiles,[73b] electron-rich substrates gave better results compared
to electron-poor ones. As such, an electron–donating N-methoxyphenyl-substituent resulted in
a higher yield of the corresponding N-arylated product 61b (90%) compared to an electron–withdrawing N-trifluoromethylphenyl group (76%, 61e). Furthermore, the N-phenylation of N'-
PMP-substituted sulfondiimine 106a proved superior to the reaction of the N'-phenylated de-
rivative 17 and methoxyphenylboronic acid 101b (Table 2-2, entry 2), as it resulted in a signifi-
cantly increased yield of product 61b (90% versus 72%). As observed in previous studies on a
BUCHWALD–HARTWIG-protocol for the N-arylation of NH-sulfondiimines (Scheme 1-30), an
electron–withdrawing tosyl-group on the nitrogen led to degradation of the starting material,
and precluded the formation of the cross–coupling product.
Scheme 2-4: Products stemming from the coupling of different NH-sulfondiimines 106 with phenyl-
boronic acid (101a).
In addition, S-tolyl- and cyclopropyl derivatives 61s and 61u were formed in good yields. As ob-
served for product 61g (Table 2-2, entry 9), in the case of S-(para-bromophenyl)-substituted
product 61t, the bromide remained accessible for further transformations after the cross–coupling reaction. Unfortunately, for an S-benzyl and a representative S,S-dialkylated sul-
fondiimine (here: tetrahydrothiophene) degradation of the starting materials, and no formation
of the desired products were observed.
34 | R e s u l t s a n d D i s c u s s i o n
To further expand the scope of this protocol, the N-alkenylation of a sulfondiimine was pro-
posed, opening up access to another class of N,N'-disubstituted sulfondiimines. Therefore, NH-
sulfondiimine 17 was coupled with an alkenyl-substituted boronic acid 110 under the optimized
reaction conditions (Scheme 2-5).
Scheme 2-5: N-Alkenylation of a sulfondiimine.
In first attempts, according to the behavior of N-alkynylated sulfoximines previously reported
by our group,[74] purification by flash column chromatography carried out with silica gel result-
ed in a partial hydrolysis of the desired product 109, which was obtained as a mixture of iso-
mers (E/Z = 1:1). To avoid the nonseparable mixture of the partially hydrolyzed isomers and the
E/Z-isomers of the desired product, column chromatography was conducted with basic alumin-
ium oxide. In this manner, solely the (E)-isomer of product 109 was obtained in a good yield
(78%; Scheme 2-5). When performing the reaction on double scale (compared to Scheme 2-5),
the yield of N-alkenylated product 109 significantly decreased to 48%. Furthermore, the substi-
tution pattern on the alkene has proven to be critical for the outcome of the transformation. As
such, attempts to access N-(3,3-dimethylbut-1-ene)- and N-(2-chloroethene)-substituted prod-
ucts failed.
2.1.4 Upscaling attempts
As it is of potential interest for industrial applications, the synthesis of N-(2-bromophenyl)-
substituted sulfondiimine 61g was chosen for upscaling attempts. In addition, subsequent ami-
nation towards a sulfondiimine-based ligand 107 was envisioned (Scheme 2-6).
Scheme 2-6: Attempts for upscaling and a sulfondiimine-based ligand.
However, in all reactions employing sulfondiimine 17 (2.0 g) and 2-bromophenylboronic acid at
25 °C in different set-ups (differently sized schlenk tubes or round bottom flasks with CaCl2-
drying tubes), incomplete conversion was observed, and the maximum product yield obtained
was 30% (1.01 g; Scheme 2-6). This represents a decrease in yield in comparison to the afore-
mentioned small-scale reaction (79 mg, 94%; Table 2-2, entry 9).
R e s u l t s a n d D i s c u s s i o n | 35
Subsequent initial attempts of synthesizing a sulfondiimine-based ligand 107 by amination of
sulfondiimine 61g employing palladium-catalyzed protocols reported by BUCHWALD (Scheme
2-6),[75] or by our group for the N-arylation of NH-sulfondiimines,[47] failed.
2.1.5 Summary and outlook
In this project, a CHAN–LAM-type protocol for the copper– atal zed C‒N ross–coupling of NH-
sulfondiimines with boronic acids has been developed (Scheme 2-7).
Scheme 2-7: Copper– atal zed C‒N ross–coupling of NH-sulfondiimines 19 with boronic acids 101.
This reaction represents a complementary and revised method to a previously reported
BUCHWALD–HARTWIG-type version (Scheme 1-30).[47] Under mild and cost-effective base-free
reaction conditions, it provides access towards more diversely N,N'-disubstituted sul-
fondiimines in good to excellent yields, including previously inaccessible N-(hetero)aryl and
N-alkenylated sulfondiimines. For future work, it is of high interest to investigate the biological
activities of these products, in particular of differently substituted N-(hetero)aryl sul-
fondiimines. Furthermore, due to incomplete conversions and low yields observed in the up-
scaling process, the screening of reaction parameters such as catalyst loading and reaction
temperature should be explored. The investigation of suitable catalytic systems for the amina-
tion of building block 61g could provide access to sulfondiimine-based ligands, and
N-alkenylated product 109 could be further functionalized at the unsaturated moiety.
2.2 N-Alkylations of N-monosubstituted sulfondiimines (Project P2)
2.2.1 Background and aim of the project
N-(Amino)alkylated sulfoximines such as Suloxifen 111, which was identified as a both orally
and parentally effective spasmolytic and antiasthmatical agent and selected as clinical candi-
date at Gödecke by SATZINGER and STOSS,[76] proved attractive in medicinal chemistry.[8a]
Figure 2-1: Suloxifen (111) represents an effective spasmolytic and antiasthmatic agent.
Although the investigations of their biological activities showed interesting results as well (Fig-
ure 1-6), synthetic access to the structurally related N-(amino)alkylated sulfondiimines 56 ap-
pears surprisingly restricted (chapter 1.1.2), and no general and effective protocol for the N-
alkylation of sulfondiimines exists.
36 | R e s u l t s a n d D i s c u s s i o n
To date, mainly N-alkylamino sulfondiimines 56 have been prepared by the formation of sul-
fondiimine alkali metal salts from NH-sulfondiimines and alkali metal hydrides, their isolation,
and subsequent alkylation with alkyl halides (Scheme 1-25). However, both the metal-salt for-
mation as well as the alkylation of the weakly nucleophilic sulfondiimine nitrogen required very
long reaction times and high reaction temperatures.[45-46] Those came along with a strongly lim-
ited product scope, excluding substituents such as longer alkyl chains.
To further explore this highly underdeveloped substrate class and transformation of interest,
the aim of this project included the development of a general, mild, and effective synthetic
strategy towards structurally diverse N-alkylated sulfondiimines. HEANEY and LEY reported on
the use of a suspension of powdered KOH in DMSO, a so-called super asi reaction
medium,[77] for the effective N-alkylation of indoles and pyrroles with alkyl halides 57. In the N-
alkylations discussed by HEANEY and LEY, the strongly ionizing solvent was proposed to en-
hance the reactivity of in situ formed N-metallated intermediates in the subsequent nucleo-
philic substitutions with alkyl halides.[78] Envisioning an analogous reactivity for N-unsubstituted
sulfondiimines, we planned to perform their N-alkylations with alkyl halides by employing the
combination of KOH in DMSO.[79] Avoiding the isolation of the sulfondiimine salts, this strategy
could represent an experimentally simple and effective alternate pathway for the desired N-
alkylation reactions.
2.2.2 Optimization
For the investigation of the desired N-alkylations, S-methyl-S-phenyl-N-phenyl-N-H-
sulfondiimine (17) was employed as the standard substrate, and butyl halides 57 were selected
as the representative alkylating agents (Table 2-3).
Table 2-3: Optimization of the sulfondiimine N-alkylation reaction conditions.
Entry X, Halide 57 T [° C] Yield [%][a]
1 Br, a r.t. 84
2 I, b r.t. 79
3 Cl, c r.t. 73[b]
4 Br, a 60 59
5 Br, a 90 56
6 Br, a r.t. 57[c]
[a] After flash column chromatography. [b] Reaction performed for 6 h. [c] Use of 0.15 M DMSO.
R e s u l t s a n d D i s c u s s i o n | 37
In order to perform the reactions under mild conditions, initial attempts were conducted at
ambient temperatures. Favorably, by reacting sulfondiimine 17 with butyl bromide (57a,
1.5 equiv) and employing a combination of KOH (2.0 equiv) in anhydrous DMSO[80] N-alkylated
product 56a was directly obtained in a high yield of 84% after only 4 h (entry 1). Other alkylat-
ing agents could be used as well, however, resulting in lower yields of product 56a. As such, the
use of butyl iodide gave product 56a in a slightly lower yield of 79% (entry 2), whereas only 74%
yield was obtained with the chloride even after an elongated reaction time of 6 h (entry 3). In-
creasing the reaction temperature remarkably decreased the product yields, presumably due to
accelerated partial degradations of the starting material (entries 4–5). Finally, with a lower con-
centration of the reagents in DMSO the yield also dropped (entry 6). Considering cost, accessi-
bility, and environmental impact in addition to the best yield observed, alkyl bromides (entry 1)
were chosen as the electrophilic reagents of choice for further investigations of this N-
alkylation protocol.
2.2.3 Substrate scope
With the optimal reaction conditions in hand (Table 2-3, entry 1), the substrate scope was in-
vestigated with respect to the alkyl bromides 57 and NH-sulfondiimines 106. At first, the alkyl
bromide 57 was varied in reactions with the representative NH-sulfondiimine 17 (Table 2-4).
Favorably, the protocol proved generally applicable, giving access to diversely N-alkylated sul-
fondiimines 56 in mostly good to excellent yields. Irrespective of their chain length, various lin-
ear alkyl bromides reacted readily, resulting in products 56b–f obtained in good yields ranging
from 64–80% (entries 1–5). For the introduction of an octadecyl group, the alkyl iodide was
used, leading to sulfondiimine 56f in 70% yield (entry 5). When employing branched alkyl bro-
mides as the reagents, a strong steric influence on the yields was observed. Whereas an isobu-
tyl-substituted product 56g was still obtained in a high yield of 79% (entry 6), a sterically more
demanding isoamyl-substituent led to only 38% of product 56h even after an elongated reac-
tion time of 9 h (entry 7). Along the same lines, an isopropyl and a cyclohexyl derivative were
not formed at all (entries 8–9). In addition, the introduction of unsaturated substituents pro-
ceeded well irrespective of the double and triple bond positions in linear bromoalkenes and
alkynes. In all cases, the unsaturated moiety remained intact after the transformation, provid-
ing different N-alkenylated and alkynylated products in good yields (56i–m, 69–88%; entries
10–14). Furthermore, the conditions proved suitable for the synthesis of aryl-substituted prod-
ucts 56n and 56o (70% and 80% yield, respectively; entries 15–16). It is of note that these re-
sults demonstrated the superiority of the protocol over previous studies[30, 47] by accessing the
first N-benzylated sulfondimine 56n (entry 15) and the propargylic sulfondiimine 56l in an en-
hanced yield of 88% compared to the previously used KH in THF (68% yield[30]). Of interest, the
introduction of a sulfondiimine into a natural product was successful. The conversion of (rac)-
NH-sulfondiimine 17 with (S)-citronellyl bromide afforded the desired N-alkylated product 56q
as a mixture of nonseparable diastereomers in 65% yield (d.r. = 1:1, entry 18). With 1-bromo-4-
chlorobutane or 1,4-dibromobutane as the reagent, disappointingly, no alkylated products
were detected, but degradation of sulfondiimine 17 completed after 5–7 h (entry 19).
38 | R e s u l t s a n d D i s c u s s i o n
Table 2-4: Substrate scope with respect to the alkyl bromides 57.
Entry Residue Alkyl bromide
57 Yield of 56 [%][a]
1 d b, 72
2 e c, 80
3
f d, 76
4 g e, 64
5
h f, 70[b]
6
i g, 79
7
j h, 38[c]
8
- - [d]
9
- - [d]
10 k i, 72
11
l j, 72
12
m k, 78
13 n l, 88
14 o m, 69
15
p n, 70
16
q o, 80
17
r p, 73
18
s q, 65[e]
19 - - [f]
[a] After flash column chromatography. [b] Reaction performed with iodide. [c] Reaction performed for 9 h. [d] No product detected after 24 h. [e] Product was obtained as a mixture of diastereomers. [f] Complete degradation of sul-fondiimine 17 after 7 h.
R e s u l t s a n d D i s c u s s i o n | 39
Furthermore, reactions of different sulfondiimines 106 were performed with butyl bromide
(57a) as the representative reagent (Scheme 2-8). In general, S-aryl-S-alkyl sulfondiimines re-
acted readily. As such, different substituents on the S-phenyl moiety were well-tolerated, af-
fording methoxy-, bromo-, and methyl-substituted products 56r–t (79–85%) in comparable
yields to the corresponding nonsubstituted product 56a (84%; Table 2-3, entry 1). Favorably,
the C‒Br o d as preserved during the reaction process, and remains accessible for further
classical cross–couplings. The yield of an S-cyclopropyl derivative 56u was in the same range
(75%).
Scheme 2-8: Scope of sulfondiimines 106.
As described for the corresponding N-arylation reactions (Scheme 1-30[47] and Scheme 2-10[71]),
the substituent on the second nitrogen atom of the particular NH-sulfondiimines showed a sig-
nificant effect on the product yields. Delightfully, in contrast to the instability of N-tosylated
sulfondiimines reported for these N-arylation protocols, the N-butylation towards
N-tosyl-substituted product 56v proceeded well (78% yield). In addition, employing 12-bromo-
1-dodecene as the reagent resulted in N-PMP-substituted sulfondiimine 56w (78% yield). Con-
trary, the attempted second N-alkylation of a N-butyl-NH sulfondiimine failed. Finally, a repre-
sentative S,S-dialkylated sulfondiimine was subjected to the N-alkylation protocol, affording
tetrahydrothiophene derivative 56x in a very good yield of 94%.
Subsequently, to deprotect PMP-substituted sulfondiimine 56w, an oxidative cleavage protocol,
previously reported in our group, was chosen.[47] Disappointingly, instead of leading to the de-
sired NH-sulfondiimine, the corresponding employment of a combination of Na2CO3 and CAN in
H2O/CH3CN resulted in the decomposition of N-alkylated sulfondiimine 56w.
Notably, the N-alkylation protocol proved applicable for sulfoximines as well. Corresponding
reactions have been carried out in our group (by Dr. Hendriks),[81] affording various N-alkylated
sulfoximines in good to excellent yields.[79]
40 | R e s u l t s a n d D i s c u s s i o n
2.2.4 Application
The newly developed protocol was applied to the synthesis of an aza-analog of Suloxifen 111
(Figure 2-1). Favorably, the first attempt already showed the possibility of accessing the desired
aza-analog 56y by employing the newly developed N-alkylation protocol (Scheme 2-9). In future
work, this synthetic application needs optimization in order to increase the product yield. Fur-
thermore, it is of interest to synthesize differently substituted aza-analogs of Suloxifen and to
test them regarding their biological activities.
Scheme 2-9: Synthesis of a sulfondiimine-based Suloxifen analog.
2.2.5 Summary and outlook
In this work, the first general protocol for N-alkylations of NH-sulfondiimines is presented, em-
ploying alkyl bromides 57 with KOH in DMSO at ambient temperature. This cost-effective and
operationally simple method gives access to various previously unprecedented N-alkylated
products 56 in good to excellent yields. In this context, the sulfondiimine-based products 56, in
particular sulfondiimine-based analogs of Suloxifen, represent molecules of interest for phar-
maceutical and agrochemical applications, and should be tested regarding their biological activ-
ities.
Scheme 2-10: N-Alkylations of NH-sulfondiimines 19 mediated by KOH in DMSO.
R e s u l t s a n d D i s c u s s i o n | 41
3 -Functionalizations
3.1 -Functionalizations of N-mono- and N,N'-disubstituted sul-fondiimines (Project P3)
3.1.1 Background and aim of the project
Taking advantage of the possibility of a stereogenic center at the sulfur atom, sulfoximines—particularly the β-hydroxy sulfoximines and their NH-derivatives—established as chiral auxilia-
ries and ligands in asymmetric synthesis and enantioselective metal catalysis.[7] Considering the
higher nucleophilicity of the deprotonated nitrogen atom compared to the S-methyl group of
NH-sulfoximines 100, common syntheses of β-hydroxy sulfoximines 117 start from N-protected
sulfoximines 118, which are metallated with strong bases and subsequently trapped with car-
bonyl reagents such as aldehydes or ketones. To access the corresponding N-unsubstituted
products 119, an additional step of deprotection was crucial (Scheme 3-1).
Scheme 3-1: β-Hydroxy sulfondiimines 122 and 123 are the objectives of this project.
Surprising in light of the contributions on sulfoximines, in spite of the additional possible substi-
tutions at the second nitrogen, the stru turall related β-hydroxy sulfondiimines have not been
reported to date. Hence, the aim of this project included the synthesis of previously unprece-
dented N,N'-disubstituted (122) and N-monosubstituted (123) β-hydroxy sulfondiimines.[82]
Accordingly, the preparation of differently substituted products 122 and 123 by the metalation
of N,N'-disubstituted sulfondiimines 121 and subsequent addition of different electrophilic rea-
gents was planned. Additionally, a step-economic alternate pathway towards
N-monosubstituted β-hydroxy sulfondiimines 123 was envisioned (Scheme 3-1).[83] Of note, this
protocol would represent a significant advancement to the literature version, as it can avoid the
laborious and challenging nitrogen protection/deprotection of sulfondiimines.
42 | R e s u l t s a n d D i s c u s s i o n
3.1.2 Optimization
For optimization attempts, the generation of sulfondiimidoyl-carbanions from
N,N'-disubstituted sulfondiimine 61a and their subsequent addition to benzaldehyde (72a) was
selected as the test reaction. The results of different basic systems in this transformation are
summarized in Table 3-1.
Initial attempts included the use of KOH (2.0 equiv) in DMSO. This combination is known to
generate a so- alled super asi edium and facilitated the aforementioned N-alkylations of
NH-sulfoximines and NH-sulfondiimines (chapter 2.2).[79] However, in case of sulfondiimine 61a,
only partial substrate degradation occurred (entry 1). As advancement, lithium-based carbani-
ons generated from substrate 61a, LDA, and n-BuLi showed significantly enhanced reactivities,
affording the desired product 122a in medium yields, unfortunately, in combination with sever-
al unidentifiable side products (entries 2–3).
Table 3-1: Optimization of the reaction conditions.
Entry Base [equiv] Solvent 1) T [°C]; t [min] 2) T [°C]; t [h] Yield [%][a]
1 KOH (2.0) DMSO 20; 15 r.t.; 20 0[b] 2 LDA (1.2) THF –78; 15 –78 to r.t.; 20 53
3 n-BuLi (1.2) THF –78; 15 –78; 1 58
4 n-BuLi (1.05) THF –78; 15 –78; 2 63[b]
5[c] n-BuLi (1.05) THF –78; 30 –78; 1 94
[a] After column chromatography. [b] Partial recovery of 61a. [c] Addition of TMEDA (2.0 equiv).
Favorably, reducing the amount of n-BuLi avoided the formation of side products (entry 4), and
the addition of TMEDA (2.0 equiv) resulted in complete conversion. Thereby, the desired
β-hydroxy sulfondiimine 122a was obtained in 94% yield (entry 5).
3.1.3 Substrate scope
3.1.3.1 N,N'-Disubstituted examples
With the optimal reaction conditions in hands (Table 3-1, entry 5), we investigated the sub-
strate scope of this reaction process with respect to the aldehydes 72, affording the first and
differently substituted β-hydroxy sulfondiimines. Therefore, sulfondiimine 61a was selected as
the representative substrate and subjected to the reaction with differently substituted alde-
hydes 72 (products 122a–k; Table 3-2). In all cases, reactions were monitored by TLC and
quenched upon full conversion. If the conversion was nonsatisfying at –78 °C, the reaction mix-
ture was warmed to room temperature.
R e s u l t s a n d D i s c u s s i o n | 43
In general, the transformations afforded the products in good to very good yields in short reac-
tion times, irrespective of the different functional groups in the aldehyde. Contextually, as ex-
pected for addition reactions, electron–withdrawing substituents resulted in higher product
yields than electron–donating ones. As such, nitro, trifluoromethyl, and chloro derivatives
122b–d have been obtained in very good yields (82–84%; entries 2–4), whereas corresponding
thiomethyl- and methoxy-substituted examples 122e (67%) and 122f (68%) gave comparably
lower yields (entries 5–6). In contrast, steric effects had no considerable impact on the yields of
the corresponding para- and ortho-methylated products 122g and 122h (78–81%; entries 7–8).
While crotonaldehyde reacted readily, accessing product 122i in 80% yield (entry 9), the use of
cinnamaldehyde 72i (39%; entry 10) and hexanal 72k (30%; entry 11) resulted in low yields of
the corresponding β-hydroxy sulfondiimines 122j and 122k, respectively. It can be noted that
the alkene moieties remained intact in products 122i and 122j (entries 9–10).
Table 3-2: The scope of aldehydes was investigated for the reaction of sulfondiimine 61a.
Entry R1-, Aldehyde 72 2) T [°C]; t [h] Yield of 122 [%][a]
1 C6H5-, a –78; 1 a, 94 2 4-NO2-C6H5-, b –78; 2 b, 82 3 4-CF3-C6H5-, c –78; 1 c, 83 4 4-Cl-C6H5-, d –78; 2 d, 84 5 4-SMe-C6H5-, e –78; 2 e, 67 6 4-OMe-C6H5-, f –78; 1 to r.t.; 2 f, 68 7 4-Me-C6H5-, g –78; 2 to r.t.; 2 g, 78 8 2-Me-C6H5-, h –78; 2 to r.t.; 2 h, 81
9 , i –78; 1.5 i, 80
10 , j –78; 3 j, 39
11 Me-(CH2)4-, k –78; 1 to r.t.; 23 k, 30[b]
[a] After column chromatography. [b] Yield determined by NMR.
The reaction of an alternative sulfondiimine (rac)-106l with benzaldehyde (72a) proceeded
well, affording N-PMP-substituted product 122l in a good yield as a mixture of diastereomers
(Scheme 3-2). As it was not possible to separate the diastereomers, the diastereomeric ratio
was determined by 1H NMR spectroscopy. Additional attempts of deprotecting N-PMP-
substituted product 122l failed with a protocol that recently proved effective for N,N'-
disubstituted sulfondiimines.[47]
44 | R e s u l t s a n d D i s c u s s i o n
Scheme 3-2: The alternative sulfondiimine (rac)-106l reacted readily.
Additionally, the employment of alternative electrophilic reagents was attempted. In this con-
text, an alkylation of sulfondiimine 61a with methyl iodide (124) at –78 °C proved successful
(94% yield of 125; Scheme 3-3). In contrast, no reaction occurred with representative ketones.
As such, when acetone (126) or acetophenone (127) (each 2.0 equiv) were employed as the
electrophilic reagents, even after stirring for 48 h at room temperature solely the degradation
of 61a occurred, and no desired products were detected.
Scheme 3-3: Alkylation of sulfondiimine 61a.
3.1.3.2 N-Monosubstituted examples
As outlined before, the one-pot synthesis of NH-β-hydroxy sulfondiimines 123 was attempted.
Avoiding the protection of the nitrogen atom of NH-sulfondiimine (rac)-17, the direct formation
of the correspo di g β-hydroxy-substituted products 123a|b succeeded by employing excess
amounts of n-butyllithium (Scheme 3-4). Accordingly, 123a proved directly accessible from NH-
sulfondiimine 17 and benzaldehyde in 44% yield as a mixture of diastereomers (top, d.r. = 1:1).
In addition, product 123b has been prepared from substrate 17 and 1,3-diphenylprop-2-yn-1-
one (128a) (62% yield of 123b, d.r. = 1:1). As observed previously for structurally analogous
sulfoximines,[84] the resulting diastereomers of 123b proved readily separable by simple flash
column chromatography, whereas separations of products derived from aldehydes failed.
These transformations have significant potential for the preparation of sulfondiimine-based
ligands.
Scheme 3-4: Direct syntheses of N-monosubstituted products 123.
R e s u l t s a n d D i s c u s s i o n | 45
3.1.4 Summary and outlook
The trapping of sulfondiimine-based ɑ-lithiated carbanions with differently substituted alde-
hydes led to several pre iousl u pre ede ted β-hydroxy sulfondiimines in good to excellent
yields (Scheme 3-5). In addition, the possibility of alkylation with methyl iodide was successfully
demonstrated for a representative N,N'-disubstituted sulfondiimine. Of special interest,
N- o osu stituted β-hydroxy sulfondiimines have been accessed by an improved protec-
tion/deprotection-free protocol (Scheme 3-5).
Scheme 3-5: The first β-hydroxy sulfondiimines have been prepared in this project.
Based on previous work, which demonstrated the possibility of accessing enantiopure sul-
fondiimine derivatives with a stereogenic center at the sulfur atom,[30] further studies should
i lude the preparatio of hiral β-hydroxy sulfondiimines from the corresponding enantiopure
substrates. Subsequently, their potential as chiral auxiliaries and ligands should be evaluated in
comparison to the existing applications of structurally related sulfoximines.[7]
R e s u l t s a n d D i s c u s s i o n | 47
4 Cyclizations towards 1,2-(Benzo)thiazines
The introduction of heterocycles into a small molecule can remarkably influence its binding to
major drug targets.[85] As such, heterocycles of diverse structure and shape are of high interest
for drug design, as evidenced by their ubiquity in active pharmaceutical ingredients.[86] Howev-
er, influenced by the demanding synthetic accessibility, the number and shapes of ring scaffolds
available for drug design remain strongly limited to date.[87] Hence, the development of syn-
thetic pathways towards poorly and entirely unexplored classes of heterocyclic scaffolds re-
mains a highly important field in organic chemistry.
1,2-Thiazines represent a six-membered lass of “‒N-based heterocycles known to feature mul-
tiple bioactivities. Related applications as pharmaceutical agents such as antipyretic and anti-
inflammatory examples have been reported in addition to applications as materials in electron-
ics, chiral ligands and auxiliaries, reagents in asymmetric fluorination, and in complex alkaloid
total synthesis. Among the 1,2-thiazine derivatives, the 1,1-dioxides have been well-explored,
while scope and applications of the structurally related 1-oxides 131 and 1-imines 132|133
appear highly underinvestigated (Scheme 4-1).[88]
In this context, the aim of the following projects included the expansion into poorly and essen-
tiall u e plored areas of drug-like he i al spa e [85a, 87a] and the enlargement of the limited
edi i al he ists’ tool o for drug desig .[87] This should be realized by the synthesis of
previously unprecedented 1,2-thiazine 1-oxides 131 and 1,2-thiazine 1-imines 132 (chapter
4.1), or their benzo derivatives 133 (chapter 4.2). Thereby, a combination of the valuable prop-
erties of aza and diaza-analogous sulfones as the objectives of this thesis with that of 3D-
heterocyclic motifs frequently occurring in active pharmaceutical ingredients[86] was intended.
Scheme 4-1: Heterocyclic compounds 131–133 represent the targets of the following projects.
48 | R e s u l t s a n d D i s c u s s i o n
4.1 Syntheses of 1,2-thiazine oxides and imines (Project P4)
4.1.1 Background and aim of the project
Representing a unique class of 3D, fully unsaturated heterocycles, sulfoximine-based 1,2-
thiazines 131 consist of half-boat conformations with the apex at the sulfur atom, and can best
be regarded as nonaromatic cyclic sulfur ylides with a charge delocalization over the azapentyl
moiety.[89] To date, the most frequently used synthetic protocols for 1,2-thiazine 1-oxides 131
involve the reaction of NH-sulfoximines 100 with 1,3-biselectrophiles such as 2-alkoxy malo-
nates 135,[90] ketene thioacetals 136,[91] or trifluoroalkyl enones 137[92] and subsequent base-
mediated intramolecular cyclizations (Scheme 4-2, top).[88] Avoiding the isolation of the N-
vinylated sulfoximine intermediates D, WILLIAMS and CRAM reported an enhanced alternative
protocol by utilizing a propargyl ketone 128a as the reaction partner (Scheme 4-2, bottom).[93]
In lieu of the 1,2-thiazines 1-imines 132 unprecedented to date, the structurally related and
partly annulated 1,2,4-thiadiazine 1-imine derivatives 96a–c obtained from cyclizations of N,N'-
disubstituted sulfondiimines 95 with sodium hydride in DMSO in mainly poor yields (14–55%;
Scheme 1-44) exist.[41a]
As N-vinylated sulfondiimines showed significant instability in previous studies,[71] the two-step
protocols applied in the synthesis of 1,2-thiazine 1-oxides 131 appear not suitable for their aza
analogs. Instead, inspired by WILLIAMS and CRAM,[93] the aim of this project was the develop-
ment of a mild and general protocol for the one-pot syntheses of heterocyclic motifs 131|132
from NH-sulfoximines 100, NH-sulfondiimines 120 and propargyl ketones 128. Thereby, extend-
ing the scope of 1,2-thiazine 1-oxides 131 and accessing the first 1-imine derivatives 132 was
aspired.[94]
Scheme 4-2: Common synthetic pathway and one-pot approach reported for 1,2-thiazine 1-oxides
131,[93] and their iminated derivatives 132 as the objectives of this project.
R e s u l t s a n d D i s c u s s i o n | 49
4.1.2 Optimization
Standard NH-sulfondiimine 17 was selected as the test substrate and subjected to reactions
with propargyl ketone 128a in combinations with different bases and solvents upon addition of
molecular sieves 4 Å (Table 4-1). In some cases, the results have been evaluated in comparison
to the corresponding reactions of NH-sulfoximine 100a.
Table 4-1: Optimization of the reaction conditions.
Entry Base t [h] T [°C] Solvent Yield of 132a [%]
1 NaH 24 RT DMSO 70 (131a)[a,b]
2 NaH 24 RT DMSO 31[a,b]
3 KOH 5 RT DMSO 83 (131a) 4 KOH 5 RT DMSO 53[a]
5 KOH 5 RT DMSO 53[a,c]
6 KOH 24 RT DMSO 57 7 KOH 5 40 DMSO 53
8 KOH 5 80 DMSO 49
9 KOH 5 120 DMSO 44[d]
10
Cs2CO3 5 80 DMSO 78
11 Cs2CO3 5 60 DMSO 64 12 Cs2CO3 5 100 DMSO 78
13 Cs2CO3 5 80 DMF 41[a]
14 Cs2CO3 5 80 MeCN 22[a]
15 Cs2CO3 5 80 1,4-dioxane 0[a]
16 Cs2CO3 5 80 toluene 0[a]
17 Cs2CO3 5 80 DCE 0[a]
18 K2CO3 5 80 DMSO 0[a]
19 Na2CO3 5 80 DMSO 0[a]
20 Cs2CO3 5 80 DMSO 99 (131a) [a] Partial recovery of 100|17. [b] First step performed for 45 min. [c] Use
of 128a (0.5 equiv instead of 1.5 equiv). [d] Partial decomposition of 17.
With the procedure reported by WILLIAMS and CRAM as starting point,[93] sodium hydride was
employed as the base in DMSO. As expected, this combination proved utilizable for the synthe-
sis of 1,2-thiazine 1-oxide 131a (entry 1). However, the yield of the corresponding aza analog
132a was low (entry 2), and o full o ersio s ould e a hie ed. With KOH i DM“O, a su-
per asi rea tio s ste effe ti e i the N-alkylations of NH-sulfoximines and
NH-sulfondiimines (chapter 2.2),[79] the yield of sulfoximine-based heterocycle 131a was high
(83%; entry 3).
50 | R e s u l t s a n d D i s c u s s i o n
However, in all cases, including varying amounts of NH-sulfondiimine 17, reaction times and
reaction temperatures, nonsatisfying yields of iminated heterocycle 132a were observed
57%; entries 5–9). Finally, the best results were obtained with cesium carbonate as the base
at 80 °C in DMSO, affording 1,2-thiazine 1-imine 132a in 78% yield (entry 10). Other reaction
temperatures (entry 11–12), solvents (DMF, MeCN, 1,4-dioxane, toluene, DCE; entries 13–17),
and counter cations (Na+, K+, entries 18–19) did not improve the yield. Favorably, this combina-
tion as well proved applicable to the synthesis of the corresponding oxidized derivative (99%
yield of 131a; entry 20).
4.1.3 Selectivity
It is of note that the propargyl ketone 128a, which has been employed by WILLIAMS and
CRAM[93] and in the aforementioned optimization of the reaction conditions (chapter 4.1.2),
incorporates two identical phenyl substituents. In contrast, for further reactions, the prepara-
tions of heterocycles 131|132 with well-positioned, potentially unequal groups at C3 and C5
were planned.
An initial investigation of the selectivity comprised the transformation of NH-sulfondiimine 17
with 4-tolyl-substituted reagents 128. Based on the previous syntheses reported for
1,2-thiazine 1-oxides (Scheme 4-2), a MICHAEL-addition/cyclization/dehydration sequence was
assumed, involving the intramolecular cyclization/dehydration of in situ formed N-vinylated
sulfondiimines (Scheme 4-3).
Scheme 4-3: A MICHAEL-addition/cyclization/dehydration sequence was anticipated.
Favorably, the outcome of both reactions matched the particular substitution patterns ex-
pected for this sequences and exclusively afforded either 1,2-thiazine 1-imine 132b or 132j in
good yields (Scheme 4-3, structure evidenced by 2D NMR spectroscopy).
4.1.4 Substrate scope
With the optimal reaction conditions in hand (Table 4-1, entries 10 and 20), we explored the
substrate scope of the reaction process. In this context, the preparation of well-defined, highly
variable heterocycles 131|132 (Scheme 4-2) was intended and required different substituents
at the sulfur substrates and the propargyl ketones. Unlike in 1971 when the protocol of WIL-
LIAMS and CRAM was reported,[93] these reagents are readily available from literature proce-
dures to date.[30, 95] In general, to properly evaluate the effects of individual substituents, at
least one phenyl group was incorporated in all products.
R e s u l t s a n d D i s c u s s i o n | 51
4.1.4.1 Reactions of sulfoximines
Reactions started either from the standard NH-sulfoximine 100a with various propargyl ketones
128b–s or from different sulfoximines 100b–g with propargyl ketone 128a, affording products
131b–n|p|q (Scheme 4-4).
Generally, electron–donating groups on the substrates afforded the corresponding products in
better yields than electron–withdrawing ones irrespective of their position. As such, C5–methoxy- and methyl-substituted products 131b and 131c were obtained in good yields (85 and
82%, respectively), whereas a nitro-substituent in the same position decreased the yield of het-
erocycle 131d to 44%. Whereas an S-para-nitro-substituted sulfoximine degraded under the
reaction conditions, heterocycle 131k bearing a tolyl group at C3 was obtained in an excellent
yield.
Scheme 4-4: Scope of propargyl ketones 128 and sulfoximines 100. [a] Yield determined by NMR.
Moreover, steric effects have been observed. For example, ortho-chloro-substituted heterocy-
cle 131g was obtained in a significantly lower yield than its para-substituted counterpart 31h
(63% versus 98%). Following the same trend, para- proved superior to meta-substitution for
C3–tolyl-substituents (99% versus 88%). Heterocycle 131e with a sterically demanding 2-
naphtyl-substituent was obtained in a comparatively low yield of 53%.
It is of note that halogenated heterocycles 131f–h|o incorporating fluorinated, chlorinated, and
brominated arenes could be prepared, whereas 131o proved of special interest for further
functionalizations (chapter 4.1.5).
52 | R e s u l t s a n d D i s c u s s i o n
In terms of avoiding arene substituents, for instance, alkyl-containing 131j and 131p were pre-
pared. Noteworthy, S-methyl-substituted product 131o was obtained in a higher yield com-
pared to the procedure of WILLIAMS and CRAM (46% versus 20%).[93] Unfortunately, the syn-
thesis of alternate other derivatives, including a fused example, failed due to the degradation of
hex-3-yn-2-one, 1-phenyldec-1-yn-3-one, and tetrahydrothiophene sulfoximine. Additional at-
tempts aimed at the preparation of a C3–(2-pyridine)-substituted heterocycle. This product
would represent an interesting analog of the 2,2'-bipyridine scaffold, which is a well-known
bidentate ligand frequently employed in catalytic reactions.[96] Unfortunately, the synthesis of
the corresponding propargyl ketone proved challenging, and no heterocyclic product could be
detected in subsequent cyclization attempts. When a corresponding S-(2-pyridyl) sulfoximine
was employed, the heterocyclic product 131r could be identified in NMR (8% yield, standard:
CH2Br2). Considering a higher stability of the starting material at lower temperatures, the reac-
tion was repeated at 60 °C. However, the NMR yield slightly decreased to 7%, and different
attempts of isolation failed. In contrast, introducing a heteroaromatic 2-thiophenyl substituent
was successful and provided product 131i in an excellent yield of 99%. Furthermore, 1,1,1-
trifluorobut-3-yn-2-one, 3-phenylpropiolaldehyde, methyl propiolate, and (E)-chalcone were
employed as alternate reagents instead of propargyl ketones. However, in all these cases solely
the degradation of the reagents, but no product formation occurred.
4.1.4.2 Reactions of sulfondiimines
Subsequent studies included the reactions of standard NH-sulfondiimine 17 with different pro-
pargyl ketones 128 (products 132b–k; Scheme 4-5).
Scheme 4-5: Substrate scope with respect to the propargyl ketones 128 and sulfondiimines 106.
R e s u l t s a n d D i s c u s s i o n | 53
In general, the same steric and electronic effects as those in the reactions of sulfoximines were
observed. Accordingly, sterically more demanding substituents led to lower yields, apparent in
the series of products 132f–g and 132j–k, and substitution with electron–donating groups
proved superior to electron–withdrawing ones. In this series, products bearing a para-nitro-
group at C5 or a heptyl substituent at C3 could not be obtained.
Employing different NH-sulfondiimines 106 with propargyl ketone 128a afforded heterocycles
132l–n (Scheme 4-5), including products 132l and 132m substituted by protecting groups
(R4 = cyano and PMP, respectively) at the second nitrogen. Unfortunately, corresponding N-
methyl and N-unsubstituted heterocycles were inaccessible by this reaction sequence due to
substrate degradation. Hence, for accessing the N-unsubstituted building block 132o of high
interest regarding further N-functionalizations, deprotections of heterocycles 132l or 132m
were envisioned (chapter 4.1.5.1).
4.1.5 Applications
To expand their synthetic value, further attempts focused on functional–group modifications
and derivatizations of the newly prepared products. In this context, the N-protected heterocy-
cles 132l and 132m (R4 = PMP, CN) and bromo-substituted product 131o (R1 = para-
bromophenyl) were selected as representative substrates and subjected to deprotection (chap-
ter 4.1.5.1), palladium–catalyzed cross–couplings (chapter 4.1.5.2), and C‒H bond activation
procedures (chapter 4.1.5.3).
4.1.5.1 Deprotection
As outlined, the deprotection of a 1,2-thiazine 1-imine was planned. Initially, N-PMP-protected
derivative 132l was chosen and subjected to deprotection conditions recently applied to N,N'-
disubstituted sulfondiimines.[47] However, complete substrate decomposition was observed in
this case. Favorably, starting from N-cyano-substituted product 132m, deprotection proceeded
smoothly by employing a one-pot protocol previously reported for N-cyano sulfoximines.[95b]
Hereby, heterocyclic building block 132o was obtained in almost quantitative yield (99%;
Scheme 4-6).
Scheme 4-6: The deprotection of heterocycle 132m afforded N-unsubstituted building block 132o.
54 | R e s u l t s a n d D i s c u s s i o n
4.1.5.2 Palladium–catalyzed amination and arylation
To further demonstrate the synthetic utility of the heterocyclic products, S-(para-
bromophenyl)-substituted heterocycle 131o (Scheme 4-4) was selected as the representative
building block and subjected to palladium–catalyzed cross–coupling procedures previously re-
ported by our group for (S)-S-(para-bromophenyl)-S-methyl-NH-sulfoximine.[97] Favorably, the
palladium–catalyzed SUZUKI-type arylation and BUCHWALD–HARTWIG-type amination of sub-
strate 131o proceeded well, providing access to heterocycles 134a|b, respectively (both 90%
yield, Scheme 4-7).
Scheme 4-7: SUZUKI-type arylation and BUCHWALD–HARTWIG-type amination of heterocycle 131o.
4.1.5.3 Regioselective direct C‒H bond functionalizations
The a ti atio of C‒H bonds, traditionally considered as unreactive, represents an attractive
strategy for highly atom- and step-economic C‒C o d for atio s. The ost pro isi g a ti a-
tion strategies involve metal–catalyzed, functional–group-directed organic reactions. Of partic-
ular interest, Cp*–rhodium(III)-catalyzed oxidative couplings of arene C(sp2)–H bonds with un-
saturated substrates were extensively investigated.[98] In contrast to the well-established O-
and N-containing directing groups, the applications of sulfur-based functional groups remained
rare.[99] As contribution to overcome these limitations, additional attempts of further function-
alizing the newly prepared sulfur-based heterocycles included the development of the first di-
re ted C‒H bond functionalizations by representative rhodium–catalyzed regioselective
alkenylations. Therefore, 1,2-thiazine 1-oxide 131a was selected as the representative sub-
strate and reacted with butyl acrylate (137) and with a catalytic system based on
[Cp*Rh(MeCN)3][SbF6]2 (Table 4-2).
Delightfully, initial attempts with copper acetate hydrate as the oxidant in DCE at 100 °C direct-
ly afforded the monoalkenylated product 136a, however, with the dialkenylated derivative
136b as a byproduct (entry 1). Changing the solvent to 1,4-dioxane increased both the yield and
the amount of byproduct (entry 2). Employing smaller amounts of copper oxidant and acrylate
did not significantly change the product yield, but favorably decreased the amount of byprod-
uct (entry 3).
R e s u l t s a n d D i s c u s s i o n | 55
In tert-AmOH, the yield of the mono- as well as the amount of the dialkenylated product slightly
increased (entry 4). Among these attempts, the use of copper acetate monohydrate (2.0 equiv)
in 1,4-dio a e as sele ted for further C‒H bond activation reactions, as the lowest amount of
byproduct in combination with the comparatively best yield of monosubstituted product 136a
was observed in this case (entry 3).
Table 4-2: Initial attempts of opti izi g the C‒H bond activation conditions.
Entry Acrylate
[equiv]
Cat. Rh
[mol%]
Cu(OAc)2·H2O
[equiv] Solvent
Yield [%][a] of
136a|136b
1 2 5 4 DCE 47|12 2 2 5 4 1,4-dioxane 65 (53)|26 (23) 3 1.5 2.5 2 1,4-dioxane 61|15
4 1.5 2.5 4 tert-AmOH 66|20 [a] Yield determined by NMR (internal standard: CH2Br2). Yield after column chroma-
tography in parenthesis.
Finally, the rhodium–catalyzed regioselective ortho-alkenylation of building block 131o led to
ortho-alkenylated product 136c in a good yield of 74% (Scheme 4-8). Here, the corresponding
dialkylated 1,2-thiazine oxide 136d was observed as the byproduct in 19% yield, which proved
readily separable by column chromatography. Product 136c is of special interest as the bromo-
substituent remains accessible for further functionalizations after the regioselective alkenyla-
tion reaction. Notably, these transformations represe t the first dire ted C‒H bond functionali-
zations of molecular flexible 1,2-thiazines.
Scheme 4-8: Regioselective ortho-alkenylation of building block 131o.
Unfortunately, when a representative phenyl-substituted 1,2-thiazine 1-imine 132a was sub-
jected to these reaction conditions, substrate degradations anticipated the formation of the
desired alkenylated product 136. Further studies are necessary to enable the C‒H bond activa-
tion in this molecular scaffold.
56 | R e s u l t s a n d D i s c u s s i o n
4.1.6 Summary and outlook
Inspired by WILLIAMS and CRAM (Scheme 4-2),[93] a one-pot, regioselective, and general proto-
col for the syntheses of differently substituted, previously unprecedented 1,2-thiazines
131|132 in good to excellent yields from readily available NH-sulfoximines 100,
NH-sulfondiimines 120, and propargyl ketones 128 was developed. Noteworthy, the 1,2-
thiazine 1-imines 132 as a previously unprecedented class of heterocycles have been accessed
for the first time.
Scheme 4-9: 1,2-Thiazines prepared in this project.
The products proved of high synthetic value being readily modifiable regiosele ti e C‒H bond activations, deprotection, and classical cross–coupling reactions. In future studies, the
biological activities of the newly prepared 1,2-thiazine derivatives should be tested. In addition,
further derivatizations of the products, for instance of the N-unprotected derivative 132o, ap-
pear of interest regarding potential lead optimizations. The preparation of enantiopure oxidized
and iminated heterocycles by applying NH-sulfoximines and NH-sulfondiimines[30] readily avail-
able in enantiomerically pure form (Scheme 1-16) are encountered possible as well.
4.2 Syntheses of 1,2-benzothiazine 1-imines (Project P5)
4.2.1 Background and aim of the project
1,2-Benzothiazines represent six- e ered “‒N-based heterocycles of high commercial im-
portance due to their potent biological activity.[88, 100] In particular, the so-called oxicams as the
most biologically active benzothiazines incorporating an 1,2-benzothiazine 1,1,4-trioxide core
have been investigated in detail.[88] Contrarily, affected by their challenging synthetic accessibil-
ity the structurally related 1,2-benzothiazine 1-oxides 134 have been rather neglected in medic-
inal chemistry and crop protection.[88, 100] As single example, STOSS and SATZINGER at Gödecke
and Warner–Lambert claimed the antisecretory activity of benzothiazine derivatives 134a
(Scheme 4-10).[101]
Regarding the synthesis of 1,2-benzothiazine 1-oxides 134, seminal work of WILLIAMS and
CRAM in 1971 included the first example 134b obtained by an imination/ring-closure reaction
sequence of sulfoxide 139 with sodium azide under acidic conditions (Scheme 4-10).[93a]
R e s u l t s a n d D i s c u s s i o n | 57
Scheme 4-10: First synthesis of a 1,2-benzothiazine oxide 134b by WILLIAMS and CRAM[93a], and deriva-
tives 134a with antisecretory activity claimed by STOSS and SATZINGER.[101-102]
Subsequent synthetic protocols involved NH-sulfoximines 100 as the substrates. Besides syn-
theses of dibenzothiazines,[103] HARMATA and coworkers reported the SONOGASHIRA-type
cross–coupling of ortho-bromo sulfoximine 100h and subsequent intramolecular alkyne ami-
dation towards benzothiazines 134c (Scheme 4-11). Disadvantageously, only with alkyl-
substituted alkynes 140 high selectivities towards the heterocycles 134c proved possible,
whereas 1,2-benzoisothiazoles 141 represented the major products with alkynylarenes 140.[95c]
Scheme 4-11: SONOGASHIRA-type synthesis of benzothiazines 134c by HARMATA and coworkers.[95c]
More recently, BOLM[99f, 99g] and coworkers investigated alternative synthetic pathways towards
1,2-benzothiazine oxides 134 involving highly atom- and step-economic Cp*–rhodium(III)-
catalyzed C‒H bond activations of the S-arene ortho-C(sp2)–H of sulfoximines 100 with alkynes
142 or diazo compounds 143 (path a|b, Scheme 4-12). Subsequently, attempts by GLORIUS[104]
and coworkers involved the application of tosyl and mesyl ketones 144 as oxidized alkyne
equivalents in some redox-neutral variations (path c, Scheme 4-12). All of those reactions rep-
resent examples for the—presumably due to the potential catalyst poisoning—scarce applica-
tions of sulfur-containing directing groups in metal–catalyzed FG–directed couplings of C–H
bonds. In contrast, although they bear an increased potential for structural diversity compared
to sulfoximine-based examples 134, no 1,2-benzothiazine 1-imines 133 exist. To date, the only
sulfondiimine-based benzothiazine existing is N-unsubstituted 2,1-benzothiazine 97, which re-
sulted from a palladium–catalyzed N-arylation of NH-sulfondiimine 17 with ortho-
bromobenzaldehyde (72l) and a subsequent intramolecular addition/condensation process
(Scheme 1-45).[47]
Inspired by the recent elegant pathways towards 1,2-benzothiazine 1-oxides 134 by direct C‒H bond functionalizations reported by BOLM[99g] or GLORIUS[104] and coworkers, the aim of this
project was to access the first 1,2-benzothiazine 1-imines 133 by rhodium–catalyzed annulation
reactions of NH-sulfondiimines 106.
58 | R e s u l t s a n d D i s c u s s i o n
Scheme 4-12: Recently published protocols for the syntheses of 1,2-thiazine 1-oxides 134.[99f, 99g, 104]
Considering different reaction partners such as alkynes 142 (chapter 4.2.2.1),[99f] diazo com-
pounds 143 (chapter 4.2.2.2),[99g] and ɑ-substituted ketones 144 (chapter 4.2.2.3),[104] as varia-
ble substitution patterns as possible were attempted for the heterocyclic products 133. There-
by, broadening the scope of sulfur-based directing groups in the Cp*–rhodium(III)-catalyzed
couplings of arene C(sp2)–H bonds was envisioned.
4.2.2 Results and discussion
4.2.2.1 Alkynes
Initially, diphenylacetylene (142a) as the representative alkyne was employed as the reaction
partner inspired by a procedure previously reported by our group (Scheme 4-12).[99f] Contextu-
ally, the oxidative annulation of NH-sulfondiimine 17 towards 3,4-substituted 1,2-benzothiazine
133 was investigated (Scheme 4-13).
Scheme 4-13: The annulation of an internal alkyne failed to give the first 1,2-benzothiazine 1-imine.
With [Cp*Rh(MeCN)3][SbF6]2 as the catalyst and copper acetate monohydrate as the oxidant in
different solvents (DMF, DCE, dioxane) no heterocyclic product could be detected in all cases.
Whereas the alkyne was recovered, full degradation of NH-sulfondiimine 17 was observed after
18 h under the harsh oxidative reaction conditions. To enhance the selectivity towards the de-
sired 1,2-benzothiazines 133, subsequent attempts included the use of reaction partners differ-
ent from alkynes.
R e s u l t s a n d D i s c u s s i o n | 59
4.2.2.2 Diazo compounds
I spired a C‒H bond activation/cyclization/condensation process recently reported for sul-
foximines by our group (Scheme 4-12),[99g] further attempts focused on regioselective rhodium–catalyzed annulation reactions of substrate 17 with diazo compounds. Contrary to the previous-
ly described annulation reactions with internal alkynes under harsh oxidative reaction condi-
tions (Scheme 4-13), no external oxidants have been necessary with diazo compounds.[99g] This
combination was envisaged to result in a better selectivity of the process and a higher stability
of the sulfondiimine substrates.
Optimization
In terms of optimization, ethyl diazoacetoacetate (143a) was used as the representative rea-
gent in the initial reactions with NH-sulfondiimine 17. According to the literature protocol,[99g]
[Cp*Rh(MeCN)3][SbF6]2 was employed as the catalyst in combination with sodium acetate as
the base (Table 4-3). At 100 °C in DCE, the desired heterocycle 133a was formed in an already
good yield of 72% after only 3 h of reaction time (entry 1). Favorably, as reported previously for
the corresponding sulfoximines,[99g] exclusively the 1,2-benzothiazine with the ester moiety at
C4 was formed.
Table 4-3: Optimization of the annulation reaction conditions.[a]
Entry Solvent T [°C] t [h] Cat. Rh
[mol%] Yield [%]
1 DCE 100 3 5 72[b] 2 DCE 80 5 5 84[b] 3 DCE 100 16 - [c] - 4 toluene 100 3 5 98[d], 99[b] 5
MeCN 100 3 5 99
[d], 100[b]
[a] Reactions performed in a nitrogen atmosphere and in a microwave
reactor. [b] Determined by NMR spectroscopy. [c] Use of [Cp*Co(C6H6)]
[PF6]2 (10 mol%). [d] After column chromatography.
At elevated temperatures in DCE, the catalytically active rhodium species was highly reactive,
and NMR and GC/MS analysis of the crude reaction mixture showed the formation of several
byproducts such as dialkylated noncyclized NH-sulfondiimine 145 (Figure 4-1).
60 | R e s u l t s a n d D i s c u s s i o n
Figure 4-1: Byproduct observed in the annulation reaction of substrate 17.
Reducing the amount of byproducts succeeded by decreasing the reaction temperature, afford-
ing product 133a in an increased yield of 84% after a slightly elongated reaction time of 5 h (en-
try 2). Extensively increasing the amount of diazo compound (4.0 equiv) even promoted the
formation of the undesired dialkylated sulfondiimine 145. When employing a cobalt
catalyst,[105] no reaction occurred, and the substrates were recovered (entry 3). The solvent
turned out to be the critical factor for success. Accordingly, excluding the alkylation of the sub-
strate, heterocyclic product 133a was obtained in excellent yields in acetonitrile (99%; entry 4)
or toluene (98%; entry 5). Finally, reducing the amount of rhodium–catalyst significantly re-
duced the yield of the desired 1,2-benzothiazine 133a (Table 4-4), and no product was formed
without the rhodium catalyst (entry 4).
Table 4-4: Optimization of the amount of rhodium catalyst.[a]
Entry t [h] Cat. Rh
[mol%] Yield [%][b]
1 3 5 97
2 3 4 89 3 3 2.5 75 4 24 - -
[a] Reactions performed in an argon atmos-
phere and in a schlenk tube. [b] After column
chromatography.
Substrate scope
During initial attempts of accessing different 1,2-benzothiazine 1-imines 133, the substrate
scope of the annulation reaction was investigated with respect to the diazo compounds 143
(products 133b–c) and NH-sulfondiimines 106 (products 133d–f). All reactions were conducted
by using the previously optimized reaction conditions (Table 4-4, entry 1).
R e s u l t s a n d D i s c u s s i o n | 61
Favorably, of special interest regarding the attempted well-defined substitution patterns in the
products, all reactions proceeded in a regioselective manner and exclusively afforded products
with the (hetero)carbonyl substituent at C4 (Scheme 4-14). By varying the diazo compound,
heterocycles 133b–c were obtained in excellent yields (99% and 95%, respectively).
Scheme 4-14: Initial attempts to investigate the substrate scope afforded benzothiazines 133b–f.
Further attempts included the variation of the S-aryl-S-alkyl-sulfondiimine employed in the
transformation. As reported for structurally related sulfoximines,[99g] electronic effects remark-
ably influenced the yields of the heterocyclic products. As such, electron–donating substituents
on the S-phenyl moiety of NH-sulfondiimines gave methoxy- (133d) and methyl-substituted
(133e) products in very good yields, whereas a corresponding nitro-substituted product re-
mained inaccessible due to substrate degradation. Of interest, S-cyclopropyl heterocycle 133f
proved readily accessible in a good yield of 89%. In contrast, no formations of the correspond-
ing S-benzyl- and N-(hydroxyalkyl) benzothiazines were detected after 24 h.
4.2.2.3 ɑ-Substituted ketones
In addition to the carbene insertion reactions of NH-sufondiimines 106 with diazo compounds
143, which afforded 3,4-substituted 1,2-benzothiazines 133a–f, an alternate strategy towards
4-unsubstituted derivatives was investigated. For the corresponding sulfoximine-based deriva-
tives 134, the synthesis of this molecular framework remained challenging for a long time.
62 | R e s u l t s a n d D i s c u s s i o n
As advancement, GLORIUS reported the use of (pseudo)halo ketones for the synthesis of
3-alkylated and -arylated examples (Scheme 4-12).[104] Inspired by this method, the transfor-
mation of NH-sulfondiimines towards 4-unsubstituted 1,2-benzothiazine 1-imines 133 was en-
visioned.
Optimization
In terms of optimization, the protocol reported by GLORIUS[104] was applied to
NH-sulfondiimine 17 as the test substrate, and its transformation with ɑ-halo (bromo, chloro)
and ɑ-pseudohalo (mesyl, tosyl) benzophenones was performed (Table 4-5). According to the
GLORIUS protocol,[104] initial attempts included the use of copper acetate (10 mol%) as external
oxidant (entries 1–5 and 8–9). Typically therein, irrespective of the ketone reagent of choice, at
lower reaction temperatures comparably better yields of the desired heterocycle 133g were
obtained (entries 2, 4 and 8). In comparison, the reaction was accelerated at elevated tempera-
tures; however, coming along with lower product yields and substrate degradations (entries 3,
5, and 9).
Table 4-5: Optimization of the reaction conditions.
Entry X, 144 Cu(OAc)2
[mol%] T [°C] t [h] Yield [%][a]
1 Br, c 10 40 20 - 2 Cl, d 10 40 20 16[b] 3 Cl, d 10 80 48 9[b]
4 OTs, b 10 40 48 73[c]
5 OTs, b 10 80 20 31[d]
6 OTs, b - 40 48 65[c]
7 OTs, b - 80 20 57
8 OMs, a 10 40 48 86
9 OMs, a 10 80 20 48[d] 10 OMs, a - 40 48 58 11 OMs, a - 80 20 58
[a] After column chromatography. [b] Determined by NMR spectros-
copy. [c] Partial recovery of 17. [d] Significant degradation of 17.
Firstly, employing 2-bromoacetophenone (144c) as the coupling partner failed (entry 1). As ad-
vancement, with the corresponding chloride 144d, 3-aryl-1,2-benzothiazine 133g was detected
for the first time by NMR spectroscopy, however, only in low yields (entries 2–3). Better yields
were achieved when a corresponding tosyl ketone 144b was applied. As such, at 40 °C a good
yield of product 133g was obtained after 48 h (73%; entry 4).
R e s u l t s a n d D i s c u s s i o n | 63
As sulfondiimine 17 previously showed instability under related oxidative reaction conditions at
elevated temperatures (Scheme 4-13), subsequent transformations were conducted without
the addition of copper acetate (entries 6–7). In comparison to the corresponding reactions un-
der oxidative conditions, copper-free reactions gave lower yields at 40 °C (65% < 73%, entries 6
and 4, respectively), but enhanced the yield at elevated temperatures (57% > 31%, entries 7
and 5, respectively). Finally, the best yields of heterocycle 133g could be obtained with ɑ-
mesylated ketone 144a as the coupling partner. As such, with copper acetate at 40 °C, 86%
yield of the desired 3-phenyl-substituted heterocycle 133g was obtained after 48 h (entry 8).
Noteworthy, the structure of 1,2-benzothiazine 133g was confirmed by single crystal X-ray
analysis (Figure 4-2).
Figure 4-2: Crystal structure of product 133g.
Substrate scope
In order to enlarge the scope of 3-substituted 1,2-benzothiazine 1-imines, sulfondiimine 17 was
subjected to different mesyl ketones 144e|f under the previously optimized reaction conditions
(Table 4-5). Initial attempts afforded product 133h (Figure 4-3). Whereas a ketone 144f contain-
ing the strongly electron–withdrawing nitro group showed no reaction at all, para-bromo-
substituted benzothiazine 133h was synthesized in an excellent yield of 94%, containing an an-
chor for further transformations by classical cross–couplings.
Figure 4-3: Initial variations of the mesyl ketone.
4.2.3 Summary and outlook
In this project, the first 1,2-benzothiazine 1-imines 133 were prepared by rhodium–catalyzed
annulation reactions of readily available NH-sulfondiimines 106. Whereas attempts of modify-
ing a protocol for oxidative annulations with alkynes[99f] proved inapplicable, regioselective syn-
theses by rhodium–catalyzed directed carbene insertion/dehydration processes proceeded well
64 | R e s u l t s a n d D i s c u s s i o n
under slightly modified reaction conditions of BOLM and coworkers.[99g] In these processes, the
critical factor for success was the right choice of the solvent. In this manner, several 3,4-
disubstituted 1,2-benzothiazine 1-imines 133 have been prepared in mainly excellent yields up
to 99%. In addition, the use of -(pseudo)halo ketones 144 as alkyne equivalents in rhodi-
um(III)–catalyzed annulation reactions of NH-sulfondiimines 106 was demonstrated, affording
4-unsubstituted heterocyclic products 133 (Scheme 4-13). A bromo-substituted example of
special interest regarding further functionalizations by cross–couplings was included, and the
structure of 1,2-benzothiazine 133g was confirmed by single crystal X-ray spectroscopic analysis
(Figure 4-2).
Scheme 4-15: Sulfondiimine-directed C‒H bond activation reactions afforded benzothiazines 133.
Although further investigations should be conducted regarding the scope of these reaction pro-
cesses, as a matter of principle, the possibility to access 3,4-disubstituted and 4-unsusbtituted
1,2-benzothiazine 1-imines 133 was demonstrated in this project. It is of note that these trans-
formations also represent the first examples and principally demonstrate the utility of sul-
fondiimines as directing groups in rhodium–catalyzed dire t C‒H bond functionalizations. In
addition, the products represent examples of a previously unprecedented class of 1-iminated
heterocycles of interest regarding their potential bioactivities according to structurally related
derivatives.[88, 100] Accordingly, future studies should include the investigation of the biological
activity of the newly prepared heterocycles. In 2016, during the preparation of this thesis, the
rhodium– atal zed C‒H o d a ti atio / lizatio /eli i atio of NH-sulfoximines 100 with
pyridotriazoles 146 as the reagents towards 1,2-benzothiazine 1-oxides 134 has been reported
(Scheme 4-16).[106] Accordingly, for future work it should be considered to optimize this syn-
thetic protocol for the preparation of sulfondiimine-based products 133.
Scheme 4-16: Synthesis of 1,2-benzothiazine 1-oxides 134 with pyridotriazole reagents 146.[106]
C o n c l u s i o n s a n d O u t l o o k | 65
IV. CONCLUSIONS AND OUTLOOK
In spite of their intriguing properties and promising biological activities, the diaza analogs of
sulfones, namely sulfondiimines, represent a highly underrated class of compounds. As contri-
bution to overcome the existing limitations, this thesis focused on the variable structural modi-
fications of sulfondiimine derivatives and their applications. By paying particular attention to
potential pharmacological and agricultural agents, a library of structurally diverse sul-
fondiimine-based products was created by the development of methods for their selective N-
/-functionalizations and cyclizations.
Initially, a CHAN–LAM-t pe proto ol for the C‒N ross–couplings of NH-sulfondiimines with
boronic acids was developed. The mild reaction conditions facilitated the expansion of the N,N'-
disubstituted sulfondiimines’ library to previously inaccessible N-(hetero)aryl derivatives of in-
terest in the light of structurally related sulfoximines applied as anticancer agents and agro-
chemicals.
Additional N-functionalization reactions of NH-sulfondiimines included the first general
N-alkylation protocol. By the application of super asi KOH/DM“O, the transformations suc-
ceeded with alkyl bromides at ambient temperatures. The scope of N-alkylated products com-
prised an analog of the bronchodilator Suloxifen.
The additions of sulfondiimine-based ɑ-lithiated carbanions to aldehydes led to the first
β-hydroxy sulfondiimines. In addition to the possible alkylations at the S- carbon, the direct
access to NH-β-hydroxy sulfondiimines was provided without the need for N-protections. For
the preparation of chiral β-hydroxy sulfondiimines and their applications according to structur-
ally related sulfoximines established as chiral auxiliaries and ligands, stereospecific reactions of
known enantiopure NH-sulfondiimines are considered possible for future work.
66 | C o n c l u s i o n s a n d O u t l o o k
In addition, applications of sulfondiimines in heterocyclic chemistry have been demonstrated.
The newly developed cyclization procedures afforded unprecedented derivatives of 1,2-
(benzo)thiazines applied as pharmaceutical agents by combining the valuable properties of
S(VI)–N compounds and heterocyclic motifs.
A wide range of 1,2-thiazines with well-positioned groups, including the first iminated deriva-
tives, resulted from one-pot MICHAEL-addition/cyclization/dehydration sequences of
NH-sulfoximines, NH-sulfondiimines, and propargyl ketones. The products represent heterocy-
clic building blocks readily modifiable by N-deprotection, classical cross–coupling strategies,
and dire t C‒H bond functionalizations.
In addition, regioselective rhodium–catalyzed annulation reactions of NH-sulfondiimines with
diazo compounds or (pseudo)halo ketones as a matter of principle afforded the first
1,2-benzothiazine imines. The structure of a representative product was confirmed by single
crystal X-ray analysis. These transformations represented the first examples and principally
demonstrated the utility of sulfondiimines as directing groups in rhodium– atal zed dire t C‒H bond functionalizations.
In summary, the ability of sulfondiimines for different applications in transition–metal-catalyzed
or -free synthetic methods, with superbasic media, as dire ti g groups i dire t C‒H bond func-
tionalizations, or as organolithium reagents has been demonstrated. On the basis of the result-
ing extended library of sulfondiimine-based compounds, the investigation of their binding to
major drug targets according to biological activities of structurally related scaffolds represents a
promising focus for future studies. As members of a nowadays highly underrated compound
class, sulfondiimines are suggested as easily patentable alternatives to known molecular scaf-
folds for the design of pharmacological and agricultural agents.
On the basis of these findings, the utility of the relatively unknown class of sulfondiimines
should be re-evaluated, and their derivatives are recommended as reasonable alternatives to
well-established structurally related scaffolds for future applications.
E x p e r i m e n t a l S e c t i o n | 67
V. EXPERIMENTAL SECTION
5 General Information
5.1 Air-sensitive techniques
According to standard Schlenk techniques,[107] reactions involving compounds sensitive to at-
mospheric air and moisture were generally conducted under an argon atmosphere in flame-
dried glass reaction vessels with septum. Liquid reagents and solvents were transferred by glass
or plastic syringes with one-way needles or V2A steel cannulas. In addition, air- and moisture-
sensitive chemicals were stored in an M.Braun LABmaster© 130 Glovebox or a dessicator. In
this context, molecular sieves were pestled, heated in vacuo, and stored in a dessicator prior to
their use in reactions.
5.2 Solvents
Solvents for reactions were purified and dried according to standard techniques in a nitrogen
atmosphere.[108] DCM (HPLC-quality) was dried by refluxing over CaCl2 and distillation. THF was
predried with KOH for several days, filtered over aluminium oxide, dried by refluxing over sodi-
um (Solvona®/benzophenone), and distilled. Toluene was dried by refluxing over sodium (Sol-
vona®/benzophenone), and distilled. Acetonitrile (99.9%), methanol (99.8%), DMF (99.8%),
DMSO (99.7%), DCE (99.5%), and 1,4-dioxane (99.5%, stabilized) were purchased from Acros
Organics (Extra Dry over Molecular Sieve, AcroSeal®) and used without further purification.
Solvents for extraction, crystallization, transfer, and column chromatography were distilled
over drying agents prior to use: chloroform (CaH2), diethylether (KOH), DCM (CaH2), ethanol
(NaOEt), ethyl acetate (CaCl2), methanol (NaOMe), and pentane (CaH2).
5.3 Chemicals and reagents
Ethyl-O-(mesitylenesulfonyl)acetohydroxamate (147) was synthesized in one step from a pro-
cedure which represents a slight modification of a protocol reported by TAMURA:[109]
In an oven-dried flask, ethyl N-hydroxyacetimidate (148, 1.0 equiv) was dissolved in dry DMF
(0.7 mL/mmol) and cooled to 0 °C. Triethylamine (1.2 equiv) was added. 2,4,6-
Trimethylbenzene-1-sulfonyl chloride (149, 1.0 equiv) was added in portions at 0 °C. It was then
stirred for 10 min at 0 °C and 30 min at room temperature.
68 | E x p e r i m e n t a l S e c t i o n
Cold water (5 mL/mmol) was added, and the aqueous phase was then extracted with Et2O (3 x
5 mL/mmol). The combined organic layers were washed with brine (5 mL/mmol), dried with
MgSO4, and the solvent was evaporated under vacuum. The crude product 147 was purified by
recrystallization from pentane.
The following chemicals were synthesized according to literature procedures:
sulfiliminium salts 23[30]
NH-sulfoximines 100[95b-d]
(donations by Dr. Christian Bohnen, Susi Grünebaum, and Pierre
Winandy)
NH-sulfondiimines 106 (Scheme 1-15)[30]
propargyl ketones 128[95a]
diazo compounds 143[110]
ɑ-tosyl and ɑ-mesyl ketones 144[111]
Other chemicals were purchased from ABCR, Acros Organics, Alfa Aesar, Cambridge Chemicals,
Fisher, Fluka, Fluorochem, Merck, Sigma–Aldrich, and TCI and used without further purification.
5.4 Instrumentation
Nuclear magnetic resonance (NMR) spectroscopy
1H, 19F, and 13C NMR spectra were recorded at room temperature either with a Varian Mercury
300, a Varian Mercury 400, a Varian V-NMRS 400, or a Varian V-NMRS 600. CDCl3 with TMS as
internal standard was used as the solvent. Chemical shifts (δ) are given in ppm relative to TMS
(δH = 0.00 ppm) as internal standard, or calibrated to the residual solvent peak [CDCl3 (13C
NMR): δC = 77.0 ppm]. NMR yields were determined with CH2Br2 as the internal standard, with
reference to a singlet signal (2H) at δH = 4.9305 in CDCl3. CCl3F was used as external standard
for 19F NMR spectra. The signals in 1H NMR spectra are noted as follows: chemical shift δ (ppm)
(multiplicity, spin-spin coupling constant J (Hz), number of protons). Spin-spin coupling con-
stants (J) are reported in Hz, and coupling patterns are abbreviated by br (broad), s (singlet), d
(doublet), t (triplet), dd (doublet of doublet), q (quartet), sept (septet), and m (multiplet).
Mass spectrometry (MS)
In case of electron impact ionization (EI, 70 eV) and chemical ionization (CI, 100 eV), mass spec-
tra were recorded with a Finnigan SSQ 7000 spectrometer. The atomic mass of the molecular
ion and the fragments per elementary charge (m/z) are reported in dimensionless quantities.
The intensities are given in parenthesis and in percent relative to the base peak. For elec-
trospray ionization (ESI) mass spectra and high resolution mass spectrometry (HRMS) a Thermo
Fisher Scientific LTQ Orbitrap XL spectrometer was used. The purity of the compounds was evi-
denced by NMR spectroscopy.
IR spectroscopy
IR spectra were recorded with a Bruker TENSOR 27 FT–IR spectrophotometer or a PerkinElmer
100 FT–IR Spectrum spectrometer.
E x p e r i m e n t a l S e c t i o n | 69
The sample preparation (KBR-pellet or neat liquids) is described in parenthesis. The positions of
the strongest absorption bands are given in wave numbers (cm–1).
Elemental analysis (CHN)
The CHN–measurements were performed with a Vario EL machine from Elementar. The values
are reported in weight percent. The compounds were considered to be pure when Δ CHN 0.4.
Melting points
Melting points were determined with open capillaries and a Büchi Melting Point B-540 ma-
chine.
5.5 Chromatography
Thin layer chromatography (TLC)
All product mixtures were analyzed by thin layer chromatography with use of aluminum foil TLC
plates with a fluorescent indicator F254 from Merck. UV-Active compounds were detected with
a UV la p λ = .
Column chromatography
In general, flash column chromatography was performed with glass columns of different size,
whose loadings involved solutions of the crude products. Unless otherwise noted, Merck silica
gel 60 (35–70 mesh) was used as the stationary phase. The best solvent system for the mobile
phase was determined by TLC prior to column chromatography.
5.6 General Procedures
5.6.1 Copper–catalyzed N-arylations/N-alkenylation of NH-sulfondiimines (GP1)
Under an atmosphere of argon, a flame-dried Schlenk tube equipped with magnetic stirrer and
septum was charged with NH-sulfondiimine (1.0 equiv), boronic acid (2.3 equiv), and copper(II)
acetate (10 mol%), and then degassed. Anhydrous methanol (0.3 M) was added, and the sep-
tum was replaced by a CaCl2-drying tube. Unless otherwise noted, the reaction mixture was
then vigorously stirred for 24 h at room temperature. Purification by flash column chromatog-
raphy with n-pentane/ethyl acetate gradient elution (see each case for details) afforded the
desired N-arylated or N-alkenylated sulfondiimines.
5.6.2 N-Alkylations of NH-sulfondiimines with KOH in DMSO (GP2)
Under an atmosphere of argon, a flame-dried Schlenk tube equipped with magnetic stirrer and
septum was charged with the NH-sulfondiimine (1.0 equiv) and potassium hydroxide
(2.0 equiv), and then degassed. The mixture was dissolved in anhydrous DMSO (1.5 mL·mmol-1),
and stirred for 5 min.
70 | E x p e r i m e n t a l S e c t i o n
Then, the alkyl bromide (1.5 equiv) was added with syringe, and the reaction mixture was
stirred for 3 to 6 h at room temperature. Water (6 mL) was added, and the mixture was ex-
tracted with DCM (3 x 8 mL). The combined organic layers were dried with anhydrous magnesi-
um sulfate, and the solvents were removed under reduced pressure. Finally, the product was
purified by flash column chromatography.
5.6.3 Reactions of lithium sulfondiimidoyl carbanions (GP3)
Under an atmosphere of argon, in a flame-dried Schlenk tube equipped with magnetic stirrer
and septum, the sulfondiimine (1.0 equiv) was dissolved in dry THF (2 mL). TMEDA (2.0 equiv)
was added, and the resulting solution was cooled to –78 °C. Then, n-butyllithium was added
dropwise at –78 °C within 5 min, and the resulting solution was stirred for 30 min at –78 °C. The
electrophilic reagent (see each case for details) was then added with syringe, and the reaction
mixture was stirred at –78 °C. The conversion of the reaction was monitored by TLC. In the case
of an incomplete conversion, the reaction mixture was slowly warmed to room temperature
(see each case for details). Upon complete conversion, saturated NH4Cl-solution (15 mL) was
added. The mixture was extracted with DCM (3 x 10 mL). The combined organic layers were
dried with anhydrous magnesium sulfate, and the solvents were removed under reduced pres-
sure. Purification by flash column chromatography with n-pentane/ethyl acetate gradient elu-
tion (see each case for details) afforded the desired product.
5.6.4 Syntheses of 1,2-thiazines from NH-sulfoximines/NH-sulfondiimines (GP4)
Under an atmosphere of argon, a flame-dried Schlenk tube equipped with magnetic stirrer and
septum was charged with either the sulfoximine or the sulfondiimine (0.50 mmol, 1.0 equiv
each), cesium carbonate (342 mg, 1.05 mmol, 2.1 equiv), and molecular sieves 4 Å (10 mg). Af-
ter the addition of dry DMSO (2 mL), the resulting suspension was stirred for 15 min at ambient
temperature. A solution of the propargyl ketone (0.75 mmol, 1.5 equiv) in dry DMSO (2 mL) was
then added dropwise, and the reaction mixture was stirred for 5 h at 80 °C. After addition of
saturated NaHCO3 solution (15 mL), the mixture was extracted with DCM (3 x 10 mL). The com-
bined organic layers were dried with anhydrous magnesium sulfate, and the solvents were re-
moved under reduced pressure. Purification by flash column chromatography with
n-pentane/ethyl acetate gradient elution (see each case for details) afforded the desired 1,2-
thiazine.
5.6.5 Syntheses of 1,2-benzothiazines from NH-sulfondiimines (GP5 and GP6)
From diazo compounds (GP5)
The syntheses of sulfondiimine-based 1,2-benzothiazines with diazo compounds were per-
formed by variation of the protocol reported by BOLM.[99g]
Under an atmosphere of argon, a flame-dried Schlenk tube equipped with magnetic stirrer and
septum was charged with the sulfondiimine (1.0 equiv), [Cp*Rh(MeCN)3][SbF6]2 (5.0 mol%), and
sodium acetate (1.2 equiv), and then degassed. A solution of the diazo compound (1.2 equiv) in
dry acetonitrile (2 mL) was added, and the reaction mixture was stirred at 100 °C for 3 h.
E x p e r i m e n t a l S e c t i o n | 71
The crude mixture was then cooled to room temperature, diluted with DCM (10 mL), and fil-
tered through a Celite/MgSO4 pad, which was washed with DCM (3 x 20 mL). The filtrate was
concentrated. Purification by flash column chromatography with n-pentane/ethyl acetate gra-
dient elution (1/0 to 1/1) afforded the desired 1,2-benzothiazine.
From ɑ-substituted ketones (GP6)
The syntheses of sulfondiimine-based 1,2-benzothiazines with ɑ-substituted ketones were per-
formed by variation of a protocol reported by GLORIUS.[104]
Under an atmosphere of argon, a flame-dried schlenk tube equipped with magnetic stirrer and
septum was charged with the sulfondiimine (1.0 equiv), [Cp*Rh(MeCN)3][SbF6]2 (5 mol%),
Cu(OAc)2 (10 mol%), NaOAc (1.4 equiv), and the ɑ-substituted ketone (1.4 equiv), and then de-
gassed. Anhydrous methanol (4 mL) was added, and the reaction mixture was stirred at 40 °C
for 48 h. It was then cooled to room temperature, diluted with DCM (10 mL), and filtered
through a Celite/MgSO4 pad, which was washed with DCM (3 x 20 mL). The filtrate was concen-
trated. Purification by flash column chromatography with n-pentane/ethyl acetate gradient
elution (1/0 to 1/1) afforded the desired 1,2-benzothiazine.
E x p e r i m e n t a l S e c t i o n | 73
6 Synthetic Procedures and Analytical Data
6.1 Syntheses of N-arylated sulfondiimines
N,N',S-Triphenyl-S-methyl sulfondiimine (61a)
Following GP1, sulfondiimine 61a was obtained from sulfondiimine 17
(50 mg, 0.22 mmol) and phenylboronic acid (101a, 61 mg, 0.5 mmol). Purifi-
cation by flash column chromatography with a gradient of n-pentane/ethyl
acetate: 9/1 to 7/3 afforded the desired product as light brown solid (57 mg,
85%).
Furthermore, 61a was obtained from sulfondiimine 17 (50 mg, 0.22 mmol)
and potassium phenyltrifluoroborate (103a, 94 mg, 0.51 mmol) as light brown solid (25 mg,
37%) after stirring the reaction mixture for 40 h at 40 °C. 1H NMR (400 MHz, CDCl3): = 8.27–8.24 (m, 2H), 7.61–7.53 (m, 3H), 7.18–7.13 (m, 8H), 6.91–6.86 (m, 2H), 3.33 (s, 3H). 13C NMR (100 MHz, CDCl3): = 145.7 (2C), 139.2, 132.9, 129.5 (2C), 129.1 (4C), 128.5 (2C), 123.0
(4C), 121.3 (2C), 44.8.
The corresponding spectroscopic data matched that reported in the literature.[47]
N-(4-Methoxyphenyl)-N',S-diphenyl-S-methyl sulfondiimine (61b)
Following GP1, sulfondiimine 61b was obtained from sulfondiimine 17 (50
mg, 0.22 mmol) and 4-methoxyphenylboronic acid (101b, 78 mg,
0.51 mmol). Purification by flash column chromatography with a gradient
of n-pentane/ethyl acetate: 8/2 to 6/4 afforded the desired product as
light brown oil (53 mg, 72%).
Furthermore, 61b was obtained as light brown oil (115 mg, 90%) from
NH-N'-(4-methoxyphenyl)-S-methyl-S-phenyl sulfondiimine (106a,
100 mg, 0.38 mmol) and phenylboronic acid (101a, 108 mg, 0.88 mmol). 1H NMR (600 MHz, CDCl3): = 8.25–8.22 (m, 2H), 7.60–7.53 (m, 3H), 7.19–7.14 (m, 4H), 7.07 (d,
J = 9.0 Hz, 2H), 6.90–6.87 (m, 1H), 6.72 (d, J = 9.0 Hz, 2H), 3.70 (s, 3H), 3.29 (s, 3H). 13C NMR (150 MHz, CDCl3): = 154.5, 145.9, 139.2, 138.5, 132.8, 129.5 (2C), 129.1 (2C), 128.5
(2C), 124.1 (2C), 122.9 (2C), 121.1, 114.4 (2C), 55.3, 44.5.
The corresponding spectroscopic data matched that reported in the literature.[47]
74 | E x p e r i m e n t a l S e c t i o n
N-(4-Thiomethylphenyl)-N',S-diphenyl-S-methyl sulfondiimine (61c)
Following GP1, sulfondiimine 61c was obtained from sulfondiimine 17 (50
mg, 0.22 mmol) and 4-thiomethylphenylboronic acid (101b, 86 mg,
0.51 mmol). Purification by flash column chromatography with a gradient
of n-pentane/ethyl acetate: 8/2 to 7/3 afforded the desired product as
light brown oil (52 mg, 67%). 1H NMR (400 MHz, CDCl3): = 8.25–8.21 (m, 2H), 7.61–7.53 (m, 3H),
7.17–7.14 (m, 4H), 7.11–7.09 (m, 4H), 6.92–6.87 (m, 1H), 3.32 (s, 3H),
2.39 (s, 3H). 13C NMR (100 MHz, CDCl3): = 145.6, 143.9, 139.1, 132.9, 129.6 (2C), 129.4, 129.2 (2C), 129.1
(2C), 128.5 (2C), 123.5 (2C), 123.0 (2C), 121.4, 44.7, 17.3.
The corresponding spectroscopic data matched that reported in the literature.[47]
N-(4-Acetylphenyl)-N',S-diphenyl-S-methyl sulfondiimine (61d)
Following GP1, sulfondiimine 61d was obtained from sulfondiimine 17
(50 mg, 0.22 mmol) and 4-acetylphenylboronic acid (101d, 84 mg,
0.51 mmol). Purification by flash column chromatography with a gradi-
ent of n-pentane/ethyl acetate: 7/3 to 1/1 afforded the desired product
as brown oil (69 mg, 90%).
1H NMR (600 MHz, CDCl3): = 8.25–8.22 (m, 2H), 7.79–7.75 (m, 2H),
7.65–7.56 (m, 3H), 7.21–7.11 (m, 6H), 6.92–6.89 (m, 1H), 3.37 (s, 3H),
2.47 (s, 3H). 13C NMR (150 MHz, CDCl3): = 197.0, 151.6, 145.0, 138.5, 133.2, 130.1, 130.0 (2C), 129.7 (2C),
129.2 (2C), 128.3 (2C), 123.0 (2C), 121.9 (2C), 121.7, 45.0, 26.2.
The corresponding spectroscopic data matched that reported in the literature.[47]
N-(3-Trifluoromethylphenyl)-N',S-diphenyl-S-methyl sulfondiimine (61e)
Following GP1, sulfondiimine 61e was obtained from sulfondiimine 17
(50 mg, 0.22 mmol) and 3-trifluoromethylphenylboronic acid (101e,
97 mg, 0.51 mmol). Purification by flash column chromatography with
a gradient of n-pentane/ethyl acetate: 9/1 to 7/3 afforded the desired
product as white solid (73 mg, 89%). Furthermore, 61e was obtained as
white solid (82 mg, 76%) from NH-N'-(3-trifluoromethylphenyl)-
S-methyl-S-phenyl sulfondiimine (106b, 86 mg, 0.29 mmol) and phenylboronic acid (101a,
81 mg, 0.66 mmol). 1H NMR (400 MHz, CDCl3): = 8.25–8.22 (m, 2H), 7.64–7.55 (m, 3H), 7.39 (s, 1H), 7.33 (d, J = 8.0
Hz, 1H), 7.22–7.08 (m, 6H), 6.93–6.88 (m, 1H), 3.34 (s, 3H). 13C NMR (100 MHz, CDCl3): = 146.5, 145.2, 138.7, 133.2, 131.4 (q, J = 32 Hz), 129.7 (2C), 129.5,
129.2 (2C), 128.4 (2C), 125.1, 124.1 (q, J = 271 Hz), 123.0 (2C), 121.6, 120.1 (q, J = 4 Hz), 117.5
(q, J = 4 Hz), 44.9. 19F NMR (376 MHz, CDCl3): = –62.69.
E x p e r i m e n t a l S e c t i o n | 75
The corresponding spectroscopic data matched that reported in the literature.[47]
N-(2-Bromophenyl)-N',S-diphenyl-S-methyl sulfondiimine (61g)
Following GP1, sulfondiimine 61g was obtained from sulfondiimine 17
(50 mg, 0.22 mmol) and 2-bromophenylboronic acid (101g, 103 mg,
0.51 mmol). Purification by flash column chromatography with a gradient
of n-pentane/ethyl acetate: 8/2 to 7/3 afforded the desired product as
light brown solid (79 mg, 94%).
Gram-Scale: Under an atmosphere of argon, a flame-dry Schlenk flask
equipped with magnetic stirrer and septum was charged with the sulfondiimine 18 (2.0 g,
8.68 mmol), the boronic acid 101g (4.01 g, 20.0 mmol), and copper(II) acetate (160 mg,
0.868 mmol) and then degassed. Dry methanol (35 mL) was added, and the septum was re-
placed by a CaCl2-drying tube. The reaction mixture was then vigorously stirred for 48 h at room
temperature. Purification by flash column chromatography with a gradient of n-pentane/ethyl
acetate: 8/2 to 0/1 afforded the desired product 61g as light brown solid (1.01 g, 30%). 1H NMR (400 MHz, CDCl3): = 8.37–8.33 (m, 2H), 7.63–7.54 (m, 4H), 7.29 (dd, J = 8.0, 1.5 Hz,
1H), 7.17–7.12 (m, 4H), 7.05 (ddd, J = 8.9, 7.3, 1.5 Hz, 1H), 6.90–6.85 (m, 1H), 6.77 (ddd, J = 8.9,
7.3, 1.5 Hz, 1H), 3.33 (s, 3H). 13C NMR (100 MHz, CDCl3): = 145.6, 143.5, 138.9, 133.1, 133.0, 129.6 (2C), 129.1 (2C), 128.8
(2C), 128.2, 123.1, 122.6, 122.6 (2C), 121.3, 120.1, 45.1.
MS (EI): m/z (%) = 386 (100), 384 ([M]+, 79), 215 (84), 200 (64).
IR (KBr): = 1585, 1471, 1284, 1254, 1081, 983, 753.
HRMS (ESI): 385.0367, calcd. for C19H18N2BrS: 385.0369.
N-(2-Chlorophenyl)-N',S-diphenyl-S-methyl sulfondiimine (61h)
Following GP1, sulfondiimine 61h was obtained from sulfondiimine 17
(50 mg, 0.22 mmol) and 2-chlorophenylboronic acid (101h, 80 mg,
0.51 mmol). Purification by flash column chromatography with a gradient
of n-pentane/ethyl acetate: 9/1 to 7/3 afforded the desired product as
brown oil (64 mg, 85%). 1H NMR (400 MHz, CDCl3): = 8.34–8.30 (m, 2H), 7.62–7.54 (m, 3H), 7.37
(dd, J = 8.0, 1.5 Hz, 1H), 7.28 (dd, J = 8.0, 1.5 Hz, 1H), 7.16–7.14 (m, 4H), 7.02–6.97 (m, 1H),
6.91–6.81 (m, 2H), 3.34 (s, 3H). 13C NMR (100 MHz, CDCl3): = 145.6, 142.3, 138.9, 133.1, 129.9, 129.6 (2C), 129.2, 129.1 (2C),
128.7 (2C), 127.4, 123.3, 122.7 (2C), 122.3, 121.3, 45.1.
MS (EI): m/z (%) = 340 ([M]+, 100), 249 (54), 234 (48), 215 (84), 200 (61), 124 (12).
IR (neat): = 3462, 3060, 2924, 1585, 1471, 1257, 1079, 745, 594, 493.
HRMS (ESI): 363.0693, calcd. for C19H17N2ClNaS: 363.0693.
76 | E x p e r i m e n t a l S e c t i o n
N-(4-Biphenyl)-N',S-diphenyl-S-methyl sulfondiimine (61i)
Following GP1, sulfondiimine 61i was obtained from sulfondiimine 17
(50 mg, 0.22 mmol) and 4-biphenylboronic acid (101i, 101 mg,
0.51 mmol). Purification by flash column chromatography with a gradi-
ent of n-pentane/ethyl acetate: 8/2 to 6/4 afforded the desired product
as white solid (71 mg, 84%). 1H NMR (400 MHz, CDCl3): = 8.29–8.26 (m, 2H), 7.63–7.55 (m, 3H),
7.53–7.49 (m, 2H), 7.43–7.34 (m, 4H), 7.27–7.15 (7H), 6.93–6.88 (m,
1H), 3.39 (s, 3H). 13C NMR (100 MHz, CDCl3): = 145.4, 145.0, 141.0, 138.9, 134.1, 133.0, 129.6 (2C), 129.2 (2C),
128.6 (2C), 128.5 (2C), 127.8 (2C), 126.5 (2C), 126.4, 123.1 (2C), 123.0 (2C), 121.5, 44.7.
The corresponding spectroscopic data matched that reported in the literature.[47]
N-(2-Naphthyl)-N',S-diphenyl-S-methyl sulfondiimine (61j)
Following GP1, sulfondiimine 61j was obtained from sulfondiimine 17
(50 mg, 0.22 mmol) and 2-naphthylboronic acid (101j, 88 mg,
0.51 mmol). Purification by flash column chromatography with a gradi-
ent of n-pentane/ethyl acetate: 9/1 to 7/3 afforded the desired product
as light brown solid (74 mg, 94%).
1H NMR (400 MHz, CDCl3): = 8.30–8.26 (m, 2H), 7.69–7.64 (m, 2H),
7.60–7.51 (m, 5H), 7.36–7.12 (m, 7H), 6.91–6.86 (m, 1H), 3.36 (s, 3H). 13C NMR (100 MHz, CDCl3): = 145.6, 143.8, 139.1, 134.6, 132.9, 129.6 (2C), 129.3, 129.1 (2C),
128.7, 128.5 (2C), 127.4, 126.8, 125.8, 124.8, 123.4, 123.2 (2C), 121.5, 117.6, 44.7.
The corresponding spectroscopic data matched that reported in the literature.[47]
N-(4-Methylphenyl)-N',S-diphenyl-S-methyl sulfondiimine (61k)
Following GP1, sulfondiimine 61k was obtained from sulfondiimine 17
(50 mg, 0.22 mmol) and 4-methylphenylboronic acid (101k, 69 mg,
0.51 mmol). Purification by flash column chromatography with a gradient
of n-pentane/ethyl acetate: 8/2 to 6/4 afforded the desired product as
light brown oil (61 mg, 87%). 1H NMR (400 MHz, CDCl3): = 8.25–8.22 (m, 2H), 7.60–7.51 (m, 3H), 7.19–7.12 (m, 4H), 7.08–7.04 (m, 2H), 6.98–6.94 (m, 2H), 6.90–6.85 (m, 1H),
3.30 (s, 3H), 2.22 (s, 3H). 13C NMR (100 MHz, CDCl3): = 145.8, 142.9, 139.3, 132.8, 130.6, 129.7 (2C), 129.5 (2C), 129.1
(2C), 128.5 (2C), 123.0 (2C), 122.8 (2C), 121.2, 44.6, 20.7.
MS (EI): m/z (%) = 320 ([M]+, 100), 229 (52), 215 (45), 214 (46), 200 (43), 196 (24).
IR (neat): = 1529, 1490, 1246, 1071, 980, 820, 735, 689.
HRMS (ESI): 321.1420, calcd. for C20H21N2S: 321.1420.
E x p e r i m e n t a l S e c t i o n | 77
N-(3-Methylphenyl)-N',S-diphenyl-S-methyl sulfondiimine (61l)
Following GP1, sulfondiimine 61l was obtained from sulfondiimine 17
(50 mg, 0.22 mmol) and 3-methylphenylboronic acid (101l, 69 mg,
0.51 mmol). Purification by flash column chromatography with a gradi-
ent of n-pentane/ethyl acetate: 8/2 to 6/4 afforded the desired product
as light brown oil (60 mg, 85%).
1H NMR (600 MHz, CDCl3): = 8.25–8.23 (m, 2H), 7.61–7.53 (m, 3H),
7.17–7.13 (m, 4H), 7.05–6.98 (m, 3H), 6.90–6.86 (m, 1H), 6.71 (d, J = 7.3 Hz, 1H), 3.31 (s, 3H),
2.23 (s, 3H). 13C NMR (150 MHz, CDCl3): = 145.8, 145.6, 139.3, 138.8, 132.8, 129.5 (2C), 129.1 (2C), 128.9,
128.5 (2C), 123.8, 123.0 (2C), 122.1, 121.2, 119.7, 44.8, 21.5.
The corresponding spectroscopic data matched that reported in the literature.[47]
N-(2-Methylphenyl)-N',S-diphenyl-S-methyl sulfondiimine (61m)
Following GP1, sulfondiimine 61m was obtained from sulfondiimine 17
(50 mg, 0.22 mmol) and 2-methylphenylboronic acid (101m, 69 mg,
0.51 mmol). Purification by flash column chromatography with a gradient
of n-pentane/ethyl acetate: 9/1 to 7/3 afforded the desired product as
brown oil (36 mg, 51%). 1H NMR (600 MHz, CDCl3): = 8.27–8.24 (m, 2H), 7.61–7.54 (m, 3H), 7.27–
7.25 (m, 1H), 7.16 (d, J = 7.4 Hz, 1H), 7.14–7.09 (m, 4H), 7.0 (ddd, J = 8.9, 7.8, 1.5 Hz, 1H), 6.86–8.81 (m, 2H), 3.31 (s, 3H), 2.42 (s, 3H). 13C NMR (150 MHz, CDCl3): = 146.0, 144.0, 139.8, 132.8, 132.7, 130.3, 129.5 (2C), 129.0 (2C),
128.5 (2C), 126.6, 122.8 (2C), 121.2, 121.1, 121.0, 45.1, 18.9.
MS (EI): m/z (%) = 320 ([M]+, 100), 229 (60), 215 (78), 214 (49), 200 (79).
IR (neat): = 1591, 1482, 1253, 1076, 984, 751, 594, 493.
HRMS (ESI): 343.1238, calcd. for C20H20N2NaS: 343.1239.
N-(6-Chloropyridin-3-yl)-N',S-diphenyl-S-methyl sulfondiimine (61n)
Following GP1, sulfondiimine 61n was obtained from sulfondiimine 17 (50
mg, 0.22 mmol) and (6-chloropyridin-3-yl)boronic acid (101n, 80 mg,
0.51 mmol). Purification by flash column chromatography with a gradient
of n-pentane/ethyl acetate: 7/3 to 6/4 afforded the desired product as
yellow solid (63 mg, 84%).
Mp.: 111–112 °C. 1H NMR (400 MHz, CDCl3): = 8.23–8.19 (m, 3H), 7.67–7.56 (m, 3H), 7.38
(dd, J = 8.5, 2.9 Hz, 1H), 7.21–7.16 (m, 2H), 7.13–7.09 (m, 2H), 7.02 (d, J = 8.6 Hz, 1H), 6.96–6.90
(m, 1H), 3.35 (s, 3H). 13C NMR (100 MHz, CDCl3): = 144.8, 144.4, 142.6, 141.9, 138.2, 133.4, 131.6, 129.8 (2C), 129.3
(2C), 128.3 (2C), 124.0, 122.9 (2C), 121.9, 44.9.
MS (EI): m/z (%) = 341 ([M]+, 65), 250 (38), 215 (100), 200 (82), 124 (31).
78 | E x p e r i m e n t a l S e c t i o n
IR (KBr): = 1583, 1455, 1360, 1251, 1056, 973, 826, 731, 684.
Elemental analysis: calcd. for C18H16N3SCl: C 63.24, H 4.72, N 12.29, found: C 63.45, H 4.82, N
12.30.
N-(Thiophen-3-yl)-N',S-diphenyl-S-methyl sulfondiimine (61o)
Following GP1, sulfondiimine 61o was obtained from sulfondiimine 17
(50 mg, 0.22 mmol) and thiophen-3-ylboronic acid (101o, 65 mg,
0.51 mmol). Purification by flash column chromatography with a gradient of
n-pentane/ethyl acetate: 8/2 to 6/4 afforded the desired product as light
brown solid (56 mg, 82%).
1H NMR (400 MHz, CDCl3): = 8.24–8.22 (m, 2H), 7.62–7.54 (m, 3H), 7.19–7.15 (m, 4H), 7.13–7.11 (m, 1H), 6.94–6.88 (m, 2H), 6.66–6.64 (m, 1H), 3.31 (s, 3H). 13C NMR (100 MHz, CDCl3): = 145.5, 143.4, 138.8, 132.9, 129.5 (2C), 129.1 (2C), 128.5 (2C),
125.6, 124.0, 123.1 (2C), 121.4, 108.2, 44.1.
MS (EI): m/z (%) = 312 ([M]+, 100), 215 (47), 200 (43) .
IR (KBr): = 1516, 1486, 1248, 1077, 757.
HRMS (ESI): 335.0647, calcd. for C17H16N2NaS2: 335.0647.
N-(Benzo[b]thien-3-yl)-N',S-diphenyl-S-methyl sulfondiimine (61p)
Following GP1, sulfondiimine 61p was obtained from sulfondiimine 17
(50 mg, 0.22 mmol) and benzo[b]thien-3-ylboronic acid (101p, 91 mg,
0.51 mmol) after 40 h reaction time. Purification by flash column chro-
matography with a gradient of n-pentane/ethyl acetate: 9/1 to 7/3 af-
forded the desired product as light brown oil (33 mg, 41%). 1H NMR (600 MHz, CDCl3): = 8.31–8.29 (m, 2H), 8.05 (d, J = 7.9 Hz, 1H),
7.76 (d, J = 7.9 Hz, 1H), 7.63–7.55 (m, 3H), 7.42–7.39 (m, 1H), 7.36–7.33 (m, 1H), 7.19–7.13 (m,
4H), 6.89 (tt, J = 7.1, 1.4 Hz, 1H), 6.79 (s, 1H), 3.37 (s, 3H). 13C NMR (150 MHz, CDCl3): = 145.5, 138.7, 138.2, 137.7, 137.6, 133.1, 129.6 (2C), 129.1 (2C),
128.5 (2C), 124.4, 123.4, 123.1 (2C), 122.6, 121.8, 121.5, 106.6, 44.1.
MS (EI): m/z (%) = 362 ([M]+, 69), 215 (58), 200 (100), 147 (34), 124 (27).
IR (neat): = 3059, 2328, 1737, 1589, 1487, 1342, 1250, 1188, 1047, 963, 846, 729.
HRMS (ESI): 363.0991, calcd. for C21H19N2S2: 363.0984.
N-(5-Indolyl)-N',S-diphenyl-S-methyl sulfondiimine (61q)
Following GP1, sulfondiimine 61q was obtained from sulfondiimine 17
(50 mg, 0.22 mmol) and 5-indolylboronic acid (101q, 83 mg, 0.51 mmol)
after 40 h reaction time. Purification by flash column chromatography
with a gradient of n-pentane/ethyl acetate: 4/1 to 2/1 afforded the de-
sired product as brown oil (46 mg, 61%). 1H NMR (400 MHz, CDCl3): = 8.30–8.27 (m, 2H), 8.02 (br s, 1H), 7.59–7.51 (m, 3H), 7.44–7.41 (m, 1H), 7.24–7.13 (m, 5H), 7.09–7.03 (m, 2H),
6.90–6.85 (m, 1H), 6.37–6.34 (m, 1H), 3.31 (s, 3H).
E x p e r i m e n t a l S e c t i o n | 79
13C NMR (100 MHz, CDCl3): = 146.3, 139.6, 138.1, 132.7, 132.0, 129.5 (2C), 129.1 (2C), 128.7
(2C), 128.6, 124.3, 123.0 (2C), 121.0, 119.8, 113.7, 111.4, 102.3, 44.5.
MS (EI): m/z (%) = 345 ([M]+, 100), 254 (43), 215 (30), 200 (39), 130 (23).
IR (neat): = 3407, 1729, 1586, 1465, 1235, 1168, 1060, 982, 802, 734, 691.
HRMS (ESI): 346.1367, calcd. for C21H20N3S: 346.1372.
N,N'-Diphenyl-S-(4-methylphenyl)-S-methyl sulfondiimine (61s)
Following GP1, sulfondiimine 61s was obtained from sulfondiimine 106d
(100 mg, 0.41 mmol) and phenylboronic acid (101a, 115 mg, 0.94 mmol).
Purification by flash column chromatography with a gradient of n-
pentane/ethyl acetate: 8/2 to 7/3 afforded the desired product as light
brown solid (114 mg, 87%).
1H NMR (600 MHz, CDCl3): = 8.11 (d, J = 8.3 Hz, 2H), 7.34 (d, J = 8.3 Hz,
2H), 7.17–7.13 (m, 8H), 6.89–6.86 (m, 2H), 3.30 (s, 3H), 2.42 (s, 3H). 13C NMR (150 MHz, CDCl3): = 145.9 (2C), 143.7, 136.1, 130.2 (2C), 129.1 (4C), 128.5 (2C), 123.0
(4C), 121.1 (2C), 44.8, 21.5.
The corresponding spectroscopic data matched that reported in the literature.[47]
N,N'-Diphenyl-S-(4-bromophenyl)-S-methyl sulfondiimine (61t)
Following GP1, sulfondiimine 61t was obtained from sulfondiimine 106e
(55 mg, 0.18 mmol) and phenylboronic acid (101a, 50 mg, 0.41 mmol). Pu-
rification by flash column chromatography with a gradient of n-
pentane/ethyl acetate: 9/1 to 7/3 afforded the desired product as light
brown oil (58 mg, 84%).
1H NMR (400 MHz, CDCl3): = 8.10 (d, J = 8.8 Hz, 2H), 7.68 (d, J = 8.8 Hz,
2H), 7.19–7.12 (m, 8H), 6.92–6.87 (m, 2H), 3.31 (s, 3H). 13C NMR (100 MHz, CDCl3): = 145.4 (2C), 138.4, 132.8 (2C), 130.2 (2C), 129.2 (4C), 128.2, 123.0
(4C), 121.5 (2C), 44.9.
MS (EI): m/z (%) = 386 (65), 384 ([M]+, 59), 295 (97), 293 (96), 280 (95), 278 (100).
IR (neat): = 1589, 1480, 1286, 1246, 1069, 976, 788, 750, 693.
HRMS (ESI): 407.0189, calcd. for C19H17N2BrNaS: 407.0188.
N-(4-Methoxyphenyl)-N',S-diphenyl-S-cyclopropyl sulfondiimine (61u)
Following GP1, sulfondiimine 61u was obtained from sulfondiimine 106f
(54 mg, 0.19 mmol) and phenylboronic acid (101a, 53 mg, 0.43 mmol).
Purification by flash column chromatography with a gradient of
n-pentane/ethyl acetate: 9/1 to 6/4 afforded the desired product as light
brown oil (39 mg, 57%). 1H NMR (400 MHz, CDCl3): = 8.16–8.12 (2H), 7.56–7.48 (m, 3H), 7.16–7.09 (m, 4H), 7.07–7.02 (2H), 6.86–6.81 (m, 1H), 6.71–6.65 (m, 2H), 3.69
(s, 3H), 2.71–2.64 (m, 1H), 1.37–1.31 (m, 2H), 0.97–0.90 (m, 2H).
80 | E x p e r i m e n t a l S e c t i o n
13C NMR (100 MHz, CDCl3): = 154.2, 146.1, 139.7, 138.8, 132.2, 129.2 (2C), 128.9 (2C), 128.6
(2C), 124.0 (2C), 123.0 (2C), 120.7, 114.3 (2C), 55.4, 36.5, 7.1, 7.0.
The corresponding spectroscopic data matched that reported in the literature.[47]
6.2 Synthesis of an N-alkenylated sulfondiimine
N-[(E)-styryl]-N',S-diphenyl-S-methyl sulfondiimine (109)
Following GP1, sulfondiimine 109 was obtained from sulfondiimine 17
(50 mg, 0.22 mmol) and (E)-styrylboronic acid (110, 76 mg, 0.51 mmol).
Purification by flash column chromatography with basic aluminiumox-
ide with a gradient of n-pentane/ethyl acetate: 9/1 to 6/4 afforded the
desired product as yellow solid (57 mg, 78%). 1H NMR (400 MHz, CDCl3): = 8.20–8.17 (m, 2H), 7.65–7.55 (m, 3H),
7.25–7.15 (m, 9H), 7.07–7.02 (m, 1H), 6.96–6.90 (m, 1H), 6.31 (d, J = 13.7 Hz, 1H), 3.31 (s, 3H). 13C NMR (100 MHz, CDCl3): = 145.1, 139.1, 138.3, 133.1, 130.7, 129.6 (2C), 129.2 (2C), 128.4
(2C), 128.4 (2C), 125.2, 124.8 (2C), 123.6 (2C), 121.8, 117.1, 44.6.
MS (EI): m/z (%) = 332 ([M]+, 36), 215 (57), 200 (100), 124 (44), 90 (25).
IR (KBr): = 2998, 1622, 1590, 1482, 1248, 1152, 1078, 1023, 952, 830, 744, 687.
HRMS (ESI): 355.1235, calcd. for C21H20N2NaS: 355.1239.
6.3 Syntheses of N-alkylated sulfondiimines
N-Butyl-N',S-diphenyl-S-methyl sulfondiimine (56a)
Following GP2, sulfondiimine 56a was obtained from sulfondiimine 17
(100 mg, 0.44 mmol), potassium hydroxide (50 mg, 0.88 mmol) and bu-
tyl bromide (57a, 71 l, 0.66 mmol). Purification by flash column chro-
matography with a gradient of n-pentane/ethyl acetate: 9/1 to 7/3 af-
forded the desired product as light brown oil (105 mg, 84%). 1H NMR (400 MHz, CDCl3): = 8.18–8.13 (m, 2H), 7.59–7.51 (m, 3H), 7.22–7.15 (m, 4H), 6.90–6.85 (m, 1H), 3.18 (s, 3H), 3.11–3.04 (m, 1H), 2.97–2.90 (m, 1H), 1.62–1.53 (m, 2H), 1.42–1.32
(m, 2H), 0.87 (t, J = 7.4 Hz, 3H). 13C NMR (100 MHz, CDCl3): = 146.8, 140.0, 132.3, 129.2 (2C), 128.9 (2C), 128.2 (2C), 122.6
(2C), 120.5, 43.8, 43.0, 34.5, 20.5, 13.8.
MS (EI): m/z (%) = 286 ([M]+, 100), 215 (19), 200 (23), 194 (22), 180 (8), 152 (60), 124 (46), 105
(27), 77 (27).
IR (neat): = 2928, 2858, 1587, 1478, 1251, 1164, 1022, 743.
HRMS (ESI): 287.1579, calcd. for C17H23N2S [M+H]+: 287.1577.
The corresponding spectroscopic data matched that reported in the literature.[47]
E x p e r i m e n t a l S e c t i o n | 81
N-Ethyl-N',S-diphenyl-S-methyl sulfondiimine (56b)
Following GP2, sulfondiimine 56b was obtained from sulfondiimine 17 (50
mg, 0.22 mmol), potassium hydroxide (25 mg, 0.44 mmol) and ethyl bromide
(57d, 25 l, 0.33 mmol). Purification by flash column chromatography with a
gradient of n-pentane/ethyl acetate: 9/1 to 1/1 afforded the desired product
as light brown oil (41 mg, 72%). 1H NMR (600 MHz, CDCl3): = 8.19–8.15 (m, 2H), 7.61–7.54 (m, 3H), 7.23–7.18 (m, 4H), 6.92–6.87 (m, 1H), 3.20 (s, 3H), 3.17–3.10 (m, 1H), 3.04–2.98 (m, 1H), 1.21 (t, J = 7.3 Hz, 3H). 13C NMR (151 MHz, CDCl3): = 146.7, 140.0, 132.4, 129.3 (2C), 129.0 (2C), 128.2 (2C), 122.7
(2C), 120.6, 43.9, 38.0, 17.8.
MS (EI): m/z (%) = 259 ([M+H]+, 25), 258 ([M]+, 100), 215 (8), 200 (19), 167 (18), 166 (25), 152
(55), 124 (41), 109 (20), 105 (25), 77 (27).
IR (neat): = 2966, 2852, 1589, 1482, 1248, 1166, 1034, 975, 749.
HRMS (ESI): 259.1259, calcd. for C15H19N2S [M+H]+: 259.1264.
N-Heptyl-N',S-diphenyl-S-methyl sulfondiimine (56c)
Following GP2, sulfondiimine 56c was obtained from sul-
fondiimine 17 (50 mg, 0.22 mmol), potassium hydroxide (25 mg,
0.44 mmol) and heptyl bromide (57e, 104 l, 0.33 mmol). Purifi-
cation by flash column chromatography with a gradient of n-
pentane/ethyl acetate: 9/1 to 6/4 afforded the desired product as
light yellow oil (58 mg, 80%). 1H NMR (600 MHz, CDCl3): = 8.18–8.15 (m, 2H), 7.60–7.54 (m, 3H), 7.22–7.17 (m, 4H), 6.91–6.86 (m, 1H), 3.20 (s, 3H), 3.09–3.04 (m, 1H), 2.96–2.90 (m, 1H), 1.61–1.55 (2H), 1.35–1.30 (m,
2H), 1.28–1.21 (m, 6H), 0.86 (t, J = 6.9 Hz, 3H). 13C NMR (151 MHz, CDCl3): = 146.7, 140.0, 132.4, 129.3 (2C), 128.9 (2C), 128.2 (2C), 122.6
(2C), 120.6, 43.8, 43.4, 32.4, 31.8, 29.1, 27.4, 22.6, 14.1.
MS (EI): m/z (%) = 329 ([M+H]+, 35), 328 ([M]+, 100), 236 (34), 215 (42), 200 (37), 152 (43), 124
(62), 105 (36), 77 (28), 70 (28).
IR (neat): = 2923, 2854, 1589, 1480, 1250, 1161, 1033, 748.
HRMS (ESI): 329.2054, calcd. for C20H29N2S [M+H]+: 329.2046.
N-Dodecyl-N',S-diphenyl-S-methyl sulfondiimine (56d)
Following GP2, sulfondiimine 56d was obtained from
sulfondiimine 17 (50 mg, 0.22 mmol), potassium hy-
droxide (25 mg, 0.44 mmol) and dodecyl bromide (57f,
160 l, 0.33 mmol). Purification by flash column chro-
matography with a gradient of n-pentane/ethyl acetate: 9/1 to 6/4 afforded the desired prod-
uct as light yellow oil (67 mg, 76%).
82 | E x p e r i m e n t a l S e c t i o n
1H NMR (600 MHz, CDCl3): = 8.18–8.15 (m, 2H), 7.61–7.53 (m, 3H), 7.22–7.17 (m, 4H), 6.91–6.86 (m, 1H), 3.20 (s, 3H), 3.09–3.03 (m, 1H), 2.96–2.90 (m, 1H), 1.61–1.55 (m, 2H), 1.35–1.21
(m, 18H), 0.88 (t, J = 6.9 Hz, 3H). 13C NMR (151 MHz, CDCl3): = 146.8, 140.0, 132.4, 129.3 (2C), 128.9 (2C), 128.2 (2C), 122.6
(2C), 120.6, 43.8, 43.4, 32.4, 31.9, 29.6, 29.6, 29.6, 29.6, 29.4, 29.3, 27.4, 22.7, 14.1.
MS (EI): m/z (%) = 399 ([M+H]+, 43), 398 ([M]+, 100), 306 (50), 216 (16), 215 (61), 200 (48), 152
(51), 124 (77), 105 (51), 77 (26), 70 (37).
IR (neat): = 2921, 2852, 1590, 1480, 1251, 1162, 1035, 748.
HRMS (ESI): 399.2813, calcd. for C25H39N2S [M+H]+: 399.2829.
N-Tetradecyl-N',S-diphenyl-S-methyl sulfondiimine (56e)
Following GP2, sulfondiimine 56e was obtained
from sulfondiimine 17 (50 mg, 0.22 mmol), potas-
sium hydroxide (25 mg, 0.44 mmol) and tetradecyl
bromide (57g, 98 l, 0.33 mmol). Purification by
flash column chromatography with a gradient of n-pentane/ethyl acetate: 9/1 to 6/4 afforded
the desired product as light brown oil (60 mg, 64%). 1H NMR (600 MHz, CDCl3): = 8.19–8.14 (m, 2H), 7.61–7.53 (m, 3H), 7.22–7.17 (m, 4H), 6.91–6.86 (m, 1H), 3.20 (s, 3H), 3.10–3.03 (m, 1H), 2.96–2.90 (m, 1H), 1.62–1.54 (m, 2H), 1.35–1.21
(m, 22H), 0.88 (t, J = 7.0 Hz, 3H). 13C NMR (151 MHz, CDCl3): = 146.8, 140.0, 132.4, 129.3 (2C), 129.0 (2C), 128.3 (2C), 122.7
(2C), 120.6, 43.8, 43.4, 32.5, 31.9, 29.7, 29.7 (2C), 29.6 (2C), 29.6, 29.4, 29.3, 27.4, 22.7, 14.1.
MS (EI): m/z (%) = 427 ([M+H]+, 40), 426 ([M]+, 100), 335 (15), 334 (58), 216 (18), 217 (69), 200
(47), 152 (49), 125 (20), 124 (78), 105 (53), 77 (26), 70 (37).
IR (neat): = 2921, 2852, 1590, 1479, 1251, 1163, 1035, 748.
HRMS (ESI): 449.2968, calcd. for C27H42N2NaS [M+Na]+: 449.2961.
N-Octadecyl-N',S-diphenyl-S-methyl sulfondiimine (56f)
Following GP2, sulfondiimine 56f was ob-
tained from sulfondiimine 17 (50 mg, 0.22
mmol), potassium hydroxide (24 mg,
0.44 mmol) and octadecyl bromide (57h,
125 mg, 0.33 mmol). Purification by flash column chromatography with a gradient of n-
pentane/ethyl acetate: 9/1 to 6/4 afforded the desired product as light brown oil (81 mg, 70%). 1H NMR (600 MHz, CDCl3): = 8.18–8.15 (m, 2H), 7.60–7.53 (m, 3H), 7.22–7.16 (m, 4H), 6.90–6.86 (m, 1H), 3.20 (s, 3H), 3.09–3.03 (m, 1H), 2.96–2.90 (m, 1H), 1.61–1.54 (m, 2H), 1.35–1.19
(m, 30H), 0.88 (t, J = 7.0 Hz, 3H). 13C NMR (151 MHz, CDCl3): = 146.8, 140.0, 132.3, 129.3 (2C), 128.9 (2C), 128.2 (2C), 122.6
(2C), 120.5, 43.8, 43.4, 32.4, 31.9, 29.7 (7C), 29.6 (2C), 29.6, 29.4, 29.3, 27.4, 22.7, 14.1.
MS (EI): m/z (%) = 485 (23), 484 (71), 483 ([M+H]+, 100), 482 ([M]+, 3), 391 (19), 390 (63), 216
(16), 215 (64), 200 (28), 152 (41), 125 (13), 124 (45), 105 (43), 77 (14), 70 (27).
E x p e r i m e n t a l S e c t i o n | 83
IR (neat): = 2921, 2852, 1590, 1479, 1251, 1164, 1036, 748.
HRMS (ESI): 483.3766, calcd. for C31H51N2S [M+H]+: 483.3768.
N-(3-Methylbutyl)-N',S-diphenyl-S-methyl sulfondiimine (56g)
Following GP2, sulfondiimine 56g was obtained from sulfondiimine 17
(50 mg, 0.22 mmol), potassium hydroxide (25 mg, 0.44 mmol) and 1-
bromo-2-methylbutane (57i, 42 l, 0.33 mmol). Purification by flash
column chromatography with a gradient of n-pentane/ethyl acetate: 9/1
to 6/4 afforded the desired product as light brown oil (52 mg, 79%). 1H NMR (400 MHz, CDCl3): = 8.19–8.14 (m, 2H), 7.61–7.52 (m, 3H), 7.22–7.16 (m, 4H), 6.92–6.85 (m, 1H), 3.20 (s, 3H), 3.14–3.05 (m, 1H), 2.99–2.91 (m, 1H), 1.69 (sept, J = 6.7 Hz, 1H),
1.53–1.44 (m, 2H), 0.85 (d, J = 3.4 Hz, 3H), 0.83 (d, J = 3.4 Hz, 3H). 13C NMR (101 MHz, CDCl3): = 146.8, 140.1, 132.4, 129.3 (2C), 128.9 (2C), 128.2 (2C), 122.7
(2C), 120.6, 43.9, 41.5, 41.5, 25.9, 22.6 (2C).
MS (EI): m/z (%) = 301 ([M+H]+, 22), 300 ([M]+, 100), 215 (26), 208 (23), 200 (39), 152 (63), 125
(21), 124 (82), 109 (14), 105 (28), 91 (14), 77 (31).
IR (KBr): = 2924, 2864, 1589, 1480, 1249, 1163, 1037, 750.
HRMS (ESI): 301.1732, calcd. for C18H25N2S [M+H]+: 301.1733.
N-(2-Methylpropyl)-N',S-diphenyl-S-methyl sulfondiimine (56h)
Following GP2, sulfondiimine 56h was obtained from sulfondiimine 17 (50
mg, 0.22 mmol), potassium hydroxide (25 mg, 0.44 mmol) and 1-bromo-2-
methylpropane (57j, 36 l, 0.33 mmol). Purification by flash column chro-
matography with a gradient of n-pentane/ethyl acetate: 9/1 to 6/4 afford-
ed the desired product as light brown oil (24 mg, 38%). 1H NMR (600 MHz, CDCl3): = 8.19–8.14 (m, 2H), 7.62–7.52 (m, 3H), 7.20–7.15 (m, 4H), 6.91–6.84 (m, 1H), 3.21 (s, 3H), 2.88 (dd, J = 12.0, 6.9 Hz, 1H), 2.74 (dd, J = 12.0, 6.9 Hz, 1H), 1.80
(sept, J = 6.7 Hz, 1H), 0.95 (d, J = 3.4 Hz, 3H), 0.93 (d, J = 3.4 Hz, 3H). 13C NMR (151 MHz, CDCl3): = 146.8, 139.9, 132.4, 129.3 (2C), 128.9 (2C), 128.3 (2C), 122.6
(2C), 120.5, 51.1, 43.9, 30.7, 20.7 (2C).
MS (EI): m/z (%) = 287 ([M+H]+, 23), 286 ([M]+, 100), 243 (14), 216 (14), 215 (70), 200 (41), 194
(14), 152 (63), 125 (15), 124 (44), 105 (21), 77 (18).
IR (neat): = 2953, 1590, 1482, 1283, 1251, 1166, 1038, 754.
HRMS (ESI): 287.1568, calcd. for C17H23N2S [M+H]+: 287.1577.
N-Allyl-N',S-diphenyl-S-methyl sulfondiimine (56i)
Following GP2, sulfondiimine 56i was obtained from sulfondiimine 17 (50
mg, 0.22 mmol), potassium hydroxide (25 mg, 0.44 mmol) and allyl bromide
(57k, 29 l, 0.33 mmol). Purification by flash column chromatography with a
gradient of n-pentane/ethyl acetate: 9/1 to 6/4 afforded the desired prod-
uct as light brown oil (43 mg, 72%).
84 | E x p e r i m e n t a l S e c t i o n
1H NMR (600 MHz, CDCl3): = 8.20–8.15 (m, 2H), 7.61–7.52 (m, 3H), 7.22–7.16 (m, 4H), 6.92–6.87 (m, 1H), 6.02–5.94 (m, 1H), 5.31–5.26 (m, 1H), 5.08–5.05 (m, 1H), 3.78–3.72 (m, 1H), 3.63–3.58 (m, 1H), 3.21 (s, 3H). 13C NMR (151 MHz, CDCl3): = 146.5, 139.8, 137.8, 132.5, 129.3 (2C), 129.0 (2C), 128.2 (2C),
122.8 (2C), 120.7, 114.8, 45.6, 44.3.
MS (EI): m/z (%) = 271 ([M+H]+, 23), 270 ([M]+, 81), 216 (14), 200 (27), 178 (35), 164 (14), 138
(11), 125 (16), 124 (100), 109 (33), 105 (25), 91 (27), 77 (75).
IR (neat): = 3060, 1590, 1482, 1283, 1250, 1162, 755.
HRMS (ESI): 271.1259, calcd. for C16H19N2S [M+H]+: 271.1264.
N-(5-Pentenyl)-N',S-diphenyl-S-methyl sulfondiimine (56j)
Following GP2, sulfondiimine 56j was obtained from sulfondiimine 17
(50 mg, 0.22 mmol), potassium hydroxide (25 mg, 0.44 mmol) and 1-
bromo-5-pentene (57l, 39 l, 0.33 mmol). Purification by flash column
chromatography with a gradient of n-pentane/ethyl acetate: 9/1 to 6/4
afforded the desired product as light brown oil (46 mg, 72%). 1H NMR (600 MHz, CDCl3): = 8.18–8.14 (m, 2H), 7.62–7.53 (m, 3H), 7.21–7.16 (m, 4H), 6.91–6.86 (m, 1H), 5.82–5.74 (m, 1H), 4.99–4.94 (m, 1H), 4.92–4.88 (m, 1H), 3.20 (s, 3H), 3.11–3.05
(m, 1H), 2.98–2.92 (m, 1H), 2.15–2.09 (m, 2H), 1.72–1.65 (m, 2H). 13C NMR (151 MHz, CDCl3): = 146.7, 139.9, 138.6, 132.4, 129.3 (2C), 129.0 (2C), 128.2 (2C),
122.6 (2C), 120.6, 114.4, 43.8, 42.9, 31.5, 31.5.
MS (EI): m/z (%) = 299 ([M+H]+, 23), 298 ([M]+, 100), 283 (26), 216 (13), 215 (71), 206 (48), 200
(62), 152 (71), 138 (64), 125 (90), 124 (100), 116 (16), 109 (16), 105 (19), 91 (15), 77 (29).
IR (neat): = 2923, 2845, 1588, 1481, 1249, 1159, 1034, 747, 691.
HRMS (ESI): 299.1575, calcd. for C18H23N2S [M+H]+: 299.1577.
N-(11-Undecenyl)-N',S-diphenyl-S-methyl sulfondiimine (56k)
Following GP2, sulfondiimine 56k was obtained from sul-
fondiimine 17 (50 mg, 0.22 mmol), potassium hydroxide
(25 mg, 0.44 mmol) and 1-bromo-11-undecene (57m, 72
l, 0.33 mmol). Purification by flash column chromatog-
raphy with a gradient of n-pentane/ethyl acetate: 9/1 to
6/4 afforded the desired product as light brown oil (66 mg, 78%). 1H NMR (600 MHz, CDCl3): = 8.19–8.14 (m, 2H), 7.61–7.53 (3H), 7.22–7.16 (m, 4H), 6.92–6.85 (m, 1H), 5.85–5.76 (m, 1H), 5.01–4.96 (m, 1H), 4.94–4.90 (m, 1H), 3.20 (s, 3H), 3.10–3.03
(m, 1H), 2.96–2.89 (m, 1H), 2.06–2.00 (m, 2H), 1.61–1.55 (m, 2H), 1.38–1.21 (m, 12H). 13C NMR (151 MHz, CDCl3): = 146.8, 140.0, 139.2, 132.4, 129.3 (2C), 128.9 (2C), 128.2 (2C),
122.6 (2C), 120.5, 114.0, 43.8, 43.4, 33.8, 32.4, 29.5, 29.4, 29.4, 29.1, 28.9, 27.4.
MS (EI): m/z (%) = 383 ([M+H]+, 39), 382 ([M]+, 100), 291 (14), 290 (41), 216 (15), 215 (59), 200
(43), 152 (48), 125 (19), 124 (74), 109 (10), 105 (47), 77 (29), 70 (30).
IR (neat): = 2923, 2851, 1591, 1483, 1283, 1251, 1162, 753.
E x p e r i m e n t a l S e c t i o n | 85
HRMS (ESI): 383.2508, calcd. for C24H35N2S [M+H]+: 383.2516.
N-Propargyl-N',S-diphenyl-S-methyl sulfondiimine (56l)
Following GP2, sulfondiimine 56l was obtained from sulfondiimine 17 (50
mg, 0.22 mmol), potassium hydroxide (25 mg, 0.44 mmol) and propargyl
bromide (57n, 34 l, 0.33 mmol). Purification by flash column chromatog-
raphy with a gradient of n-pentane/ethyl acetate: 9/1 to 1/1 afforded the
desired product as light brown oil (52 mg, 88%). 1H NMR (600 MHz, CDCl3): = 8.21–8.16 (m, 2H), 7.64–7.52 (m, 3H), 7.22–7.16 (m, 4H), 6.94–6.87 (m, 1H), 3.95–3.88 (m, 1H), 3.83–3.75 (m, 1H), 3.27 (s, 3H), 2.20 (t, J = 2.5 Hz, 1H). 13C NMR (151 MHz, CDCl3): = 146.0, 139.2, 132.7, 129.3 (2C), 129.0 (2C), 128.2 (2C), 122.8
(2C), 121.1, 83.3, 70.7, 44.5, 32.3.
MS (EI): m/z (%) = 268 ([M]+, 26), 201 (76), 199 (17), 176 (17), 168 (10), 162 (18), 138 (18), 124
(100), 109 (37), 106 (21), 93 (24), 92 (30), 77 (36).
IR (neat): = 3287, 1588, 1482, 1248, 1142, 1032, 752.
HRMS (ESI): 291.0926, calcd. for C16H16N2NaS [M+H]: 291.0926.
The corresponding spectroscopic data matched that reported in the literature.[30]
N-(3-Pentynyl)-N',S-diphenyl-S-methyl sulfondiimine (56m)
Following GP2, sulfondiimine 56m was obtained from sulfondiimine
17 (50 mg, 0.22 mmol), potassium hydroxide (25 mg, 0.44 mmol) and
1-bromo-2-pentyne (57o, 34 l, 0.33 mmol). Purification by flash col-
umn chromatography with a gradient of n-pentane/ethyl acetate: 9/1
to 1/1 afforded the desired product as light brown oil (45 mg, 69%). 1H NMR (400 MHz, CDCl3): = 8.22–8.17 (m, 2H), 7.62–7.52 (m, 3H), 7.22–7.15 (m, 4H), 6.93–6.87 (m, 1H), 3.93–3.86 (m, 1H), 3.81–3.75 (m, 1H), 3.26 (s, 3H), 2.17–2.07 (m, 2H), 1.05 (t, J =
7.5 Hz, 3H). 13C NMR (101 MHz, CDCl3): = 146.3, 139.5, 132.6, 129.3 (2C), 129.0 (2C), 128.3 (2C), 122.8
(2C), 120.9, 84.4, 78.3, 44.4, 32.8, 13.8, 12.5.
MS (EI): m/z (%) = 297 ([M+H]+, 27), 296 ([M]+, 70), 216 (12), 215 (16), 204 (49), 200 (51), 190
(46), 171 (17), 167 (15), 152 (93), 138 (36), 132 (15), 125 (16), 124 (100), 109 (30), 91 (19), 77
(42).
IR (neat): = 2921, 1587, 1438, 1249, 1149, 1020, 749.
HRMS (ESI): 297.1418, calcd. for C18H21N2NaS [M+H]+: 297.1420.
N-Benzyl-N',S-diphenyl-S-methyl sulfondiimine (56n)
Following GP2, sulfondiimine 56n was obtained from sulfondiimine 17 (50
mg, 0.22 mmol), potassium hydroxide (25 mg, 0.44 mmol) and benzyl
bromide (57p, 39 l, 0.33 mmol). Purification by flash column chromatog-
raphy with a gradient of n-pentane/ethyl acetate: 9/1 to 6/4 afforded the
desired product as light brown oil (49 mg, 70%).
86 | E x p e r i m e n t a l S e c t i o n
1H NMR (400 MHz, CDCl3): = 8.21–8.16 (m, 2H), 7.59–7.51 (m, 3H), 7.40–7.16 (m, 9H), 6.92–6.86 (m, 1H), 4.31 (d, J = 14.5 Hz, 1H), 4.16 (d, J = 14.5 Hz, 1H), 3.18 (3, 3H). 13C NMR (101 MHz, CDCl3): = 146.6, 141.5, 139.8, 132.5, 129.3 (2C), 129.0 (2C), 128.2 (2C),
128.2 (2C), 127.8 (2C), 126.5, 122.7 (2C), 120.7, 46.9, 44.4.
MS (EI): m/z (%) = 321([M+H]+, 39), 320 ([M]+, 100), 228 (30), 216 (13), 200 (12), 124 (17), 105
(12), 91 (15), 77 (15).
IR (neat): = 1588, 1483, 1248, 1146, 1024, 738.
HRMS (ESI): 321.1413, calcd. for C20H21N2S [M+H]+: 321.14120.
N-(3-Phenylpropyl)-N',S-diphenyl-S-methyl sulfondiimine (56o)
Following GP2, sulfondiimine 56o was obtained from sulfondiimine
17 (50 mg, 0.22 mmol), potassium hydroxide (24 mg, 0.44 mmol) and
1-bromo-3-phenylpropane (57q, 50 l, 0.33 mmol). Purification by
flash column chromatography with a gradient of n-pentane/ethyl ace-
tate: 9/1 to 1/1 afforded the desired product as light yellow oil (61
mg, 80%). 1H NMR (600 MHz, CDCl3): = 8.18–8.14 (m, 2H), 7.60–7.53 (m, 3H), 7.25–7.12 (m, 9H), 6.92–6.86 (m, 1H), 3.20 (s, 3H), 3.16–3.10 (m, 1H), 3.04–2.99 (m, 1H), 2.69 (t, J = 7.8 Hz, 2H), 1.94–1.88 (m, 2H). 13C NMR (151 MHz, CDCl3): = 146.7, 142.3, 139.9, 132.4, 129.3 (2C), 129.0 (2C), 128.4 (2C),
128.2 (2C), 128.2 (2C), 125.5, 122.6 (2C), 120.6, 43.9, 42.9, 33.8, 33.6.
MS (EI): m/z (%) = 349 ([M+H]+, 69), 348 ([M]+, 100), 257 (12), 256 (31), 215 (26), 200 (14), 152
(82), 124 (12), 105 (9).
IR (neat): = 2926, 1589, 1482, 1249, 1150, 1034, 745.
HRMS (ESI): 349.1734, calcd. for C22H25N2S [M+H]+: 349.1733.
N-(2-Cyclohexylethyl)-N',S-diphenyl-S-methyl sulfondiimine (56p)
Following GP2, sulfondiimine 56p was obtained from sulfondiimine 17
(50 mg, 0.22 mmol), potassium hydroxide (25 mg, 0.44 mmol) and (2-
bromoethyl)cyclohexane (57r, 52 l, 0.33 mmol). Purification by flash
column chromatography with a gradient of n-pentane/ethyl acetate:
9/1 to 6/4 afforded the desired product as light yellow oil (55 mg, 73%). 1H NMR (400 MHz, CDCl3): = 8.18–8.14 (m, 2H), 7.60–7.52 (m, 3H), 7.22–7.16 (m, 4H), 6.92–6.85 (m, 1H), 3.20 (s, 3H), 3.14–3.06 (m, 1H), 2.99–2.91 (m, 1H), 1.68–1.57 (m, 5H), 1.52–1.45
(m, 2H), 1.41–1.32 (m, 1H), 1.23–1.08 (m, 3H), 0.90–0.78 (m, 2H). 13C NMR (101 MHz, CDCl3): = 146.8, 140.1, 132.4, 129.2 (2C), 128.9 (2C), 128.2 (2C), 122.7
(2C), 120.5, 43.8, 40.9, 40.0, 35.4, 33.3, 33.3, 26.6, 26.3 (2C).
MS (EI): m/z (%) = 341 ([M+H]+, 58), 340 ([M]+, 100), 248 (25), 215 (25), 200 (17), 152 (20), 124
(17), 105 (9).
IR (neat): = 2918, 2848, 1587, 1483, 1250, 1158, 1017, 751.
HRMS (ESI): 341.2045, calcd. for C21H29N2S [M+H]+: 341.2046.
E x p e r i m e n t a l S e c t i o n | 87
N-Citronellyl-N',S-phenyl-S-methyl sulfondiimine (56q)
Following GP2, sulfondiimine 56q was obtained from sul-
fondiimine 17 (50 mg, 0.22 mmol), potassium hydroxide (24 mg,
0.44 mmol) and citronellyl bromide (57s, 65 l, 0.33 mmol).
Purification by flash column chromatography with a gradient of
n-pentane/ethyl acetate: 9/1 to 6/4 afforded the desired prod-
uct as mixture of diastereomers (d.r. = 1:1) and as light yellow oil (53 mg, 65%). 1H NMR (600 MHz, CDCl3, mixture of diastereomers): = 8.17 (both, d, J = 7.3 Hz, 4H), 7.62–7.54 (both, m, 6H), 7.21–7.17 (both, m, 8H), 6.92–6.86 (both, m, 2H), 5.06 (both, t, J = 6.7 Hz,
2H), 3.21 (both, s, 6H), 3.15–3.04 (both, m, 2H), 3.01–2.90 (both, m, 2H), 1.99–1.86 (both, m,
4H, both), 1.66 (both, s, 6H, both), 1.65–1.60 (both, m, 2H, both), 1.57 (both, d, J = 2.8 Hz, 6H),
1.55–1.49 (both, m, 2H), 1.45–1.39 (both, m, 2H), 1.32–1.26 (both, m, 2H), 1.14–1.06 (both, m,
2H), 0.82 (both, q, J = 3.3 Hz, 6H). 13C NMR (150 MHz, CDCl3, mixture of diastereomers): = 146.7 (both, 2C), 140.0 (both, 2C),
132.4 (both, 2C), 130.9 (both, 2C), 129.3 (both, 4C), 129.0 (both, 4C), 128.3 (both, 4C), 125.0
(both, 2C), 122.7 (both, 4C), 120.7 (both, 2C), 43.8 (both, 2C), 41.3 (both, 2C), 39.6 (both, 2C),
37.1 (each), 37.1 (each), 30.5 (each), 30.5 (each), 25.7 (both, 2C), 25.5 (each), 25.4 (each), 19.5
(each), 19.5 (each), 17.6 (both, 2C).
MS (EI): m/z (%) = 369 ([M+H]+, 17), 368 ([M]+, 63), 276 (20), 216 (18), 215 (100), 201 (11), 200
(75), 152 (37), 138 (19), 125 (13), 123 (72), 108 (12), 104 (12).
IR (neat): = 2923, 1592, 1484, 1252, 756.
HRMS (ESI): 369.2358, calcd. for C23H33N2S [M+H]+: 369.2359.
N-Phenyl-N'-butyl-S-(4-methoxyphenyl)-S-methyl sulfondiimine (56r)
Following GP2, sulfondiimine 56r was obtained from sulfondiimine
106i (100 mg, 0.38 mmol), potassium hydroxide (43 mg, 0.77 mmol)
and butyl bromide (57a, 61 l, 0.57 mmol). Purification by flash col-
umn chromatography with a gradient of n-pentane/ethyl acetate:
9/1 to 1/2 afforded the desired product as light brown oil (102 mg,
85%). 1H NMR (600 MHz, CDCl3): = 8.09–8.05 (m, 2H), 7.22–7.16 (m, 4H), 7.04–7.99 (m, 2H), 6.89–6.85 (m, 1H), 3.85 (s, 3H), 3.18 (s, 3H), 3.08–3.03 (m, 1H), 2.96–2.90 (m, 1H), 1.61–1.53 (m, 2H),
1.41–1.33 (m, 2H), 0.87 (t, J = 7.4 Hz, 3H). 13C NMR (151 MHz, CDCl3): = 162.8, 146.9, 130.9, 130.3 (2C), 128.8 (2C), 122.5 (2C), 120.3,
114.4 (2C), 55.5, 44.0, 43.0, 34.6, 20.5, 13.9.
MS (EI): m/z (%) = 316 ([M]+, 100), 245 (22), 230 (20), 224 (22), 182 (61), 154 (35), 139 (16).
IR (neat): = 2928, 1590, 1487, 1253, 1168, 1088, 1033, 757.
HRMS (ESI): 317.1680, calcd. for C18H25ON2S [M+H]+: 317.1682.
88 | E x p e r i m e n t a l S e c t i o n
N-Phenyl-N'-butyl-S-(4-bromophenyl)-S-methyl sulfondiimine (56s)
Following GP2, sulfondiimine 56s was obtained from sulfondiimine
106e (100 mg, 0.32 mmol), potassium hydroxide (37 mg, 0.65 mmol)
and butyl bromide (57a, 52 l, 0.49 mmol). Purification by flash col-
umn chromatography with a gradient of n-pentane/ethyl acetate: 9/1
to 7/3 afforded the desired product as light yellow oil (92 mg, 79%). 1H NMR (400 MHz, CDCl3): = 8.05–8.00 (m, 2H), 7.72–7.65 (m, 2H), 7.23–7.14 (m, 4H), 6.93–6.86 (m, 1H), 3.19 (s, 3H), 3.10–3.02 (m, 1H), 2.95–2.87 (m, 1H), 1.59–1.51 (m, 2H), 1.41–1.32
(m, 2H), 0.87 (t, J = 7.4 Hz, 3H). 13C NMR (101 MHz, CDCl3): = 146.4, 139.2, 132.5 (2C), 130.0 (2C), 129.0 (2C), 127.6, 122.6
(2C), 120.8, 43.9, 43.1, 34.5, 20.5, 13.9.
MS (EI): m/z (%) = 365 ([M+H]+, 34), 364 ([M]+, 100), 274 (17), 272 (16), 232 (38), 230 (37), 105
(27).
IR (KBr): = 2927, 2860, 1792, 1584, 1479, 1290, 1248, 1165, 1001, 748.
HRMS (ESI): 365.0682, calcd. for C17H22N2BrS [M+H]+: 365.0682.
N-Phenyl-N'-butyl-S-tolyl-S-methyl sulfondiimine (56t)
Following GP2, sulfondiimine 56t was obtained from N-phenyl-S-tolyl-
S-methyl sulfondiimine (106d, 100 mg, 0.41 mmol), potassium hydrox-
ide (46 mg, 0.82 mmol) and butylbromide (57a, 65 L, 0.61 mmol)
provided the product (102 mg, 83% yield) as light brown oil after puri-
fication by flash column chromatography (n-pentane/ethyl acetate 9:1 to 1:1). 1H NMR (600 MHz, CDCl3): = 8.03 (d, J = 8.0 Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 7.22–7.14 (m, 4H),
6.89–6.84 (m, 1H), 3.17 (s, 3H), 3.09–3.03 (m, 1H), 2.96–2.90 (m, 1H), 2.42 (s, 3H), 1.60–1.53
(m, 2H), 1.40–1.33 (m, 2H), 0.87 (t, J = 7.4 Hz, 3H). 13C NMR (151 MHz, CDCl3): = 146.9, 143.0, 136.8, 129.9 (2C), 128.8 (2C), 128.2 (2C), 122.6
(2C), 120.4, 43.9, 43.0, 34.6, 21.4, 20.5, 13.9.
MS (EI): m/z (%) = 301 ([M+H]+, 34), 300 ([M]+, 100), 229 (14), 214 (13), 208 (13), 166 (41), 138
(23), 105 (8).
IR (neat): = 2955, 2926, 1592, 1485, 1253, 1169, 1039, 756.
HRMS (ESI): 301.1733, calcd. for C18H25N2S: 301.1733.
N-Phenyl-N'-butyl-S-cyclopropyl-S-phenyl sulfondiimine (56u)
Following GP2, sulfondiimine 56u was obtained from sulfondiimine 106j
(100 mg, 0.39 mmol), potassium hydroxide (44 mg, 0.78 mmol) and bu-
tyl bromide (57a, 63 l, 0.59 mmol). Purification by flash column chro-
matography with a gradient of n-pentane/ethyl acetate: 9/1 to 8/2 af-
forded the desired product as light yellow oil (91 mg, 75%). 1H NMR (600 MHz, CDCl3): = 8.09–8.05 (m, 2H), 7.55–7.47 (m, 3H), 7.18–7.10 (m, 4H), 6.84–6.79 (m, 1H), 3.12–3.07 (m, 1H), 3.00–2.94 (m, 1H), 2.62–2.55 (m, 1H), 1.57–1.51 (m, 2H), 1.40–1.33 (m, 2H), 1.32–1.27 (m, 1H), 1.24–1.18 (m, 1H), 0.96–0.89 (m, 2H), 0.86 (t, J = 7.4 Hz, 3H).
E x p e r i m e n t a l S e c t i o n | 89
13C NMR (151 MHz, CDCl3): = 146.9, 140.3, 131.8, 129.0 (2C), 128.7 (2C), 128.2 (2C), 122.6
(2C), 120.0, 43.0, 35.4, 34.8, 20.5, 13.9, 6.7, 6.6.
MS (EI): m/z (%) = 313 ([M+H]+, 42), 312 ([M]+, 100), 241 (24), 220 (22), 200 (16), 178 (65), 150
(16), 117 (17), 105 (15), 77 (13).
IR (neat): = 2927, 2859, 1589, 1481, 1252, 1166, 1009, 887, 753, 692.
HRMS (ESI): 313.1722, calcd. for C19H25N2S [M+H]+: 313.1733.
N-Tosyl-N'-butyl-S-methyl-S-phenyl sulfondiimine (56v)
Following GP2, sulfondiimine 56v was obtained from sul-
fondiimine 106c (70 mg, 0.23 mmol), potassium hydroxide (26
mg, 0.45 mmol) and butyl bromide (57a, 37 l, 0.35 mmol). Purifi-
cation by flash column chromatography with a gradient of n-
pentane/ethyl acetate: 9/1 to 3/7 afforded the desired product as
colorless oil (65 mg, 78%). 1H NMR (400 MHz, CDCl3): = 8.01–7.96 (m, 2H), 7.94–7.90 (m, 2H), 7.67–7.62 (m, 1H), 7.60–7.54 (m, 2H), 7.28–7.24 (m, 2H), 3.52 (s, 3H), 2.45–2.37 (m, 1H), 2.40 (s, 3H), 2.25–2.17 (m, 1H),
1.33–1.05 (m, 4H), 0.76 (t, J = 7.2 Hz, 3H). 13C NMR (101 MHz, CDCl3): = 142.3, 141.4, 137.4, 133.4, 129.7 (2C), 129.1 (2C), 128.1 (2C),
126.7 (2C), 46.5, 43.7, 33.8, 21.4, 20.1, 13.7.
MS (EI): m/z (%) = 365 ([M+H]+, 66), 321 (11), 295 (18), 194 (100), 194 (33), 138 (36), 124 (31),
91 (16).
IR (neat): = 2932, 1449, 1293, 1146, 1031, 808, 741.
HRMS (ESI): 365.1351, calcd. for C18H25N2S2 [M+H]+: 365.1352.
N-(4-Methoxyphenyl)-N'-dodecyl-S-methyl-S-phenyl sulfondiimine (56w)
Following GP2, sulfondiimine 56w was obtained
from sulfondiimine 106l (100 mg, 0.38 mmol),
potassium hydroxide (43 mg, 0.77 mmol) and
dodecyl bromide (57t, 138 l, 0.58 mmol). Purifi-
cation by flash column chromatography with a
gradient of n-pentane/ethyl acetate: 9/1 to 1/1 afforded the desired product as brown oil (129
mg, 78%). 1H NMR (400 MHz, CDCl3): = 8.18–8.13 (m, 2H), 7.60–7.51 (m, 3H), 7.14–7.08 (m, 2H), 6.79–6.73 (m, 2H), 3.74 (s, 3H), 3.15 (s, 3H), 3.11–3.03 (m, 1H), 2.97–2.89 (m, 1H), 1.63–1.54 (m, 2H),
1.38–1.21 (m, 18H), 0.88 (t, J = 6.8 Hz, 3H). 13C NMR (101 MHz, CDCl3): = 154.0, 140.1, 139.6, 132.2, 129.2 (2C), 128.3 (2C), 123.7 (2C),
114.3 (2C), 55.3, 43.6, 43.3, 32.5, 31.8, 29.6, 29.6, 29.6 (2C), 29.4, 29.3, 27.4, 22.6, 14.0.
MS (EI): m/z (%) = 428 ([M]+, 100), 306 (30), 230 (22), 152 (24), 135 (46), 124 (53), 107 (38), 70
(19).
IR (neat): = 2922, 2851, 1498, 1456, 1232, 1164, 1084, 1037, 828, 733.
HRMS (ESI): 429.2939, calcd. for C26H41ON2S [M+H]+: 429.2934.
90 | E x p e r i m e n t a l S e c t i o n
N-Phenyl-N'-butyl tetrahydrothiophenyl sulfondiimine (56x)
Following GP2, sulfondiimine 56x was obtained from sulfondiimine 106h
(80 mg, 0.41 mmol), potassium hydroxide (46 mg, 0.82 mmol) and butyl
bromide (57a, 66 l, 0.62 mmol). Purification by flash column chroma-
tography with a gradient of n-pentane/ethyl acetate: 9/1 to 0/1 afford-
ed the desired product as light brown oil (97 mg, 95%). 1H NMR (600 MHz, CDCl3): = 7.22–7.17 (m, 2H), 7.15–7.10 (m, 2H), 6.90–6.85 (m, 1H), 3.43–3.38 (m, 2H), 3.27–3.20 (m, 2H), 3.01 (t, J = 7.3 Hz, 2H), 2.28–2.19 (m, 4H), 1.54–1.47 (m, 2H),
1.36–1.28 (m, 2H), 0.86 (t, J = 7.4 Hz, 3H). 13C NMR (151 MHz, CDCl3): = 147.7, 128.9 (2C), 121.6 (2C), 120.1, 53.2 (2C), 44.3, 34.4,
23.9 (2C), 20.4, 13.8.
MS (EI): m/z (%) = 251 ([M+H]+, 43), 250 ([M]+, 100), 179 (22), 158 (30), 116 (50), 105 (11).
IR (KBr): = 2936, 2862, 1587, 1478, 1246, 1149, 993, 756.
HRMS (ESI): 251.1576, calcd. for C14H23N2S [M+H]+: 251.1577.
N-(N,N-Diethylaminoethyl)-N',S-diphenyl-S-methyl sulfondiimine (56y)
Following GP2, sulfondiimine 56y was obtained from a solution of sul-
fondiimine 17 (200 mg, 0.87 mmol) and potassium hydroxide (146 mg,
2.6 mmol) in anhydrous DMSO (1 mL) and subsequent addition of a
solution of N,N-diethylamino-ethylbromide hydrobromide (116,
341 mg, 1.31 mmol) in anhydrous DMSO (1 mL). In this case,[a] for rea-
sons of safety,[112] the flame-dry schlenk tube was connected to a wash bottle filled with water,
and stirred under a constant argon flow. Purification by flash column chromatography with a
gradient of n-pentane/ethyl acetate/DCM: 8/2/0 to 0/0/1 afforded the desired product as light
brown oil (49 mg, 17%). 1H NMR (600 MHz, CDCl3): = 8.22–8.17 (m, 2H), 7.64–7.54 (m, 3H), 7.22–7.11 (m, 4H), 6.86–6.92 (m, 1H), 3.36–3.28 (m, 1H), 3.27 (s, 3H), 3.23–3.14 (m, 1H), 2.86 (t, J = 7.1 Hz, 2H), 2.79 (q,
J = 7.2 Hz, 4H), 1.13 (t, J = 7.2 Hz, 6H). 13C NMR (151 MHz, CDCl3): = 146.3, 139.6, 132.6, 129.4 (2C), 129.0 (2C), 128.2 (2C), 122.7
(2C), 120.8, 53.7, 47.2 (2C), 44.3, 39.6, 10.3 (2C).
MS (EI): m/z (%) = 330 ([M+H]+, 27), 237 (26), 231 (14), 230 (14), 215 (39), 201 (11), 200 (20), 86
(100), 58 (12).
IR (neat): = 2923, 1666, 1598, 1486, 1283, 1251, 1170, 752.
HRMS (ESI): 330.1996, calcd. for C19H28N3S [M+H]+: 330.1999.
[a] N,N-Diethylaminoethyl bromide is generated in situ from the hydrobromide reagent and structurally related to a group of N-(2-chloroethyl)-substituted amine derivatives known as nitrogen mustards. Bearing a strong cytotoxic effect, these compounds are utilizable for chemical warfare purposes. Hence, this transformation was handled under specific safety precautions.
E x p e r i m e n t a l S e c t i o n | 91
6.4 Syntheses of β-hydroxy sulfondiimines
1-(N,N'-Diphenyl-S-phenylsulfondiimidoyl)-2-phenylethan-2-ol (122a)
Following GP3, β-hydroxy sulfondiimine 122a was obtained from sul-
fondiimine 61a (50 mg, 0.163 mmol) and benzaldehyde (72a, 35 L,
0.326 mmol, 2.00 equiv), employing n-butyllithium (1.6 M, 0.171 mmol,
107 L, 1.05 equiv) and after stirring for 1 h at –78 °C. Purification by
flash column chromatography with a gradient of n-pentane/ethyl ace-
tate: 9/1 to 8/2 afforded the desired product as brown oil (63 mg,
94%). 1H NMR (600 MHz, CDCl3): = 8.24 (d, J = 7.7 Hz, 2H), 7.69–7.65 (m, 1H), 7.63–7.58 (m, 2H),
7.27–7.14 (m, 13H), 7.02 (br s, 1H, OH), 7.96–7.91 (m, 2H), 5.00 (d, J = 10.4 Hz, 1H), 4.00 (dd, J =
14.1, 10.4 Hz, 1H), 2.99 (d, J = 14.1 Hz, 1H). 13C NMR (151 MHz, CDCl3): = 144.6, 114.4, 140.9, 136.4, 133.5, 129.8 (2C), 129.3 (2C), 129.2
(2C), 129.2 (2C), 128.6 (2C), 128.0, 125.6 (2C), 123.4 (2C), 122.8 (2C), 122.1, 121.8, 69.2, 62.8.
(EI): m/z (%) = 412 ([M]+, 6), 320 (15), 199 (100), 197 (33), 181 (22), 180 (25), 167 (31), 165 (45),
123 (29), 106 (22), 105 (24), 103 (27), 93 (17), 77 (41).
IR (neat): = 3269, 3061, 2863, 1590, 1483, 1446, 1284, 1247, 1176, 1068, 974, 906, 856, 832,
792, 747, 690.
HRMS (ESI): 413.1682, calcd. for C26H25ON2S: 413.1682.
1-(N,N'-Diphenyl-S-phenylsulfondiimidoyl)-2-(4-nitrophenyl)ethan-2-ol (122b)
Following GP3, β-hydroxy sulfondiimine 122b was obtained from
sulfondiimine 61a (50 mg, 0.163 mmol) and 4-nitrobenzaldehyde
(72b, 49 mg, 0.326 mmol, 2.00 equiv), employing n-butyllithium
(1.6 M, 0.171 mmol, 107 L, 1.05 equiv) and after stirring for 2 h
at –78 °C. Purification by flash column chromatography with a
gradient of n-pentane/ethyl acetate: 9/1 to 7/3 afforded the de-
sired product as brown oil (61 mg, 82%). 1H NMR (400 MHz, CDCl3): = 8.26–8.21 (m, 2H), 8.13–8.08 (m, 2H), 7.73–7.67 (m, 1H), 7.66–7.60 (m, 2H), 7.37–7.32 (m, 2H), 7.29 (br s, 1H), 7.23–7.15 (m, 8H), 6.99–6.92 (m, 2H), 5.10 (d, J
= 10.2 Hz, 1H), 3.91 (dd, J = 14.1, 10.4 Hz, 1H), 3.02 (dd, J = 14.1, 1.5 Hz, 1H). 13C NMR (101 MHz, CDCl3): = 148.1, 147.5, 144.3, 144.1, 136.3, 133.8, 129.9 (2C), 129.4 (2C),
129.4 (2C), 129.2 (2C), 126.6 (2C), 123.8 (2C), 123.3 (2C), 122.9 (2C), 122.3, 122.2, 68.6, 62.4.
MS (ESI): m/z (%) = 458.15 ([M+H]+).
IR (neat): = 3244, 3063, 1714, 1592, 1520, 1483, 1445, 1344, 1285, 1247, 1074, 974, 907, 851,
730, 690, 593.
HRMS (ESI): 458.1532, calcd. for C26H24O3N3S: 458.1533.
92 | E x p e r i m e n t a l S e c t i o n
1-(N,N'-Diphenyl-S-phenylsulfondiimidoyl)-2-[4-(trifluoromethyl)phenyl]ethan-2-ol (122c)
Following GP3, β-hydroxy sulfondiimine 122c was obtained from
sulfondiimine 61a (50 mg, 0.163 mmol) and
4-(trifluoromethyl)benzaldehyde (72c, 45 L, 0.326 mmol,
2.00 equiv), employing n-butyllithium (1.6 M, 0.171 mmol, 107 L,
1.05 equiv) and after stirring for 1 h at –78 °C. Purification by flash
column chromatography with a gradient of n-pentane/ethyl ace-
tate: 9/1 to 7/3 afforded the desired product as light brown solid (65 mg, 83%).
m.p.: 60–61 °C. 1H NMR (600 MHz, CDCl3): = 8.24–8.21 (m, 2H), 7.70–7.66 (m, 1H), 7.63–7.59 (m, 2H), 7.50 (d,
J = 8.2 Hz, 2H), 7.28 (d, J = 8.2 Hz, 2H), 7.23–7.18 (m, 8H), 7.16 (br s, 1H), 6.98–6.93 (m, 2H),
5.06 (d, J = 10.2 Hz, 1H), 3.92 (dd, J = 14.1, 10.4 Hz, 1H), 3.02 (dd, J = 14.1, 1.5 Hz, 1H). 13C NMR (151 MHz, CDCl3): = 114.9, 144.5, 144.2, 136.4, 133.7, 130.2 (q, J = 32 Hz, 1C), 129.9
(2C), 129.4 (2C), 129.3 (2C), 129.2 (2C), 126.1 (2C), 125.5 (q, J = 4 Hz, 2C), 123.9 (q, J = 272 Hz,
1C), 123.3 (2C), 122.9 (2C), 122.2, 122.1, 68.8, 62.6. 19F NMR (282 MHz, CDCl3): = –62.66.
MS (EI): m/z (%) = 480 ([M]+, 9), 389 (34), 201 (71), 200 (100), 167 (19), 105 (16), 97 (20), 77
(20), 65 (10).
IR (KBr): = 3247, 3062, 1591, 1483, 1445, 1415, 1322, 1287, 1249, 1163, 1119, 1065, 1018,
973, 832, 791, 752, 688.
HRMS (ESI): 503.1375, calcd. for C27H23ON2F3NaS: 503.1375.
1-(N,N'-Diphenyl-S-phenylsulfondiimidoyl)-2-(4-chlorophenyl)ethan-2-ol (122d)
Following GP3, β-hydroxy sulfondiimine 122d was obtained from
sulfondiimine 61a (50 mg, 0.163 mmol) and 4-chlorobenzaldehyde
(72d, 40 L, 0.326 mmol, 2.00 equiv), employing n-butyllithium (1.6
M, 0.171 mmol, 107 L, 1.05 equiv) and after stirring for 2 h at –78
°C. Purification by flash column chromatography with a gradient of
n-pentane/ethyl acetate: 9/1 to 7/3 afforded the desired product as
brown oil (61 mg, 84%). 1H NMR (600 MHz, CDCl3): = 8.24–8.21 (m, 2H), 7.70–7.66 (m, 1H), 7.63–7.59 (m, 2H), 7.23–7.17 (m, 10H), 7.12–7.07 (m, 3H), 6.98– 6.92 (m, 2H), 4.97 (d, J = 9.9 Hz, 1H), 3.93 (dd, J = 14.4
Hz, 10.4 Hz, 1H), 2.96 (dd, J = 14.1 Hz, 1.3 Hz, 1H). 13C NMR (151 MHz, CDCl3): = 144.5, 144.3, 139.5, 136.3, 133.8, 133.6, 129.8 (2C), 129.3 (2C),
129.3 (2C), 129.2 (2C), 128.7 (2C), 127.1 (2C), 123.4 (2C), 122.8 (2C), 122.2, 122.0, 68.6, 62.7.
MS (EI): m/z (%) = 446 ([M]+, 9), 355 (20), 202 (17), 201 (100), 200 (80), 182 (21), 167 (18), 105
(14), 97 (16), 92 (16), 91 (18), 77 (28), 65 (14).
IR (neat): = 3244, 3019, 1739, 1589, 1482, 1249, 1073, 801, 752, 686.
HRMS (ESI): 469.1112, calcd. for C26H23ON2ClNaS: 469.1112.
E x p e r i m e n t a l S e c t i o n | 93
1-(N,N'-Diphenyl-S-phenylsulfondiimidoyl)-2-(4-thiomethylphenyl)ethan-2-ol (122e)
Following GP3, β-hydroxy sulfondiimine 122e was obtained from
sulfondiimine 61a (50 mg, 0.163 mmol) and
4-thiomethylbenzaldehyde (72a, 44 L, 0.326 mmol, 2.00 equiv),
employing n-butyllithium (1.6 M, 0.171 mmol, 107 L, 1.05 equiv)
and after stirring for 2 h at –78 °C. Purification by flash column
chromatography with a gradient of n-pentane/ethyl acetate: 1/0
to 7/3 afforded the desired product as light yellow solid (50 mg, 67%).
m.p.: 61–62 °C. 1H NMR (600 MHz, CDCl3): = 8.23–8.22 (m, 2H), 7.69–7.65 (m, 1H), 7.62–7. 58 (m, 2H), 7.22–7.15 (m, 8H), 7.15–7.12 (m, 2H), 7.09–7.05 (m, 2H), 7.00 (s, 1H), 6.97–6.91 (m, 2H), 4.95 (d, J =
10.2 Hz, 1H), 3.95 (dd, J = 14.1, 10.4 Hz, 1H), 2.97 (dd, J = 14.1, 0.9 Hz, 1H), 2.41 (s, 3H). 13C NMR (151 MHz, CDCl3): = 144.6, 144.4, 138.4, 137.9, 136.4, 133.5, 129.8 (2C), 129.3 (2C),
129.2 (2C), 129.2 (2C), 126.7 (2C), 126.2 (2C), 123.4 (2C), 122.8 (2C), 122.1, 121.9, 68.8, 62.8,
15.8.
MS (EI): m/z (%) = 458 ([M]+, 4), 215 (11), 202 (17), 201 (86), 200 (100), 182 (14), 167 (19), 152
(15), 124 (16), 109 (18), 105 (13), 97 (18), 91 (35), 77 (28).
IR (KBr): = 3246, 3052, 2322, 2064, 1737, 1588, 1481, 1241, 1241, 1069, 977, 816, 751, 685.
HRMS (ESI): 459.1559, calcd. for C27H27ON2S2: 459.1559.
1-(N,N'-Diphenyl-S-phenylsulfondiimidoyl)-2-(4-methoxyphenyl)ethan-2-ol (122f)
Following GP3, β-hydroxy sulfondiimine 122f was obtained from
sulfondiimine 61a (50 mg, 0.163 mmol) and
4-methoxybenzaldehyde (72f, 40 L, 0.326 mmol, 2.00 equiv),
employing n-butyllithium (1.6 M, 0.171 mmol, 107 L, 1.05 equiv)
and after stirring for 1 h at –78 °C and 2 h at r.t.. Purification by
flash column chromatography with a gradient of n-pentane/ethyl
acetate: 1/0 to 8/2 afforded the desired product as light brown solid (49 mg, 68%).
m.p.: 60–61 °C. 1H NMR (400 MHz, CDCl3): = 8.25–8.21 (m, 2H), 7.70–7.64 (m, 1H), 7.63–7.57 (m, 2H), 7.22–7.14 (m, 8H), 7.10–7.05 (m, 2H), 6.98–6.90 (m, 3H), 6.81–6.75 (m, 2H), 4.95 (d, J = 10.2 Hz, 1H),
3.99 (dd, J = 14.0, 10.4 Hz, 1H), 3.74 (s, 3H), 2.96 (dd, J = 14.0, 1.3 Hz, 1H). 13C NMR (101 MHz, CDCl3): = 159.3, 144.7, 144.5, 136.5, 133.5, 133.2, 129.8 (2C), 129.3 (2C),
129.2 (2C), 129.2 (2C), 126.9 (2C), 123.4 (2C), 122.8 (2C), 122.0, 121.8, 113.9 (2C), 68.8, 62.9,
55.3.
MS (ESI): m/z (%) = 443.17 ([M+H]+).
IR (KBr): = 3233, 3060, 2930, 2836, 2161, 1590, 1482, 1445, 1286, 1244, 1173, 1069, 1030,
973, 829, 752, 689.
HRMS (ESI): 443.1788, calcd. for C27H27O2N2S: 443.1788.
94 | E x p e r i m e n t a l S e c t i o n
1-(N,N'-Diphenyl-S-phenylsulfondiimidoyl)-2-[4-tolyl]ethan-2-ol (122g)
Following GP3, β-hydroxy sulfondiimine 122g was obtained from
sulfondiimine 61a (50 mg, 0.163 mmol) and 4-methylbenzaldehyde
(72g, 40 L, 0.326 mmol, 2.00 equiv), employing n-butyllithium (1.6
M, 0.171 mmol, 107 L, 1.05 equiv) and after stirring for 2 h at –78
°C and 2 h at r.t.. Purification by flash column chromatography with
a gradient of n-pentane/ethyl acetate: 9/1 to 7/3 afforded the de-
sired product as brown solid (54 mg, 78%).
m.p.: 115–116 °C. 1H NMR (600 MHz, CDCl3): = 8.25–8.22 (m, 2H), 7.69–7.65 (m, 1H), 7.63–7.59 (m, 2H), 7.21–7.16 (m, 8H), 7.07–7.03 (m, 4H), 6.98 (br s, 1H), 6.97–6.91 (m, 2H), 4.96 (d, J = 10.2 Hz, 1H), 3.99
(dd, J = 14.1, 10.4 Hz, 1H), 2.96 (d, J = 13.9 Hz, 1H), 2.27 (s, 3H). 13C NMR (151 MHz, CDCl3): = 144.6, 144.4, 138.0, 137.8, 136.4, 133.5, 129.8 (2C), 129.3 (2C),
129.2 (4C), 129.2 (2C), 125.6 (2C), 123.4 (2C), 122.8 (2C), 122.1, 121.8, 69.0, 62.8, 21.1.
MS (EI): m/z (%) = 426 ([M]+, 11), 335 (23), 202 (17), 201 (100), 200 (73), 182 (19), 167 (14), 119
(13), 105 (15), 91 (27), 77 (22).
IR (KBr): = 3277, 3058, 2920, 2102, 1589, 1482, 1245, 1069, 977, 748, 689.
HRMS (ESI): 449.1658, calcd. for C27H26ON2NaS: 449.1658.
1-(N,N'-Diphenyl-S-phenylsulfondiimidoyl)-2-(2-tolyl)ethan-2-ol (122h)
Following GP3, β-hydroxy sulfondiimine 122h was obtained from sul-
fondiimine 61a (50 mg, 0.163 mmol) and 2-methylbenzaldehyde (72h,
38 L, 0.326 mmol, 2.00 equiv), employing n-butyllithium (1.6 M, 0.171
mmol, 107 L, 1.05 equiv) and after stirring for 2 h at –78 °C and 2 h at
r.t.. Purification by flash column chromatography with a gradient of
n-pentane/ethyl acetate: 9/1 to 7/3 afforded the desired product as
brown solid (56 mg, 81%).
m.p.: 69–70 °C. 1H NMR (400 MHz, CDCl3): = 8.30–8.24 (m, 2H), 7.71–7.59 (m, 3H), 7.56–7.52 (m, 1H), 7.23–7.17 (m, 9H), 7.13–7.08 (m, 1H), 6.99–6.90 (m, 3H), 6.82 (br s, 1H), 5.24 (d, J = 9.9 Hz, 1H), 3.93
(dd, J = 14.1, 10.0 Hz, 1H), 2.86 (dd, J = 14.1, 0.8 Hz, 1H), 1.65 (s, 3H). 13C NMR (101 MHz, CDCl3): = 144.7, 144.4, 138.9, 136.6, 133.6, 133.4, 130.3, 129.8 (2C), 129.3
(2C), 129.3 (4C), 127.7, 126.6, 125.6, 123.4 (2C), 122.7 (2C), 122.1, 121.8, 65.8, 62.0, 18.0.
MS (EI): m/z (%) = 426 ([M]+, 57), 201 (100), 200 (71), 182 (18), 167 (13), 105 (11), 91 (21), 77
(12).
IR (KBr): = 3290, 3061, 2920, 1590, 1482, 1446, 1284, 1248, 1175, 1068, 973,750, 688.
HRMS (ESI): 449.1657, calcd. for C27H26ON2NaS: 449.1658.
E x p e r i m e n t a l S e c t i o n | 95
1-(N,N'-Diphenyl-S-phenylsulfondiimidoyl)-(E)-pent-3-en-2-ol (122i)
Following GP3, β-hydroxy sulfondiimine 122i was obtained from sul-
fondiimine 61a (50 mg, 0.163 mmol) and (E)-but-2-enal (72i, 27 L,
0.326 mmol, 2.00 equiv), employing n-butyllithium (1.6 M,
0.171 mmol, 107 L, 1.05 equiv) and after stirring for 1.5 h at –78 °C.
Purification by flash column chromatography with a gradient of n-
pentane/ethyl acetate: 9/1 to 7/3 afforded the desired product as
light brown solid (49 mg, 80%).
m.p.: 88.5–89.5 °C. 1H NMR (600 MHz, CDCl3): = 8.22–8.18 (m, 2H), 7.67–7.63 (m, 1H), 7.61–7.57 (m, 2H), 7.26–7.19 (m, 4H), 7.16–7.11 (m, 4H), 6.98–6.94 (m, 1H), 6.91–6.87 (m, 1H), 6.68 (s, 1H), 5.67–5.56
(m, 1H), 5.31–5.23 (m, 1H), 4.41–4.36 (m, 1H), 3.87 (dd, J = 14.1, 10.2 Hz, 1H), 2.86–2.82
(m, 1H), 1.60 (d, J = 6.4 Hz, 3H). 13C NMR (151 MHz, CDCl3): = 144.7, 144.6, 136.5, 133.4, 130.1, 129.7 (2C), 129.3 (2C), 129.2
(2C), 129.2 (2C), 128.4, 123.4 (2C), 122.6 (2C), 122.0, 121.6, 67.5, 60.6, 17.6.
MS (EI): m/z (%) = 376 ([M]+, 19), 285 (23), 201 (100), 200 (86), 182 (20), 176 (30), 167 (22), 132
(10), 120 (25), 97 (22), 92 (20), 77 (23), 65 (13).
IR (KBr): = 3058, 1589, 1481, 1442, 1281, 1245, 1173, 1065, 967, 752, 689.
HRMS (ESI): 399.1501, calcd. for C23H24ON2NaS: 399.1502.
1-(N,N'-Diphenyl-S-phenylsulfondiimidoyl)-(E)-4-phenyl-but-3-en-2-ol (122j)
Following GP3, β-hydroxy sulfondiimine 122j was obtained from
sulfondiimine 61a (50 mg, 0.163 mmol) and cinnamaldehyde (72j,
41 L, 0.326 mmol, 2.00 equiv), employing n-butyllithium (1.6 M,
0.171 mmol, 107 L, 1.05 equiv) and after stirring for 3 h at –78 °C.
Purification by flash column chromatography with a gradient of n-
pentane/ethyl acetate: 1/0 to 7/3 afforded the desired product as
yellow solid (28 mg, 39%).
m.p.: 62.5–63.5 °C. 1H NMR (600 MHz, CDCl3): = 8.25–8.22 (m, 2H), 7.69–7.65 (m, 1H), 7.62–7.58 (m, 2H), 7.27–7.25 (m, 4H), 7.22–7.20 (m, 4H), 7.17–7.15 (m, 4H), 6.98–6.95 (m, 1H), 6.94–6.89 (m, 2H), 6.57
(dd, J = 15.9, 1.2 Hz, 1H), 5.95 (dd, J = 15.9, 6.0 Hz, 1H), 4.66–4.62 (m, 1H), 3.92 (dd, J = 14.1,
10.2 Hz, 1H), 2.98 (dd, J = 14.1, 1.2 Hz, 1H), OH invisible. 13C NMR (151 MHz, CDCl3): = 144.6, 144.4, 136.5, 136.1, 133.5, 131.4, 129.8 (2C), 129.3 (2C),
129.3 (2C), 129.2 (2C), 128.5 (2C), 128.0, 127.9, 126.5 (2C), 123.4 (2C), 122.7 (2C), 122.2, 121.8,
67.5, 60.4.
MS (EI): m/z (%) = 438 ([M]+, 1), 238 (29), 224 (19), 220 (12), 201 (59), 200 (94), 194 (28), 167
(30), 131 (20), 115 (24), 104 (20), 97 (36), 92 (43), 91 (100), 77 (74), 64 (20), 51 (19).
IR (KBr): = 3261, 1731, 1587, 1479, 1244, 1067, 971, 749, 683.
HRMS (ESI): 461.1658, calcd. for C28H26ON2NaS: 461.1658.
96 | E x p e r i m e n t a l S e c t i o n
1-[N-(4-Methoxyphenyl)-N'-phenyl-S-phenylsulfondiimidoyl]-2-phenylethan-2-ol (122l)
Following GP3, β-hydroxy sulfondiimine 122l was obtained from sul-
fondiimine 106l (111 mg, 0.33 mmol) and benzaldehyde (72a, 67 L,
0.66 mmol, 2.00 equiv), employing n-butyllithium (1.6 M, 0.171 mmol,
107 L, 1.05 equiv) and after stirring for 1 h at –78 °C. Purification by
flash column chromatography with n-pentane/ ethyl acetate: 9/1 af-
forded the product as mixture of diastereomers [d.r. (dia1:dia2) = 2:1]
and as beige oil (97 mg, 67%). 1H NMR (600 MHz, CDCl3, mixture of dia1 and dia2): = 8.28–8.22 (both, m, 4H), 7.68–7.63
(both, m, 2H), 7.63–7.56 (both, m, 4H), 7.27–7.22 (both, m, 4H), 7.22–7.13 (both, m, 14H),
7.13–7.08 (both, m, 4H), 7.04 (both, br s, 2H), 6.97–6.90 (both, m, 2H), 6.78–6.72 (both, m, 4H),
5.02–4.95 (both, m, 2H), 3.99–3.91 (both, m, 2H), 3.72 (dia1, s, 3H), 3.71 (dia2, s, 3H), 3.00
(dia2, d, J = 14.1 Hz, 1H), 2.94 (dia1, d, J = 14.1 Hz, 1H). 13C NMR (151 MHz, CDCl3, mixture of dia1 and dia2): = 155.1 (dia1), 154.8 (dia2), 144.8 (dia1),
144.6 (dia2), 141.1 (both, 2C), 137.6 (dia2), 137.1 (dia1), 136.8 (dia2), 136.4 (dia1), 133.5 (dia1),
133.4 (dia2), 129.7 (both, 4C), 129.2 (both, 4C), 128.5 (both, 4C), 128.0 (both, 2C), 125.6 (both,
4C), 124.5 (both, 4C), 123.8, 123.3, 122.8 (both, 4C), 121.9, 121.7, 114.6 (both, 4C), 69.2, 69.1,
63.0, 62.7, 55.4 (both, 2C), C–OH invisible.
MS (EI): m/z (%) = 442 ([M]+, 17), 336 (48), 245 (41), 215 (34), 212 (22), 200 (100), 167 (24), 135
(30), 124 (32), 123 (17), 122 (21), 121 (76), 109 (19), 107 (25), 106 (58), 105 (50), 91 (19), 77
(30).
IR (neat): = 3262, 2925, 1736, 1591, 1481, 1234, 1061, 829, 733.
HRMS (ESI): 465.1609, calcd. for C27H26O2N2NaS: 465.1607.
1-(N-H-N'-Phenyl-S-phenylsulfondiimidoyl)-2-phenylethan-2-ol (123a)
Following GP3, NH-β-hydroxy sulfondiimine 123a was obtained from
sulfondiimine 17 (50 mg, 0.217 mmol) and benzaldehyde (72a, 50 L,
0.434 mmol, 2.00 equiv), employing an excess of n-butyllithium (1.6 M,
0.456 mmol, 143 L, 2.10 equiv) and after stirring for 1 h at –78 °C. Pu-
rification by flash column chromatography with n-pentane/ethyl ace-
tate: 8/2 to 7/3 afforded the product as mixture of diastereomers (d.r. = 1:1) and as light brown
solid (32 mg, 44%).
m.p.: 53–54 °C. 1H NMR (600 MHz, CDCl3, mixture of diastereomers): = 8.21–8.17 (each, m, 2H), 8.15–8.12
(each, m, 2H), 7.69–7.63 (both, m, 2H), 7.62–7.57 (both, m, 4H), 7.32–7.29 (both, m, 5H), 7.27–7.24 (both, m, 5H), 7.20–7.15 (both, m, 4H), 7.10–7.07 (both, m, 4H), 6.94–6.89 (both, m, 2H),
5.21 (each, dd, J = 10.4, 0.9 Hz, 1H), 4.98 (each, d, J = 10.2 Hz, 1H), 3.82 (each, dd, J = 13.6, 10.4
Hz, 1H), 3.60 (each, dd, J = 14.1, 10.2, 1H), 3.27 (each, dd, J = 14.2, 1.5 Hz, 1H), 3.00 (each, dd, J
= 13.6, 1.3 Hz, 1H), 2.60 (both, br s, 2H), OH invisible. 13C NMR (151 MHz, CDCl3, mixture of diastereomers): = 144.5 (both, 2C), 141.2, 141.1, 139.6,
138.0, 133.4, 133.3, 129.7 (both, 2C), 129.6 (both, 2C), 129.1 (both, 2C), 129.0 (both, 2C), 128.7
E x p e r i m e n t a l S e c t i o n | 97
(both, 2C), 128.6 (both, 2C), 128.6 (both, 2C), 128.2 (both, 2C), 128.1, 128.1, 125.8 (both, 2C),
125.7 (both, 2C), 123.1 (both, 2C), 122.9 (both, 2C), 121.6, 121.4, 69.5, 68.7, 68.3, 65.7.
MS (EI): m/z (%) = 337 (34), 336 ([M]+, 43), 230 (17), 200 (42), 194 (48), 125 (37), 124 (69), 107
(69), 105 (68), 93 (100), 65 (23).
IR (KBr): = 3212, 3061, 2927, 1733, 1590, 1472, 1250, 1049, 957, 735.
HRMS (ESI): 337.1375, calcd. for C20H21ON2S: 337.1369.
1-(N-H-N'-Phenyl-S-phenylsulfondiimidoyl)-2,4-diphenylbut-3-yn-2-ol (123b)
Following GP3, NH-β-hydroxy sulfondiimine 123b was obtained
from NH-sulfondiimine 17 (100 mg, 0.434 mmol) and 1,3-
diphenylprop-2-yn-1-one (128a, 107 mg, 0.521 mmol, 1.2 equiv),
employing an excess of n-butyllithium (1.6 M, 0.57 mL, 0.911
mmol, 2.1 equiv) and after stirring for 5 h at –78 °C. Notably, 1,3-
diphenylprop-2-yn-1-one was added dropwise as solution in THF
(1 mL) within 5 min. Purification by flash column chromatography with a gradient of
n-pentane/ethyl acetate: 1/0 to 8/2 proved suitable to separate the two diastereomers of the
product (d.r. = 1:1).
Diastereomer dia1 was obtained as light brown solid (59 mg, 31%):
m.p.: 126–127 °C. 1H NMR (600 MHz, CDCl3): = 8.70 (br s, 1H), 8.17–8.13 (m, 2H), 7.77–7.71 (m, 2H), 7.57–7.55
(m, 1H), 7.51–7.43 (m, 4H), 7.40–7.28 (m, 6H), 7.17–7.14 (m, 2H), 7.11–7.07 (m, 2H), 6.93–6.86
(m, 1H), 3.90 (d, J = 13.4 Hz, 1H), 3.29 (br s, 1H), 3.29 (d, J = 13.4 Hz, 1H). 13C NMR (151 MHz, CDCl3): = 144.3, 143.0, 139.4, 133.1, 131.7 (2C), 129.6 (2C), 128.9 (2C),
128.9, 128.5 (2C), 128.4 (2C), 128.4 (2C), 128.3, 125.4 (2C), 122.9 (2C), 121.8, 121.5, 89.5, 87.3,
70.1, C–OH invisible.
MS (EI): m/z (%) = 412 (4), 230 (49), 178 (82), 176 (11), 129 (66), 124 (100), 109 (15), 91 (15), 77
(35), 51 (21).
MS (CI): m/z (%) = 437 ([M+H]+, 1).
IR (KBr): = 3316, 3065, 2925, 2095, 1712, 1589, 1467, 1258, 1035, 953, 831, 754, 690.
HRMS (ESI): 437.1682, calcd. for C28H25N2OS: 437.1688.
Diastereomer dia2 was obtained as brown oil (59 mg, 31%): 1H NMR (400 MHz, CDCl3): = 8.07–8.00 (m, 2H), 7.76–7.70 (m, 2H), 7.50–7.45 (m, 1H), 7.40–7.22 (m, 10H), 7.17–7.11 (m, 2H), 7.08–7.03 (m, 2H), 6.93–6.85 (m, 1H), 4.08 (d, J = 14.1 Hz,
1H), 3.65 (d, J = 14.1 Hz, 1H), NH and OH invisible. 13C NMR (101 MHz, CDCl3): = 144.3, 143.0, 139.4, 133.1, 131.7 (2C), 129.5 (2C), 128.9 (2C),
128.8, 128.5 (2C), 128.4 (2C), 128.3 (2C), 128.3, 125.4 (2C), 122.9 (2C), 121.8, 121.5, 89.5, 87.3,
70.1, C–OH invisible.
MS (EI): m/z (%) = 412 (10), 230 (62), 206 (40), 178 (68), 129 (57), 124 (100), 109 (23), 91 (53),
77 (93), 51 (40). MS (CI): m/z (%) = 465 ([M+C2H5]+, 1).
IR (neat): = 3059, 2899, 1730, 1590, 1477, 1253, 1054, 955, 741.
HRMS (ESI): 437.1686, calcd. for C28H25N2OS: 437.1688.
98 | E x p e r i m e n t a l S e c t i o n
6.5 Alkylation of a lithium sulfondiimidoyl carbanion
N,N',S-Triphenyl-S-ethyl sulfondiimine (125)
Following GP3, sulfondiimine 125 was obtained from sulfondiimine 61a
(50 mg, 0.163 mmol) and methyl iodide (124, 11 L, 0.171 mmol, 1.05 equiv),
employing n-butyllithium (1.6 M, 0.171 mmol, 107 L, 1.05 equiv) and after
stirring for 1.5 h at –78 °C. Purification by flash column chromatography with
a gradient of n-pentane/ethyl acetate: 9/1 to 7/3 afforded the desired prod-
uct as brown solid (49 mg, 94%).
m.p.: 125–126 °C. 1H NMR (600 MHz, CDCl3): = 8.21–8.28 (m, 2H), 7.61–7.52 (m, 3H), 7.20–7.12 (m, 8H), 6.88–6.84 (m, 2H), 3.64 (q, J = 7.4 Hz, 2H), 1.07 (t, J = 7.4 Hz, 3H). 13C NMR (151 MHz, CDCl3): = 145.9 (2C), 136.1, 132.8, 129.5 (2C), 129.4 (2C), 129.1 (4C), 123.0
(4C), 121.0 (2C), 50.2, 7.8.
MS (EI): m/z (%) = 320 ([M]+, 26), 229 (59), 200 (100), 182 (20), 167 (17), 105 (10), 97 (17), 77
(15).
IR (KBr): = 3054, 1590, 1480, 1445, 1285, 1251, 1174, 1067, 1023, 964, 797, 747, 692.
HRMS (ESI): 321.1420, calcd. for C20H21N2S: 321.1420.
6.6 Syntheses of 1,2-thiazine 1-oxides
1,3,5-Triphenyl-1,2-thiazine 1-oxide (131a)
Following GP4, heterocycle 131a was obtained from NH-sulfoximine 100a
(78 mg, 0.50 mmol) and 1,3-diphenylprop-2-yn-1-one (128a, 155 mg,
0.75 mmol). Purification by flash column chromatography with a gradient of
n-pentane/ethyl acetate: 1/0 to 9/1 afforded the desired product as yellow
foam (170 mg, 99%).
m.p.: 95–96 °C.
1H NMR (600 MHz, CDCl3): = 8.01–8.00 (m, 2H), 7.94–7.92 (m, 2H), 7.62–7.54 (m, 5H), 7.46–7.40 (m, 6H), 6.74 (s, 1H), 5.95 (s, 1H). 13C NMR (151 MHz, CDCl3): = 154.1, 150.8, 142.6, 139.1, 138.5, 132.9, 129.5 (2C), 128.9 (2C),
128.8 (2C), 128.7 (2C), 128.4 (2C), 127.1 (2C), 127.1 (2C), 97.9, 92.8.
MS (EI): m/z (%) = 343 ([M]+, 28), 219 (17), 218 (100), 217 (78), 216 (12), 192 (48), 191 (51), 190
(11), 189 (25), 165 (13), 125 (11), 115 (33), 105 (18), 89 (14), 77 (36), 51 (13).
IR (KBr): = 3057, 1735, 1554, 1475, 1309, 1200, 1108, 1024, 970, 834, 702.
HRMS (ESI): 366.0923, calcd. for C22H17NONaS: 366.0923.
E x p e r i m e n t a l S e c t i o n | 99
1,3-Diphenyl-5-(4-methoxyphenyl)-1,2-thiazine 1-oxide (131b)
Following GP4, heterocycle 131b was obtained from NH-sulfoximine
100a (78 mg, 0.50 mmol) and 1-(4-methoxyphenyl)-3-phenylprop-2-yn-1-
one (128b, 177 mg, 0.75 mmol). Purification by flash column chromatog-
raphy with a gradient of n-pentane/ethyl acetate: 9/1 to 6/4 afforded
the desired product as orange oil (158 mg, 85%). 1H NMR (600 MHz, CDCl3): = 8.00 (d, J = 7.2 Hz, 2H), 7.92 (d, J = 7.7 Hz,
2H), 7.60–7.50 (m, 5H), 7.45–7.36 (m, 3H), 6.96 (d, J = 8.4 Hz, 2H), 6.72
(s, 1H), 5.91 (s, 1H), 3.83 (s, 3H). 13C NMR (151 MHz, CDCl3): = 160.8, 154.0, 150.2, 142.8, 138.8, 132.8, 131.2, 129.4, 128.7
(2C), 128.6 (2C), 128.4 (2C), 128.4 (2C), 127.0 (2C), 114.2 (2C), 97.6, 91.8, 55.3.
MS (EI): m/z (%) = 374 (19), 373 ([M]+, 71), 249 (20), 248 (100), 233 (14), 222 (24), 221 (17), 205
(16), 204 (18), 178 (15), 145 (10), 135 (13), 125 (15), 105 (13), 102 (19), 97 (13), 51 (15).
IR (neat): = 3060, 2954, 2325, 1736, 1600, 1555, 1473, 1306, 1247, 1183, 1112, 1024, 967,
916, 839, 753, 689.
HRMS (ESI): 374.1221, calcd. for C23H20O2NS: 374.1209.
1,3-Diphenyl-5-(4-tolyl)-1,2-thiazine 1-oxide (131c)
Following GP4, heterocycle 131c was obtained from NH-sulfoximine 100a
(78 mg, 0.5 mmol) and 3-phenyl-1-(4-tolyl)prop-2-yn-1-one (128c, 165 mg,
0.75 mmol). Purification by flash column chromatography with a gradient
of n-pentane/ethyl acetate: 1/0 to 9/1 afforded the desired product as
yellow solid (147 mg, 82%).
m.p.: 71–72 °C. 1H NMR (600 MHz, CDCl3): = 8.00 (d, J = 7.2 Hz, 2H), 7.92 (d, J = 7.7 Hz,
2H), 7.58–7.49 (m, 5H), 7.44–7.36 (m, 3H), 7.25 (d, J = 7.7 Hz, 2H), 6.73 (s,
1H), 5.93 (s, 1H), 2.38 (s, 3H). 13C NMR (151 MHz, CDCl3): = 154.0, 150.6, 142.7, 139.7, 138.6, 136.0, 132.8, 129.5 (2C),
129.4, 128.7 (2C), 128.6 (2C), 128.3 (2C), 127.0 (2C), 126.9 (2C), 97.8, 92.3, 21.2.
MS (EI): m/z (%) = 358 (21), 357 ([M]+, 91), 264 (10), 233 (18), 232 (100), 217 (40), 206 (33), 205
(23), 128 (14), 115 (11), 105 (15), 77 (26).
IR (KBr): = 3053, 1735, 1553, 1470, 1308, 1204, 1105, 1027, 970, 822, 739.
HRMS (ESI): 380.1079, calcd. for C23H19NONaS: 380.1080.
1,3-Diphenyl-5-(4-nitrophenyl)-1,2-thiazine 1-oxide (131d)
Following GP4, heterocycle 131d was obtained from NH-sulfoximine
100a (78 mg, 0.5 mmol) and 1-(4-nitrophenyl)-3-phenylprop-2-yn-1-one
(128d, 188 mg, 0.75 mmol). Purification by flash column chromatography
with a gradient of n-pentane/ethyl acetate: 1/0 to 9/1 afforded the de-
sired product as yellow solid (85 mg, 44%).
m.p.: 152–153 °C.
100 | E x p e r i m e n t a l S e c t i o n
1H NMR (600 MHz, CDCl3): = 8.35–8.24 (m, 2H), 8.04–7.89 (m, 4H), 7.82–7.72 (m, 2H), 7.70–7.54 (m, 3H), 7.46–7.39 (m, 3H), 6.71 (s, 1H), 5.98 (s, 1H). 13C NMR (151 MHz, CDCl3): = 154.9, 148.2, 148.1, 145.4, 141.8, 137.9, 133.2, 129.8, 128.9
(2C), 128.7 (2C), 128.4 (2C), 128.1 (2C), 127.0 (2C), 124.0 (2C), 97.5, 93.3.
MS (EI): m/z (%) = 388 ([M]+, 36), 263 (29), 217 (27), 216 (12), 189 (13), 114 (26), 105 (30), 97
(21), 77 (100), 63 (11), 57 (11), 51 (62).
IR (KBr): = 3067, 1739, 1507, 1340, 1193, 1111, 1021, 969, 854, 730.
HRMS (ESI): 411.0774, calcd. for C22H16N2O3NaS: 411.0774.
1,3-Diphenyl-5-(naphthalen-2-yl)-1,2-thiazine 1-oxide (131e)
Following GP4, heterocycle 131e was obtained from NH-sulfoximine
100a (77 mg, 0.49 mmol) and 1-(naphthalen-2-yl)-3-phenylprop-2-yn-1-
one (128e, 190 mg, 0.75 mmol) after stirring at 80 °C for 6 h. Purifica-
tion by flash column chromatography with a gradient of
n-pentane/ethyl acetate: 1/0 to 95/5 afforded the desired product as
yellow solid (102 mg, 53%).
m.p.: 70–71 °C. 1H NMR (600 MHz, CDCl3): = 8.14–8.12 (m, 1H), 8.08–8.05 (m, 2H), 8.00–7.98 (m, 2H), 7.94–7.91 (m, 2H), 7.89–7.87 (m, 1H), 7.74–7.71 (m, 1H), 7.63–7.60 (m, 1H), 7.59–7.54 (m, 4H), 7.48–7.43 (m, 3H), 6.89 (s, 1H), 6.10 (s, 1H). 13C NMR (150 MHz, CDCl3): = 154.2, 150.7, 142.7, 138.6, 136.4, 133.7, 133.2, 132.9, 129.5,
128.8 (2C), 128.7 (2C), 128.7, 128.4, 128.4 (2C), 127.7, 127.1 (2C), 126.9, 126.7, 126.7, 124.6,
98.2, 93.0.
MS (EI): m/z (%) = 393 ([M]+, 1), 155 (22), 127 (25), 125 (15), 109 (10), 105 (100), 77 (54), 69
(15), 51 (16).
IR (KBr): = 3416, 3055, 2925, 2323, 2084, 1920, 1671, 1564, 1466, 1366, 1203, 1116, 817, 747,
696.
HRMS (ESI): 394.1261, calcd. for C26H20NOS: 394.1260.
1,3-Diphenyl-5-(4-fluorophenyl)-1,2-thiazine 1-oxide (131f)
Following GP4, heterocycle 131f was obtained from NH-sulfoximine 100a
(78 mg, 0.5 mmol) and 1-(4-fluorophenyl)-3-phenylprop-2-yn-1-one (128f,
168 mg, 0.75 mmol). Purification by flash column chromatography with a
gradient of n-pentane/ethyl acetate: 9/1 to 8/2 afforded the desired prod-
uct as yellow foam (150 mg, 83%).
m.p.: 69–70 °C. 1H NMR (600 MHz, CDCl3): = 8.01–7.97 (m, 2H), 7.94–7.90 (m, 2H), 7.61–7.56 (m, 3H), 7.56–7.52 (m, 2H), 7.43–7.37 (m, 3H), 7.16–7.10 (m, 2H), 6.68
(s, 1H), 5.90 (s, 1H).
E x p e r i m e n t a l S e c t i o n | 101
13C NMR (151 MHz, CDCl3): = 163.5 (d, J = 249 Hz, 1C), 154.3, 149.6, 142.4, 138.4, 135.1 (d, J =
3.1 Hz, 1C), 133.0, 129.6, 129.0, 128.9, 128.8 (2C), 128.6 (2C), 128.4 (2C), 127.1 (2C), 115.9,
115.8, 97.7, 92.6. 19F NMR (564 MHz, CDCl3): = –111.53 (m, 1F).
MS (EI): m/z (%) = 362 (18), 361 ([M]+, 69), 268 (14), 237 (16), 236 (100), 235 (54), 210 (33), 209
(32), 207 (14), 133 (42), 125 (21), 123 (10), 109 (25), 107 (16), 105 (19), 104 (12), 97 (22), 83
(15), 77 (76), 51 (42).
IR (KBr): = 3062, 1600, 1555, 1476, 1315, 1227, 1197, 1160, 1116, 1018, 969, 921, 845, 748,
688.
HRMS (ESI): 384.0834, calcd. for C22H16NOFNaS: 384.0829.
1,3-Diphenyl-5-(4-chlorophenyl)-1,2-thiazine 1-oxide (131g)
Following GP4, heterocycle 131g was obtained from NH-sulfoximine 100a
(78 mg, 0.5 mmol) and 1-(4-chlorophenyl)-3-phenylprop-2-yn-1-one (128g,
192 mg, 0.75 mmol). Purification by flash column chromatography with a
gradient of n-pentane/ethyl acetate: 1/0 to 75/25 afforded the desired
product as yellow foam (186 mg, 98%).
m.p.: 117–118 °C. 1H NMR (400 MHz, CDCl3): = 8.03–7.96 (m, 2H), 7.95–7.89 (m, 2H), 7.62–7.52 (m, 5H), 7.45–7.38 (m, 5H), 6.68 (s, 1H), 5.91 (s, 1H).
13C NMR (101 MHz, CDCl3): = 154.4, 149.4, 142.3, 138.3, 137.5, 135.6, 133.0, 129.6, 129.1
(2C), 128.8 (2C), 128.7 (2C), 128.4 (4C), 127.1 (2C), 97.6, 92.6.
MS (EI): m/z (%) = 379 (15), 378 (11), 377 ([M]+, 42), 254 (22), 253 (13), 252 (71), 226 (21), 225
(19), 218 (11), 217 (65), 216 (29), 191 (21), 190 (14), 189 (40), 149 (26), 141 (12), 139 (39), 125
(29), 114 (25), 113 (25), 111 (18), 105 (61), 104 (18), 101 (10), 97 (26), 89 (16), 77 (100), 65 (11),
63 (14), 51 (45), 50 (11).
IR (KBr): = 3048, 2330, 2084, 1549, 1474, 1384, 1309, 1228, 1186, 1091, 1011, 967, 912, 836,
808, 746, 683.
HRMS (ESI): 378.0714, calcd. for C22H17NOClS: 378.0714.
1,3-Diphenyl-5-(2-chlorophenyl)-1,2-thiazine 1-oxide (131h)
Following GP4, heterocycle 131h was obtained from NH-sulfoximine 100a
(78 mg, 0.5 mmol) and 1-(2-chlorophenyl)-3-phenylprop-2-yn-1-one (128h,
181 mg, 0.75 mmol). Purification by flash column chromatography with a
gradient of n-pentane/ethyl acetate: 1/0 to 85/15 afforded the desired
product as yellow solid (118 mg, 63%).
m.p.: 64–65 °C. 1H NMR (600 MHz, CDCl3): = 7.99–7.91 (m, 4H), 7.61–7.52 (m, 3H), 7.49–
7.44 (m, 1H), 7.42–7.36 (m, 4H), 7.34–7.30 (m, 2H), 6.53 (s, 1H), 5.81 (s, 1H). 13C NMR (151 MHz, CDCl3): = 153.3, 149.2, 142.6, 138.4, 138.2, 133.0, 131.9, 130.1, 130.1,
129.8, 129.5, 128.8 (2C), 128.6 (2C), 128.3 (2C), 127.1 (2C), 126.9, 99.5, 95.1.
102 | E x p e r i m e n t a l S e c t i o n
MS (EI): m/z (%) = 377 ([M]+, 28), 254 (26), 253 (16), 252 (78), 227 (11), 226 (22), 225 (25), 218
(17), 217 (100), 216 (41), 191 (22), 190 (18), 189 (56), 151 (12), 149 (33), 139 (32), 134 (10), 125
(35), 115 (11), 114 (32), 113 (27), 111 (12), 109 (20), 105 (36), 104 (14), 101 (11), 97 (30), 89
(17), 77 (86), 75 (14), 65 (11), 63 (14), 51 (41).
IR (KBr): = 3062, 2326, 1729, 1557, 1469, 1379, 1309, 1206, 1116, 1030, 970, 922, 821, 741,
689.
HRMS (ESI): 400.0541, calcd. for C22H16NOClNaS: 400.0533.
1,3-Diphenyl-5-(thiophen-2-yl)-1,2-thiazine 1-oxide (131i)
Following GP4, heterocycle 131i was obtained from NH-sulfoximine 100a
(78 mg, 0.5 mmol) and 3-phenyl-1-(thiophen-2-yl)prop-2-yn-1-one (128i,
159 mg, 0.75 mmol). Purification by flash column chromatography with a
gradient of n-pentane/ethyl acetate: 1/0 to 9/1 afforded the desired prod-
uct as yellow solid (173 mg, 99%).
m.p.: 125–126 °C. 1H NMR (600 MHz, CDCl3): = 8.00–7.97 (m, 2H), 7.95–7.92 (m, 2H), 7.63–
7.59 (m, 1H), 7.57–7.54 (m, 2H), 7.50 (m, 1H), 7.46–7.39 (m, 4H), 7.14–7.10 (m, 1H), 6.79 (s,
1H), 6.01 (s, 1H). 13C NMR (151 MHz, CDCl3): = 154.6, 143.2, 142.6, 141.6, 138.4, 133.0, 129.7, 128.8 (2C), 128.8
(2C), 128.5 (2C), 128.1, 127.6, 127.1 (2C), 126.2, 96.9, 90.5.
MS (EI): m/z (%) = 349 ([M]+, 38), 224 (100), 223 (30), 198 (22), 197 (28), 121 (30), 109 (13), 97
(20), 77 (50), 51 (21).
IR (KBr): = 3455, 3064, 2926, 2328, 2099, 1727, 1553, 1465, 1296, 1190, 1094, 1021, 953, 840,
698.
HRMS (ESI): 350.0671, calcd. for C20H16NOS2: 350.0668.
5-(tert-Butyl)-1,3-diphenyl-1,2-thiazine 1-oxide (131j)
Following GP4, heterocycle 131j was obtained from NH-sulfoximine 100a
(78 mg, 0.5 mmol) and 4,4-dimethyl-1-phenylpent-1-yn-3-one (128j,
140 mg, 0.75 mmol). Purification by flash column chromatography with a
gradient of n-pentane/ethyl acetate: 1/0 to 10/1 afforded the desired
product as yellow solid (108 mg, 67%).
m.p.: 119–121 °C. 1H NMR (400 MHz, CDCl3): δ = 7.95–7.85 (m, 4H), 7.62–7.50 (m, 3H), 7.44–7.34 (m, 3H), 6.51 (s,
1H), 5.75 (s, 1H), 1.30 (s, 9H). 13C NMR (101 MHz, CDCl3): δ = 161.7, 153.1, 142.9, 139.1, 132.7, 129.2, 128.7 (2C), 128.6 (2C),
128.3 (2C), 127.0 (2C), 96.6, 92.3, 36.3, 29.7 (3C).
MS (EI): m/z (%) = 323 ([M]+, 10 ), 281 (19), 230 (31), 198 (56), 157 (40), 77 (33), 57 (26).
IR (neat): = 3458, 3069, 2960, 2319, 2097, 1740, 1560, 1464, 1371, 1302, 1201, 1094, 979,
841, 748.
HRMS (ESI): 346.1232, calcd. for C20H21NONaS: 346.1236.
E x p e r i m e n t a l S e c t i o n | 103
1,5-Diphenyl-3-(4-tolyl)-1,2-thiazine 1-oxide (131k)
Following GP4, heterocycle 131k was obtained from NH-sulfoximine 100a
(78 mg, 0.5 mmol) and 1-phenyl-3-(p-tolyl)prop-2-yn-1-one (128k, 165 mg,
0.75 mmol). Purification by flash column chromatography with a gradient
of n-pentane/ethyl acetate: 1/0 to 9/1 afforded the desired product as
yellow foam (178 mg, 99%).
m.p.: 64–65 °C. 1H NMR (600 MHz, CDCl3): = 7.94–7.88 (m, 4H), 7.63–7.53 (m, 5H), 7.47–7.42 (m, 3H), 7.23 (d, J = 7.9 Hz, 2H), 6.71 (s, 1H), 5.92 (s, 1H), 2.38 (s, 3H).
13C NMR (151 MHz, CDCl3): = 154.2, 150.8, 142.8, 139.7, 139.2, 135.7, 132.8, 129.5, 129.1
(2C), 128.9 (2C), 128.7 (2C), 128.6 (2C), 127.1 (2C), 127.0 (2C), 97.5, 92.4, 21.3.
MS (EI): m/z (%) = 358 (24), 357 ([M]+, 100), 264 (11), 233 (15), 232 (83), 231 (13), 217 (27), 192
(45), 191 (29), 115 (24), 91 (18), 77 (19), 65 (10).
IR (KBr): = 3060, 2111, 1581, 1553, 1478, 1439, 1317, 1228, 1195, 1117, 1021, 969, 805, 749,
724.
HRMS (ESI): 358.1260, calcd. for C23H20NOS: 358.1260.
1,5-Diphenyl-3-(4-trifluoromethylphenyl)-1,2-thiazine 1-oxide (131l)
Following GP4, heterocycle 131l was obtained from NH-sulfoximine 100a
(78 mg, 0.5 mmol) and 1-phenyl-3-(4-(trifluoromethyl)phenyl)-prop-2-yn-
1-one (128l, 206 mg, 0.75 mmol). Purification by flash column chroma-
tography with a gradient of n-pentane/ethyl acetate: 1/0 to 8/2 afforded
the desired product as light brown oil (179 mg, 88%). 1H NMR (400 MHz, CDCl3): = 8.11 (d, J = 7.7 Hz, 2H), 7.92 (d, J = 6.9 Hz,
2H), 7.67–7.39 (m, 10 H), 6.78 (s, 1H), 6.02 (s, 1H). 13C NMR (151 MHz, CDCl3): = 152.2, 150.6, 142.1, 141.8, 138.6, 133.1,
131.0 (q, J = 32 Hz, 1C), 129.7, 128.9 (2C), 128.8 (2C), 128.6 (2C), 127.3 (2C), 127.0 (2C), 125.2
(q, J = 4 Hz, 2C), 122.7, 98.7, 94.1. 19F NMR (376 MHz, CDCl3): = –62.50.
MS (EI): m/z (%) = 412 (26), 411 ([M]+, 100), 287 (11), 286 (59), 217 (11), 192 (12).
IR (neat): = 3062, 2005, 1743, 1557, 1482, 1321, 1164, 1116, 1066, 1014, 969, 847, 808, 748,
722, 685.
HRMS (ESI): 412.0977, calcd. for C23H17NOF3S: 412.0978.
1,5-Diphenyl-3-(3-tolyl)-1,2-thiazine 1-oxide (131m)
Following GP4, heterocycle 131m was obtained from NH-sulfoximine 100a
(78 mg, 0.5 mmol) and 1-phenyl-3-(m-tolyl)prop-2-yn-1-one (128m, 165 mg,
0.75 mmol). Purification by flash column chromatography with a gradient of
n-pentane/ethyl acetate: 1/0 to 8/2 afforded the desired product as yellow
foam (157 mg, 88%).
m.p.: 130–131 °C.
104 | E x p e r i m e n t a l S e c t i o n
1H NMR (600 MHz, CDCl3): = 7.93 (d, J = 7.7 Hz, 2H), 7.82 (s, 1H), 7.78 (d, J = 7.9 Hz, 1H), 7.63–7.52 (m, 5H), 7.46–7.42 (m, 3H), 7.30 (t, J = 7.7 Hz, 1H), 7.21 (d, J = 7.7 Hz, 1H), 6.72 (s, 1H), 5.94
(s, 1H), 2.39 (s, 3H). 13C NMR (151 MHz, CDCl3): = 154.3, 150.8, 142.7, 139.1, 138.5, 138.0, 132.9, 130.3, 129.5,
128.8 (2C), 128.7 (2C), 128.6 (2C), 128.3, 127.8, 127.1 (2C), 124.2, 97.9, 92.6, 21.4.
MS (EI): m/z (%) = 358 (19), 357 ([M]+, 72), 264 (13), 233 (18), 232 (100), 231 (20), 230 (16), 217
(41), 216 (12), 202 (11), 192 (55), 191 (38), 189 (13), 125 (12), 119 (12), 115 (30), 105 (12), 91
(20), 89 (13), 77 (27), 65 (12), 51 (10).
IR (KBr): = 3058, 2332, 2073, 1739, 1553, 1479, 1371, 1312, 1197, 1108, 981, 919, 888, 820,
695.
HRMS (ESI): 380.1086, calcd. for C23H19ONNaS: 380.1080.
1,5-Diphenyl-3-(2,5-dimethylphenyl)-1,2-thiazine 1-oxide (131n)
Following GP4, heterocycle 131n was obtained from NH-sulfoximine
100a (60 mg, 0.39 mmol) and 3-(2,5-dimethylphenyl)-1-phenylprop-2-
yn-1-one (128n, 136 mg, 0.58 mmol). Purification by flash column
chromatography with a gradient of n-pentane/ethyl acetate: 1/0 to 8/2
afforded the desired product as yellow oil (88 mg, 48%). 1H NMR (600 MHz, CDCl3): = 7.93 (d, J = 7.7 Hz, 2H), 7.61–7.52 (m,
5H), 7.45–7.41 (m, 3H), 7.33 (s, 1H), 7.10 (m, 2H), 6.34 (s, 1H), 5.93 (s,
1H), 2.47 (s, 3H), 2.34 (s, 3H). 13C NMR (151 MHz, CDCl3): = 157.0, 150.4, 142.5, 139.6, 138.9, 135.2, 133.0, 133.0, 130.7,
129.6, 129.6, 129.3, 128.9 (2C), 128.8 (4C), 127.2 (2C), 101.4, 91.5, 20.9, 20.0.
MS (EI): m/z (%) = 372 (21), 371 ([M]+, 74), 247 (22), 246 (100), 245 (30), 244 (27), 231 (25), 230
(26), 229 (11), 202 (11), 192 (18), 191 (14), 115 (21), 105 (18), 77 (26).
IR (neat): = 3057, 2925, 1715, 1552, 1482, 1382, 1315, 1195, 1102, 996, 908, 817, 723.
HRMS (ESI): 372.1416, calcd. for C24H22NOS: 372.1417.
1-(4-Bromophenyl)-3,5-diphenyl-1,2-thiazine 1-oxide (131o)
Following GP4, heterocycle 131o was obtained from NH-sulfoximine 100b
(117 mg, 0.5 mmol) and 1,3-diphenylprop-2-yn-1-one (128a, 155 mg,
0.75 mmol). Purification by flash column chromatography with a gradient
of n-pentane/ethyl acetate: 1/0 to 95/5 afforded the desired product as
yellow solid (177 mg, 84%).
m.p.: 135–136 °C. 1H NMR (600 MHz, CDCl3): = 8.00–7.97 (m, 2H), 7.76 (d, J = 8.7 Hz, 2H),
7.67 (d, J = 8.7 Hz, 2H), 7.62–7.59 (m, 2H), 7.46–7.38 (m, 6H), 6.74 (s, 1H), 5.93 (s, 1H). 13C NMR (151 MHz, CDCl3): = 154.3, 151.3, 141.8, 138.9, 138.3, 132.0 (2C), 130.1 (2C), 129.7,
129.6, 128.9 (2C), 128.4 (2C), 128.3, 127.1 (2C), 127.0 (2C), 98.1, 92.5.
MS (EI): m/z (%) = 421 ([M]+, 8), 289 (13), 250 (20), 218 (100), 217 (69), 192 (12), 191 (55), 190
(13), 189 (28), 115 (29), 105 (85), 97 (21), 85 (21), 77 (78), 71 (25), 69 (28), 57 (37), 55 (21).
E x p e r i m e n t a l S e c t i o n | 105
IR (KBr): = 3066, 2100, 1554, 1478, 1436, 1383, 1320, 1227, 1192, 1118, 1090, 1065, 1007,
969, 909, 818, 793, 732, 690.
HRMS (ESI): 422.0208, calcd. for C22H17NOBrS: 422.0209.
1-Methyl-3,5-diphenyl-1,2-thiazine 1-oxide (131p)[93]
Following GP4, heterocycle 131p was obtained from NH-sulfoximine 100c (47
mg, 0.5 mmol) and 1,3-diphenylprop-2-yn-1-one (128a, 155 mg, 0.75 mmol)
after stirring for 5 h at 100 °C. Purification by flash column chromatography
with a gradient of n-pentane/ethyl acetate: 1/0 to 9/1 afforded the desired
product as yellow foam (63 mg, 46%).
m.p.: 115–116 °C. 1H NMR (600 MHz, CDCl3): = 7.98–7.93 (m, 2H), 7.61–7.57 (m, 2H), 7.47–7.39
(m, 6H), 6.60 (s, 1H), 6.10 (s, 1H), 3.48 (s, 3H). 13C NMR (151 MHz, CDCl3): = 154.7, 151.5, 139.1, 138.3, 129.6, 129.6, 128.9 (2C), 128.4 (2C),
127.1 (2C), 127.0 (2C), 98.5, 91.4, 47.5.
MS (EI): m/z (%) = 281 ([M]+, 78), 266 (25), 219 (17), 218 (100), 217 (48), 216 (10), 191 (14), 189
(20), 115 (33), 105 (44), 89 (24), 77 (57), 63 (46), 51 (37).
HRMS (ESI): 282.0948, calcd. for C17H16NOS: 282.0947.
IR (KBr): = 3371, 3051, 2930, 2327, 2095, 1561, 1473, 1266, 1050, 739.
6.7 Syntheses of 1,2-thiazine 1-imines
1-(N-Phenylimine)-1,3,5-triphenyl-1,2-thiazine (132a)
Following GP4, heterocycle 132a was obtained from NH-sulfondiimine 17
(116 mg, 0.5 mmol) and 1,3-diphenylprop-2-yn-1-one (128a, 155 mg,
0.75 mmol). Purification by flash column chromatography with a gradient
of n-pentane/ethyl acetate: 1/0 to 95/5 afforded the desired product as
yellow foam (164 mg, 78%).
m.p.: 98–99 °C. 1H NMR (600 MHz, CDCl3): = 8.21–8.18 (m, 2H), 7.99–7.96 (m, 2H),
7.57–7.47 (m, 5H), 7.42–7.36 (m, 6H), 7.15–7.10 (m, 2H), 6.90–6.80 (m, 3H), 6.57 (s, 1H), 5.39
(s, 1H). 13C NMR (151 MHz, CDCl3): = 155.9, 153.8, 144.3, 143.8, 139.3, 138.9, 132.3, 129.4, 129.3,
128.9 (2C), 128.8 (2C), 128.8 (2C), 128.6 (2C), 128.4 (2C), 127.0 (2C), 126.9 (2C), 123.6 (2C),
121.7, 96.3, 87.8.
MS (EI): m/z (%) = 418 ([M]+, 10), 327 (12), 309 (26), 251 (19), 250 (100), 238 (23), 218 (17), 217
(12), 147 (10), 115 (20), 109 (11), 91 (16), 77 (23).
IR (KBr): = 3051, 2321, 1739, 1551, 1474, 1379, 1253, 1046, 822, 694.
HRMS (ESI): 441.1396, calcd. for C28H22N2NaS: 441.1396.
106 | E x p e r i m e n t a l S e c t i o n
1-(N-Phenylimine)-1,3-diphenyl-5-(4-methylphenyl)-1,2-thiazine (132b)
Following GP4, heterocycle 132b was obtained from NH-sulfondiimine
17 (116 mg, 0.5 mmol) and 3-phenyl-1-(4-tolyl)prop-2-yn-1-one (128c,
165 mg, 0.75 mmol). Purification by flash column chromatography with
a gradient of n-pentane/ethyl acetate: 1/0 to 93/7 afforded the desired
product as light brown oil (158 mg, 74%). 1H NMR (600 MHz, CDCl3): = 8.18 (d, J = 7.2 Hz, 2H), 7.97 (s, J = 7.4 Hz,
2H), 7.52–7.47 (m, 3H), 7.41–7.33 (m, 5H), 7.16 (d, J = 7.7 Hz, 2H), 7.11
(t, J = 7.7 Hz, 2H), 6.85 (t, J = 7.2 Hz, 1H), 6.82 (d, J = 7.9 Hz, 2H), 6.57 (s,
1H), 5.37 (s, 1H), 2.32 (s, 3H). 13C NMR (151 MHz, CDCl3): = 155.7, 153.6, 144.3, 143.8, 139.5, 138.9, 136.2, 132.2, 129.4
(2C), 129.3, 128.8 (2C), 128.7 (2C), 128.5 (2C), 128.3 (2C), 126.9 (2C), 126.7 (2C), 123.5 (2C),
121.5, 96.1, 87.3, 21.1.
MS (EI): m/z (%) = 432 ([M]+, 4), 341 (11), 323 (18), 265 (19), 264 (100), 252 (17), 232 (16), 220
(10), 129 (20), 128 (17), 119 (16), 115 (21), 109 (27), 105 (11), 104 (15), 91 (30), 77 (43), 65 (14),
51 (12).
IR (neat): = 3464, 2964, 1681, 1593, 1468, 1258, 1141, 1044, 990, 906, 825, 744, 692.
HRMS (ESI): 455.1553, calcd. for C29H24N2NaS: 455.1552.
1-(N-Phenylimine)-1,3-diphenyl-5-(4-methoxyphenyl)-1,2-thiazine (132c)
Following GP4, heterocycle 132c was obtained from NH-sulfondiimine
17 (116 mg, 0.5 mmol) and 1-(4-methoxyphenyl)-3-phenylprop-2-yn-1-
one (128b, 177 mg, 0.75 mmol). Purification by flash column chroma-
tography with a gradient of n-pentane/ethyl acetate: 9/1 to 7/3 af-
forded the desired product as dark yellow foam (148 mg, 66%).
m.p.: 67–68 °C. 1H NMR (600 MHz, CDCl3): = 8.21–8.19 (m, 2H), 7.99–7.96 (m, 2H),
7.58–7.54 (m, 3H), 7.49–7.46 (m, 2H), 7.42–7.38 (m, 3H), 7.14–7.10
(2H), 6.92–6.90 (m, 2H), 6.89–6.85 (m, 1H), 6.82–6.79 (m, 2H), 6.56 (s, 1H), 5.36 (s, 1H), 3.81 (s,
3H). 13C NMR (151 MHz, CDCl3): = 160.7, 155.8, 153.2, 144.5, 144.0, 139.1, 132.2, 131.5, 129.3,
128.9 (2C), 128.8 (2C), 128.5 (2C), 128.4 (2C), 128.2 (2C), 127.0 (2C), 123.6 (2C), 121.6, 114.2
(2C), 96.0, 86.9, 55.4.
MS (EI): m/z (%) = 448 ([M]+, 5), 339 (16), 281 (19), 280 (100), 268 (13), 248 (17), 236 (11), 145
(18), 135 (17), 109 (33), 105 (12), 104 (14), 102 (13), 92 (10), 91 (37), 77 (54), 65 (18), 64 (18),
63 (11), 51 (27).
IR (KBr): = 3059, 2326, 2077, 1736, 1594, 1474, 1249, 1173, 1116, 1029, 962, 900, 835, 752,
689.
HRMS (ESI): 471.1514, calcd. for C29H24N2NaOS: 471.1502.
E x p e r i m e n t a l S e c t i o n | 107
1-(N-Phenylimine)-1,3-diphenyl-5-(thiophen-2-yl)-1,2-thiazine (132d)
Following GP4, heterocycle 132d was obtained from NH-sulfondiimine 17
(116 mg, 0.5 mmol) and 3-phenyl-1-(thiophen-2-yl)prop-2-yn-1-one (128i,
159 mg, 0.75 mmol). Purification by flash column chromatography with a
gradient of n-pentane/ethyl acetate: 1/0 to 9/1 afforded the desired
product as brown oil (186 mg, 88%). 1H NMR (600 MHz, CDCl3): = 8.22–8.18 (m, 2H), 7.98–7.94 (m, 2H),
7.60–7.57 (m, 3H), 7.43–7.40 (m, 4H), 7.38–7.36 (m, 1H), 7.14–7.11 (m,
2H), 7.08–7.06 (m, 1H), 6.90–6.87 (m, 1H), 6.84–6.81 (m, 2H), 6.62 (s, 1H), 5.48 (s, 1H). 13C NMR (151 MHz, CDCl3): = 156.3, 145.8, 144.1, 143.8, 141.6, 138.8, 132.4, 129.5, 128.9
(2C), 128.8 (2C), 128.6 (2C), 128.4 (2C), 128.0, 127.2, 127.0 (2C), 125.7, 123.6 (2C), 121.7, 95.1,
85.7.
MS (EI): m/z (%) = 424 ([M]+, 3), 315 (22), 257 (18), 256 (100), 224 (20), 109 (31), 77 (30), 65
(17), 51 (14).
IR (neat): = 3061, 1590, 1551, 1474, 1348, 1286, 1255, 1192, 1118, 1087, 1051, 1024, 907,
830, 723, 691.
HRMS (ESI): 447.0960, calcd. for C26H20N2NaS2: 447.0960.
1-(N-Phenylimine)-1,3-diphenyl-5-(naphthalen-2-yl)-1,2-thiazine (132e)
Following GP4, heterocycle 132e was obtained from NH-
sulfondiimine 17 (115 mg, 0.5 mmol) and 1-(naphthalen-2-yl)-3-
phenylprop-2-yn-1-one (128e, 193 mg, 0.75 mmol) after stirring at
80 °C for 6 h. Purification by flash column chromatography with a
gradient of n-pentane/ethyl acetate: 1/0 to 95/5 afforded the de-
sired product as orange oil (115 mg, 49%). 1H NMR (600 MHz, CDCl3): = 8.26–8.21 (m, 2H), 8.03–7.98 (m, 3H),
7.87–7.82 (m, 3H), 7.62–7.56 (m, 4H), 7.51–7.49 (m, 2H), 7.44–7.40 (m, 3H), 7.16–7.12 (m, 2H),
6.91–6.87 (m, 1H), 6.87–6.84 (m, 2H), 6.70 (s, 1H), 5.53 (s, 1H). 13C NMR (151 MHz, CDCl3): = 156.0, 153.7, 144.4, 143.9, 139.0, 136.6, 133.6, 133.2, 132.3,
129.5, 128.9 (2C), 128.8 (2C), 128.7 (2C), 128.6, 128.4 (2C), 128.4, 127.7, 127.1 (2C), 126.8,
126.6, 126.3, 124.5, 123.6 (2C), 121.7, 96.5, 88.1.
MS (EI): m/z (%) = 202 (11), 201 (19), 155 (29), 127 (30), 121 (11), 110 (21), 109 (60), 106 (41),
105 (41), 93 (22), 92 (35), 85 (66), 83 (100), 78 (12), 77 (73), 69 (23), 66 (15), 65 (55), 63 (13), 57
(17), 55 (10), 51 (39), 50 (24), 49 (13), 48 (26), 47 (42).
(ESI): m/z (%) = 469.17 ([M+H]+).
IR (neat): = 3052, 2925, 2324, 2093, 1921, 1676, 1555, 1473, 1258, 1047, 902, 820, 744, 692.
HRMS (ESI): 469.1733, calcd. for C32H25N2S: 469.1733.
108 | E x p e r i m e n t a l S e c t i o n
1-(N-Phenylimine)-1,3-diphenyl-5-(2-chlorophenyl)-1,2-thiazine (132f)
Following GP4, heterocycle 132f was obtained from NH-sulfondiimine 17
(116 mg, 0.5 mmol) and 1-(2-chlorophenyl)-3-phenyl-prop-2-yn-1-one
(128h, 181 mg, 0.75 mmol). Purification by flash column chromatog-
raphy with a gradient of n-pentane/ethyl acetate: 1/0 to 85/15 afforded
the desired product as light brown oil (138 mg, 61%). 1H NMR (600 MHz, CDCl3): = 8.24–8.21 (m, 2H), 7.95–7.93 (m, 2H),
7.59–7.55 (m, 3H), 7.41–7.36 (m, 4H), 7.27–7.22 (m, 2H), 7.21–7.15 (m,
3H), 6.94–6.90 (m, 1H), 6.86–6.83 (m, 2H), 6.38 (s, 1H), 5.23 (s, 1H). 13C NMR (151 MHz, CDCl3): = 155.1, 152.5, 144.3, 143.8, 138.7, 138.6, 132.4, 131.8, 130.0,
130.0, 129.6, 129.4, 128.9 (2C), 128.8 (2C), 128.6 (2C), 128.4 (2C), 127.0 (2C), 126.8, 123.8 (2C),
121.8, 98.0, 90.1.
MS (EI): m/z (%) = 452 ([M]+, 7), 361 (15), 357 (14), 343 (17), 314 (17), 286 (38), 285 (20), 284
(100), 272 (12), 252 (18), 232 (11), 217 (16), 149 (16), 139 (13), 109 (18), 105 (12), 91 (24), 77
(37), 65 (11), 64 (11), 51 (15).
IR (neat): = 3058, 2326, 1728, 1585, 1555, 1472, 1374, 1254, 1118, 1048, 814, 746, 688.
HRMS (ESI): 475.1006, calcd. for C28H21N2NaClS: 475.1006.
1-(N-Phenylimine)-1,3-diphenyl-5-(4-chlorophenyl)-1,2-thiazine (132g)
Following GP4, heterocycle 132g was obtained from NH-sulfondiimine
17 (116 mg, 0.5 mmol) and 1-(4-chlorophenyl)-3-phenylprop-2-yn-1-one
(128g, 192 mg, 0.75 mmol). Purification by flash column chromatography
with a gradient of n-pentane/ethyl acetate: 1/0 to 85/15 afforded the
desired product as yellow foam (168 mg, 74%).
m.p.: 74–75 °C. 1H NMR (400 MHz, CDCl3): = 8.21–8.16 (m, 2H), 8.00–7.94 (m, 2H),
7.59–7.54 (m, 3H), 7.45–7.38 (m, 5H), 7.37–7.33 (m, 2H), 7.15–7.09 (m,
2H), 6.91–6.85 (m, 1H), 6.83–6.76 (m, 2H), 6.51 (s, 1H), 5.35 (s, 1H). 13C NMR (101 MHz, CDCl3): = 156.2, 152.4, 144.1, 143.5, 138.7, 137.7, 135.4, 132.4, 129.5,
129.0 (2C), 128.9 (2C), 128.8 (2C), 128.6 (2C), 128.4 (2C), 128.2 (2C), 127.0 (2C), 123.6 (2C),
121.8, 95.9, 87.7.
MS (EI): m/z (%) = 452 ([M]+, 9), 361 (14), 343 (29), 342 (14), 286 (34), 285 (18), 284 (100), 272
(19), 252 (11), 109 (26), 91 (59), 77 (35), 64 (13).
IR (KBr): = 3057, 2332, 1912, 1587, 1547, 1476, 1380, 1254, 1177, 1088, 1053, 898, 837, 748,
689.
HRMS (ESI): 475.1022, calcd. for C28H21N2NaClS: 475.1006.
E x p e r i m e n t a l S e c t i o n | 109
1-(N-Phenylimine)-1,3-diphenyl-5-(4-fluorophenyl)-1,2-thiazine (132h)
Following GP4, heterocycle 132h was obtained from NH-sulfondiimine 17
(116 mg, 0.5 mmol) and 1-(4-fluorophenyl)-3-phenylprop-2-yn-1-one
(128f, 168 mg, 0.75 mmol). Purification by flash column chromatography
with a gradient of n-pentane/ethyl acetate: 1/0 to 85/15 afforded the
desired product as neon-yellow foam (145 mg, 66%).
m.p.: 66–67 °C. 1H NMR (600 MHz, CDCl3): = 8.22–8.17 (m, 2H), 8.00–7.96 (m, 2H),
7.59–7.55 (m, 3H), 7.49–7.45 (m, 2H), 7.43–7.38 (m, 3H), 7.13 (t, J = 7.7
Hz, 2H), 7.07 (t, J = 8.7 Hz, 2H), 6.89 (t, J = 7.4 Hz, 1H), 6.81 (d, J = 7.9 Hz, 2H), 6.52 (s, 1H), 5.35
(s, 1H). 13C NMR (150 MHz, CDCl3): = 163.5 (d, J = 250 Hz, 1C), 156.1, 152.6, 144.2, 143.6, 138.8, 135.4
(d, J = 3 Hz, 1C), 132.4, 129.5, 128.9 (2C), 128.8 (2C), 128.7, 128.7, 128.6 (2C), 128.4 (2C), 127.0
(2C), 123.6 (2C), 121.8, 115.8, 115.7, 96.1, 87.6. 19F NMR (564 MHz, CDCl3): = –111.83 (m, 1F).
MS (EI): m/z (%) = 436 ([M]+, 8), 345 (13), 327 (28), 269 (21), 268 (100), 256 (27), 236 (17), 235
(11), 133 (24), 109 (16), 91 (17), 77 (26), 51 (12).
IR (KBr): = 3059, 1594, 1551, 1475, 1398, 1286, 1253, 1159, 1118, 1090, 1052, 964, 895, 842,
752, 688.
HRMS (ESI): 437.1483, calcd. for C28H22N2FS: 437.1482.
1-(N-Phenylimine)-5-phenyl-3-(4-trifluoromethylphenyl)-1,2-thiazine (132i)
Following GP4, heterocycle 132i was obtained from NH-sulfondiimine
17 (116 mg, 0.5 mmol) and 1-phenyl-3-(4-(trifluoromethyl)phenyl)-
prop-2-yn-1-one (128l, 206 mg, 0.75 mmol). Purification by flash col-
umn chromatography with a gradient of n-pentane/ethyl acetate: 1/0
to 95/5 afforded the desired product as brown oil (185 mg, 78%). 1H NMR (600 MHz, CDCl3): = 8.23–8.17 (m, 2H), 8.08 (d, J = 7.9 Hz,
2H), 7.66 (d, J = 8.2 Hz, 2H), 7.61–7.58 (m, 3H), 7.52–7.48 (m, 2H),
7.42–7.39 (m, 3H), 7.13 (t, J = 7.7 Hz, 2H), 6.90 (t, J = 7.2 Hz, 1H), 6.80
(d, J = 7.9 Hz, 2H), 6.59 (s, 1H), 5.49 (s, 1H). 13C NMR (151 MHz, CDCl3): = 153.9, 153.6, 143.9, 143.2, 142.2, 139.0, 132.6, 131.0 (q, J = 32
Hz), 129.5, 128.9 (2C), 128.9 (4C), 128.7 (2C), 127.2 (2C), 126.9 (2C), 125.3 (q, J = 4 Hz, 2C),
123.6 (2C), 123.2, 122.0, 97.0, 89.3. 19F NMR (376 MHz, CDCl3): = –62.54.
MS (EI): m/z (%) = 486 ([M]+, 24), 395 (20), 378 (12), 377 (50), 376 (20), 319 (19), 318 (100), 286
(15), 105 (13), 77 (16).
IR (neat): = 3061, 2925, 1714, 1590, 1553, 1481, 1319, 1257, 1164, 1117, 1062, 1017, 966,
847, 806, 750, 690.
HRMS (ESI): 487.1434, calcd. for C29H22N2F3S: 487.1450.
110 | E x p e r i m e n t a l S e c t i o n
1-(N-Phenylimine)-1,5-diphenyl-3-(4-tolyl)-1,2-thiazine (132j)
Following GP4, heterocycle 132j was obtained from NH-sulfondiimine
17 (116 mg, 0.5 mmol) and 1-phenyl-3-(p-tolyl)prop-2-yn-1-one (128k,
165 mg, 0.75 mmol). Purification by flash column chromatography with
a gradient of n-pentane/ethyl acetate: 1/0 to 95/5 afforded the desired
product as yellow foam (179 mg, 83%).
m.p.: 68–69 °C. 1H NMR (600 MHz, CDCl3): = 8.21–8.18 (m, 2H), 7.89 (d, J = 7.9 Hz,
2H), 7.58–7.54 (m, 3H), 7.51–7.48 (m, 2H), 7.40–7.36 (m, 3H), 7.22 (d, J
= 8.2 Hz, 2H), 7.12 (t, J = 7.9 Hz, 2H), 6.87 (t, J = 7.4 Hz, 1H), 6.80 (d, J = 7.9 Hz, 2H), 6.56 (s, 1H),
5.37 (s, 1H), 2.37 (s, 3H). 13C NMR (151 MHz, CDCl3): = 155.9, 153.8, 144.4, 143.9, 139.6, 139.4, 136.0, 132.2, 129.3,
129.1 (2C), 128.9 (2C), 128.7 (2C), 128.7 (2C), 128.5 (2C), 126.9 (2C), 126.9 (2C), 123.5 (2C),
121.6, 95.8, 87.4, 21.3.
MS (EI): m/z (%) = 432 ([M]+, 16), 323 (37), 265 (22), 264 (100), 238 (23), 232 (13).
IR (KBr): = 3057, 2112, 1588, 1548, 1476, 1439, 1283, 1254, 1180, 1118, 1089, 1051, 1022,
963, 813, 751, 690.
HRMS (ESI): 433.1732, calcd. for C29H25N2S: 433.1733.
1-(N-Phenylimine)-1,5-diphenyl-3-(3-tolyl)-1,2-thiazine (132k)
Following GP4, heterocycle 132k was obtained from NH-sulfondiimine 17
(116 mg, 0.5 mmol) and 1-phenyl-3-(m-tolyl)prop-2-yn-1-one (128m, 165
mg, 0.75 mmol). Purification by flash column chromatography with a gra-
dient of n-pentane/ethyl acetate: 1/0 to 8/2 afforded the desired product
as yellow oil (168 mg, 78%). 1H NMR (600 MHz, CDCl3): = 8.23–8.18 (m, 2H), 7.80 (s, 1H), 7.77 (d, J =
7.9 Hz, 1H), 7.58–7.53 (m, 3H), 7.52–7.47 (m, 2H), 7.40–7.36 (m, 3H), 7.30
(t, J = 7.4 Hz, 1H), 7.20 (d, J = 7.7 Hz, 1H), 7.14–7.11 (m, 2H), 6.88 (t, J =
7.4 Hz, 1H), 6.81 (d, J = 7.7 Hz, 2H), 6.57 (s, 1H), 5.38 (s, 1H), 2.38 (s, 3H). 13C NMR (151 MHz, CDCl3): = 156.1, 153.9, 144.4, 143.9, 139.4, 138.9, 138.1, 132.3, 130.2,
129.3, 128.9 (2C), 128.8 (2C), 128.7 (2C), 128.6 (2C), 128.3, 127.7, 126.9 (2C), 124.1, 123.5 (2C),
121.6, 96.3, 87.6, 21.5.
MS (EI): m/z (%) = 433 (13), 432 ([M]+, 36), 422 (20), 421 (61), 410 (14), 342 (16), 341 (55), 340
(11), 324 (19), 323 (70), 322 (68), 321 (20), 316 (18), 268 (30), 267 (12), 265 (22), 264 (100), 254
(15), 253 (76), 251 (14), 238 (27), 232 (16), 201 (12), 194 (18), 119 (16), 115 (15), 105 (61), 91
(14), 77 (47), 65 (10), 51 (11).
IR (neat): = 3058, 1672, 1588, 1547, 1479, 1371, 1255, 1181, 1089, 1052, 907, 819, 725, 694.
HRMS (ESI): 455.1562, calcd. for C29H24N2NaS: 455.1552.
E x p e r i m e n t a l S e c t i o n | 111
1-[N-(4-Methoxyphenyl)imine]-1,3,5-triphenyl-1,2-thiazine (132l)
Following GP4, heterocycle 132l was obtained from NH-sulfondiimine
106l (130 mg, 0.5 mmol) and 1,3-diphenylprop-2-yn-1-one (128a, 155
mg, 0.75 mmol). Purification by flash column chromatography with a
gradient of n-pentane/ethyl acetate: 1/0 to 85/15 afforded the de-
sired product as orange oil (118 mg, 53%). 1H NMR (600 MHz, CDCl3): = 8.23–8.15 (m, 2H), 8.00–7.95 (m, 2H),
7.57–7.52 (m, 3H), 7.51–7.47 (m, 2H), 7.43–7.35 (m, 6H), 6.78 (d, J =
8.9 Hz, 2H), 6.68 (d, J = 8.9 Hz, 2H), 6.51 (s, 1H), 5.40 (s, 1H), 3.66 (s, 3H). 13C NMR (150 MHz, CDCl3): = 155.7, 155.0, 153.5, 143.6, 139.4, 139.0, 137.2, 132.2, 129.3,
129.3, 128.8 (2C), 128.7 (2C), 128.6 (2C), 128.4 (2C), 127.0 (2C), 126.9 (2C), 124.6 (2C), 114.2
(2C), 96.2, 88.0, 55.3.
MS (EI): m/z (%) = 448 ([M]+, 1), 268 (26), 251 (19), 250 (100), 223 (23), 218 (25), 217 (24), 189
(21), 147 (21), 123 (15), 122 (72), 121 (58), 115 (32), 109 (82), 106 (28), 103 (26), 95 (21), 91
(17), 78 (40), 77 (83), 65 (55), 52 (34), 51 (57).
IR (neat): = 3060, 2112, 1583, 1548, 1498, 1476, 1378, 1283, 1233, 1177, 1118, 1092, 1050,
907, 832, 790, 727.
HRMS (ESI): 449.1681, calcd. for C29H25N2OS: 449.1682.
N-(1,3,5-Triphenyl-1,2-thiazin-1-ylidene)cyanamide (132m)
Following GP4, heterocycle 132m was obtained from NH-sulfondiimine
106m (14 mg, 0.08 mmol) and 1,3-diphenylprop-2-yn-1-one (128a, 25 mg,
0.12 mmol). Purification by flash column chromatography with a gradient of
n-pentane/ethyl acetate: 1/0 to 2/1 afforded the desired product as yellow
gum (17 mg, 57%).
1H NMR (600 MHz, CDCl3): δ = 8.08–8.03 (m, 2H), 8.02–7.97 (m, 2H), 7.73–7.68 (m, 1H), 7.67–7.61 (m, 4H), 7.51–7.44 (m, 6H), 6.74 (s, 1H), 5.74 (s, 1H).
13C NMR (151 MHz, CDCl3): δ = 155.9, 155.4, 140.4, 138.1, 137.3, 134.2, 130.5, 130.4, 129.5
(2C), 129.1 (2C), 128.6 (2C), 128.6 (2C), 127.2 (2C), 127.2 (2C), 114.0, 98.3, 85.0.
MS (EI): m/z (%) = 367 ([M]+, 2), 327 (27), 251 (18), 250 (100), 238 (23), 218 (14).
IR (neat): = 3459, 3041, 2322, 2180, 1968, 1740, 1553, 1472, 1372, 1187, 708.
HRMS (ESI): 390.1036, calcd. for C23H17N3NaS: 390.1035.
1-(N-Phenylimine)-1-(4-methoxyphenyl)-3,5-diphenyl-1,2-thiazine (132n)
Following GP4, heterocycle 132n was obtained from NH-sulfondiimine
106i (130 mg, 0.5 mmol) and 1,3-diphenylprop-2-yn-1-one (128a,
155 mg, 0.75 mmol). Purification by flash column chromatography with
a gradient of n-pentane/ethyl acetate: 1/0 to 9/1 afforded the desired
product as orange foam (194 mg, 86%).
m.p.: 63–64 °C.
112 | E x p e r i m e n t a l S e c t i o n
1H NMR (600 MHz, CDCl3): = 8.11 (d, J = 8.9 Hz, 2H), 7.97 (d, J = 7.4 Hz, 2H), 7.51–7.48 (m, 2H),
7.41–7.35 (m, 6H), 7.11 (t, J = 7.7 Hz, 2H), 7.02 (d, J = 8.9 Hz, 2H), 6.86 (t, J = 7.4 Hz, 1H), 6.79 (d,
J = 7.7 Hz, 2H), 6.55 (s, 1H), 5.37 (s, 1H), 3.83 (s, 3H). 13C NMR (150 MHz, CDCl3): = 162.8, 155.7, 153.3, 144.5, 139.4, 139.0, 135.5, 130.9 (2C),
129.3, 129.2, 128.8 (2C), 128.7 (2C), 128.4 (2C), 127.0 (2C), 126.9 (2C), 123.6 (2C), 121.5, 113.9
(2C), 96.1, 88.3, 55.7.
MS (EI): m/z (%) = 448 ([M]+, 4), 357 (31), 309 (44), 250 (78), 231 (41), 218 (35), 139 (100), 105
(19), 93 (20), 77 (33), 65 (19).
IR (KBr): = 3058, 1588, 1549, 1479, 1380, 1287, 1251, 1175, 1117, 1093, 1050, 1025, 965, 901,
832, 756, 694.
HRMS (ESI): 449.1683, calcd. for C29H25N2OS: 449.1682.
6.8 Synthesis of an N-unsubstituted 1,2-thiazine 1-imine
1,3,5-Triphenyl- λ6,2-thiazin-1-imine (132o)
The deprotection of N-cyano-substituted 1,2-thiazine 132m was carried out according to a pre-
viously reported protocol. [95b]
Under an atmosphere of argon, a flame-dried Schlenk tube equipped with
magnetic stirrer and septum was charged with N-cyano-1,2-thiazine 132m
(18 mg, 0.05 mmol, 1.0 equiv). After dissolving in DCM (0.9 mL), the solu-
tion was cooled to 0 °C. Then, TFAA (0.02 mL, 0.15 mmol, 3.0 equiv) was
added by syringe, and the resulting mixture was stirred for 2 h at r.t.. The
reaction mixture was then concentrated and treated with K2CO3 (35 mg,
0.25 mmol, 5.0 equiv) in MeOH (0.4 mL) at r.t. for 2 h. The solvent was re-
moved under reduced pressure and the product was purified by flash column chromatography
with n-pentane/ethyl acetate gradient elution (1/0 to 2/1). NH-1,2-thiazine 132o was obtained
as yellow oil (17 mg, 99%). 1H NMR (600 MHz, CDCl3): δ = 8.13–8.04 (m, 2H), 8.01–7.95 (m, 2H), 7.64–7.58 (m, 2H), 7.58–7.52 (m, 3H), 7.47–7.38 (m, 6H), 6.50 (s, 1H), 5.66 (s, 1H), 2.95 (br s, 1H). 13C NMR (151 MHz, CDCl3): δ = 154.2, 150.1, 143.7, 139.3, 139.0, 132.4, 129.4, 129.4, 128.9
(2C), 128.8 (2C), 128.4 (2C), 128.2 (2C), 127.0 (2C), 127.0 (2C), 95.4, 91.5.
MS (EI): m/z (%) = 342 ([M]+, 100), 327 (16), 250 (37), 238 (17), 233 (30), 219 (65), 218 (72), 217
(39), 191 (16), 162 (16), 115 (23), 109 (16), 77 (22), 51 (14).
IR (neat): = 2963, 2112, 1476, 1261, 1090, 1021, 799, 688.
HRMS (ESI): 343.1259, calcd. for C22H19N2S: 343.1264.
E x p e r i m e n t a l S e c t i o n | 113
6.9 Derivatizations of 1,2-thiazine 1-oxides
1-[4'-Methoxy-(1,1'-biphenyl)-4-yl]-3,5-diphenyl-1,2-thiazine 1-oxide (134a)
The SUZUKI–MIYAURA coupling was carried out according to a
previously reported protocol.[97]
Under an atmosphere of argon, a flame-dried Schlenk tube
equipped with magnetic stirrer and septum was charged with 1,2-
thiazine 131o (85 mg, 0.2 mmol, 1.0 equiv), 4-methoxy-
phenylboronic acid (101b, 37 mg, 0.24 mmol, 1.2 equiv), Pd(PPh3)4
(5 mg, 0.004 mmol, 2 mol%) and potassium carbonate (39 mg,
0.28 mmol, 1.4 equiv). Then, MeCN (2 mL) and deionized water (1
mL) were added and the resulting suspension was refluxed for 18
h. After cooling, the reaction was quenched with saturated aqueous NaHCO3-solution (15 mL).
Then, the mixture was extracted with DCM (3 x 10 mL). The combined organic layers were dried
with anhydrous magnesium sulfate and the solvents were removed under reduced pressure.
Purification by flash column chromatography with n-pentane/ethyl acetate gradient elution
(1/0 to 5/1) afforded the desired arylated 1,2-thiazine 134a as yellow solid (81 mg, 90%).
m.p.: 178–180 °C. 1H NMR (600 MHz, CDCl3): δ = 8.02 (dd, J = 8.0, 1.3 Hz, 2H), 7.95 (d, J = 8.6 Hz, 2H), 7.71 (d, J =
8.6 Hz, 2H), 7.64 (dd, J = 7.7, 1.7 Hz, 2H), 7.56 (d, J = 8.8 Hz, 2H), 7.49–7.38 (m, 6H), 7.01 (d, J =
8.8 Hz, 2H), 6.75 (s, 1H), 6.00 (s, 1H), 3.86 (s, 3H).
13C NMR (151 MHz, CDCl3): δ = 160.1, 154.1, 150.7, 145.6, 140.4, 139.2, 138.6, 131.6, 129.5
(2C), 129.2 (2C), 128.9 (2C), 128.6 (2C), 128.4 (2C), 127.2 (2C), 127.1 (2C), 126.9 (2C), 114.5 (2C),
98.0, 93.0, 55.4.
MS (EI): m/z (%) = 449 ([M]+, 11), 432 (11), 297 (100), 250 (29), 231 (31), 218 (78), 217 (61), 191
(22), 189 (21), 168 (26), 165 (12), 152 (25), 149 (13), 139 (56), 115 (30), 105 (11), 77 (16).
IR (neat): = 3457, 3053, 2562, 2295, 2093, 1934, 1739, 1559, 1474, 1198, 1106, 1028, 814,
697.
HRMS (ESI): 450.1506, calcd. for C29H24NO2S: 450.1522.
1-(4-Morpholinophenyl)-3,5-diphenyl-1,2-thiazine 1-oxide (134b)
The BUCHWALD–HARTWIG amination was carried out according to a
previously published protocol.[97]
Under an atmosphere of argon, a flame-dried Schlenk tube equipped
with magnetic stirrer and septum was charged with 1,2-thiazine 131o
(85 mg, 0.2 mmol, 1.0 equiv), Pd(OAc)2 (9 mg, 0.004 mmol, 2 mol%),
BINAP (4 mg, 0.006 mmol, 3 mol%) and cesium carbonate (91 mg,
0.28 mmol, 1.4 equiv). Then, toluene (2 mL) and morpholine (135,
0.02 mL, 0.24 mmol, 1.2 equiv) were added by syringe and the result-
ing suspension was refluxed for 18 h. After cooling, the reaction was quenched with saturated
aqueous NaHCO3-solution (15 mL). Then, the mixture was extracted with DCM (3 x 10 mL).
114 | E x p e r i m e n t a l S e c t i o n
The combined organic layers were dried with anhydrous magnesium sulfate and the solvents
were removed under reduced pressure. Purification by flash column chromatography with n-
pentane/ethyl acetate gradient elution (1/0 to 1/1) afforded the desired aminated 1,2-thiazine
134b as yellow solid (77 mg, 90%).
m.p.: 221–223 °C. 1H NMR (400 MHz, CDCl3): δ = 8.03–7.96 (m, 2H), 7.79–7.72 (m, 2H), 7.65–7.57 (m, 2H), 7.47–7.35 (m, 6H), 6.96–6.87 (m, 2H), 6.71 (s, 1H), 5.93 (s, 1H), 3.86–3.80 (m, 4H), 3.32–3.25 (m, 4H). 13C NMR (101 MHz, CDCl3): δ = 154.1, 153.8, 150.0, 139.3, 138.8, 131.2, 130.6 (2C), 129.3 (2C),
128.8 (2C), 128.4 (2C), 127.2 (2C), 127.1 (2C), 113.4 (2C), 97.7, 93.6, 66.5 (2C), 47.5 (2C).
MS (EI): m/z (%) = 428 ([M]+, 28), 412 (32), 411 (100), 277 (84), 276 (40), 219 (25), 210 (38), 198
(29), 191 (19), 183 (22), 152 (25), 139 (10), 134 (14), 115 (11), 77 (10).
IR (neat): = 3060, 2964, 2845, 2617, 2321, 2101, 1898, 1587, 1479, 1377, 1312, 1237, 1187,
1106, 1030, 969, 923, 821, 758, 699.
HRMS (ESI): 429.1613, calcd. for C26H25N2O2S: 429.1631.
Butyl (E)-3-[2-(1-oxido-1,5-diphenyl-1λ6,2-thiazin-3-yl)phenyl]acrylate (136a)
Under an atmosphere of argon, a flame-dry Schlenk tube equipped with
magnetic stirrer and septum was charged with the 1,2-thiazine 131a
(34 mg, 0.1 mmol, 1.0 equiv), [Cp*Rh(MeCN)3][SbF6]2 (4 mg, 0.005 mmol, 5
mol%) and Cu(OAc)2·H2O (80 mg, 0.4 mmol, 4.0 equiv). Then, dry 1,4-
dioxane (1.5 mL) and n-butyl acrylate (137, 28 L, 0.2 mmol, 2.0 equiv)
were added by syringe, the resulting suspension was refluxed for 24 h.
After cooling, the reaction was quenched with saturated aqueous NaHCO3-
solution (15 ml). Then, the mixture was extracted with DCM (3 x 10 mL). The combined organic
layers were dried with anhydrous magnesium sulfate and the solvents were removed under
reduced pressure. Purification by flash column chromatography with n-pentane/ethyl acetate
gradient elution (1/0 to 10/1 to 5/1) afforded the desired alkenylated 1,2-thiazine 136a as pale
yellow gum (25 mg, 53%). 1H NMR (600 MHz, CDCl3): δ = 8.21 (d, J = 15.9 Hz, 1H), 8.01–7.96 (m, 2H), 7.70 (dd, J = 7.6, 1.2
Hz, 1H), 7.67 (dd, J = 7.5, 0.8 Hz, 1H), 7.64–7.53 (m, 5H), 7.48–7.38 (m, 5H), 6.43 (d, J = 15.9 Hz,
1H), 6.33 (s, 1H), 6.02 (s, 1H), 4.21 (t, J = 6.7 Hz, 2H), 1.73–1.61 (m, 2H), 1.40 (qt, J = 7.4, 7.4 Hz,
2H), 0.93 (t, J = 7.4 Hz, 3H). 13C NMR (151 MHz, CDCl3): δ = 167.0, 154.1, 150.0, 143.8, 141.8, 140.6, 138.6, 133.1, 133.0,
130.0, 129.8, 129.6, 129.0 (2C), 129.0, 128.9 (3C), 128.8, 127.3 (2C), 127.0, 119.4, 103.4, 92.9,
64.4, 30.7, 19.2, 13.8.
MS (EI): m/z (%) = 469 ([M]+, 24), 452 (17), 368 (100), 243 (92), 175 (24), 158 (66), 147 (78), 77
(40).
IR (KBr): = 2947, 2350, 2088, 1912, 1712, 1458, 1189, 728.
HRMS (ESI): 470.1784, calcd. for C29H28NO3S: 470.1784.
E x p e r i m e n t a l S e c t i o n | 115
Dibutyl 3,3'-[2-(1-oxido-1,5-diphenyl-1λ6,2-thiazin-3-yl)-1,3-phenylene](2E,2'E)-diacrylate
(136b)
Heterocycle 136b represents a byproduct of the synthesis of
136a and was obtained as yellow gum (14 mg, 23%). 1H NMR (600 MHz, CDCl3): δ = 8.04–7.97 (m, 2H), 7.87 (d, J = 15.9
Hz, 2H), 7.71 (d, J = 7.9 Hz, 2H), 7.63–7.52 (m, 5H), 7.44–7.39 (m,
4H), 6.40 (d, J = 15.9 Hz, 2H), 6.23 (d, J = 0.7 Hz, 1H), 6.04 (d, J =
0.8 Hz, 1H), 4.22– 4.13 (m, 4H), 1.64 (dt, J = 6.4, 6.4 Hz , 4H), 1.37
(qt, J = 7.5, 7.5 Hz, 4H), 0.88 (t, J = 7.4 Hz, 6H). 13C NMR (151 MHz, CDCl3): δ = 166.6 (2C), 152.3, 149.7, 142.2 (2C), 141.5, 140.8, 138.3, 133.9
(2C), 133.3, 129.7, 129.3 (2C), 128.9 (4C), 128.8, 127.7 (2C), 127.3 (2C), 120.4 (2C), 104.2, 93.3,
64.4 (2C), 30.7 (2C), 19.2 (2C), 13.7 (2C).
MS (EI): m/z (%) = 595 ([M]+, 1), 494 (26), 420 (29), 368 (45), 328 (36), 295 (53), 268 (50), 250
(55), 243 (51), 227 (50), 183 (50), 158 (44), 141 (63), 125 (100), 109 (76), 105 (63), 77 (98), 51
(50).
IR (KBr): = 3250, 3059, 2948, 2316, 2091, 1918, 1710, 1467, 1175, 987, 721.
HRMS (ESI): 596.2465, calcd. for C36H38NO5S: 596.2465.
n-Butyl-(E)-2-{2-[1-(4-bromophenyl)-1-oxido-5-phenyl-1,2-thiazin-3-yl]phenyl}acrylate (136c)
Under an atmosphere of argon, a flame-dry Schlenk tube equipped with
magnetic stirrer and septum was charged with the 1,2-thiazine 131o
(85 mg, 0.2 mmol, 1.0 equiv), [Cp*Rh(MeCN)3][SbF6]2 (8 mg, 0.01 mmol,
5 mol%) and Cu(OAc)2•H2O (80 mg, 0.4 mmol, 2.0 equiv). Then, dry
1,4-dioxane (2 mL) and n-butyl acrylate (137, 0.04 mL, 0.3 mmol,
1.5 equiv) were added by syringe and the resulting suspension was re-
fluxed for 18 h. After cooling, the reaction was quenched with saturated
aqueous NaHCO3-solution (15 mL). Then, the mixture was extracted with DCM (3 x 10 mL). The
combined organic layers were dried with anhydrous magnesium sulfate and the solvents were
removed under reduced pressure. Purification by flash column chromatography with n-
pentane/ethyl acetate gradient elution (1/0 to 10/1) afforded the desired alkenylated 1,2-
thiazine 136c as pale yellow gum (81 mg, 74%). 1H NMR (400 MHz, CDCl3): δ = 8.17 (d, J = 16.0 Hz, 1H), 7.88–7.82 (m, 2H), 7.75–7.69 (m, 2H),
7.69–7.63 (m, 2H), 7.63–7.57 (m, 2H), 7.47–7.38 (m, 5H), 6.42 (d, J = 15.9 Hz, 1H), 6.35 (s, 1H),
6.00 (s, 1H), 4.28–4.16 (m, 2H), 1.72–1.62 (m, 2H), 1.46–1.36 (m, 2H), 0.94 (t, J = 7.4 Hz, 3H).
13C NMR (101 MHz, CDCl3): δ = 167.0, 154.5, 150.5, 143.7, 141.0, 140.5, 138.4, 132.9, 132.2
(2C), 130.5 (2C), 129.9, 129.8, 129.8, 129.1, 128.9 (2C), 128.6, 127.3 (2C), 127.1, 119.4, 103.4,
92.6, 64.4, 30.8, 19.2, 13.7.
MS (EI): m/z (%) = 547 ([M]+, 3), 448 (11), 446 (11), 278 (12), 244 (39), 243 (100), 242 (31), 241
(12), 230 (21), 215 (12).
IR (neat): = 3066, 2955, 2871, 2322, 2078, 1987, 1911, 1710, 1633, 1558, 1473, 1383, 1311,
1236, 1170, 1063, 1005, 971, 819, 738.
116 | E x p e r i m e n t a l S e c t i o n
HRMS (ESI): 548.0873, calcd. for C29H27NO3BrS: 548.0890.
Dibutyl 3,3'-{2-[1-(4-bromophenyl)-1-oxido-5-phenyl-1λ6,2-thiazin-3-yl]}-1,3-phenylene)-
(2E,2'E)-diacrylate (136d)
Heterocycle 136d represents a byproduct of the synthesis of
136c and was obtained as yellow gum (26 mg, 19%). 1H NMR (400 MHz, CDCl3): δ = 7.94–7.85 (m, 2H), 7.83 (d, J =
16.2 Hz, 2H), 7.74–7.67 (m, 4H), 7.59–7.53 (m, 2H), 7.47–7.39
(m, 4H), 6.40 (d, J = 15.9 Hz, 2H), 6.24 (s, 1H), 6.02 (s, 1H), 4.24–4.13 (m, 4H), 1.69–1.60 (m, 4H), 1.44–1.32 (m, 4H), 0.90 (t, J =
7.4 Hz, 6H). 13C NMR (151 MHz, CDCl3): δ = 166.6 (2C), 152.5, 150.3, 142.1 (2C), 140.8, 140.6, 138.0, 133.7
(2C), 132.2 (2C), 130.8 (2C), 129.9, 128.94 (2C), 128.87, 128.8, 127.8 (2C), 127.2 (2C), 120.4 (2C),
104.2, 92.9, 64.5 (2C), 30.7 (2C), 19.2 (2C), 13.7 (2C).
MS (EI): m/z (%) = 410 (15), 408 (21), 328 (11), 227 (35), 221 (49), 219 (58), 205 (100), 203 (97),
189 (38), 187 (31), 157 (25), 155 (30), 147 (40). MS (ESI): m/z (%) = 674.16 ([M+H]+).
IR (neat): = 3446, 3037, 2320, 2180, 1739, 1467, 1186, 580.
HRMS (ESI): 674.1554, calcd. for C36H37NO5BrS: 674.1570.
6.10 Synthesis of a 2,1-benzothiazine
N,2-Diphenyl- λ6-benzo[c][1,2]thiazin-2-imine (97)
[47]
2,1-Benzothiazine 97 was synthesized by variation of a procedure patent-
ed for sulfonamides by FENSOME and others.[113]
To a solution of sulfondiimine 61v (49 mg, 0.147 mmol) in anhydrous ace-
tonitrile (1 mL) was added cesium carbonate (100 mg, 0.306 mmol,
2.0 equiv), and the mixture was heated to 50 °C under an atmosphere of
argon for 4 h. After cooling, the reaction was quenched with saturated aqueous NH4Cl-solution
(10 mL). Then, the mixture was extracted with ethyl acetate (3 x 10 mL). The combined organic
layers were washed with saturated NaCl-solution (4 x 10 mL), dried with anhydrous magnesium
sulfate and the solvents were removed under reduced pressure. Purification by flash column
chromatography with n-pentane/ethyl acetate gradient elution (9/1 to 7/3) afforded the de-
sired product 97 as dark brown solid (40 mg, 86%).
m.p.: 133.5–134.5 °C. 1H NMR (400 MHz, CDCl3): δ = 8.16–8.11 (m, 2H), 7.64 (d, J = 9.4 Hz, 1H), 7.60–7.55 (m, 3H),
7.44–7.38 (m, 1H), 7.30–7.24 (m, 2H), 7.10–7.04 (m, 2H), 6.98–6.93 (m, 1H), 6.89–6.84 (m, 1H),
6.79–6.75 (m, 2H), 5.91 (d, J = 9.7 Hz, 1H). 13C NMR (400 MHz, CDCl3): δ = 146.9, 144.6, 142.9, 141.8, 132.7, 132.1, 129.7, 129.0 (2C), 128.9
(2C), 128.6 (2C), 124.0, 123.4 (2C), 121.8, 119.5, 115.4, 107.3.
The corresponding spectroscopic data matched that reported in the literature.[47]
E x p e r i m e n t a l S e c t i o n | 117
6.11 Syntheses of 1,2-benzothiazines
Ethyl 1,3-dimethylbenzo[e][1,2]thiazine-4-carboxylate 1-(N-phenylimine) (133a)
Following GP5, 1,2-benzothiazine 133a was obtained from NH-sulfondiimine
17 (50 mg, 0.217 mmol) and ethyl-2-diazo-3-oxobutanoate (143a, 41 mg,
0.261 mmol). Purification by flash column chromatography with a gradient of
n-pentane/ethyl acetate: 1/0 to 1/1 afforded the desired product as brown oil
(68 mg, 97%). 1H NMR (600 MHz, CDCl3): = 7.72–7.66 (m, 2H), 7.50–7.46 (m, 1H), 7.28–7.23
(m, 1H), 7.10–7.06 (m, 2H), 6.88–6.84 (m, 1H), 6.78–6.75 (m, 2H), 4.40–4.34
(m, 2H), 3.45 (s, 3H), 2.34 (s, 3H), 1.39 (t, J = 7.2 Hz, 3H). 13C NMR (150 MHz, CDCl3): = 168.8, 155.2, 144.1, 137.3, 133.1, 128.8 (2C), 126.1, 124.5,
124.3, 123.1 (2C), 121.9, 113.5, 103.5, 60.6, 48.8, 25.1, 14.3.
MS (EI): m/z (%) = 341 (3), 340 ([M+], 15), 234 (100), 206 (31), 91 (14).
IR: = 2978, 1701, 1573, 1476, 1351, 1261, 1070, 755.
HRMS (ESI): 341.1326, calcd. for C19H21N2O2S : 341.1318.
Methyl 1-methyl-3-ethylbenzo[e][1,2]thiazine-4-carboxylate-1-(N-phenylimine) (133b)
Following GP5, 1,2-benzothiazine 133b was obtained from NH-sulfondiimine 17
(67 mg, 0.291 mmol) and methyl-2-diazo-3-oxopentanoate (143b, 49 mg,
0.312 mmol). Purification by flash column chromatography with a gradient of n-
pentane/ethyl acetate: 1/0 to 1/1 afforded the desired product as light yellow
oil (98 mg, 99%). 1H NMR (600 MHz, CDCl3): = 7.65 (dd, J = 8.2, 1.0 Hz, 1H), 7.50 (d, J = 8.4 Hz,
1H), 7.43–7.39 (m, 1H), 7.22–7.18 (m, 1H), 7.00 (t, J = 8.2 Hz, 2H), 6.79 (t, J = 7.2
Hz, 1H), 6.71–6.68 (m, 2H), 3.82 (s, 3H), 3.41 (s, 3H), 2.54–2.43 (m, 2H), 1.16 (t, J = 7.4 Hz, 3H). 13C NMR (150 MHz, CDCl3): = 169.5, 159.9, 144.2, 137.3, 133.2, 128.8 (2C), 126.3, 124.7,
124.3, 123.3 (2C), 122.0, 113.7, 102.9, 51.7, 49.0, 31.4, 13.5.
MS (EI): m/z (%) = 341 ([M+H]+, 3), 235 (14), 234 (100), 91 (19), 64 (11).
IR (neat): = 2942, 1714, 1473, 1255, 1084, 761.
HRMS (ESI): 341.1323, calcd. for C19H21N2O2S : 341.1318.
Ethyl 1-methyl-3-ethylphenylbenzo[e][1,2]thiazine-4-carboxylate 1-(N-phenylimine) (133c)
Following GP5, 1,2-benzothiazine 133c was obtained from
NH-sulfondiimine 17 (50 mg, 0.216 mmol) and ethyl 2-diazo-3-oxo-5-
phenylpentanoate (143c, 64 mg, 0.261 mmol). Purifi-cation by flash
column chromatography with a gradient of n-pentane/ethyl acetate:
1/0 to 1/1 afforded the desired product as brown oil (89 mg, 95%). 1H NMR (600 MHz, CDCl3): = 7.71 (dd, J = 8.1 Hz, 1.2 Hz, 1H), 7.61–7.56 (m, 1H), 7.50–7.45 (m, 1H), 7.29–7.21 (m, 5H), 7.20–7.13 (m, 1H),
7.10–7.05 (m, 2H), 6.89–6.84 (m, 1H), 6.82–6.78 (m, 2H), 4.36 (t, J = 7.1 Hz, 2H), 3.39 (s, 3H),
3.06–2.86 (m, 4H), 1.37 (t, J = 7.1 Hz, 3H).
118 | E x p e r i m e n t a l S e c t i o n
13C NMR (150 MHz, CDCl3): = 168.8, 157.1, 144.2, 141.6, 137.3, 133.2, 128.8 (2C), 128.4 (2C),
128.3 (2C), 126.4, 125.8, 124.6, 124.4, 123.3 (2C), 122.0, 113.7, 103.9, 60.1, 48.9, 39.5, 35.0,
14.4.
MS (EI): m/z (%) = 431 (3), 430 ([M] +, 9), 325 (23), 324 (100), 284 (39), 251 (30), 250 (83), 226
(29), 91 (36).
IR (neat): = 2991, 1700, 1575, 1476, 1361, 1263, 1195, 1080, 867, 751.
HRMS (ESI): 431.1795, calcd. for C26H27N2O2S: 431.1788.
Ethyl 6-methoxy-1,3-dimethyl[e][1,2]thiazine-4-carboxylate 1-(N-phenylimine) (133d)
Following GP5, 1,2-benzothiazine 133d was obtained from NH-
sulfondiimine 106i (55 mg, 0.211 mmol) and ethyl-2-diazo-3-
oxobutanoate (143b, 40 mg, 0.253 mmol). Purification by flash column
chromatography with a gradient of n-pentane/ethyl acetate: 1/0 to 1/1
afforded the desired product as brown oil (72 mg, 92%). 1H NMR (600 MHz, CDCl3): = 7.62 (d, J = 8.7 Hz, 1H), 7.21 (d, J = 2.5 Hz,
1H), 7.11–7.06 (m, 2H), 6.88–6.85 (m, 1H), 6.81 (dd, J = 8.9, 2.5 Hz, 1H),
6.79–6.76 (m, 2H), 4.41–4.33 (m, 2H), 3.82 (s, 3H), 3.43 (s, 3H), 2.35 (s, 3H), 1.40 (t, J = 7.2 Hz,
3H). 13C NMR (150 MHz, CDCl3): = 169.0, 163.2, 156.6, 144.4, 139.7, 128.8 (2C), 126.7, 123.1 (2C),
121.8, 114.9, 106.4, 105.5, 103.0, 60.5, 55.4, 49.4, 25.5, 14.3.
MS (EI): m/z (%) = 371 (6), 370 (23), 297 (12), 265 (18), 264 (100), 236 (28).
IR (neat): = 2663, 2317, 2092, 1860, 1063.
HRMS (ESI): 371.1430, calcd. for C20H23N2O3S: 371.1424.
Ethyl 1,3,6-trimethyl[e][1,2]thiazine-4-carboxylate 1-(N-phenylimine) (133e)
Following GP5, 1,2-benzothiazine 133e was obtained from NH-
sulfondiimine 106d (50 mg, 0.205 mmol) and ethyl-2-diazo-3-
oxobutanoate (143b, 61 mg, 0.246 mmol). Purification by flash column
chromatography with a gradient of n-pentane/ethyl acetate: 1/0 to 1/1
afforded the desired product as brown oil (70 mg, 96%). 1H NMR (600 MHz, CDCl3): = 7.60 (d, J = 8.2 Hz, 1H), 7.45 (s, 1H), 7.11–7.04 (m, 3H), 6.88–6.83 (m, 1H), 6.79–6.76 (m, 2H), 4.41–4.35 (m, 2H),
3.44 (s, 3H), 2.36 (s, 3H), 2.32 (s, 3H), 1.40 (t, J = 7.2 Hz, 3H). 13C NMR (150 MHz, CDCl3): = 169.0, 154.9, 144.3, 144.0, 137.4, 128.8 (2C), 127.5, 124.6,
124.1, 123.1 (2C), 121.8, 110.7, 103.3, 60.6, 49.2, 25.0, 22.0, 14.3.
MS (EI): m/z (%) = 355 (4), 354 ([M]+, 17), 249 (14), 248 (100), 220 (19), 91 (9).
IR (neat): = 2980, 1698, 1574, 1472, 1258, 1074, 756.
HRMS (ESI): 355.1483, calcd. for C20H23N2O2S: 355.1475.
E x p e r i m e n t a l S e c t i o n | 119
Ethyl 1-cyclopropan-3-methylbenzo[e][1,2]thiazine-4-carboxylate 1-(N-phenylimine) (133f)
Following GP5, 1,2-benzothiazine 133f was obtained from NH-sulfondiimine
106j (15 mg, 0.041 mmol) and ethyl 2-diazo-3-oxo-3-phenylpropanoate (143b,
8 mg, 0.049 mmol). Purification by flash column chromatography with a gradi-
ent of n-pentane/ethyl acetate: 1/0 to 1/1 afforded the desired product as
brown oil (13 mg, 89%). 1H NMR (600 MHz, CDCl3): = 7.75 (dd, J = 8.2, 1.2 Hz, 1H), 7.64 (d, J = 8.4 Hz,
1H), 7.49–7.45 (m, 1H), 7.28–7.24 (m, 1H), 7.07–7.04 (m, 2H), 6.85–6.81 (m,
1H), 6.70–6.67 (m, 2H), 4.40–4.33 (m, 2H), 3.11–3.04 (m, 1H), 2.34 (s, 3H), 1.87–1.81 (m, 1H,
CH), 1.40 (t, J = 7.2 Hz, 3H), 1.28–1.23 (m, 1H), 1.20–1.15 (m, 1H), 1.08–1.03 (m, 1H). 13C NMR (150 MHz, CDCl3): = 169.1, 155.2, 144.1, 137.4, 132.9, 128.8 (2C), 126.1, 125.0,
124.1, 123.0 (2C), 121.7, 114.8, 103.4, 60.7, 37.8, 25.2, 14.3, 5.9, 4.8.
MS (EI): m/z (%) = 367 (5), 366 ([M]+, 24), 275 (33), 235 (13), 234 (100), 206 (29).
IR (neat): = 1698, 1573, 1476, 1265, 1198, 1062, 854, 761.
HRMS (ESI): 367.1482, calcd. for C21H23N2O2S: 367.1475.
1-Methyl-3-phenylbenzo[e][1,2]thiazine 1-(N-phenylimine) (133g)
Following GP5, 1,2-benzothiazine 133g was obtained from NH-
sulfondiimine 17 (23 mg, 0.1 mmol) and 2-oxo-2-phenylethyl methanesul-
fonate (144a, 30 mg, 0.14 mmol). Purification by flash column chromatog-
raphy with a gradient of n-pentane/ethyl acetate: 1/0 to 1/1 afforded the
desired product as brown solid (28 mg, 86%).
m.p.: 48–49 °C. 1H NMR (400 MHz, CDCl3): = 7.93–7.89 (m, 2H), 7.74 (d, J = 7.9 Hz, 1H),
7.47–7.28 (m, 4H), 7.29–7.23 (m, 2H), 7.05–6.99 (m, 2H), 6.83–6.78 (m, 1H), 6.75–6.70 (m, 2H),
6.48 (s, 1H), 3.65 (s, 3H). 13C NMR (100 MHz, CDCl3): = 149.2, 144.9, 140.0, 138.9, 132.8, 128.8 (2C), 128.8, 128.3 (2C),
126.5, 126.4, 126.4 (2C), 124.8, 123.0 (2C), 121.5, 114.8, 96.5, 50.1.
MS (EI): m/z (%) = 331 (2), 330 ([M]+, 6), 225 (16), 224 (100), 212 (29), 121 (13).
IR (neat): = 3033, 2304, 1580, 1472, 1253, 1106, 1036, 752, 690.
HRMS (ESI): 331.1270, calcd. for C21H19N2S: 331.1264.
1-Methyl-3-(4-bromophenyl)benzo[e][1,2]thiazine 1-(N-phenylimine) (133h)
Following GP5, 1,2-benzothiazine 133h was obtained from NH-
sulfondiimine 17 (50 mg, 0.217 mmol) and 2-(4-bromophenyl)-2-
oxoethyl methanesulfonate (144e, 89 mg, 0.304 mmol). Purification by
flash column chromatography with a gradient of n-pentane/ethyl ace-
tate: 1/0 to 1/1 afforded the desired product as yellow solid (83 mg,
94%).
m.p.: 98–99 °C.
120 | E x p e r i m e n t a l S e c t i o n
1H NMR (600 MHz, CDCl3): = 7.80–7.77 (m, 2H), 7.75 (d, J = 7.9 Hz, 1H), 7.53–7.50 (m, 2H),
7.47–7.44 (m, 1H), 7.30–7.25 (m, 2H), 7.04–7.00 (m, 2H), 6.83–6.79 (m, 1H), 6.71–6.68 (m, 2H),
6.45 (s, 1H), 3.65 (s, 3H). 13C NMR (150 MHz, CDCl3): = 147.9, 144.7, 139.7, 137.8, 132.9, 131.4 (2C), 128.8 (2C), 127.9
(2C), 126.7, 126.6, 124.8, 123.0 (2C), 122.9, 121.7, 115.0, 96.6, 50.1.
MS (EI): m/z (%) = 411 (1), 410 (6), 408 ([M]+, 6), 305 (13), 304 (82), 303 (16), 302 (81), 223 (16),
222 (17), 213 (16), 212 (100), 91 (63), 64 (21).
IR (neat): = 2089, 1581, 1477, 1251, 1106, 1015, 788, 754, 695.
HRMS (ESI): 409.0377, calcd. for C21H18BrN2S: 409.0369.
A p p e n d i x | 121
VI. APPENDIX
7 Crystal Structural Data
7.1 N-H-N',S-diphenyl-S-methyl sulfondiimine (17)
Figure 7-1: Crystal structure of standard NH-sulfondiimine 17.
Experimental Details
Data Collection
A colorless prism crystal of C13H14N2S having approximate dimensions of 0.400 x 0.150 x 0.100
mm was mounted on a glass fiber. All measurements were made on a Rigaku XtaLAB mini dif-
fractometer by using graphite monochromated Mo K radiation. The crystal-to-detector dis-
tance was 50.00 mm. Cell constants and an orientation matrix for data collection corresponded
to a C-centered monoclinic cell with dimensions: a = 17.717(10) Å, b = 5.828(3) Å, =
92.499(6)°, c = 23.802(13) Å, V = 2455(3) Å3. For Z = 8 and F.W. = 230.33, the calculated density
is 1.246 g/cm3. Based on the reflection conditions of: hkl: h+k = 2n and h0l: l = 2n packing con-
siderations, a statistical analysis of intensity distribution and the successful solution and re-
finement of the structure, the space group was determined to be: C2/c (#15). The data were
collected at a temperature of –100 + 1 °C to a maximum 2 value of 55.0°. A total of 540 oscilla-
tion images were collected. A sweep of data was done with use of oscillations from –60.0 to
120.0° in 1.0° steps. The exposure rate was 16.0 [sec./°]. The detector swing angle was 30.37°.
A second sweep was performed with oscillations from –60.0 to 120.0° in 1.0° steps. Readout
was performed in the 0.146 mm pixel mode.
Data Reduction
Of the 12553 reflections that were collected, 2815 were unique (Rint = 0.0438). Data were col-
lected and processed with use of CrystalClear (Rigaku). The linear absorption coefficient for
Mo K radiation is 2.376 cm–1.
122 | A p p e n d i x
A numerical absorption correction was applied, which resulted in transmission factors ranging
from 0.934 to 0.977. The data were corrected for Lorentz and polarization effects.
Structure Solution and Refinement
The structure was solved by direct methods and expanded by using Fourier techniques. The
non-hydrogen atoms were refined anisotropically. Hydrogen atoms were refined by using the
riding model. The final cycle of full-matrix least-squares refinement on F2 was based on 2815
observed reflections and 149 variable parameters and converged (largest parameter shift was
0.02 times its esd) with unweighted and weighted agreement factors of: R1 = ||Fo| – |Fc|| /
|Fo| = 0.0429 and wR2 = [ ( w (Fo2 – Fc
2) 2 )/ w (Fo2) 2]1/2 = 0.1069. The standard deviation of
an observation of unit weight was 0.99. Unit weights were used. The maximum and minimum
peaks on the final difference Fourier map corresponded to 0.25 and –0.35 e/Å3, respectively.
Neutral atom scattering factors were taken from Cromer and Waber. Anomalous dispersion
effects were included in Fcalc; the values for f' and f" were those of Creagh and McAuley. The
values for the mass attenuation coefficients are those of Creagh and Hubbell. All calculations
were performed with the CrystalStructure crystallographic software package except for refine-
ment, which was performed with SHELXL–97.
Crystal Data
Empirical Formula C13H14N2S
Formula Weight 230.33
Crystal Color, Habit colorless, prism
Crystal Dimensions 0.400 x 0.150 x 0.100 mm
Crystal System monoclinic
Lattice Type C-centered
Lattice Parameters a = 17.717(10) Å, b = 5.828(3) Å, c = 23.802(13) Å,
= 92.499(6)°, V = 2455(3) Å3
Space Group C2/c (#15)
Z value 8
Dcalc 1.246 g/cm3
F000 976.00
(Mo K) 2.376 cm–1
Intensity Measurements
Diffractometer XtaLAB mini
Radiation Mo K ( = 0.71075 Å), graphite monochromated
Voltage, Current 50 kV, 12 mA
Temperature –100.0 °C
Detector Aperture 75 mm (diameter)
Data Images 540 exposures
oscillation Range –60.0 – 120.0°
Exposure Rate 16.0 sec./°
A p p e n d i x | 123
Detector Swing Angle 30.37°
Detector Position 50.00 mm
Pixel Size 0.146 mm
2max 55.0°
No. of Reflections Measured Total 12553
Unique: 2815 (Rint = 0.0438)
Corrections Lorentz–polarization
Absorption (trans. factors: 0.934 – 0.977)
Structure Solution and Refinement
Structure Solution Direct Methods (SHELX97)
Refinement Full-matrix least-squares on F2
Function Minimized w (Fo2 – Fc
2)2
Least Squares Weight: w = 1/[2(Fo2) + (0.0440 . P)2 + 3.2078 . P] where P =
(Max(Fo2,0) + 2Fc
2)/3
2max cutoff 55.0°
Anomalous Dispersion: All non-hydrogen atoms
No. Observations (All reflections) 2815
No. Variables 149
Reflection/Parameter Ratio 18.89
Residuals:
R1 (I>2.00(I)) 0.0429
R (All reflections) 0.0558
wR2 (All reflections) 0.1069
Goodness of Fit Indicator 0.989
Max Shift/Error in Final Cycle 0.017
Maximum peak in Final Diff. Map 0.25 e/Å3
Minimum peak in Final Diff. Map –0.35 e/Å3
124 | A p p e n d i x
Table 7-1: Atomic coordinates and Biso/Beq.
atom x y z Beq
S1 0.79759(2) 0.58398(7) 0.32317(2) 1.730(11) N2 0.71936(8) 0.6992(3) 0.31022(6) 1.92(3) N7 0.81459(9) 0.3296(3) 0.31422(7) 2.31(3) C3 0.65354(10) 0.6111(3) 0.33394(7) 1.94(3) C4 0.82773(10) 0.6318(3) 0.39463(7) 1.88(3) C5 0.64833(12) 0.4109(4) 0.36578(8) 2.63(4) C6 0.85653(10) 0.7691(4) 0.28553(8) 2.32(4) C8 0.8957(2) 0.5175(5) 0.47850(9) 3.84(5) C9 0.51441(13) 0.4676(5) 0.37380(9) 3.69(5)
C10 0.80791(12) 0.8363(4) 0.41964(8) 2.61(4) C11 0.87122(12) 0.4701(4) 0.42361(8) 2.87(4) C12 0.58753(11) 0.7357(4) 0.32252(9) 3.07(4) C13 0.83273(13) 0.8780(4) 0.47491(9) 3.26(4) C14 0.87651(13) 0.7192(4) 0.50395(9) 3.50(5) C15 0.57883(13) 0.3421(4) 0.38511(9) 3.30(5) C16 0.51911(13) 0.6638(5) 0.34213(10) 3.99(5)
Beq = 8/3 2(U11(aa*)2 + U22(bb*)2 + U33(cc*)2 + 2U12(aa*bb*)
cos + 2U13(aa*cc*)cos + 2U23(bb*cc*)cos ).
Table 7-2: Atomic coordinates and Biso involving hydrogen atoms.
atom x y z Biso
H5 0.6922 0.3217 0.3743 3.16 H6A 0.8432 0.9290 0.2931 2.79 H6B 0.8496 0.7384 0.2452 2.79 H6C 0.9094 0.7423 0.2975 2.79 H8 0.9262 0.4088 0.4988 4.61 H9 0.4674 0.4197 0.3876 4.43
H10 0.7779 0.9461 0.3994 3.13 H11 0.8840 0.3294 0.4063 3.44 H12 0.5896 0.8723 0.3009 3.69 H13 0.8193 1.0171 0.4927 3.91 H14 0.8935 0.7491 0.5416 4.21 H15 0.5759 0.2053 0.4066 3.95 H16 0.4748 0.7511 0.3336 4.79 H7 0.8035 0.2992 0.2794 3.89
A p p e n d i x | 125
Table 7-3: Anisotropic displacement parameters.
atom U11 U22 U33 U12 U13 U23
S1 0.0250(3) 0.0223(3) 0.0182(3) 0.0019(2) –0.0016(2) 0.0002(2) N2 0.0248(8) 0.0262(8) 0.0217(8) 0.0034(6) –0.0014(6) 0.0039(6) N7 0.0364(10) 0.0262(8) 0.0245(9) 0.0059(7) –0.0050(7) –0.0042(7) C3 0.0262(10) 0.0292(10) 0.0182(9) –0.0022(7) –0.0000(7) –0.0039(7) C4 0.0256(9) 0.0253(9) 0.0205(9) –0.0035(7) 0.0003(7) –0.0006(7) C5 0.0390(12) 0.0336(11) 0.0277(10) –0.0008(9) 0.0037(8) 0.0013(8) C6 0.0286(10) 0.0334(10) 0.0264(10) 0.0016(8) 0.0034(8) 0.0043(8) C8 0.061(2) 0.055(2) 0.0285(12) 0.0087(12) –0.0139(11) 0.0036(10) C9 0.0331(12) 0.071(2) 0.0369(13) –0.0168(11) 0.0063(10) –0.0081(11)
C10 0.0395(12) 0.0288(10) 0.0308(10) 0.0003(9) –0.0001(9) –0.0047(8) C11 0.0487(13) 0.0336(11) 0.0259(10) 0.0071(9) –0.0069(9) –0.0013(8) C12 0.0307(11) 0.0453(13) 0.0410(12) 0.0054(9) 0.0039(9) 0.0088(10) C13 0.056(2) 0.0379(12) 0.0299(11) –0.0054(10) 0.0026(10) –0.0131(9) C14 0.053(2) 0.057(2) 0.0230(10) –0.0117(11) –0.0056(10) –0.0051(10) C15 0.053(2) 0.0421(12) 0.0304(11) –0.0160(11) 0.0083(10) 0.0004(9) C16 0.0277(12) 0.074(2) 0.050(2) 0.0030(11) 0.0041(10) 0.0078(13)
The general temperature factor expression: exp(–22(a*2U11h2+b*2U22k2+c*2U33l2+2a*b*U12hk +
2a*c*U13hl + 2b*c*U23kl)).
Table 7-4: Bond lengths (Å).
atom atom distance atom atom distance
S1 N2 1.5588(17) S1 N7 1.5293(18) S1 C4 1.782(2) S1 C6 1.772(2) N2 C3 1.414(3) C3 C5 1.396(3) C3 C12 1.393(3) C4 C10 1.384(3) C4 C11 1.383(3) C5 C15 1.392(4) C8 C11 1.386(3) C8 C14 1.372(4) C9 C15 1.372(4) C9 C16 1.374(4)
C10 C13 1.390(3) C12 C16 1.383(4) C13 C14 1.374(4)
Table 7-5: Bond lengths involving hydrogens (Å).
atom atom distance atom atom distance
N7 H7 0.861 C5 H5 0.950 C6 H6A 0.980 C6 H6B 0.980 C6 H6C 0.980 C8 H8 0.950 C9 H9 0.950 C10 H10 0.950
C11 H11 0.950 C12 H12 0.950 C13 H13 0.950 C14 H14 0.950 C15 H15 0.950 C16 H16 0.950
126 | A p p e n d i x
Table 7-6: Bond angles (°).
atom atom atom angle atom atom atom angle
N2 S1 N7 124.67(9) N2 S1 C4 110.37(9) N2 S1 C6 100.15(9) N7 S1 C4 103.42(9) N7 S1 C6 113.31(10) C4 S1 C6 103.22(9) S1 N2 C3 120.41(13) N2 C3 C5 126.53(17) N2 C3 C12 115.64(17) C5 C3 C12 117.80(18) S1 C4 C10 118.30(14) S1 C4 C11 120.45(14)
C10 C4 C11 121.24(17) C3 C5 C15 120.03(19) C11 C8 C14 120.9(3) C15 C9 C16 118.8(3) C4 C10 C13 118.81(19) C4 C11 C8 118.6(2) C3 C12 C16 121.1(2) C10 C13 C14 120.4(2) C8 C14 C13 120.0(2) C5 C15 C9 121.4(3) C9 C16 C12 120.8(3)
Table 7-7: Bond angles involving hydrogens (°).
atom atom atom angle atom atom atom angle
S1 N7 H7 107.2 C3 C5 H5 120.0 C15 C5 H5 120.0 S1 C6 H6A 109.5 S1 C6 H6B 109.5 S1 C6 H6C 109.5
H6A C6 H6B 109.5 H6A C6 H6C 109.5 H6B C6 H6C 109.5 C11 C8 H8 119.6 C14 C8 H8 119.6 C15 C9 H9 120.6 C16 C9 H9 120.6 C4 C10 H10 120.6 C13 C10 H10 120.6 C4 C11 H11 120.7 C8 C11 H11 120.7 C3 C12 H12 119.4
C16 C12 H12 119.4 C10 C13 H13 119.8 C14 C13 H13 119.8 C8 C14 H14 120.0 C13 C14 H14 120.0 C5 C15 H15 119.3 C9 C15 H15 119.3 C9 C16 H16 119.6
C12 C16 H16 119.6
Table 7-8: Possible hydrogen bonds.
Donor H Acceptor D...A D–H H...A D–H...A
N7 H7 S1 1.5293(18) 0.86 1.96 48.04 intramol. N7 H7 N21 3.091(3) 0.86 2.23 175.90
Symmetry Operators: (1) –X+1/2+1,Y+1/2–1,–Z+1/2.
A p p e n d i x | 127
Table 7-9: Torsion Angles (°).
atom1 atom2 atom3 atom4 angle
N7 S1 N2 C3 54.35(16) N2 S1 C4 C11 148.27(12) C6 S1 N2 C3 –177.87(11) N7 S1 C4 C11 12.84(15) C6 S1 C4 C11 –105.45(14) S1 N2 C3 C12 176.06(10) N2 C3 C12 C16 178.32(15) C12 C3 C5 C15 –0.2(3) S1 C4 C11 C8 177.76(12)
C11 C4 C10 C13 0.2(3) C11 C8 C14 C13 –0.3(4) C15 C9 C16 C12 –0.8(4) C4 C10 C13 C14 0.4(3)
C10 C13 C14 C8 –0.3(4) N2 S1 C4 C10 –33.15(15) C4 S1 N2 C3 –69.56(13) N7 S1 C4 C10 –168.59(12) C6 S1 C4 C10 73.12(14) S1 N2 C3 C5 –5.9(3) N2 C3 C5 C15 –178.16(15) C5 C3 C12 C16 0.1(3) S1 C4 C10 C13 –178.38(12)
C10 C4 C11 C8 –0.8(3) C3 C5 C15 C9 –0.3(3)
C14 C8 C11 C4 0.8(4) C16 C9 C15 C5 0.7(4) C3 C12 C16 C9 0.4(4)
Torsion angles having bond angles > 160° or < 20° are
excluded.
Table 7-10: Intramolecular contacts less than 3.60 Å.
atom atom distance atom atom distance
S1 C5 3.045(3) N2 C10 3.086(3) N7 C3 3.342(3) N7 C5 3.275(3) N7 C11 2.869(3) C3 C4 3.352(3) C3 C9 2.807(4) C3 C10 3.588(3) C4 C5 3.470(4) C4 C14 2.753(3) C5 C16 2.760(4) C6 C10 3.365(4) C8 C10 2.765(4) C11 C13 2.771(4)
C12 C15 2.743(4)
128 | A p p e n d i x
Table 7-10: continued.
atom atom distance atom atom distance
N2 N71 3.091(3) N7 N22 3.091(3) N7 C63 3.426(3) C3 C62 3.471(3) C6 N74 3.426(3) C6 C31 3.471(3)
C13 C135 3.543(4) Symmetry Operators: (1) –X+1/2+1,Y+1/2,–Z+1/2;
(2) –X+1/2+1,Y+1/2–1,–Z+1/2; (3) X,Y–1,Z; (4) X,Y+1,Z;
(5) –X+1/2+1,–Y+1/2+1,–Z+1.
Table 7-11: Intramolecular contacts less than 3.60 Å involving hydrogens.
atom atom distance atom atom distance
S1 H5 2.738 S1 H10 2.815 S1 H11 2.863 N2 H5 2.731 N2 H6A 2.617 N2 H6B 2.844 N2 H6C 3.403 N2 H10 2.731 N2 H12 2.512 N2 H7 2.880 N7 H5 2.648 N7 H6A 3.568 N7 H6B 2.975 N7 H6C 2.971 N7 H11 2.466 C3 H10 3.285 C3 H15 3.269 C3 H16 3.270 C3 H7 3.515 C4 H5 3.027 C4 H6A 2.995 C4 H6C 2.854 C4 H8 3.240 C4 H13 3.247 C4 H7 3.370 C5 H9 3.269 C5 H12 3.250 C5 H7 3.565 C6 H10 3.268 C6 H7 2.896 C8 H13 3.235 C9 H5 3.263 C9 H12 3.248 C10 H6A 3.149
C10 H6C 3.527 C10 H11 3.268 C10 H14 3.257 C11 H5 3.444 C11 H6C 3.487 C11 H10 3.268 C11 H14 3.255 C12 H5 3.253 C12 H9 3.257 C13 H8 3.234 C14 H10 3.258 C14 H11 3.257 C15 H16 3.223 C16 H15 3.221 H5 H11 3.450 H5 H15 2.332 H5 H7 3.064 H6A H10 2.829
H6B H7 2.818 H6C H11 3.577 H6C H7 3.210 H8 H11 2.340 H8 H14 2.316 H9 H15 2.321 H9 H16 2.327 H10 H13 2.346
H11 H7 3.287 H12 H16 2.319 H13 H14 2.321
A p p e n d i x | 129
Table 7-11: continued.
atom atom distance atom atom distance
S1 H71 3.219 N2 H6A2 3.085 N2 H6B2 3.210 N2 H71 2.232 N7 H6A3 2.446 N7 H6B2 3.222 N7 H103 3.106 N7 H122 3.295 N7 H164 2.892 C3 H6A2 3.208 C3 H6B2 2.874 C3 H145 3.216 C3 H71 3.039 C4 H96 3.001 C5 H6B2 2.827 C5 H135 3.417 C5 H145 3.077 C6 H96 3.181 C6 H122 3.265 C6 H77 3.230 C6 H71 3.175 C8 H88 3.206 C8 H96 3.468 C8 H133 3.239 C8 H159 3.049 C9 H6A10 3.527 C9 H6C10 2.861 C9 H1111 3.246 C9 H145 3.026 C10 H96 2.999
C10 H117 3.197 C11 H96 3.261 C11 H103 3.509 C11 H133 3.264 C11 H164 3.151 C12 H6A2 3.546 C12 H6B2 3.520 C12 H6B1 3.546 C12 H145 3.237 C12 H157 3.402 C12 H71 3.187 C13 H87 3.544 C13 H96 3.241 C13 H117 3.248 C14 H88 3.577 C14 H96 3.467 C14 H159 3.348 C15 H6B2 3.454 C15 H89 3.132 C15 H123 3.404 C15 H135 3.453 C15 H145 2.980 C16 H6A10 3.555 C16 H6C10 3.280 C16 H1111 3.051 C16 H145 3.152 H5 H6B2 2.946 H5 H103 2.715 H5 H123 3.597 H5 H135 3.318 H5 H145 3.582 H6A N21 3.085
H6A N77 2.446 H6A C31 3.208 H6A C96 3.527 H6A C121 3.546 H6A C166 3.555 H6A H96 3.078 H6A H166 3.114 H6A H77 2.288 H6A H71 3.149 H6B N21 3.210 H6B N71 3.222 H6B C31 2.874 H6B C51 2.827 H6B C122 3.546 H6B C121 3.520 H6B C151 3.454 H6B H51 2.946 H6B H122 2.649 H6B H77 3.475 H6B H71 2.773 H6C C96 2.861 H6C C166 3.280 H6C H96 2.556 H6C H122 3.184 H6C H164 3.192 H6C H166 3.284
130 | A p p e n d i x
Table 7-11: continued.
atom atom distance atom atom distance
H8 C88 3.206 H8 C133 3.544 H8 C148 3.577 H8 C159 3.132 H8 H88 2.820 H8 H133 2.966 H8 H148 3.499 H8 H159 2.351 H9 C410 3.001 H9 C610 3.181 H9 C810 3.468 H9 C1010 2.999 H9 C1110 3.261 H9 C1310 3.241 H9 C1410 3.467 H9 H6A10 3.078 H9 H6C10 2.556 H9 H1010 3.386 H9 H1111 2.853 H9 H145 3.503
H10 N77 3.106 H10 C117 3.509 H10 H57 2.715 H10 H96 3.386 H10 H117 2.920 H10 H145 3.585 H10 H77 3.565 H11 C94 3.246 H11 C103 3.197 H11 C133 3.248 H11 C164 3.051 H11 H94 2.853 H11 H103 2.920 H11 H133 3.011 H11 H164 2.455 H12 N71 3.295 H12 C61 3.265 H12 C157 3.404 H12 H57 3.597 H12 H6B1 2.649 H12 H6C1 3.184 H12 H157 3.195 H12 H1612 3.424 H12 H71 2.781 H13 C55 3.417 H13 C87 3.239 H13 C117 3.264 H13 C155 3.453 H13 H55 3.318 H13 H87 2.966 H13 H117 3.011 H13 H155 3.379 H14 C35 3.216 H14 C55 3.077 H14 C95 3.026 H14 C125 3.237 H14 C155 2.980 H14 C165 3.152 H14 H55 3.582 H14 H88 3.499 H14 H95 3.503 H14 H105 3.585 H14 H159 2.961 H14 H155 3.445 H15 C89 3.049 H15 C123 3.402 H15 C149 3.348 H15 H89 2.351 H15 H123 3.195 H15 H135 3.379 H15 H149 2.961 H15 H145 3.445 H16 N711 2.892 H16 C1111 3.151 H16 H6A10 3.114 H16 H6C10 3.284 H16 H6C11 3.192 H16 H1111 2.455 H16 H1212 3.424 H16 H711 3.257 H7 S12 3.219 H7 N22 2.232 H7 C32 3.039 H7 C63 3.230 H7 C62 3.175 H7 C122 3.187 H7 H6A3 2.288 H7 H6A2 3.149
A p p e n d i x | 131
Table 7-11: continued.
atom atom distance atom atom distance
H7 H6B3 3.475 H7 H6B2 2.773 H7 H103 3.565 H7 H122 2.781 H7 H164 3.257
Symmetry Operators: (1) –X+1/2+1,Y+1/2,–Z+1/2;
(2) –X+1/2+1,Y+1/2–1,–Z+1/2; (3) X,Y–1,Z;
(4) X+1/2,Y+1/2–1,Z; (5) –X+1/2+1,–Y+1/2+1,–Z+1;
(6) X+1/2,Y+1/2,Z; (7) X,Y+1,Z; (8) –X+2,–Y+1,–Z+1;
(9) –X+1/2+1,–Y+1/2,–Z+1; (10) X+1/2–1,Y+1/2–1,Z;
(11) X+1/2–1,Y+1/2,Z; (12) –X+1,Y,–Z+1/2.
7.2 1-Methyl-3-phenylbenzo[e][1,2]thiazine 1-(N-phenylimine) (133g)
Figure 7-2: Crystal structure of product 133g.
Experimental Details
Data Collection
A colorless prism crystal of C21H18N2S having approximate dimensions of 0.300 x 0.300 x 0.300
mm was mounted on a glass fiber. All measurements were made with use of a Rigaku XtaLAB
mini diffractometer with graphite monochromated Mo K radiation. The crystal-to-detector
distance was 50.01 mm. Cell constants and an orientation matrix for data collection corre-
sponded to a primitive monoclinic cell with dimensions: a = 11.447(2) Å, b = 9.5601(9) Å, =
109.141(5)°, c = 16.258(2) Å, V = 1680.8(4) Å3. For Z = 4 and F.W. = 330.45, the calculated densi-
ty is 1.306 g/cm3. The reflection conditions of: h0l: h+l = 2n and 0k0: k = 2n uniquely determine
the space group to be: P21/n (#14). The data were collected at a temperature of –100 + 1°C to a
maximum 2 value of 54.9°. A total of 540 oscillation images were collected. A sweep of data
was done with oscillations from –60.0 to 120.0° in 1.0° steps. The exposure rate was 8.0
[sec./°]. The detector swing angle was 30.33°. A second sweep was performed with oscilla-
tions from –60.0 to 120.0° in 1.0° steps. The exposure rate was 8.0 [sec./°]. The detector swing
angle was 30.33°. Another sweep was performed with oscillations from –60.0 to 120.0° in
1.0° steps. The exposure rate was 8.0 [sec./°].
132 | A p p e n d i x
The detector swing angle was 30.33°. The crystal-to-detector distance was 50.01 mm. Readout
was performed in the 0.146 mm pixel mode.
Data Reduction
Of the 17415 reflections that were collected, 3852 were unique (Rint = 0.0314). Data were col-
lected and processed with CrystalClear (Rigaku). The linear absorption coefficient , for Mo K
radiation is 1.960 cm–1. A numerical absorption correction was applied which resulted in trans-
mission factors ranging from 0.937 to 0.943. The data were corrected for Lorentz and polariza-
tion effects.
Structure Solution and Refinement
The structure was solved by direct methods and expanded with Fourier techniques. The non-
hydrogen atoms were refined anisotropically. Hydrogen atoms were refined with the riding
model. The final cycle of full-matrix least-squares refinement on F2 was based on 3852 observed
reflections and 217 variable parameters and converged (largest parameter shift was 0.00 times
its esd) with unweighted and weighted agreement factors of: R1 = ||Fo| – |Fc|| / |Fo| =
0.0428 and wR2 = [ (w (Fo2 – Fc2)2 )/ w (Fo2)2]1/2 = 0.1053. The standard deviation of an ob-
servation of unit weight was 1.05. Unit weights were used. The maximum and minimum peaks
on the final difference Fourier map corresponded to 0.27 and –0.38 e/Å3, respectively. Neutral
atom scattering factors were taken from Cromer and Waber. Anomalous dispersion effects
were included in Fcalc; the values for f' and f" were those of Creagh and McAuley. The values
for the mass attenuation coefficients are those of Creagh and Hubbell. All calculations were
performed with the CrystalStructure crystallographic software package except for refinement,
which was performed with SHELXL–97.
Crystal Data
Empirical Formula C21H18N2S
Formula Weight 330.45
Crystal Color, Habit colorless, prism
Crystal Dimensions 0.300 x 0.300 x 0.300 mm
Crystal System monoclinic
Lattice Type Primitive
Lattice Parameters a = 11.447(2) Å, b = 9.5601(9) Å,
c = 16.258(2) Å, = 109.141(5)°,
V = 1680.8(4) Å3
Space Group P21/n (#14)
Z value 4
Dcalc 1.306 g/cm3
F000 696.00
(Mo K) 1.960 cm–1
A p p e n d i x | 133
Intensity Measurements
Diffractometer XtaLAB mini
Radiation MoK ( = 0.71075 Å), graphite monochro-
mated
Voltage, Current 50 kV, 12 mA
Temperature –100.0 °C
Detector Aperture 75 mm (diameter)
Data Images 540 exposures
oscillation Range –60.0 – 120.0°
Exposure Rate 8.0 sec./°
Detector Swing Angle 30.33°
Detector Position 50.01 mm
Pixel Size 0.146 mm
2max 54.9°
No. of Reflections Measured Total 17415
Unique 3852 (Rint = 0.0314)
Corrections Lorentz–polarization
Absorption (trans. factors: 0.937 – 0.943)
Structure Solution and Refinement
Structure Solution Direct Methods (SHELX97)
Refinement Full-matrix least-squares on F2
Function Minimized w (Fo2 – Fc2)2
Least Squares Weights w = 1/ [2(Fo2) + (0.0408 . P)2 + 0.9406 . P]
where P = (Max(Fo2,0) + 2Fc
2)/3
2max cutoff 54.9°
Anomalous Dispersion All non-hydrogen atoms
No. Observations (All reflections) 3852
No. Variables 217
Reflection/Parameter Ratio 17.75
Residuals:
R1 (I>2.00(I)) 0.0428
R (All reflections) 0.0496
wR2 (All reflections) 0.1053
Goodness of Fit Indicator 1.049
Max Shift/Error in Final Cycle 0.001
Maximum peak in Final Diff. Map 0.27 e/Å3
Minimum peak in Final Diff. Map –0.38 e/Å3
134 | A p p e n d i x
Table 7-12: Atomic coordinates and Biso/Beq.
atom x y z Beq
S1 0.61558(3) 0.74136(4) 0.50003(2) 2.081(10) N2 0.66583(12) 0.8945(2) 0.50443(9) 2.24(3)
N25 0.63647(12) 0.6555(2) 0.58419(9) 2.56(3) C3 0.74992(13) 0.7130(2) 0.39026(10) 1.89(3) C4 0.6562(2) 0.6544(2) 0.41799(10) 2.07(3) C5 0.80606(13) 0.8452(2) 0.42289(10) 1.93(3) C6 0.76376(13) 0.9275(2) 0.47495(9) 1.88(3) C8 0.8171(2) 1.0674(2) 0.50500(10) 2.13(3) C9 0.5971(2) 0.5290(2) 0.38394(11) 2.71(3)
C10 0.7829(2) 0.6368(2) 0.32653(10) 2.34(3) C11 0.9765(2) 0.6558(2) 0.70929(12) 2.95(4) C12 0.7587(2) 0.5335(2) 0.71060(10) 2.51(3) C13 0.7554(2) 0.6283(2) 0.64443(10) 2.18(3) C14 0.7233(2) 0.5141(2) 0.29229(11) 2.81(3) C15 0.6298(2) 0.4603(2) 0.32041(12) 3.11(4) C16 0.4530(2) 0.7563(2) 0.46270(12) 2.91(4) C17 0.8478(2) 1.1602(2) 0.44959(12) 2.92(3) C18 0.8696(2) 0.4997(2) 0.77407(11) 2.85(3) C19 0.8665(2) 0.6892(2) 0.64434(11) 2.65(3) C20 0.9791(2) 0.5604(2) 0.77364(11) 2.91(4) C21 0.8329(2) 1.1091(2) 0.59005(12) 2.91(4) C22 0.9037(2) 1.3339(2) 0.5627(2) 3.99(5) C23 0.8902(2) 1.2940(2) 0.4785(2) 3.79(4) C24 0.8769(2) 1.2408(3) 0.6186(2) 3.73(4)
Beq = 8/3 2(U11(aa*)2 + U22(bb*)2 + U33(cc*)2 + 2U12(aa*bb*)
cos + 2U13(aa*cc*)cos + 2U23(bb*cc*)cos )
Table 7-13: Bond lengths (Å).
atom atom distance atom atom distance
S1 N2 1.5660(14) S1 N25 1.5452(16) S1 C4 1.7587(18) S1 C16 1.7638(17) N2 C6 1.392(3) N25 C13 1.4167(18) C3 C4 1.408(3) C3 C5 1.439(2) C3 C10 1.415(3) C4 C9 1.399(3) C5 C6 1.356(3) C6 C8 1.485(2) C8 C17 1.389(3) C8 C21 1.393(3) C9 C15 1.375(3) C10 C14 1.379(3)
C11 C19 1.389(3) C11 C20 1.381(3) C12 C13 1.398(3) C12 C18 1.386(3) C13 C19 1.399(3) C14 C15 1.393(3) C17 C23 1.394(3) C18 C20 1.384(3) C21 C24 1.378(3) C22 C23 1.381(4) C22 C24 1.376(4)
A p p e n d i x | 135
Table 7-14: Atomic coordinates and Biso involving hydrogen atoms.
atom x y z Biso
H5 0.8750 0.8759 0.4074 2.31 H9 0.5350 0.4916 0.4045 3.25
H10 0.8472 0.6708 0.3070 2.81 H11 1.0512 0.6994 0.7094 3.53 H12 0.6841 0.4918 0.7121 3.01 H14 0.7463 0.4656 0.2489 3.38 H15 0.5886 0.3764 0.2958 3.73
H16A 0.4264 0.8101 0.4084 3.49 H16B 0.4263 0.8044 0.5067 3.49 H16C 0.4160 0.6628 0.4523 3.49 H17 0.8398 1.1324 0.3919 3.50 H18 0.8703 0.4343 0.8182 3.42 H19 0.8667 0.7535 0.5998 3.18 H20 1.0551 0.5367 0.8170 3.49 H21 0.8132 1.0462 0.6288 3.49 H22 0.9314 1.4256 0.5821 4.79 H23 0.9099 1.3578 0.4402 4.54 H24 0.8888 1.2674 0.6771 4.48
Table 7-15: Bond angles (°).
atom atom atom angle atom atom atom angle
N2 S1 N25 120.53(8) N2 S1 C4 106.96(9) N2 S1 C16 105.68(8) N25 S1 C4 114.72(8)
N25 S1 C16 100.79(9) C4 S1 C16 106.80(8) S1 N2 C6 121.40(12) S1 N25 C13 122.99(13) C4 C3 C5 121.74(16) C4 C3 C10 116.35(14) C5 C3 C10 121.88(16) S1 C4 C3 118.28(12) S1 C4 C9 119.43(15) C3 C4 C9 122.28(17) C3 C5 C6 122.15(16) N2 C6 C5 125.21(14) N2 C6 C8 112.40(14) C5 C6 C8 122.37(16) C6 C8 C17 121.74(15) C6 C8 C21 119.38(16)
C17 C8 C21 118.85(16) C4 C9 C15 119.43(18) C3 C10 C14 121.17(18) C19 C11 C20 121.14(18)
C13 C12 C18 120.71(17) N25 C13 C12 115.36(15) N25 C13 C19 126.18(16) C12 C13 C19 118.44(14) C10 C14 C15 120.88(18) C9 C15 C14 119.85(17) C8 C17 C23 120.12(19) C12 C18 C20 120.57(17)
C11 C19 C13 120.04(17) C11 C20 C18 119.07(15) C8 C21 C24 120.68(19) C23 C22 C24 119.95(19)
C17 C23 C22 120.1(2) C21 C24 C22 120.3(2)
136 | A p p e n d i x
Table 7-16: Anisotropic displacement parameters.
atom U11 U22 U33 U12 U13 U23
S1 0.0185(2) 0.0336(3) 0.0267(2) –0.0016(2) 0.0070(2) 0.0046(2) N2 0.0248(7) 0.0311(7) 0.0312(7) –0.0012(6) 0.0118(6) –0.0010(6)
N25 0.0232(7) 0.0445(9) 0.0291(7) –0.0018(6) 0.0082(6) 0.0092(7) C3 0.0201(7) 0.0261(8) 0.0233(7) 0.0007(6) 0.0039(6) 0.0020(6) C4 0.0220(7) 0.0274(8) 0.0263(8) –0.0013(6) 0.0040(6) 0.0032(6) C5 0.0213(7) 0.0261(8) 0.0260(8) –0.0023(6) 0.0079(6) 0.0014(6) C6 0.0195(7) 0.0277(8) 0.0226(7) –0.0000(6) 0.0047(6) 0.0029(6) C8 0.0204(7) 0.0268(8) 0.0312(8) 0.0017(6) 0.0049(6) –0.0028(7) C9 0.0270(8) 0.0336(9) 0.0379(9) –0.0072(7) 0.0045(7) 0.0041(8)
C10 0.0283(8) 0.0311(9) 0.0287(8) 0.0025(7) 0.0081(7) –0.0011(7) C11 0.0258(8) 0.0442(10) 0.0372(10) –0.0026(8) 0.0040(7) –0.0016(8) C12 0.0330(9) 0.0372(9) 0.0258(8) –0.0015(7) 0.0108(7) –0.0003(7) C13 0.0261(8) 0.0328(9) 0.0232(8) –0.0002(7) 0.0072(6) –0.0010(7) C14 0.0362(9) 0.0337(9) 0.0322(9) 0.0031(8) 0.0047(7) –0.0058(7) C15 0.0389(10) 0.0300(9) 0.0406(10) –0.0071(8) 0.0013(8) –0.0060(8) C16 0.0202(8) 0.0504(11) 0.0387(10) –0.0004(7) 0.0080(7) 0.0106(8) C17 0.0390(10) 0.0301(9) 0.0363(9) –0.0043(8) 0.0049(8) 0.0016(7) C18 0.0432(10) 0.0396(10) 0.0233(8) 0.0046(8) 0.0079(7) 0.0032(7) C19 0.0259(8) 0.0399(10) 0.0330(9) –0.0019(7) 0.0070(7) 0.0056(8) C20 0.0325(9) 0.0454(11) 0.0260(8) 0.0062(8) 0.0005(7) –0.0037(8) C21 0.0279(9) 0.0450(10) 0.0378(10) –0.0010(8) 0.0108(7) –0.0118(8) C22 0.0327(10) 0.0307(10) 0.074(2) 0.0018(8) –0.0015(10) –0.0193(10) C23 0.0427(11) 0.0288(9) 0.0613(13) –0.0061(8) 0.0020(10) 0.0063(9) C24 0.0335(10) 0.0508(12) 0.0531(12) 0.0010(9) 0.0081(9) –0.0259(10)
The general temperature factor expression: exp(–22(a*2U11h2 + b*2U22k2 + c*2U33l2 +
2a*b*U12hk + 2a*c*U13hl + 2b*c*U23kl)).
Table 7-17: Bond lengths involving hydrogens (Å).
atom atom distance atom atom distance
C5 H5 0.950 C9 H9 0.950 C10 H10 0.950 C11 H11 0.950 C12 H12 0.950 C14 H14 0.950 C15 H15 0.950 C16 H16A 0.980 C16 H16B 0.980 C16 H16C 0.980 C17 H17 0.950 C18 H18 0.950 C19 H19 0.950 C20 H20 0.950 C21 H21 0.950 C22 H22 0.950 C23 H23 0.950 C24 H24 0.950
A p p e n d i x | 137
Table 7-17: continued.
atom atom atom angle atom atom atom angle
C3 C5 H5 118.9 C6 C5 H5 118.9 C4 C9 H9 120.3 C15 C9 H9 120.3 C3 C10 H10 119.4 C14 C10 H10 119.4
C19 C11 H11 119.4 C20 C11 H11 119.4 C13 C12 H12 119.6 C18 C12 H12 119.6 C10 C14 H14 119.6 C15 C14 H14 119.6 C9 C15 H15 120.1 C14 C15 H15 120.1 S1 C16 H16A 109.5 S1 C16 H16B 109.5 S1 C16 H16C 109.5 H16A C16 H16B 109.5
H16A C16 H16C 109.5 H16B C16 H16C 109.5 C8 C17 H17 119.9 C23 C17 H17 119.9
C12 C18 H18 119.7 C20 C18 H18 119.7 C11 C19 H19 120.0 C13 C19 H19 120.0 C11 C20 H20 120.5 C18 C20 H20 120.5 C8 C21 H21 119.7 C24 C21 H21 119.7
C23 C22 H22 120.0 C24 C22 H22 120.0 C17 C23 H23 120.0 C22 C23 H23 120.0 C21 C24 H24 119.8 C22 C24 H24 119.9
Table 7-18: Intramolecular contacts less than 3.60 Å.
atom atom distance atom atom distance
S1 C5 3.0176(18) S1 C19 3.0957(16) N2 C3 2.925(3) N2 C13 3.344(2) N2 C17 3.578(3) N2 C19 3.298(2) N2 C21 2.839(3) N25 C9 3.362(3) C3 C15 2.827(3) C4 C6 2.905(3) C4 C13 3.488(3) C4 C14 2.756(3) C5 C17 3.057(3) C6 C19 3.468(3) C8 C22 2.783(3) C9 C10 2.785(3) C9 C16 3.236(3) C11 C12 2.760(3)
C13 C20 2.804(2) C17 C24 2.766(3) C18 C19 2.772(3) C21 C23 2.761(4) N25 C91 3.382(3) C5 C232 3.574(3) C9 N251 3.382(3) C10 C222 3.458(3)
C16 C213 3.356(3) C16 C243 3.569(3) C18 C244 3.559(3) C21 C163 3.356(3) C22 C102 3.458(3) C23 C52 3.574(3) C24 C163 3.569(3) C24 C185 3.559(3)
Symmetry Operators: (1) –X+1,–Y+1,–Z+1; (2) –X+2,–Y+2, –Z+1; (3) –X+1,–Y+2,–Z+1; (4) X,Y–1,Z; (5) X,Y+1,Z.
138 | A p p e n d i x
Table 7-19: Torsion Angles (°).
atom1 atom2 atom3 atom4 angle
N2 S1 N25 C13 –57.20(16) N2 S1 C4 C3 17.85(12) C4 S1 N2 C6 –23.38(11)
N25 S1 C4 C3 –118.63(10) C4 S1 N25 C13 72.92(14)
C16 S1 C4 C3 130.63(11) S1 N2 C6 C5 16.11(18) S1 N25 C13 C12 –171.62(11) C4 C3 C5 C6 –6.9(2) C5 C3 C4 C9 177.13(12)
C10 C3 C4 S1 177.67(11) C5 C3 C10 C14 –176.26(12) S1 C4 C9 C15 –179.36(9) C3 C5 C6 N2 1.6(2) N2 C6 C8 C17 –136.53(13) C5 C6 C8 C17 42.0(2) C6 C8 C17 C23 175.89(13)
C17 C8 C21 C24 0.7(3) C4 C9 C15 C14 1.7(3)
C19 C11 C20 C18 –1.4(3) C13 C12 C18 C20 0.7(3) C18 C12 C13 C19 –0.7(3) C12 C13 C19 C11 –0.4(3) C8 C17 C23 C22 1.0(3) C8 C21 C24 C22 1.2(3)
C24 C22 C23 C17 0.9(3) N25 S1 N2 C6 110.05(12) N2 S1 C4 C9 –163.55(9) C16 S1 N2 C6 –136.92(11) N25 S1 C4 C9 59.98(12) C16 S1 N25 C13 –172.78(12) C16 S1 C4 C9 –50.77(13) S1 N2 C6 C8 –165.45(8) S1 N25 C13 C19 10.0(3) C5 C3 C4 S1 –4.31(19) C4 C3 C10 C14 1.8(2)
C10 C3 C4 C9 –0.90(19) C10 C3 C5 C6 171.02(12) C3 C4 C9 C15 –0.8(2) C3 C5 C6 C8 –176.69(11) N2 C6 C8 C21 41.16(17) C5 C6 C8 C21 –140.34(14) C6 C8 C21 C24 –177.01(13)
C21 C8 C17 C23 –1.8(3)
A p p e n d i x | 139
Table 7-19: continued.
atom1 atom2 atom3 atom4 angle
C3 C10 C14 C15 –0.9(3) C20 C11 C19 C13 1.4(3) C18 C12 C13 N25 –179.21(15) N25 C13 C19 C11 177.98(15) C10 C14 C15 C9 –0.9(3) C12 C18 C20 C11 0.3(3) C23 C22 C24 C21 –2.0(3)
Torsion angles having bond angles > 160° or < 20° are
excluded.
Table 7-20: Intramolecular contacts less than 3.60 Å involving hydrogens.
atom atom distance atom atom distance
S1 H9 2.833 S1 H19 2.802 N2 H5 3.275 N2 H16A 2.792 N2 H16B 2.886 N2 H16C 3.495 N2 H19 2.678 N2 H21 2.608
N25 H9 3.180 N25 H12 2.516 N25 H16A 3.410 N25 H16B 2.722 N25 H16C 2.725 N25 H19 2.729 C3 H9 3.311 C3 H14 3.288 C3 H19 3.250 C4 H5 3.327 C4 H10 3.263 C4 H15 3.257 C4 H16A 2.981 C4 H16C 2.981 C4 H19 3.282 C5 H10 2.672 C5 H17 2.840 C5 H19 2.866 C6 H17 2.681 C6 H19 2.590 C6 H21 2.634 C8 H5 2.645 C8 H19 3.336 C8 H23 3.268 C8 H24 3.263 C9 H14 3.249 C9 H16A 3.421 C9 H16C 2.946
C10 H5 2.676 C10 H15 3.265 C11 H18 3.242 C12 H19 3.265 C12 H20 3.265 C13 H11 3.270 C13 H18 3.274 C14 H9 3.256 C15 H10 3.263 C16 H9 2.960 C17 H5 2.844 C17 H21 3.254 C17 H22 3.262 C18 H11 3.241 C19 H12 3.263 C19 H20 3.270 C19 H21 3.461 C20 H12 3.260 C20 H19 3.266 C21 H17 3.256 C21 H19 3.419 C21 H22 3.246 C22 H17 3.260 C22 H21 3.243 C23 H24 3.244 C24 H23 3.244
140 | A p p e n d i x
Table 7-20: continued.
atom atom distance atom atom distance
H5 H10 2.505 H5 H17 2.484 H5 H19 3.370 H9 H15 2.330 H9 H16A 3.297 H9 H16C 2.415
H10 H14 2.314 H11 H19 2.331 H11 H20 2.329 H12 H18 2.327 H14 H15 2.338 H17 H23 2.343 H18 H20 2.337 H19 H21 2.935 H21 H24 2.321 H22 H23 2.330 H22 H24 2.325 H22 H24 2.325 C5 H203 3.041 C6 H16B4 3.438 C6 H203 2.897 C8 H56 3.384 C8 H16B4 2.992 C9 H121 3.089 C9 H16C1 3.277 C10 H113 3.131
C10 H145 3.351 C10 H177 3.364 C10 H226 3.173 C10 H238 3.299 C11 H149 3.235 C11 H16A10 3.483 C11 H228 2.948 C11 H236 3.112 C12 H91 3.276 C12 H16A10 3.495 C12 H16C1 3.325 C12 H2111 2.986 C12 H228 3.471 C12 H248 3.086 C13 H91 3.356 C13 H16C1 3.470 C13 H182 3.402 C13 H228 3.191 C14 H57 3.341 C14 H119 3.299 C14 H113 3.385 C14 H177 3.058 C14 H209 3.575 C14 H238 3.035 C15 H107 3.519 C15 H121 3.485 C15 H238 3.307 C16 H91 3.178 C16 H203 3.565 C16 H214 3.477 C17 H56 3.279 C17 H116 3.434 C17 H145 3.572 C17 H16B4 3.453 C18 H16A10 2.751 C18 H2111 3.039 C18 H228 3.492 C18 H248 2.774 C19 H228 2.902 C19 H236 3.309 C20 H109 3.501 C20 H149 3.291 C20 H16A10 2.750 C20 H228 3.247 C20 H248 3.212 C21 H56 3.333 C21 H122 3.472 C21 H16A4 3.076 C21 H16B4 2.984 C21 H16C4 3.473 C21 H182 3.565 C22 H56 3.142 C22 H106 2.942 C22 H16C4 3.587 C23 H56 3.167 C23 H116 3.337 C23 H196 3.449 C24 H56 3.206 C24 H106 3.106 C24 H1510 3.294 C24 H16A4 3.389 C24 H16B4 3.427
A p p e n d i x | 141
Table 7-20: continued.
atom atom distance atom atom distance
C24 H16C4 3.299 H5 C86 3.384 H5 C145 3.341 H5 C176 3.279 H5 C216 3.333 H5 C226 3.142 H5 C236 3.167 H5 C246 3.206 H5 H145 2.610 H5 H155 3.463 H5 H203 3.569 H9 S11 3.477 H9 N251 2.470 H9 C121 3.276 H9 C131 3.356 H9 C161 3.178 H9 H91 3.454 H9 H121 2.606 H9 H16B1 3.140 H9 H16C1 2.656
H10 C155 3.519 H10 C209 3.501 H10 C226 2.942 H10 C246 3.106 H10 H113 3.467 H10 H145 3.047 H10 H155 2.828 H10 H177 3.261 H10 H209 3.275 H10 H226 2.743 H10 H246 3.006 H11 C310 3.184 H11 C410 3.496 H11 C1010 3.131 H11 C149 3.299 H11 C1410 3.385 H11 C176 3.434 H11 C236 3.337 H11 H1010 3.467 H11 H149 2.701 H11 H176 2.865 H11 H228 3.340 H11 H236 2.670 H12 C91 3.089 H12 C151 3.485 H12 C2111 3.472 H12 H91 2.606 H12 H151 3.330 H12 H16A1 3.484 H12 H16C1 2.937 H12 H2111 2.629 H12 H248 3.361 H12 H2411 3.445 H14 C37 3.320 H14 C57 2.897 H14 C107 3.351 H14 C119 3.235 H14 C177 3.572 H14 C209 3.291 H14 H57 2.610 H14 H107 3.047 H14 H119 2.701 H14 H177 2.697 H14 H209 2.813 H14 H238 3.228 H15 C243 3.294 H15 H57 3.463 H15 H107 2.828 H15 H121 3.330 H15 H213 3.499 H15 H243 2.820 H16A N24 3.476
H16A C113 3.483 H16A C123 3.495 H16A C183 2.751 H16A C203 2.750 H16A C214 3.076 H16A C244 3.389 H16A H121 3.484 H16A H183 2.814 H16A H203 2.821 H16A H214 2.948 H16A H244 3.494 H16B N24 3.051 H16B C64 3.438 H16B C84 2.992 H16B C174 3.453 H16B C214 2.984
142 | A p p e n d i x
Table 7-20: continued.
atom atom distance atom atom distance
H16B C244 3.427 H16B H91 3.140 H16B H182 3.273 H16B H202 3.576 H16B H214 3.233 H16C N251 3.121 H16C C91 3.277 H16C C121 3.325 H16C C131 3.470 H16C C214 3.473 H16C C224 3.587 H16C C244 3.299 H16C H91 2.656 H16C H121 2.937 H16C H244 3.496 H17 C105 3.364 H17 C145 3.058 H17 H105 3.261 H17 H116 2.865 H17 H145 2.697 H17 H196 3.493 H17 H203 3.480 H18 S111 3.442 H18 N211 3.068 H18 N2511 3.115 H18 C1311 3.402 H18 C2111 3.565 H18 H16A10 2.814 H21 H1510 3.499 H21 H16A4 2.948 H21 H16B4 3.233 H21 H182 2.737 H22 C106 3.173 H22 C1112 2.948 H22 C1212 3.471 H22 C1312 3.191 H22 C1812 3.492 H22 C1912 2.902 H22 C2012 3.247 H22 H106 2.743 H22 H1112 3.340 H22 H1912 3.256 H22 H2313 2.855 H23 C1012 3.299 H23 C116 3.112 H23 C1412 3.035 H23 C1512 3.307 H23 C196 3.309 H23 H116 2.670 H23 H1412 3.228 H23 H196 3.031 H23 H2213 2.855 H23 H2313 3.578 H24 C1212 3.086 H24 C1812 2.774 H24 C2012 3.212 H24 H106 3.006 H24 H1212 3.361 H24 H122 3.445 H24 H1510 2.820 H24 H16A4 3.494 H24 H16C4 3.496 H24 H1812 2.859 H24 H2012 3.549
Symmetry Operators: (1) –X+1,–Y+1,–Z+1; (2) –X+1/2+1,
Y+1/2,–Z+1/2+1; (3) X+1/2–1,Y+1/2+1,Z+1/2–1;
(4) –X+1,–Y+2,–Z+1; (5) –X+1/2+1,Y+1/2,–Z+1/2;
(6) –X+2,–Y+2,–Z+1; (7) –X+1/2+1,Y+1/2–1,–Z+1/2;
(8) X,Y–1,Z; (9) –X+2,–Y+1,–Z+1; (10) X+1/2,–Y+1/2+1,Z
+1/2; (11) –X+1/2+1,Y+1/2–1,–Z+1/2+1; (12) X,Y+1,Z;
(13) –X+2,–Y+3,–Z+1.
A p p e n d i x | 143
8 Abbreviation List
Ac acetate
acac acetylacetonate
acr addition–condensation reaction
AmOH amyl alcohol
AMPK adenosine monophosphate–activated protein kinase
Ar aryl
aq. aqueous
BASF Badis he A ili - und Soda-Fa rik
BINAP 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl
Bn benzyl
Boc tert-butyloxycarbonyl
BrettPhos 2-(dicyclohexylphosphino)-3,6-dimethoxy- ′, ′, ′-triisopropyl- , ′-biphenyl
Bu butyl
CAN cerium ammonium nitrate
cat. or [] catalyst
calc, calcd. calculated
Cbz carboxybenzyl
CHN elemental analysis
chloramine-T N-chloro 4-methylbenzenesulfonamide
CI chemical ionization
cond. reaction conditions
Cp* pentamethylcyclopentadienyl group
d doublet
2D two-dimensional
3D three-dimensional
DABCO 1,4-diazabicyclo[2.2.2]octane
dba dibenzylideneacetone
DCC dicyclohexylcarbodiimide
DCE 1,2-dichloroethane
DCM dichloromethane
DIPEA N,N-diisopropylethylamine
DMAP 4-(dimethylamino)pyridine
DME dimethoxyethane
DMEDA N,N'-dimethylethylenediamine
DMF dimethylformamide
DMSO dimethylsulfoxide
DPH O-(2,4-dinitrophenyl)hydroxylamine
dppf 1,1'-bis(diphenylphosphino)ferrocene
144 | A p p e n d i x
d.r. diastereomeric ratio
DTBP di-tert-butylhypochlorite
E element
(E) E-configuration
E+ electrophile
ECD electronic circular dichroism spectroscopy
ee enantiomeric excess
EI electron ionization
EN electronegativity
ESI electrospray ionization
Et ethyl
equiv equivalent
FG functional group
FT–IR Fourier transform infrared spectroscopy
F.W. molecular weight
GP general procedure
GC/MS gas chromatography mass spectrometry
h hour
het, hetero heterocycle/heterocyclic
HOBt 1-hydroxybenzotriazole
HOSA hydroxylamine-O-sulfonic acid
HPLC high-performance liquid chromatography
HRMS high-resolution mass spectrometry
i iso
IR infrared spectroscopy
(l) liquid
LDA lithium diisopropylamide
M metal
m multiplet
m meta
MAPK mitogen–activated protein kinase
mCPBA meta-chloroperbenzoic acid
Me methyl
MMP matrix metalloproteinase
MNK MAPK interacting protein kinase
m.p. melting point
mRNA messenger ribonucleic acid
Ms mesyl
MS molecular sieves
MS mass spectrometry
MSH O-mesitylenesulfonylhydroxylamine
A p p e n d i x | 145
NBS N-bromosuccinimide
NCS N-chlorosuccinimide
NMR nuclear magnetic resonance
Ns nosyl
o ortho
p para
P project
PG protecting group
Ph phenyl
PMP para-methoxyphenyl
ppm parts per million
Pr propyl
prim primary
PTSA para-toluenesulfonic acid
Py or pyr pyridyl
q quartet
quant. quantitative
(R) R-configuration
R residue
rac racemic
reflux refluxing
r.t. room temperature
RuPhos 2-dicyclohexylphoshpino-2',6'-diisopropoxybiphenyl
s singlet
(S) S-configuration
sat. saturated
sec secondary
SFC supercritical fluid chromatography
t, tert tertiary
t triplet
t time
T temperature
TBAF tetrabutylammonium fluoride
TCI tokyo chemical industry
Tf triflyl
TFA trifluoroacetic acid
TFAA trifluoroacetic anhydride
THF tetrahydrofurane
TLC thin layer chromatography
TMS tetramethylsilyl residue, tetramethylsilane
TMEDA N,N,N',N'-tetramethylethylenediamine
146 | A p p e n d i x
Tol tolyl
Ts tosyl
UV ultraviolet
X residue
X-ray X-radiation
Y residue
(Z) Z-configuration
A p p e n d i x | 147
9 Acknowledgement
An dieser Stelle möchte ich mich bei allen Menschen bedanken, die mich in den letzten Jahren
begleitet und unterstützt haben.
Im Besonderen danke ich meinem Doktorvater und Mentor Prof. Dr. Carsten Bolm. Ich weiß es
sehr zu schätzen, dass Sie trotz Ihrer vielfältigen Verpflichtungen stets die Zeit gefunden haben
mich zu unterstützen und zu fördern. Sie ermöglichten mir die Teilnahme an dem Graduierten-
kolleg „“eleCa , de da it er u de e Fors hu gsaufe thalt a der Osaka U i ersit u d die Teilnahme an zahlreichen Konferenzen im In- und Ausland und die dortige Präsentation meiner
Forschungsergebnisse. Ich danke Ihnen für das Vertrauen, das Sie in mich gesetzt haben, be-
sonders für die Freiheiten in der Thema- und Projekteauswahl und deren Umsetzung. Ich konn-
te mir Ihrer Unterstützung stets sicher sein und dafür bin ich sehr dankbar.
I furthermore want to thank Prof. Dr. Masahiro Miura and Prof. Dr. Tetsuya Satoh for the warm
welcome in Osaka, their support during my stay, and the insights into the chemistry of C-H
bond functionalization. I am grateful to Yuki Yokoyama and Yuto Unoh for the collaborative
work in Osaka, and to Kazutaka Takamatsu as well for the help in the lab and daily life. I wish to
acknowledge Yuto Unoh for the measurement of crystal structures in Osaka (chapter 7), his
collaborative work in Aachen (chapter 4.1.5), and for helpful discussions. I wish to thank all Jap-
anese collaborators for insights into the Japanese working and living style and the Japanese
way of achieving one’s aim. うもありが うございます!
Zudem möchte ich mich herzlich bei Prof. Dr. Albrecht Salzer für seine Unterstützung im Rah-
e o „“eleCa , darü er hi aus, u d eso ders ei der Be er u g für die Bosto -Reise be-
danken.
Ein herzliches Dankeschön geht auch an alle, die in den verschiedenen Projekten in Aachen mit-
gewirkt haben: Jan-Hendrik Schöbel im Rahmen seiner Bachelor- (Kapitel 3.1.3.1) und einer
Forschungsarbeit (Kapitel 4.2), Hannah Schumacher als Forschungsstudentin und HiWi, Marina
Bohlem für die Mitarbeit am N-Alkylierungsprojekt (Kapitel 2.2.3) und Annika Bär für ihre her-
vorragende und zuverlässige Arbeit als Auszubildende in meinem Labor.
Des Weiteren danke ich Dr. Ingo Schiffers, Ingrid Voss, Daniela Gorissen und Gwenda Golm für
ihre Unterstützung in administrativen Angelegenheiten. Ich danke allen Mitarbeitern der analy-
tischen und administrativen Abteilungen des Instituts und insbesondere Dr. Christoph Räuber
für wertvolle Diskussionen bei der Auswertung der 2D-NMR-Spektren der Thiazine.
Ich danke Dr. Christine M. M. Hendriks für die Korrektur dieser Arbeit, für viele wertvolle Dis-
kussionen, und besonders für die Zusammenarbeit im Rahmen des N-Alkylierungsprojektes
(Kapitel 2.2).
Ich danke Susi Grünebaum (Danke für die tollen Doktorhüte!) und Pierre Winandy für die Syn-
these von Sulfondiimin-Precursorn, und ihnen und Dr. Christian Bohnen für die Gabe von NH-
Sulfoximinen.
I deeply thank my labmates Dr. Xiaoyun Chen (Thank you for every single conversation I could
enjoy with you!) and Dr. Shunxi Dong for a great time in lab 1.03. Thank you for the insights into
the Chinese community. 谢谢!
148 | A p p e n d i x
Particularly, I am grateful to Dr. Daniel Priebbenow for his help, the discussions, and his support
during our time together in AK Bolm. (Dan, my English wouldn’t be the same without you!)
Ich danke weiterhin allen ehemaligen und jetzigen Mitarbeitern des AK Bolm, besonders den
offee or er - und den Mensa- beziehungsweise Pontstraße-Gängern, u d alle „“eleCat’s für den ständigen Austausch von Forschungsergebnissen, viele Diskussionen, die tolle Atmo-
sphäre und viele gemeinsame Aktivitäten. Besonderer Dank gilt hierbei Dr. Hannah Baars, Dr.
Christian Bohnen, Dr. Julien Engel, Dr. Daniel Hack, Dr. Christine M. M. Hendriks, Steffen Mader,
Dr. Anne-Dorothee Steinkamp und Jens Reball, die meine Zeit im AK Bolm und bei „“eleCa zu einer ganz besonderen gemacht haben.
Ganz besonders danke ich meinen Freunden Alexander und Gian und meiner besten Freundin
Marie, der Liebe meines Lebens Tobias, meiner Schwester Sara und meinen Eltern für ihre nie
endende Unterstützung in allen Lebenslagen, ihre Freundschaft und dafür, dass sie mich so lie-
ben wie ich bin.
A p p e n d i x | 149
10 References
[1] M. Halka, B. Nordstrom, Periodic Table of the Elements: Nonmetals, 1 ed., Facts on File, New York, 2010.
[2] D. E. Newton, Chemical Elements, 2 ed., Gale, Cengage Learning, Farmington Hills, 2010. [3] J. Drabowicz, J. Lewkowski, W. Kudelska, T. Girek, Sci. Synth. 2008, 39, 123-185. [4] The number resulted from chemical substructure substance searches performed with Scifinder®
on 05.12.2016. Heterocyclic derivatives are included in the count. [5] a) S. Nakamura, T. Toru, Sci. Synth. 2007, 31a, 833-877; b) R. Sato, T. Kimura, Sci. Synth. 2007,
39, 745-750. [6] A. Kalir, H. H. Kalir, in Sulphur-Containing Functional Groups (Eds.: S. Patai, Z. Rappoport), John
Wiley & Sons, Inc., Chichester, UK, 1993, pp 957-973. [7] a) C. Worch, A. C. Mayer, C. Bolm, in Organosulfur Chemistry in Asymmetric Synthesis (Eds.: T.
Toru, C. Bolm), Wiley-VCH, Weinheim, 2008, pp 209-229; b) C. Bolm, in Asymmetric Synthesis
with Chemical and Biological Methods (Eds.: D. Enders, K.-E. Jaeger), Wiley-VCH, Weinheim, 2007, pp 149-176; c) M. Reggelin, C. Zur, Synthesis 2000, 1-64; d) H.-J. Gais, Heteroatom Chem.
2007, 18, 472-481. [8] a) U. Lücking, Angew. Chem. 2013, 125, 9570-9580; Angew. Chem. Int. Ed. 2013, 52, 9399-9408;
b) M. Frings, C. Bolm, A. Blum, C. Gnamm, Eur. J. Med. Chem. 2017, 126, 225-245. [9] R. A. Bohmann, Master thesis, RWTH Aachen University, 2012. [10] M. Haake, in Topics in Sulfur Chemistry, Vol. 1 (Ed.: A. Senning), Thieme, Stuttgart, 1976, pp 185-
215. [11] R. Sato, N. Saito, M. Saito, Chem. Lett. 1983, 1603-1606. [12] R. Sato, S. Chiba, N. Saito, M. Sato, M. Saito, Phosphorus Sulfur Silicon Relat. Elem. 1984, 19,
205-211. [13] K. Akutagawa, N. Furukawa, S. Oae, Phosphorus Sulfur Silicon Relat. Elem. 1984, 19, 369-374. [14] N. C. Webb, R. A. Gloss, Tetrahedron Lett. 1967, 1043-1047. [15] H. Oberhammer, W. Zeil, Z. Naturforsch. 1969, 24a, 1612-1616. [16] T. Yoshimura, H. Ishikawa, T. Fujie, E. Takata, R. Miyatake, H. Kita, E. Tsukurimichi, Synthesis
2008, 1835-1840. [17] J. A. Cogliano, G. L. Braude, J. Org. Chem. 1964, 29, 1397-1400. [18] R. Appel, H. W. Fehlhaber, D. Hänssgen, R. Schöllhorn, Chem. Ber. 1966, 99, 3108-3117. [19] R. G. Laughlin, W. Yellin, J. Am. Chem. Soc. 1967, 89, 2435-2443. [20] M. Haake, Tetrahedron Lett. 1970, 11, 4449-4450. [21] N. Furukawa, K. Akutagawa, S. Oae, Phosphorus Sulfur Silicon Relat. Elem. 1984, 20, 1-14. [22] T. Yoshimura, H. Kita, K. Takeuchi, E. Takata, K. Hasegawa, C. Shimasaki, E. Tsukurimichi, Chem.
Lett. 1992, 21, 1433-1436. [23] V. Bizet, C. M. M. Hendriks, C. Bolm, Chem. Soc. Rev. 2015, 44, 3378-3390. [24] R. Appel, J. Kohnke, Chem. Ber. 1971, 104, 2023-2024. [25] N. Furukawa, T. Omata, S. Oae, J. Chem. Soc., Chem. Commun. 1973, 590-591. [26] N. Furukawa, K. Akutagawa, T. Yoshimura, T. Akasaka, S. Oae, Synthesis 1979, 289-290. [27] B. W. Christensen, A. Kjær, J. Chem. Soc., Chem. Commun. 1975, 784. [28] a) B. A. Shainyan, L. L. Tolstikova, Chem. Rev. 2013, 113, 699-733; b) R. Y. Gavrilova, N. V.
Kondratenko, V. I. Popov, L. M. Yagupolskii, Zh. Org. Khim. 1989, 25, 1118-1119. [29] G. Georg, M. Haake, Synthesis 1983, 919. [30] M. Candy, C. Guyon, S. Mersmann, J.-R. Chen, C. Bolm, Angew. Chem. 2012, 124, 4516-4519;
Angew. Chem. Int. Ed. 2012, 51, 4440-4443. [31] S. Mersmann, Doctoral thesis, RWTH Aachen University, 2013. [32] M. Haake, in Organic Sulfur Compounds, Vol. E 11, 4 ed. (Ed.: D. Klamann), Thieme, Stuttgart,
1985, pp 1321-1326. [33] R. Appel, D. Hänssgen, Angew. Chem. 1967, 79, 96; Angew. Chem. Int. Ed. Engl. 1967, 6, 91.
150 | A p p e n d i x
[34] R. Appel, G. Vollmer, Chem. Ber. 1970, 103, 2555-2561. [35] a) R. Appel, B. Ross, Chem. Ber. 1969, 102, 1020-1027; b) R. Appel, B. Ross, Chem. Ber. 1969,
102, 3769-3774. [36] O. P. Shitov, A. P. Seleznev, V. A. Tartakovskii, Bull. Acad. Sci. USSR, Div. Chem. Sci. 1991, 40,
1115-1116. [37] T. Yoshimura, T. Fujie, T. Fujii, Tetrahedron Lett. 2007, 48, 427-430. [38] J. R. Dehli, C. Bolm, Synthesis 2005, 1058-1060. [39] W. Ried, R. Pauli, Liebigs Ann. Chem. 1986, 384-388. [40] S. Dong, M. Frings, H. Cheng, J. Wen, D. Zhang, G. Raabe, C. Bolm, J. Am. Chem. Soc. 2016, 138,
2166-2169. [41] a) W. Ried, M. A. Jacobi, Chem. Ber. 1988, 121, 1689-1692; b) W. Ried, M. A. Jacobi, Chem. Ber.
1988, 121, 383-386. [42] M. Haake, W. Jürgler, Z. Naturforsch. 1988, 43b, 763-768. [43] W. Ried, M. A. Jacobi, Chem. Ber. 1988, 121, 805-808. [44] W. Ried, M. A. Jacobi, Chem. Ber. 1987, 120, 1455-1459. [45] M. Haake, G. Georg, H. Fode, B. Eichenauer, K. H. D. Ahrens, I. Szelenyi, Pharm. Ztg. 1983, 128,
1529-1533. [46] M. Haake, H. Fode, B. Eichenauer, K. H. Ahrens, Ger. Offen. 2520230, 1976. [47] M. Candy, R. A. Bohmann, C. Bolm, Adv. Synth. Catal. 2012, 354, 2928-2932. [48] M. A. Schwartz, H. V. Wart, WO1995009620 A1, 1995. [49] a) Q.-X. A. Sang, M.-C. Jia, M. A. Schwartz, M. C. Jaye, H. K. Kleinman, M. A. Ghaffari, Y.-L. Luo,
Biochem. Biophys. Res. Commun. 2000, 274, 780-786; b) M.-C. Jia, M. A. Schwartz, Q. A. Sang, Adv. Exp. Med. Biol. 2000, 476, 181-194.
[50] U. Lücking, A. Scholz, P. Lienau, G. Siemeister, R. Bohlmann, U. Bömer, WO2015150273 A1, 2015.
[51] S. Joshi, L. C. Platanias, World J. Biol. Chem. 2014, 5, 321-333. [52] D. Wiedenmayer, A. Blum, D. Gottschling, A. Heckel, J. P. Hehn, WO2015091156 A1, 2015. [53] Y. Tamura, Y. Hinata, E. Kojima, H. Ozasa, WO2016031842 A1, 2016. [54] D. Gottschling, J. P. Hehn, C. Hoenke, E. Langkopf, WO2016113300 A1, 2016. [55] P. D. Lowder, D. T. Manning, J. L. Phillips, M. T. Pilato, T.-T. Wu, WO1996039389 A1, 1996. [56] a) P. D. Lowder, D. T. Manning, J. L. Phillips, M. T. Pilato, T.-T. Wu, US6136983 A, 2000; b) P. D.
Lowder, D. T. Manning, J. L. Phillips, M. T. Pilato, T.-T. Wu, US6060495 A, 2000; c) P. D. Lowder, D. T. Manning, J. L. Phillips, M. T. Pilato, T.-T. Wu, US6060502 A, 2000.
[57] P. Bindschädler, W. Von Deyn, K. Körber, F. Kaiser, R. Paulini, D. L. Culbertson, P. Neese, F. J. Braun, WO2013167633 A1, 2013.
[58] T. Pitterna, A. G. C. Richard, F. H. Ottmar, A. D. Stoller, M. J. P. Joseph, A. Edmunds, GB2520098 A, 2015.
[59] G. I. Georg, S. A. Pfeifer, M. Haake, Tetrahedron Lett. 1985, 26, 2739-2742. [60] a) M. Haake, H. Fode, B. Eichenauer, Liebigs Ann. Chem. 1972, 759, 107-113; b) M. Haake, H.
Fode, K. Ahrens, Z. Naturforsch. 1973, 28b, 539-540. [61] M. Haake, Angew. Chem. 1970, 82, 391; Angew. Chem. Int. Ed. Engl. 1970, 9, 373. [62] W. Ried, R. Pauli, Chem. Ber. 1985, 118, 2561-2564. [63] a) A. Stoller, K. Kreuz, M. Haake, J. Wenger, CHIMIA 2003, 57, 725-730; b) W. E. Diederich, M.
Haake, J. Org. Chem. 2003, 68, 3817-3830. [64] M. Haake, B. Eichenauer, K. H. Ahrens, Z. Naturforsch. 1974, 29b, 284-285. [65] M. Haake, W. Jürgler, R. Spreemann, Phosphorus Sulfur Silicon Relat. Elem. 1994, 95-96, 315-
316. [66] A. Stoller, M. Haake, H. Zondler, WO1996001814 A1, 1996. [67] W. Ried, M. A. Jacobi, Chem. Ber. 1986, 119, 1745-1749. [68] a) S. J. Shetty, G. D. Patel, B. B. Lohray, V. B. Lohray, G. Chakrabarti, A. Chatterjee, M. R. Jain, P.
R. Patel, WO2007077574 A2, 2007; b) U. Lücking, G. Siemeister, R. Jautelat, WO2006099974 A1, 2006.
A p p e n d i x | 151
[69] K. Tsukuda, S. Yamada, M. Yamaguchi, S. Kajita, Y. Miyashita, T. Tamai, K. Shibayama, WO2008035737 A1, 2008.
[70] C. Moessner, C. Bolm, Org. Lett. 2005, 7, 2667-2669. [71] R. A. Bohmann, C. Bolm, Org. Lett. 2013, 15, 4277-4279. [72] T. D. Quach, R. A. Batey, Org. Lett. 2003, 5, 4397-4400. [73] a) S. V. Ley, A. W. Thomas, Angew. Chem. 2003, 115, 5558-5607; Angew. Chem. Int. Ed. 2003,
42, 5400-5449; b) J. X. Qiao, P. Y. S. Lam, Synthesis 2011, 829-856. [74] L. Wang, H. Huang, D. L. Priebbenow, F. Pan, C. Bolm, Angew. Chem. 2013, 125, 3562-3564;
Angew. Chem. Int. Ed. 2013, 52, 3478-3480. [75] J. P. Wolfe, H. Tomori, J. P. Sadighi, J. Yin, S. L. Buchwald, J. Org. Chem. 2000, 65, 1158-1174. [76] G. Satzinger, P. Stoss, Arzneim.-Forsch. 1970, 20, 1214-1217. [77] B. A. Trofimov, Sulf. Rep. 1992, 11, 207-227. [78] H. Heaney, S. V. Ley, J. Chem. Soc., Perkin Trans. 1 1973, 499-500. [79] C. M. M. Hendriks, R. A. Bohmann, M. Bohlem, C. Bolm, Adv. Synth. Catal. 2014, 356, 1847-1852. [80] H. Baars, A. Beyer, S. V. Kohlhepp, C. Bolm, Org. Lett. 2014, 16, 536-539. [81] C. M. M. Hendriks, Doctoral thesis, RWTH Aachen University, 2016. [82] J.-H. Schöbel, Bachelor thesis, RWTH Aachen University, 2014. [83] R. A. Bohmann, J.-H. Schöbel, C. Bolm, Synlett 2016, 27, 2201-2204. [84] C. R. Johnson, C. J. Stark, Jr., J. Org. Chem. 1982, 47, 1193-1196. [85] a) M. Aldeghi, S. Malhotra, D. L. Selwood, A. W. E. Chan, Chem. Biol. Drug Des. 2014, 83, 450-
461; b) G. Klebe, in Wirkstoffdesign, Spektrum Akademischer Verlag, Heidelberg, 2009, pp 121-124.
[86] R. Dua, S. Shrivastava, S. K. Sonwane, S. K. Srivastava, Adv. Biol. Res. 2011, 5, 120-144. [87] a) T. Tsukamoto, ACS Med. Chem. Lett. 2013, 4, 369-370; b) S. D. Roughley, A. M. Jordan, J. Med.
Chem. 2011, 54, 3451-3479; c) J. Hert, J. J. Irwin, C. Laggner, M. J. Keiser, B. K. Shoichet, Nat.
Chem. Biol. 2009, 5, 479-483; d) G. W. Bemis, M. A. Murcko, J. Med. Chem. 1996, 39, 2887-2893. [88] a) S. M. Weinreb, R. K. Orr, in Comprehensive Heterocyclic Chemistry III, Vol. 8 (Eds.: A. R.
Katritzky, C. A. Ramsden, E. F. V. Scriven, R. J. K. Taylor), Elsevier, Oxford, 2008, pp 513-566; b) R. S. Garigipati, S. M. Weinreb, in Comprehensive Heterocyclic Chemistry II, Vol. 6 (Eds.: A. R. Katritzky, C. W. Rees, E. F. V. Scriven), Pergamon Press, Oxford, 1996, pp 349-382.
[89] a) M. Ikeda, H. Tsubouchi, M. Tsunekawa, H. Kondo, Y. Tamura, Chem. Pharm. Bull. 1984, 32, 3028-3035; b) T. Fujiwara, T. Hombo, K. Tomita, Y. Tamura, M. Ikeda, J. Chem. Soc., Chem.
Commun. 1978, 197-198. [90] a) A. C. Barnes, P. D. Kennewell, J. B. Taylor, J. Chem. Soc., Chem. Commun. 1973, 776-777; b) Y.
Tamura, M. Tsunekawa, T. Miyamoto, M. Ikeda, J. Org. Chem. 1977, 42, 602-608. [91] a) W. Ried, M. Saynovits, Chem. Ber. 1988, 121, 1005-1007; b) W. D. Rudorf, Synthesis 1983,
926-928; c) M. Watanabe, M. Minohara, K. Masuda, T. Kinoshita, S. Furukawa, Heterocycles
1976, 4, 1875-1880. [92] a) H. G. Bonacorso, S. R. T. Bittencourt, R. V. Lourega, A. F. C. Flores, N. Zanatta, M. A. P.
Martins, Synthesis 2000, 1431-1434; b) H. G. Bonacorso, R. P. Vezzosi, R. L. Drekener, N. Zanatta, M. A. P. Martins, Lett. Org. Chem. 2009, 6, 145-150.
[93] a) T. R. Williams, D. J. Cram, J. Am. Chem. Soc. 1971, 93, 7333-7335; b) T. R. Williams, D. J. Cram, J. Org. Chem. 1973, 38, 20-26.
[94] R. A. Bohmann, Y. Unoh, M. Miura, C. Bolm, Chem. Eur. J. 2016, 22, 6783-6786. [95] a) S. Roy, M. P. Davydova, R. Pal, K. Gilmore, G. A. Tolstikov, S. F. Vasilevsky, I. V. Alabugin, J.
Org. Chem. 2011, 76, 7482-7490; b) O. García Mancheño, O. Bistri, C. Bolm, Org. Lett. 2007, 9, 3809-3811; c) M. Harmata, K.-o. Rayanil, M. G. Gomes, P. Zheng, N. L. Calkins, S.-Y. Kim, Y. Fan, V. Bumbu, D. R. Lee, S. Wacharasindhu, X. Hong, Org. Lett. 2005, 7, 143-145; d) J. Kim, J. Ok, S. Kim, W. Choi, P. H. Lee, Org. Lett. 2014, 16, 4602-4605.
[96] C. Kaes, A. Katz, M. W. Hosseini, Chem. Rev. 2000, 100, 3553-3590. [97] G. Y. Cho, H. Okamura, C. Bolm, J. Org. Chem. 2005, 70, 2346-2349. [98] G. Song, F. Wang, X. Li, Chem. Soc. Rev. 2012, 41, 3651-3678.
152 | A p p e n d i x
[99] a) K. Nobushige, K. Hirano, T. Satoh, M. Miura, Org. Lett. 2014, 16, 1188-1191; b) K. Nobushige, K. Hirano, T. Satoh, M. Miura, Tetrahedron 2015, 71, 6506-6512; c) Y. Unoh, K. Hirano, T. Satoh, M. Miura, Org. Lett. 2015, 17, 704-707; d) K. Parthasarathy, C. Bolm, Chem. Eur. J. 2014, 20, 4896-4900; e) W. Dong, K. Parthasarathy, Y. Cheng, F. Pan, C. Bolm, Chem. Eur. J. 2014, 20, 15732-15736; f) W. Dong, L. Wang, K. Parthasarathy, F. Pan, C. Bolm, Angew. Chem. 2013, 125, 11787-11790; Angew. Chem. Int. Ed. 2013, 52, 11573-11576; g) Y. Cheng, C. Bolm, Angew.
Chem. 2015, 127, 12526-12529; Angew. Chem. Int. Ed. 2015, 54, 12349-12352; h) Y. Yokoyama, Y. Unoh, R. A. Bohmann, T. Satoh, K. Hirano, C. Bolm, M. Miura, Chem. Lett. 2015, 44, 1104-1106.
[100] J. G. Lombardino, D. E. Kuhla, in Adv. Heterocycl. Chem., Vol. 28 (Eds.: A. R. Katritzky, A. J. Boulton), Academic Press, 1981, pp 73-126.
[101] a) P. Stoss, G. Satzinger, Ger. Offen. 2207235, 1973; b) P. Stoss, G. Satzinger, US3803131 A, 1974.
[102] P. Stoss, G. Satzinger, Chem. Ber. 1972, 105, 2575-2583. [103] A. Garimallaprabhakaran, X. Hong, M. Harmata, ARKIVOC 2012, 119-128. [104] D.-G. Yu, F. de Azambuja, F. Glorius, Angew. Chem. 2014, 126, 2792-2796; Angew. Chem. Int. Ed.
2014, 53, 2754-2758. [105] N. L. Snyder, E. J. Medici, in C‒H Bond Activation in Organic Synthesis (Ed.: J. J. Li), CRC Press,
Boca Raton, 2015, pp 217-250. [106] W. H. Jeon, J.-Y. Son, J. E. Kim, P. H. Lee, Org. Lett. 2016, 18, 3498-3501. [107] D. F. Shriver, M. A. Drezdzon, The Manipulation of Air-Sensitive Compounds, 2 ed., Wiley, New
York, 1986. [108] W. L. F. Armarego, C. L. L. Chai, Purification of Laboratory Chemicals, 5 ed., Elsevier, Oxford,
2003. [109] Y. Tamura, J. Minamikawa, K. Sumoto, S. Fujii, M. Ikeda, J. Org. Chem. 1973, 38, 1239-1241. [110] N. D. Koduri, Z. Wang, G. Cannell, K. Cooley, T. M. Lemma, K. Miao, M. Nguyen, B. Frohock, M.
Castaneda, H. Scott, D. Albinescu, S. R. Hussaini, J. Org. Chem. 2014, 79, 7405-7414. [111] H. Kikui, K. Moriyama, H. Togo, Synthesis 2013, 45, 791-797. [112] H. Arnold, Fortschr. chem. Forsch. 1966, 7, 196-232. [113] A. Fensome, J. A. Goldberg, C. C. McComas, C. W. Mann, E. G. Melenski, J. P. Sabatucci, R. P.
Woodworth, Jr., WO2008073956 A3, 2008.